
<html lang="en"     class="pb-page"  data-request-id="7dc342ef-b656-49ed-9f34-5a28820f0d7f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.9b00413;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-14;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity" /></meta><meta name="dc.Creator" content="Yongzhi  Gao" /></meta><meta name="dc.Creator" content="Matthijs J.  van Haren" /></meta><meta name="dc.Creator" content="Ed E.  Moret" /></meta><meta name="dc.Creator" content="Johannes J. M.  Rood" /></meta><meta name="dc.Creator" content="Davide  Sartini" /></meta><meta name="dc.Creator" content="Alessia  Salvucci" /></meta><meta name="dc.Creator" content="Monica  Emanuelli" /></meta><meta name="dc.Creator" content="Pierrick  Craveur" /></meta><meta name="dc.Creator" content="Nicolas  Babault" /></meta><meta name="dc.Creator" content="Jian  Jin" /></meta><meta name="dc.Creator" content="Nathaniel I.  Martin" /></meta><meta name="dc.Description" content="Nicotinamide N-methyltransferase (NNMT) catalyzes the methylation of nicotinamide to form N-methylnicotinamide. Overexpression of NNMT is associated with a variety of diseases, including a number o..." /></meta><meta name="Description" content="Nicotinamide N-methyltransferase (NNMT) catalyzes the methylation of nicotinamide to form N-methylnicotinamide. Overexpression of NNMT is associated with a variety of diseases, including a number o..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 2, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00413" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00413" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00413" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00413" /></link>
        
    
    

<title>Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00413" /></meta><meta property="og:title" content="Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0012.jpeg" /></meta><meta property="og:description" content="Nicotinamide N-methyltransferase (NNMT) catalyzes the methylation of nicotinamide to form N-methylnicotinamide. Overexpression of NNMT is associated with a variety of diseases, including a number of cancers and metabolic disorders, suggesting a role for NNMT as a potential therapeutic target. By structural modification of a lead NNMT inhibitor previously developed in our group, we prepared a diverse library of inhibitors to probe the different regions of the enzyme’s active site. This investigation revealed that incorporation of a naphthalene moiety, intended to bind the hydrophobic nicotinamide binding pocket via π–π stacking interactions, significantly increases the activity of bisubstrate-like NNMT inhibitors (half-maximal inhibitory concentration 1.41 μM). These findings are further supported by isothermal titration calorimetry binding assays as well as modeling studies. The most active NNMT inhibitor identified in the present study demonstrated a dose-dependent inhibitory effect on the cell proliferation of the HSC-2 human oral cancer cell line." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00413"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00413">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00413&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00413&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00413&amp;href=/doi/10.1021/acs.jmedchem.9b00413" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6597-6614</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00362" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00454" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Bisubstrate Inhibitors of Nicotinamide <i>N</i>-Methyltransferase (NNMT) with Enhanced Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yongzhi Gao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yongzhi Gao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yongzhi++Gao">Yongzhi Gao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthijs J. van Haren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthijs J. van Haren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthijs+J.++van+Haren">Matthijs J. van Haren</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ed E. Moret</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ed E. Moret</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology & Drug Discovery Group, Utrecht Institute for Pharmaceutical Sciences, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ed+E.++Moret">Ed E. Moret</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Johannes J. M. Rood</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Johannes J. M. Rood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacoepidemiology & Clinical Pharmacology Group, Utrecht Institute for Pharmaceutical Sciences, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Johannes+J.+M.++Rood">Johannes J. M. Rood</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Davide Sartini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Davide Sartini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Sciences, Universitá Politecnica delle Marche, Via Ranieri 65, 60131 Ancona, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Davide++Sartini">Davide Sartini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessia Salvucci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessia Salvucci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Sciences, Universitá Politecnica delle Marche, Via Ranieri 65, 60131 Ancona, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessia++Salvucci">Alessia Salvucci</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Monica Emanuelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Monica Emanuelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Sciences, Universitá Politecnica delle Marche, Via Ranieri 65, 60131 Ancona, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Emanuelli">Monica Emanuelli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pierrick Craveur</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pierrick Craveur</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info"> Synsight, Genopole Entreprises, 4 Rue Pierre Fontaine, 91000 Évry, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pierrick++Craveur">Pierrick Craveur</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicolas Babault</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicolas Babault</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info"> Synsight, Genopole Entreprises, 4 Rue Pierre Fontaine, 91000 Évry, France</div><div class="loa-info-affiliations-info">Center for Chemical Biology and Drug Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Babault">Nicolas Babault</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jian Jin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Chemical Biology and Drug Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Jin">Jian Jin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2387-3862" title="Orcid link">http://orcid.org/0000-0002-2387-3862</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Nathaniel I. Martin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nathaniel I. Martin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#f19fdf98df9c908385989fb193989e9d9e9688df9d949895949f849f9887df9f9d"><span class="__cf_email__" data-cfemail="0d63236423606c7f7964634d6f646261626a74236168646968637863647b236361">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nathaniel+I.++Martin">Nathaniel I. Martin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8246-3006" title="Orcid link">http://orcid.org/0000-0001-8246-3006</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00413&amp;href=/doi/10.1021%2Facs.jmedchem.9b00413" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6597–6614</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 2, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 March 2019</li><li><span class="item_label"><b>Published</b> online</span>2 July 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 July 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00413" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00413</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by-nc text">with CC-BY-NC-ND<a href="/page/policy/authorchoice_ccbyncnd_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00413"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3634</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00413" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yongzhi&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Matthijs&quot;,&quot;last_name&quot;:&quot;J. van Haren&quot;},{&quot;first_name&quot;:&quot;Ed&quot;,&quot;last_name&quot;:&quot;E. Moret&quot;},{&quot;first_name&quot;:&quot;Johannes&quot;,&quot;last_name&quot;:&quot;J. M. Rood&quot;},{&quot;first_name&quot;:&quot;Davide&quot;,&quot;last_name&quot;:&quot;Sartini&quot;},{&quot;first_name&quot;:&quot;Alessia&quot;,&quot;last_name&quot;:&quot;Salvucci&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Emanuelli&quot;},{&quot;first_name&quot;:&quot;Pierrick&quot;,&quot;last_name&quot;:&quot;Craveur&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Babault&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Nathaniel&quot;,&quot;last_name&quot;:&quot;I. Martin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6597-6614&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00413&quot;},&quot;abstract&quot;:&quot;Nicotinamide N-methyltransferase (NNMT) catalyzes the methylation of nicotinamide to form N-methylnicotinamide. Overexpression of NNMT is associated with a variety of diseases, including a number of cancers and metabolic disorders, suggesting a role for NNMT as a potential therapeutic target. By structural modification of a lead NNMT inhibitor previously developed in our group, we prepared a diverse library of inhibitors to probe the different regions of the enzyme’s active site. This investigation revealed that incorporation of a naphthalene moiety, intended to bind the hydrophobic nicotinamide binding pocket via π–π stacking interactions, significantly increases the activity of bisubstrate-like NNMT inhibitors (half-maximal inhibitory concentration 1.41 μM). These findings are further supported by isothermal titration calorimetry binding assays as well as modeling studies. The most active NNMT inhibitor identified in the present study demonstrated a dose-dependent inhibitory effect on the cell proliferation&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00413&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00413" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00413&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00413" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00413&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00413" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00413&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00413&amp;href=/doi/10.1021/acs.jmedchem.9b00413" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00413" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00413" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00413%26sid%3Dliteratum%253Aachs%26pmid%3D31265285%26genre%3Darticle%26aulast%3DGao%26date%3D2019%26atitle%3DBisubstrate%2BInhibitors%2Bof%2BNicotinamide%2BN-Methyltransferase%2B%2528NNMT%2529%2Bwith%2BEnhanced%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D14%26spage%3D6597%26epage%3D6614%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292236" title="Aldehydes">Aldehydes</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/jmcmar.2019.62.issue-14/20190725/jmcmar.2019.62.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nicotinamide <i>N</i>-methyltransferase (NNMT) catalyzes the methylation of nicotinamide to form <i>N</i>-methylnicotinamide. Overexpression of NNMT is associated with a variety of diseases, including a number of cancers and metabolic disorders, suggesting a role for NNMT as a potential therapeutic target. By structural modification of a lead NNMT inhibitor previously developed in our group, we prepared a diverse library of inhibitors to probe the different regions of the enzyme’s active site. This investigation revealed that incorporation of a naphthalene moiety, intended to bind the hydrophobic nicotinamide binding pocket via π–π stacking interactions, significantly increases the activity of bisubstrate-like NNMT inhibitors (half-maximal inhibitory concentration 1.41 μM). These findings are further supported by isothermal titration calorimetry binding assays as well as modeling studies. The most active NNMT inhibitor identified in the present study demonstrated a dose-dependent inhibitory effect on the cell proliferation of the HSC-2 human oral cancer cell line.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nicotinamide <i>N</i>-methyltransferase (NNMT) is an important metabolic enzyme that catalyzes the transfer of a methyl group from the cofactor, <i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine (SAM), onto its various substrates, most notably nicotinamide (NA) and other pyridines, to form 1-methyl-nicotinamide (MNA) or the corresponding pyridinium ions.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> The past decade has seen a renewed interest in the biological function of NNMT in a range of human diseases. While it was previously assumed that NNMT’s primary roles were limited to nicotinamide metabolism and xenobiotic detoxification of endogenous metabolites, broader roles of NNMT in human health and disease are becoming clearer.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> NNMT has been found to be overexpressed in a variety of diseases, including metabolic disorders,<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> cardiovascular disease,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> cancer,<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10−14)</a> and Parkinson’s disease.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> In general, overexpression of NNMT has been linked to disease progression in the aforementioned afflictions, with the exception of its role in Parkinson’s disease where NNMT seems to be neuroprotective.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Collectively, NNMT appears to play a unique role in the regulation of post-translational modifications and signal transduction, making it an attractive and viable therapeutic target.</div><div class="NLM_p">Despite the growing interest, few small-molecule NNMT inhibitors have been described to date. Among these structures, the product of the enzymatic reaction, MNA, is a known inhibitor of NNMT and has generally been used in biochemical activity assays.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Recently, Cravatt and co-workers reported chloroacetamide-based covalent NNMT inhibitors that react with cysteine C165 in the SAM-binding pocket of the enzyme.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Notably, Sanofi researchers have also recently reported a series of nicotinamide analogues that inhibit NNMT activity, leading to decreased MNA production, stabilization of insulin levels, glucose regulation, and weight loss in mouse models of metabolic disorders.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> In another approach, the group of Watowich focused on the development of inhibitors based on NNMT’s alternative substrate, quinoline. Their compounds showed improvement of symptoms in diet-induced obese mice.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Previous work in our group has focused on bisubstrate inhibitors designed to mimic the transition state of the methylation reaction catalyzed by NNMT with compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) showing activity on par with the known general methyltransferase inhibitor, sinefungin.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic overview of the design strategy of the second generation of inhibitors based on trivalent bisubstrate compounds 1<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and 2.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Designing bisubstrate analogues as inhibitors is an established and effective strategy that has been applied to a range of methyltransferase enzymes, including catechol <i>O</i>-methyltransferase,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> histone lysine methyltransferases,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> arginine methyltransferases,<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28−30)</a> and more recently nicotinamide <i>N</i>-methyltransferase.<a onclick="showRef(event, 'ref24 ref31'); return false;" href="javascript:void(0);" class="ref ref24 ref31">(24,31)</a> A recently published co-crystal structure of a bisubstrate inhibitor bound to NNMT [Protein Data Bank (PDB) ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CHH">6CHH</a>] clearly delineates key interactions with residues in the enzyme active site, providing valuable information for further optimization of improved bisubstrate-like inhibitors.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The work here described builds on our previous findings for “trivalent” inhibitor <b>1</b>, which is assumed to simultaneously bind in the adenosine, amino acid, and nicotinamide binding pockets of the NNMT active site. Based on insights provided by recent NNMT crystal structures, we have designed new inhibitors, wherein the nicotinamide moiety is replaced by other aromatic substituents accompanied by variation in the length of the linker connecting the amino acid moiety. Based on the high conservation of the residues in the adenosine binding pocket, no changes were made to the adenosine group. A schematic overview of the design strategy is presented in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design</h3><div class="NLM_p last">The ternary crystal structure of NNMT (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ROD">3ROD</a>) reveals the interactions of nicotinamide and <i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-homocysteine (SAH) with the active site residues.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The active site can be roughly divided into three binding regions for the adenosine group, the amino acid moiety, and the nicotinamide unit. The starting point was a trivalent bisubstrate compound, <b>1</b>, which was designed to bind all three binding regions. To find the optimal substitutions, a systematic approach was applied, where variations were made to the nicotinamide mimic on the one hand and the amino acid moiety on the other. The benzamide group, representing nicotinamide, was also replaced by methyl benzoate or benzoic acid moieties. Notably, the crystal structure of the NNMT–nicotinamide–SAH ternary complex reveals π–π stacking between tyrosine (Tyr) residue Y204 and the nicotinamide substrate.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> We, therefore, also prepared an analogue bearing a naphthalene unit in the presumed nicotinamide position with the aim of introducing stronger π–π stacking with the tyrosine residues of the NNMT active site. We also explored variation of the amino acid moiety as part of our design strategy: in some analogues the amine of the amino acid unit was omitted to reduce charge and in others the carboxylic acid was replaced by the corresponding primary amide. In addition, variation in the length of the carbon chain linking the amino acid moiety was examined. Furthermore, inspired by the structure of histone methyltransferase DOTL1 inhibitor pinometostat,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we also investigated the incorporation of an isopropyl group to replace the amino acid moiety entirely.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">Key aldehyde intermediates (compounds <b>6</b>, <b>8</b>, <b>9</b>, <b>16</b>, <b>17</b>, <b>22</b>, <b>23</b>, <b>27</b>, and <b>28</b>) required for the synthesis of the various bisubstrate analogues pursued were prepared from commercially available materials, in good overall yields, as summarized in <a class="ref internalNav" href="#sch1" aria-label="scheme 1">scheme 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The trivalent inhibitors were then prepared via a convenient double-reductive amination strategy starting from the commercially available 2′-3′-<i>O</i>-isopropylidene-6-aminomethyl-adenosine starting material and the corresponding aldehydes (<a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Aldehydes <b>6</b>, <b>8</b>, and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, MeOH, room temperature (rt), 16 h (95%); (b) (i) SOCl<sub>2</sub>, reflux, 2 h, (ii) tritylamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h (72%); (c) diisobutylaluminum hydride (DIBAL-H), −78 °C to rt, 2 h (85%); (d) pyridinium dichromate (PDC), CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (53–64%); (e) NaBH<sub>4</sub>, BF<sub>3</sub>.Et<sub>2</sub>O, tetrahydrofuran (THF), 0 °C to rt, 2 h (89%); (f) LiOH, THF/H<sub>2</sub>O (2:1); (g) 2-<i>tert</i>-butyl-1,3-diisopropylisourea, CH<sub>2</sub>Cl<sub>2</sub>, <i>tert</i>-butanol (39% over two steps).</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Aldehydes <b>16</b>, <b>17</b>, <b>22</b>, and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TrtCl, CH<sub>3</sub>CN, K<sub>2</sub>CO<sub>3</sub>, rt, 48 h (20–28%); (b) KOH, EtOH, reflux, overnight (37–93%) (c) NaBH<sub>4</sub>, BF<sub>3</sub>·Et<sub>2</sub>O, THF, 0 °C to rt, 2 h (64–81%); (d) PDC, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (65–78%); (e) <i>tert</i>-butanol, 4-dimethylaminopyridine (DMAP), <i>N</i>-hydroxysuccinimide, Et<sub>3</sub>N, toluene, overnight (25–93%).</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Aldehydes <b>27</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>3</sub>NHOCH<sub>3</sub>·HCl, BOP, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (85–88%); (b) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub> (94%); (c) DIBAL-H in hexanes (1 M), THF, −78 °C, assumed quant.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Intermediate Compounds <b>29</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH(OAc)<sub>3</sub>, AcOH, 1,2-dichloroethane (DCE), rt, overnight (50–74%).</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Representative Scheme for the Synthesis of the Final Compounds; Shown for Compounds <b>1</b> and <b>57</b>–<b>61</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>The same procedure was used starting from aldehydes <b>30</b>–<b>32</b> to form intermediate compounds <b>39</b>–<b>56</b> and <b>80</b> and final compounds <b>62</b>–<b>79</b> and <b>81</b> as detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Reagents and conditions: (a) aldehyde, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, overnight (49–77%); (b) (i) trifluoroacetyl (TFA), CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, (ii) H<sub>2</sub>O, rt, 30 min (47–73%).</p></p></figure><div class="NLM_p">The preparation of aromatic aldehydes <b>6</b>, <b>8</b>, and <b>9</b> began with the selective mono-deprotection of dimethyl isophthalate using sodium hydroxide (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Monomethyl isophthalate (<b>3</b>) was subsequently transformed into trityl-protected amide <b>4</b> using tritylamine via its acid chloride intermediate and reduced by diisobutylaluminum hydride (DIBAL-H) to give alcohol <b>5</b>. The alcohol was oxidized to aldehyde <b>6</b> using pyridinium dichromate (PDC). For aldehydes <b>8</b> and <b>9</b>, the carboxylic acid of <b>3</b> was selectively reduced using a mixture of sodium borohydride and boron trifluoride diethyl etherate.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The resulting alcohol (<b>7</b>) was oxidized using PDC to yield the corresponding aldehyde (<b>8</b>). Following hydrolysis of the methyl ester in <b>8</b> and subsequent conversion to the <i>tert</i>-butyl ester, aldehyde <b>9</b> was obtained.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Aliphatic aldehydes <b>16</b> and <b>17</b> containing trityl-protected amide functionalities were prepared from succinimide and glutarimide, respectively (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The cyclic amides were first trityl-protected and subsequently ring-opened using potassium hydroxide. Reduction to the corresponding alcohols and oxidization using PDC gave aldehydes <b>16</b> and <b>17</b>.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> In an analogous fashion, aldehydes <b>22</b> and <b>23</b>, both containing <i>tert</i>-butyl ester moieties, were prepared by ring opening of succinic or glutaric anhydride with <i>tert</i>-butyl alcohol to obtain mono-esters <b>18</b> and <b>19</b>.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> The carboxylic acid functionalities were reduced to alcohols <b>20</b> and <b>21</b> and then oxidized using PDC to yield aldehydes <b>22</b> and <b>23</b>.</div><div class="NLM_p">Aldehydes <b>27</b> and <b>28</b>, both containing protected amino acid functionalities, were prepared starting from the appropriately protected aspartic acid and glutamic acid building blocks (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Conversion of the side chain carboxylates to their corresponding Weinreb amides yielded intermediates <b>24</b> and <b>25</b>. Reduction of aspartate-derived <b>24</b> with DIBAL-H gave amino acid aldehyde <b>27</b> in high yield. For the preparation of aldehyde <b>28</b>, a similar route was followed with the addition of a second Boc-protection of intermediate <b>25</b> to avoid an intramolecular cyclization side reaction.<a onclick="showRef(event, 'ref24 ref41'); return false;" href="javascript:void(0);" class="ref ref24 ref41">(24,41)</a></div><div class="NLM_p last">With the necessary aldehyde building blocks in hand, assembly of the bisubstrate inhibitors was performed in each case starting from commercially available 2′-3′-<i>O</i>-isopropylidene-6-aminomethyl-adenosine (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Using a reliable reductive amination approach, aromatic aldehydes <b>6</b>, <b>8</b>, and <b>9</b>, and commercially available 2-naphthaldehyde were each coupled to the protected adenosine species to yield intermediates <b>29</b>–<b>32</b>. These intermediates were next connected with aliphatic aldehydes <b>16</b>, <b>17</b>, <b>22</b>, <b>23</b>, <b>27</b>, and <b>28</b> or acetone via a second reductive amination step to give the corresponding protected tertiary amine intermediates <b>33</b>–<b>56</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Global deprotection of the acid-labile protecting groups was carried out in CH<sub>2</sub>Cl<sub>2</sub>/TFA (1:1) with isopropylidene group cleavage facilitated by subsequent addition of water. The crude products were purified by preparative high-performance liquid chromatography (HPLC) to yield bisubstrate analogues <b>1</b> and <b>57</b>–<b>60</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Inhibition Studies</h3><div class="NLM_p">The bisubstrate analogues were next tested for their NNMT inhibitory activity using a method recently developed in our group.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This assay employs ultra-high-performance (UHP) hydrophilic liquid interaction chromatography (HILIC) coupled to quadrupole time-of-flight mass spectrometry (Q-TOF-MS) to rapidly and efficiently assess NNMT inhibition by analysis of the formation of MNA. The NNMT inhibition of all compounds was initially screened at a fixed concentration of 250 μM for all of the compounds. In cases where at least 50% inhibition was detected at this concentration, full inhibition curves were measured in triplicate to determine the corresponding half-maximal inhibitory concentration (IC<sub>50</sub>) values. As reference compounds, we included the well-established and general methyltransferase inhibitors sinefungin and SAH. In addition, we also synthesized two recently described NNMT inhibitors, compound <b>2</b> and 6-(methylamino)-nicotinamide, following the procedures described in the corresponding publications.<a onclick="showRef(event, 'ref21 ref31'); return false;" href="javascript:void(0);" class="ref ref21 ref31">(21,31)</a> The structures of these reference compounds are provided in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of the reference compounds used in NNMT inhibition studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The results of the NNMT inhibition studies are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and clearly show that only minor adjustments to the functional groups found in the enzyme’s natural substrates are tolerated. Among the compounds studied, the most potent inhibition was observed when the aliphatic moiety corresponded to the same length in the amino acid side chain as present in the methyl donor SAM. Notably, the preferred aromatic moiety was found to be the naphthalene group, an apparent confirmation of our hypothesis that increased π–π stacking can lead to enhanced binding in the nicotinamide pocket. The bisubstrate analogue containing both of these elements (compound <b>78</b>), displayed the highest inhibitory activity against NNMT with an IC<sub>50</sub> of 1.41 μM. Interestingly, the amino acid and naphthyl moieties were also found to independently enhance the activity of the other inhibitors prepared. In this way, a suboptimal moiety at one position can be compensated for—to an extent—by including either the SAM amino acid motif or the naphthalene unit at the other position. For example, bisubstrate analogues containing the benzamide, benzoic acid, or methyl benzoate groups only show inhibitory activity if they also contain the amino acid motif (compounds <b>1</b>, <b>2</b>, <b>66</b>, and <b>72</b>) with IC<sub>50</sub> values of 4.36–23.4 μM, respectively. On the other hand, among the bisubstrate analogues lacking the amino acid motif, inclusion of the naphthalene moiety (compounds <b>74</b>–<b>79</b>) enhances NNMT inhibition, albeit with moderate IC<sub>50</sub> values in the range of 52.6–129.9 μM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Tabulated Overview of the Chemical Structures and Inhibition Results of the Final Compounds and Reference Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Assays performed in triplicate on at least six different inhibitor concentrations. Standard errors of the mean reported.</p></div></div><div></div></div><div class="NLM_p">Other notable findings were the results obtained with the reference compounds. The general methyltransferase inhibitors, sinefungin and SAH, showed inhibitory activities in line with those previously reported.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Interestingly, the 6-methylamino-NA compound, recently described by Sanofi to be a submicromolar inhibitor,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> gave an IC<sub>50</sub> of 19.8 μM in our assay. The recently published bisubstrate analogue <b>2</b> exhibited good activity (IC<sub>50</sub> 4.4 μM) on par with published values.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Given the potent inhibition measured for both compounds <b>2</b> and <b>78</b>, we also prepared and tested compound <b>81</b>, an analogue of <b>78</b> bearing the same naphthyl moiety but with the amino acid motif containing an additional methylene unit as in <b>2</b>. Somewhat surprisingly, this linker elongation resulted in a complete loss of inhibitory activity (IC<sub>50</sub> > 250 μM).</div><div class="NLM_p last">To gain insight into the selectivity of compound <b>78</b>, we also tested its activity against representative members of both the arginine and lysine families of methyltransferases, PRMT1 and NSD2, respectively. In both cases, compound <b>78</b> was tested at a concentration of 50 μM and showed no significant inhibition (>50% of the enzyme’s activity remained), see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf" class="ext-link">Table S1</a>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Isothermal Titration Calorimetry (ITC) Binding Studies</h3><div class="NLM_p">To further evaluate the binding interactions of the most active bisubstrate analogues with NNMT, isothermal titration calorimetry (ITC) studies were performed. Compounds <b>1</b>, <b>66</b>, <b>72</b>, and <b>78</b>, all containing the amino acid moiety but with varying aromatic substituents, were investigated. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the dissociation constants (<i>K</i><sub>d</sub>) measured for these compounds track very well with the IC<sub>50</sub> values measured in the in vitro assay. Compounds <b>1</b> and <b>66</b> display similar binding to NNMT with <i>K</i><sub>d</sub> values of 36 and 25 μM, respectively, whereas compound <b>72</b> binds less tightly with a <i>K</i><sub>d</sub> of 124 μM. In good agreement with the results of the inhibition assay, the most active inhibitor, compound <b>78</b>, also displayed the highest binding affinity for NNMT with a <i>K</i><sub>d</sub> of 5.6 μM. As expected, the inhibitors were each found to bind the enzyme with a 1:1 stoichiometry.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ITC isotherms and thermograms including thermodynamic binding parameters measured for compounds <b>1</b>, <b>66</b>, <b>72</b>, and <b>78</b> with human NNMT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Modeling Studies</h3><div class="NLM_p">To further investigate the way in which the inhibitors bind within the NNMT active site, modeling studies were performed. Working from the available crystal structure of the NNMT protein bounded to nicotinamide and SAH (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ROD">3ROD</a>),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> compounds <b>1</b>, <b>2</b>, <b>78</b>, and <b>81</b> were modeled in the binding pocket. In an attempt to explain the significant difference in the activity of <b>78</b> and <b>81</b>, additional molecular dynamic simulations were also performed for compounds <b>1</b>, <b>2</b>, <b>78</b>, and <b>81</b>. Although these simulations suggest differences in the binding interaction of the compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf" class="ext-link">Figure S1</a>, Supporting Information), the calculated binding energies for each are all very similar (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf" class="ext-link">Table S2</a>, Supporting Information). In terms of their active site orientations, compounds <b>1</b>, <b>2</b>, <b>78</b>, and <b>81</b> are all predicted to position their three branches roughly in the same regions of the active site; however, their orientations and interactions are quite different.</div><div class="NLM_p">From the modeling data, two distinct features are apparent. First, when the chain linking the amino acid moiety is shorter (as in compounds <b>1</b> and <b>78</b>), the formation of an intramolecular hydrogen bond interaction was observed between the carboxylate of the amino acid moiety and the protonated tertiary amine (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). This intramolecular interaction is highly stable for compound <b>78</b> and less stable for compound <b>1</b>. This additional interaction reduces the entropic energy of the ligand, thereby potentially stabilizing its binding, and re-orients the amino acid part in the pocket, preventing the polar interactions with neighboring residues (e.g., Y25, D61, Y69, and T163) observed when the chain is longer (as present in compounds <b>2</b> and <b>81</b>). This intramolecular hydrogen bond may explain the difference in activity observed between compounds <b>78</b> and <b>81</b>. The second distinct feature is the tyrosine-rich environment around the naphthalene moiety of <b>78</b> compared to the nicotinamide unit of <b>1</b>. The orientation of the tyrosine residues surrounding this part of the molecule leads to π–π stacking interactions with the naphthalene and hints at an explanation for the strong inhibition and high affinity of compound <b>78</b> with the NNMT protein (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Modeling results for compound <b>78</b> in the NNMT active site (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ROD">3ROD</a>). Molecular dynamics simulation indicates the presence of an intramolecular hydrogen bond (2.7 Å, shown in cyan) specific to compound <b>78</b> (in green) that would be expected to reduce the entropic energy of the ligand and potentially stabilize binding to NNMT (in white). Proposed intermolecular hydrogen bond network (in yellow) and π–π stacking interactions with Tyr residues (in purple) stabilize compound <b>78</b> in the NNMT active site (hydrogens omitted for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Cell-Based Assays</h4><div class="NLM_p">To evaluate the cellular activity of the bisubstrate inhibitors, the compounds were tested for their effect on cell proliferation in the human oral cancer cell line, HSC-2. We recently found that NNMT expression levels are high in this particular cell line and may contribute to its proliferation and tumorigenic capacity.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, there were no significant differences in the cell proliferation rate between HSC-2 cells treated with dimethyl sulfoxide (DMSO) at 0.1% concentration and cells grown with only the culture medium, at any time of each performed assay. Upon treatment with the NNMT inhibitors, cell proliferation was not significantly inhibited by compounds <b>1</b>, <b>2</b>, and <b>81</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In contrast, relative to the DMSO control, treatment with compound <b>78</b> led to a notable decrease in cell proliferation. In particular, cell proliferation was significantly (<i>p</i> < 0.05) inhibited by compound <b>78</b> at 10 μM (20% reduction), 50 μM (21% reduction), and 100 μM (27% reduction) concentrations, 48 h after treatment. Interestingly, at the longest 72 h time point taken, treatment with compound <b>78</b> leads to an even greater and significant (<i>p</i> < 0.01) decrease in cell proliferation (44% reduction), at the highest concentration (100 μM) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Results of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) cell viability assay on HSC-2 human oral cancer cells. Only compound <b>78</b> showed a significant effect on cell proliferation after 48 and 72 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We next investigated the effect of compound <b>78</b> on cellular NNMT activity by assessing its impact on MNA production in the same HSC-2 cell line. Cells were treated with 100 μM of <b>78</b>, and MNA levels were determined after 0, 1, 2, and 3 days. Cells treated with compound <b>78</b> show a significant (<i>p</i> < 0.01) decrease in the levels of MNA (50% reduction) compared to controls after 48 h. Interestingly, at 72 h an increase in cellular MNA production was detected; however, the same effect was also observed in the DMSO control (but not in the untreated control), suggesting an effect attributable to longer term DMSO exposure. The results of the cellular MNA analysis are presented in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf" class="ext-link">Figure S2</a>, Supporting Information.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Building from our earlier findings with first reported ternary bisubstrate NNMT inhibitor <b>1</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> we designed and prepared a focused library of novel inhibitors to provide new structure–activity insights. In doing so, various structural motifs were investigated for their ability to enhance inhibitor activity and binding within the NNMT active site. By probing the SAM and NA binding pockets with different spacers and functional groups, we found that the optimal ligands are the endogenous amino acid side chain and the naphthalene moiety. Among the naphthalene-containing bisubstrate analogues prepared, compound <b>78</b> showed the most potent NNMT inhibition. In this way, the activity of our initial NNMT inhibitor <b>1</b> (IC<sub>50</sub> 14.9 μM) was improved 10-fold with compound <b>78</b>, displaying an IC<sub>50</sub> value of 1.41 μM. Notably, using an assay designed to directly measure NNMT product formation, compound <b>78</b> was shown to be more potent than most other NNMT inhibitors reported to date. ITC-based binding studies provided additional insights into the affinity of the inhibitors for the enzyme with the measured <i>K</i><sub>d</sub> value following a trend similar to that observed for the IC<sub>50</sub> data obtained in the in vitro inhibition assays. From modeling studies, the improved activity of compound <b>78</b> can be rationalized by the apparent presence of an intramolecular hydrogen bonding interaction predisposing the compound to an active conformation with lower entropic cost. In addition, the modeling indicates that the naphthalene group in <b>78</b> is properly oriented so as to benefit from additional π–π stacking interactions with several tyrosine residues in the nicotinamide binding pocket of the enzyme. The cellular data obtained for compound <b>78</b> show a significant inhibitory effect on cell proliferation in HSC-2 oral cancer cells. These promising results provide important new insights for the design and further optimization of potent NNMT inhibitors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedures</h3><div class="NLM_p last">All reagents employed were of American Chemical Society grade or finer and were used without further purification unless otherwise stated. For compound characterization, <sup>1</sup>H NMR spectra were recorded at 400 MHz with chemical shifts reported in parts per million downfield relative to tetramethylsilane, H<sub>2</sub>O (δ 4.79), CHCl<sub>3</sub> (7.26), or DMSO (δ 2.50). <sup>1</sup>H NMR data are reported in the following order: multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; and m, multiplet), coupling constant (<i>J</i>) in hertz (Hz) and the number of protons. Where appropriate, the multiplicity is preceded by br, indicating that the signal was broad. <sup>13</sup>C NMR spectra were recorded at 101 MHz with chemical shifts reported relative to CDCl<sub>3</sub> (δ 77.16), methanol (δ 49.00), or DMSO (δ 39.52). The <sup>13</sup>C NMR spectra of the compounds recorded in D<sub>2</sub>O could not be referenced. High-resolution mass spectrometry (HRMS) analysis was performed using a Q-TOF instrument. Compounds <b>1</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><b>2</b>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><b>3</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><b>7</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><b>8</b>,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><b>9</b>,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a><b>10</b>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><b>12</b>,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a><b>14</b>,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a><b>16</b>,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a><b>18</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><b>19</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><b>20</b>,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a><b>21</b>,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a><b>22</b>,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><b>23</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><b>24</b>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a><b>25</b>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a><b>26</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a><b>27</b>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and <b>28</b><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> were prepared as previously described and had NMR spectra and mass spectra consistent with the assigned structures. Purity was confirmed to be ≥95% by analytical reversed-phase HPLC using a Phenomenex Kinetex C18 column (5 μm, 250 × 4.6 mm<sup>2</sup>) eluted with a water–acetonitrile gradient moving from 0 to 100% CH<sub>3</sub>CN (0.1% TFA) in 30 min. The compounds were purified via preparative HPLC using a ReproSil-Pur C18-AQ column (10 μm, 250 × 22 mm<sup>2</sup>) eluted with a water–acetonitrile gradient moving from 0 to 50% CH<sub>3</sub>CN (0.1% TFA) over 60 min at a flow rate of 12.0 mL/min with UV detection at 214 and 254 nm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Methyl 3<i>-</i>(Tritylcarbamoyl)benzoate (<b>4</b>)</h3><div class="NLM_p last">Monomethyl isophthalate <b>3</b> (0.98 g, 5.4 mmol) was refluxed in 10 mL of SOCl<sub>2</sub> at 90 °C for about 1 h (until the reaction mixture was a clear solution). SOCl<sub>2</sub> was removed under reduced pressure and the acid chloride intermediate was redissolved in 15 mL of dry CH<sub>2</sub>Cl<sub>2</sub> and transferred to a cooled (ice bath) solution of tritylamine (1.41 g, 5.4 mmol) and 2 mL of triethylamine in 30 mL of CH<sub>2</sub>Cl<sub>2</sub>. The reaction was stirred overnight under a N<sub>2</sub> atmosphere, allowing the mixture to warm to room temperature. After the reaction was completed [monitored by thin-layer chromatography (TLC) (petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> = 1:1)], the reaction mixture was washed with water and brine, and the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by column chromatography (petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> = 2:1) to give compound <b>4</b> as a white powder (1.64 g, 72% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.45 (t, <i>J</i> = 1.6 Hz, 1H), 8.18 (m, 1H), 8.03 (m, 1H), 7.53 (t, <i>J</i> = 7.8 Hz, 1H), 7.41–7.26 (m, 15H), 3.94 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.3, 165.4, 144.5, 135.6, 132.5, 131.7, 130.6, 128.9, 128.7, 128.1, 128.1, 127.6, 127.2, 71.0, 52.4. HRMS [electrospray ionization (ESI)]: calcd for C<sub>28</sub>H<sub>23</sub>NO<sub>3</sub> [M + Na]<sup>+</sup> 444.1576, found 444.1581.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-(Hydroxymethyl)-<i>N</i>-tritylbenzamide (<b>5</b>)</h3><div class="NLM_p last">Methyl 3-(tritylcarbamoyl)benzoate <b>4</b> (0.56 g, 1.33 mmol) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL) under a N<sub>2</sub> atmosphere, the reaction solution was cooled down to −78 °C, and then diisobutylaluminum hydride (DIBAL-H) (5.5 mL, 1.0 M hexane solution) was added slowly. The reaction mixture was stirred at −78 °C for 2 h. Saturated (sat.) aqueous (aq) NH<sub>4</sub>Cl (50 mL) was added slowly to quench the reaction at −78 °C, followed by the addition of a saturated Rochelle salt solution (100 mL). The mixture was stirred at room temperature overnight, extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The crude product was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/EtOAc = 9:1) to obtain <b>5</b> as a white powder (0.44 g, 85% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.92 (s, 1H), 7.78 (s, 1H), 7.75–7.71 (m, 1H), 7.47 (d, <i>J</i> = 7.8 Hz, 1H), 7.40 (t, <i>J</i> = 7.6 Hz, 1H), 7.36–7.18 (m, 15H), 5.26 (br, 1H), 4.54 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.0, 145.3, 143.0, 135.5, 129.6, 128.9, 128.3, 127.9, 126.7, 126.5, 126.2, 79.6, 69.9, 69.9, 63.0. HRMS (ESI): calcd for C<sub>27</sub>H<sub>23</sub>NO<sub>2</sub> [2M + Na]<sup>+</sup> 809.3355, found 809.3359.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-Formyl-<i>N</i>-tritylbenzamide (<b>6</b>)</h3><div class="NLM_p last">3-(Hydroxymethyl)-<i>N</i>-tritylbenzamide <b>5</b> (0.20 g, 0.51 mmol) and pyridinium dichromate (PDC) (0.23 g, 0.61 mmol) were placed in a 50 mL round bottom flask and 10 mL of dry CH<sub>2</sub>Cl<sub>2</sub> was added under a N<sub>2</sub> atmosphere at room temperature. The reaction was stirred till completion, as monitored by TLC (petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> = 5:1). The mixture was filtered and the organic layer was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The resulting crude product was purified by column chromatography (petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> = 9:1) to obtain <b>6</b> as a white powder (0.13 g, yield 64%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.09 (s, 1H), 9.31 (s, 1H), 8.39 (s, 1H), 8.17 (d, <i>J</i> = 7.7 Hz, 1H), 8.06 (d, <i>J</i> = 7.7 Hz, 1H), 7.68 (t, <i>J</i> = 7.7 Hz, 1H), 7.41–7.17 (m, 15H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 191.5, 165.1, 144.4, 136.5, 136.2, 133.0, 132.5, 129.5, 128.6, 128.5, 128.1, 127.7, 127.3, 77.2, 71.1. HRMS (ESI): calcd for C<sub>27</sub>H<sub>21</sub>NO<sub>2</sub> [2M + Na]<sup>+</sup> 805.3042, found 805.3047.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-(Triphenylmethyl)glutarimide (<b>11</b>)</h3><div class="NLM_p last">Glutarimide (2.8 g, 25 mmol), triphenylchloromethane (7.4 g, 25 mmol), and potassium carbonate (3.7 g, 25 mmol) were added to 100 mL of acetonitrile, and the mixture was stirred at room temperature overnight. Saturated aqueous NaHCO<sub>3</sub> (50 mL) was added, and the mixture was extracted with EtOAc. The combined organic layers were dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (petroleum ether/EtOAc = 4:1) to obtain <b>11</b> as a white powder (1.8 g, yield 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.45–7.35 (m, 6H), 7.20 (t, <i>J</i> = 7.8 Hz, 6H), 7.08 (t, <i>J</i> = 7.3 Hz, 3H), 2.66 (t, <i>J</i> = 6.4 Hz, 4H), 2.01 (p, <i>J</i> = 6.5 Hz, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.4, 143.4, 128.5, 127.3, 125.9, 35.5, 16.7. HRMS (ESI): calcd for C<sub>24</sub>H<sub>21</sub>NO<sub>2</sub> [M + Na]<sup>+</sup> 378.1470, found 378.1493.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5-Oxo-5-(tritylamino)pentanoic Acid (<b>13</b>)</h3><div class="NLM_p last">To 2.80 g of KOH dissolved in 50 mL of ethanol was added <i>N</i>-tritylglutarimide <b>11</b> (1.00 g, 2.8 mmol), and the mixture was refluxed for 48 h. The mixture was then concentrated to dryness and redissolved in H<sub>2</sub>O. Acidification of the basic solution with conc. HCl to pH = 2 and filtration of the product gave compound <b>13</b> as a white powder (0.96 g, yield 91%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.30–7.17 (m, 15H), 2.37 (t, <i>J</i> = 7.4 Hz, 2H), 2.25 (t, <i>J</i> = 7.4 Hz, 2H), 1.79–1.87 (m 2H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 175.5, 173.3, 144.6, 128.6, 127.3, 127.2, 126.7, 126.3, 35.2, 32.6, 20.7. HRMS (ESI): calcd for C<sub>24</sub>H<sub>23</sub>NO<sub>3</sub> [M + Na]<sup>+</sup> 396.1576, found 396.1573.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-Hydroxy-<i>N</i>-tritylpentanamide (<b>15</b>)</h3><div class="NLM_p last">To a solution of <b>13</b> (2.60 g, 6.96 mmol) in dry THF (60 mL) cooled to 0 °C was added NaBH(OAc)<sub>3</sub> (0.28 g, 7.3 mmol). The solution was stirred until evolution of H<sub>2</sub> stopped, and BF<sub>3</sub>.OEt<sub>2</sub> (1.1 mL, 8.8 mmol) was added dropwise. The reaction was stirred at room temperature for 4 h. The reaction was quenched by adding 50 mL of H<sub>2</sub>O at 0 °C. The mixture was extracted with EtOAc, and the combined organic layers were washed with sat. aq Na<sub>2</sub>CO<sub>3</sub> and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by column chromatography (100% EtOAc) to give compound <b>15</b> as a white powder (1.60 g, 64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22–6.74 (m, 15H), 6.36 (br, 1H), 3.29–3.19 (br, 2H), 2.01 (t, <i>J</i> = 7.2 Hz, 2H), 1.46–1.36 (m, 2H), 1.24 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.9, 144.7, 128.6, 127.9, 127.0, 62.0, 37.0, 32.0, 21.4. HRMS (ESI): calcd for C<sub>24</sub>H<sub>25</sub>NO<sub>2</sub> [M + Na]<sup>+</sup> 382.1783, found 382.1783.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-Oxo-<i>N</i>-tritylpentanamide (<b>17</b>)</h3><div class="NLM_p last">5-Hydroxy-<i>N</i>-tritylpentanamide <b>15</b> (1.30 g, 3.6 mmol) and PDC (2.00 g, 5.4 mmol) were dissolved in 50 mL of dry CH<sub>2</sub>Cl<sub>2</sub> and stirred for 2 h under a N<sub>2</sub> atmosphere at room temperature. The mixture was filtered, and the organic layer was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by column chromatography (100% CH<sub>2</sub>Cl<sub>2</sub>) to give compound <b>17</b> as an off-white powder (0.84 g, 65% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.71 (s, 1H), 7.36–7.10 (m, 15H), 6.59 (s, 1H), 2.44 (t, <i>J</i> = 7.0 Hz, 2H), 2.32 (t, <i>J</i> = 7.2 Hz, 2H), 1.97–1.88 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 202.0, 170.8, 144.6, 128.6, 127.9, 127.0, 70.5, 42.9, 36.1, 17.9. HRMS (ESI): calcd for C<sub>24</sub>H<sub>23</sub>NO<sub>2</sub> [M + Na]<sup>+</sup> 380.1626, found 380.1629.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]-dioxol-4-yl)methyl)amino)methyl)-<i>N</i>-tritylbenzamide (<b>29</b>)</h3><div class="NLM_p last">3-Formyl-<i>N</i>-tritylbenzamide <b>6</b> (1.22 g, 3.12 mmol), 2′-3′-<i>O</i>-isopropylidene-6-aminomethyl-adenosine (1.00 g, 3.43 mmol), and acetic acid (0.45 mL, 8 mmol) were dissolved in 1,2-dichloroethane (DCE, 50 mL) and stirred at room temperature under a N<sub>2</sub> atmosphere. After 3 h, NaBH(OAc)<sub>3</sub> (1.09 g, 5.15 mmol) was added, and the reaction mixture was stirred overnight at room temperature. The reaction was quenched by adding 1 N NaOH solution (50 mL), and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the crude product was purified by column chromatography (10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give compound <b>29</b> as a white powder (1.25 g, 59% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.89 (s, 1H), 8.34 (s, 1H), 8.06 (s, 1H), 7.79 (s, 1H), 7.71 (d, <i>J</i> = 7.7 Hz, 1H), 7.43 (d, <i>J</i> = 7.7 Hz, 1H), 7.39–7.24 (m, 15H), 7.20 (m, 3H), 6.09 (d, <i>J</i> = 3.1 Hz, 1H), 5.76 (s, 1H), 5.46 (M, 1H), 5.00 (m, 1H), 4.28–4.23 (m, 1H), 3.73 (s, 2H), 2.75–2.66 (m, 2H), 1.54 (s, 3H), 1.31 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.9, 156.5, 153.1, 149.3, 145.3, 140.4, 135.6, 128.9, 128.3, 127.9, 127.6, 126.7, 126.5, 119.7, 113.7, 89.7, 85.3, 83.1, 82.6, 69.9, 55.3, 53.0, 50.8, 27.5, 25.7. HRMS (ESI): calcd for C<sub>40</sub>H<sub>39</sub>N<sub>7</sub>O<sub>4</sub> [M + Na]<sup>+</sup> 704.2961, found 704.2975.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl 3-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)amino)benzoate (<b>30</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>29</b>, coupling methyl 3-formylbenzoate <b>8</b> (0.51 g, 3.12 mmol) and 2′-3′-<i>O</i>-isopropylidene-6-aminomethyl-adenosine (1.00 g, 3.43 mmol) afforded compound <b>30</b> as a white powder (0.92 g, 65% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (s, 1H), 7.92 (s, 1H), 7.90–7.83 (m, 2H), 7.44 (d, <i>J</i> = 7.6 Hz, 1H), 7.32 (t, <i>J</i> = 7.6 Hz, 1H), 6.37 (d, <i>J</i> = 5.7 Hz, 2H), 5.95 (d, <i>J</i> = 3.1 Hz, 1H), 5.45 (m, 1H), 5.04 (m, 1H), 4.40–4.34 (m, 1H), 3.86 (s, 3H), 3.79 (s, 2H), 2.90–2.83 (m, 2H), 1.58 (s, 3H), 1.35 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.1, 155.8, 155.8, 153.0, 149.2, 140.4, 140.4, 139.8, 132.6, 132.6, 130.1, 129.1, 129.1, 128.4, 128.4, 128.2, 120.2, 114.4, 91.0, 85.5, 83.2, 83.2, 82.2, 82.2, 53.3, 52.1, 52.1, 50.6, 27.3, 27.2, 25.4, 25.3. HRMS (ESI): calcd for C<sub>22</sub>H<sub>26</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 455.2043, found 455.2050.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>tert</i>-Butyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)amino)methyl)benzoate (<b>31</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>29</b>, coupling <i>tert</i>-butyl 3-formylbenzoate <b>9</b> (0.64 g, 3.12 mmol) and 2′-3′-<i>O</i>-isopropylidene-6-aminomethyl-adenosine (1.00 g, 3.43 mmol) afforded compound <b>31</b> as a white powder (0.77 g, 50% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 7.89 (s, 1H), 7.86–7.83 (m, 2H), 7.43 (d, <i>J</i> = 7.7 Hz, 1H), 7.31 (t, <i>J</i> = 7.6 Hz, 1H), 6.36–6.27 (m, 2H), 5.96 (d, <i>J</i> = 3.3 Hz, 1H), 5.46 (m, 1H), 5.04 (m, 1H), 4.38 (m, 1H), 3.80 (s, 2H), 2.94–2.81 (m, 2H), 1.58 (s, 3H), 1.55 (s, 9H), 1.36 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 165.7, 155.8, 155.8, 153.0, 149.3, 140.2, 139.8, 132.0, 132.0, 129.0, 128.2, 128.1, 120.3, 114.5, 91.0, 85.4, 83.2, 82.2, 80.9, 53.4, 50.6, 28.1, 27.3, 25.4. HRMS (ESI): calcd for C<sub>25</sub>H<sub>32</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 497.2512, found 497.2511.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 9-((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-2,2-Dimethyl-6-(((naphthalen-2-ylmethyl)amino)methyl)tetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)-9<i>H</i>-purin-6-amine (<b>32</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>29</b>, coupling 2-naphthaldehyde (0.49 g, 3.12 mmol) and 2′-3′-<i>O</i>-isopropylidene-6-aminomethyl-adenosine (1.00 g, 3.43 mmol) afforded compound <b>32</b> as a white powder (1.03 g, 74% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 7.88 (s, 1H), 7.78 (m, 3H), 7.70 (s, 1H), 7.48–7.38 (m, 3H), 6.05 (s, 2H), 5.99 (d, <i>J</i> = 3.3 Hz, 1H), 5.48 (m, 1H), 5.06 (m, 1H), 4.45–4.39 (m, 1H), 3.95 (s, 2H), 3.01–2.87 (m, 2H), 2.33 (br, 2H), 1.61 (s, 3H), 1.38 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.7, 153.0, 149.3, 139.9, 137.4, 133.3, 132.6, 128.0, 127.6 126.4, 126.4, 126.0, 125.5, 120.3, 114.5, 91.0, 85.6, 83.3, 82.3, 53.9, 50.7, 27.3, 25.4. HRMS (ESI): calcd for C<sub>24</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 447.2145, found 447.2167.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]-dioxol-4-yl)methyl)(4-oxo-4-(tritylamino)butyl)amino)methyl)-<i>N</i>-tritylbenzamide (<b>33</b>)</h3><div class="NLM_p last">Oxo-<i>N</i>-tritylbutanamide <b>16</b> (62 mg, 0.18 mmol), compound <b>29</b> (100 mg, 0.15 mmol), and AcOH (one drop) were dissolved in 1,2-dichloroethane (DCE, 10 mL) and stirred at room temperature under a N<sub>2</sub> atmosphere. After 3 h, NaBH<sub>4</sub> (49 mg, 0.23 mmol) was added, and the reaction mixture was stirred overnight at room temperature. The reaction was quenched by adding 1 N NaOH (10 mL), and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the crude product was purified by column chromatography (10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give compound <b>33</b> as a white powder (83 mg, 55% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H), 7.69 (s, 1H), 7.67 (s, 1H), 7.53 (d, <i>J</i> = 7.1 Hz, 2H), 7.39–7.09 (m, 32H), 6.61 (s, 1H), 5.95 (d, <i>J</i> = 1.9 Hz, 1H), 5.65 (s, 2H), 5.36 (m, 1H), 4.89 (m, 1H), 4.40–4.34 (m, 1H), 3.56 (d, <i>J</i> = 3.4 Hz, 2H), 2.68 (d, <i>J</i> = 6.8 Hz, 2H), 2.46 (m, 2H), 2.26 (m, 2H), 1.81–1.69 (m, 2H), 1.52 (s, 3H), 1.30 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.5, 166.7, 155.4, 152.9, 149.0, 144.8, 144.7, 140.0, 139.9, 135.3, 131.5, 128.8, 128.7, 128.0, 127.9, 127.0, 126.9, 125.3, 114.1, 90.8, 85.7, 83.8, 83.4, 70.7, 70.4, 58.6, 56.0, 53.5, 34.9, 27.0, 25.3, 22.7. HRMS (ESI): calcd for C<sub>63</sub>H<sub>60</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup> 1009.4765, found 1009.4765.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(5-oxo-5-(tritylamino)pentyl)amino)methyl)-<i>N</i>-tritylbenzamide (<b>34</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling compound <b>29</b> (100 mg, 0.15 mmol) with 5-oxo-<i>N</i>-tritylpentanamide <b>17</b> (64 mg, 0.18 mmol) afforded compound <b>34</b> as a white powder (88 mg, 57% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1H), 7.67 (s, 2H), 7.57 (br, 1H), 7.52 (s, 1H), 7.41–7.13 (m, 32H), 6.62 (s, 1H), 5.96 (d, <i>J</i> = 1.8 Hz, 1H), 5.83 (br, 2H), 5.38 (m, 1H), 4.92 (m, 1H), 4.40–4.34 (m, 1H), 3.54 (s, 2H), 2.65 (d, <i>J</i> = 6.9 Hz, 2H), 2.46–2.38 (m, 2H), 2.13 (m, 2H), 1.56 (s, 3H), 1.42–1.33 (m, 2H), 1.30 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.6, 166.6, 155.5, 152.9, 149.1, 144.8, 144.8, 140.3, 140.0, 135.2, 131.6, 128.8, 128.7, 128.2, 128.0, 127.9, 127.5, 127.0, 127.0, 125.4, 114.1, 90.9, 85.9, 83.8, 83.4, 77.3, 70.7, 70.4, 58.6, 56.1, 53.9, 37.1, 27.1, 26.3, 25.4, 23.1. HRMS (ESI): calcd for C<sub>64</sub>H<sub>62</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup> 1023.4921, found 1023.4918.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 4-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(3-(tritylcarbamoyl)benzyl)amino)butanoate (<b>35</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 4-oxobutanoate <b>22</b> (29 mg, 0.18 mmol) and compound <b>29</b> (100 mg, 0.15 mmol) afforded compound <b>35</b> as a white powder (61 mg, 49% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1H), 7.70 (d, <i>J</i> = 5.8 Hz, 2H), 7.58 (d, <i>J</i> = 7.6 Hz, 2H), 7.38–7.15 (m, 17H), 5.97 (d, <i>J</i> = 2.0 Hz, 3H), 5.36 (m, 1H), 4.93 (m, 1H), 4.35 (m, 1H), 3.63–3.52 (m, 2H), 2.76–2.63 (m, 2H), 2.47 (t, <i>J</i> = 7.1 Hz, 2H), 2.23–2.12 (m, 2H), 1.75–1.65 (m, 2H), 1.55 (s, 3H), 1.36 (s, 9H), 1.29 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.7, 166.7, 155.5, 152.9, 149.0, 144.8, 144.8, 140.0, 139.9, 131.6, 128.8, 128.7, 128.0, 128.0, 127.0, 125.5, 120.1, 90.8, 85.8, 83.9, 83.4, 80.1, 70.7, 61.9, 58.8, 55.9, 53.4, 33.0, 32.4, 28.0, 27.1, 25.3, 22.4. HRMS (ESI): calcd for C<sub>48</sub>H<sub>53</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 824.4136, found 824.4142.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl 5-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(3-(tritylcarbamoyl)benzyl)amino)pentanoate (<b>36</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 5-oxopentanoate <b>23</b> (31 mg, 0.18 mmol) and compound <b>29</b> (100 mg, 0.15 mmol) afforded compound <b>36</b> as a white powder (67 mg, 53% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 7.70 (d, <i>J</i> = 8.7 Hz, 2H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.51 (s, 1H), 7.42–7.27 (m, 14H), 7.19 (t, <i>J</i> = 7.7 Hz, 1H), 5.98 (s, 1H), 5.72 (s, 2H), 5.38 (m, 1H), 4.94 (s, 1H), 4.40–4.33 (m, 1H), 3.57 (s, 2H), 2.70–2.65 (m, 2H), 2.47 (t, <i>J</i> = 7.0 Hz, 2H), 2.13 (t, <i>J</i> = 7.2 Hz, 2H), 1.57 (s, 3H), 1.52–1.45 (m, 2H), 1.41 (s, 9H), 1.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.9, 166.6, 155.4, 152.9, 149.1, 144.8, 140.2, 139.9, 135.2, 131.6, 128.7, 128.2, 128.0, 127.4, 127.0, 125.4, 120.2, 114.1, 90.8, 85.8, 83.9, 83.4, 80.0, 70.7, 58.7, 56.0, 54.0, 35.2, 28.1, 27.1, 26.3, 25.3, 22.7. HRMS (ESI): calcd for C<sub>49</sub>H<sub>55</sub>N<sub>7</sub>O<sub>5</sub> [M + H]<sup>+</sup> 838.4292, found 838.4298.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>tert</i>-Butyl (<i>S</i>)-4-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(3-(tritylcarbamoyl)benzyl)amino)-2-((<i>tert</i>-butoxycarbonyl)amino)butanoate (<b>37</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl (<i>R</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutanoate <b>27</b> (49 mg, 0.18 mmol) and compound <b>29</b> (100 mg, 0.15 mmol) afforded compound <b>37</b> as a white powder (94 mg, 67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H), 7.70 (m, 2H), 7.57 (d, <i>J</i> = 9.9 Hz, 2H), 7.41–7.14 (m, 15H), 5.98 (s, 1H), 5.59 (s, 2H), 5.37 (m, 2H), 4.91 (s, 1H), 4.36 (s, 1H), 4.17 (s, 1H), 3.62 (d, <i>J</i> = 13.8 Hz, 1H), 3.54 (d, <i>J</i> = 13.8 Hz, 1H), 2.76–2.48 (m, 4H), 1.99 (d, <i>J</i> = 6.2 Hz, 1H), 1.76 (br, 1H), 1.57 (s, 3H), 1.39 (m, 15H), 1.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.6, 166.6, 155.4, 152.9, 149.0, 144.8, 140.0, 139.5, 135.4, 131.6, 128.8, 128.0, 127.0, 125.5, 114.2, 90.7, 85.6, 83.9, 83.4, 81.7, 79.4, 70.7, 58.9, 58.2, 55.9, 52.7, 50.9, 50.6, 36.5, 29.7, 28.3, 28.2, 28.0, 27.9, 27.1, 25.3. HRMS (ESI): calcd for C<sub>53</sub>H<sub>61</sub>N<sub>8</sub>O<sub>8</sub> [M + H]<sup>+</sup> 939.4749, found 939.4784.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(isopropyl)amino)methyl)-<i>N</i>-tritylbenzamide (<b>38</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 5 mL of dry acetone (large excess) and compound <b>29</b> (100 mg, 0.15 mmol) afforded compound <b>38</b> as a white powder (68 mg, 63% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (s, 1H), 7.75 (s, 1H), 7.60 (d, <i>J</i> = 10.4 Hz, 2H), 7.49–7.40 (m, 2H), 7.33–7.21 (m, 15H), 5.91 (s, 1H), 5.34 (m, 2H), 4.92–4.87 (m, 1H), 4.23 (d, <i>J</i> = 3.2 Hz, 1H), 3.57 (s, 2H), 2.92–2.83 (m, 1H), 2.76–2.68 (m, 1H), 2.59 (m, 1H), 1.49 (s, 3H), 1.25 (s, 3H), 1.01 (d, <i>J</i> = 6.6 Hz, 3H), 0.90 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.7, 155.7, 152.9, 149.0, 144.8, 141.4, 139.9, 135.2, 131.4, 128.7, 128.3, 128.0, 127.1, 125.4, 120.2, 114.0, 90.9, 86.5, 83.7, 83.3, 70.7, 54.4, 51.8, 50.5, 27.1, 25.4, 18.7, 17.2. HRMS (ESI): calcd for C<sub>43</sub>H<sub>45</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup> 724.3611, found 724.3618.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Methyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(4-oxo-4-(tritylamino)butyl)amino)methyl)benzoate (<b>39</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 4-oxo-<i>N</i>-tritylbutanamide <b>16</b> (62 mg, 0.18 mmol) and compound <b>30</b> (68 mg, 0.15 mmol) afforded compound <b>39</b> as a white powder (63 mg, 54% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 7.90 (s, 1H), 7.84–7.79 (m, 1H), 7.77 (s, 1H), 7.40 (d, <i>J</i> = 7.7 Hz, 1H), 7.31–7.08 (m, 17H), 6.60 (s, 1H), 5.97 (d, <i>J</i> = 2.2 Hz, 1H), 5.67 (s, 2H), 5.34 (m, 1H), 4.86 (m, 1H), 4.34 (m, 1H), 3.85 (s, 3H), 3.57 (m, 2H), 2.74–2.62 (m, 2H), 2.45 (t, <i>J</i> = 7.0 Hz, 2H), 2.31–2.16 (m, 2H), 1.75 (m, 2H), 1.53 (s, 3H), 1.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.5, 167.0, 155.4, 153.0, 149.1, 144.7, 139.9, 139.6, 133.3, 129.9, 129.7, 128.7, 128.2, 128.1, 127.9, 127.0, 126.9, 120.2, 114.2, 90.8, 85.4, 83.7, 83.4, 70.4, 58.5, 55.7, 53.6, 52.1, 34.9, 27.0, 25.2, 22.7. HRMS (ESI): calcd for C<sub>45</sub>H<sub>48</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 782.3666, found 782.3666.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(5-oxo-5-(tritylamino)pentyl)amino)methyl)benzoate (<b>40</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 5-oxo-<i>N</i>-tritylpentanamide <b>17</b> (64 mg, 0.18 mmol) and compound <b>30</b> (68 mg, 0.15 mmol) afforded compound <b>40</b> as a white powder (67 mg, 53% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 7.89 (s, 1H), 7.83 (d, <i>J</i> = 7.8 Hz, 1H), 7.76 (s, 1H), 7.44 (d, <i>J</i> = 7.6 Hz, 1H), 7.26–7.17 (m, 14H), 6.69 (s, 1H), 6.35 (br, 2H), 5.99 (d, <i>J</i> = 1.8 Hz, 1H), 5.39 (m, 1H), 4.90 (m, 1H), 4.36 (m, 1H), 3.83 (s, 3H), 3.62–3.48 (m, 2H), 2.65 (m, 2H), 2.41 (t, <i>J</i> = 6.9 Hz, 2H), 2.14 (p, <i>J</i> = 8.2 Hz, 2H), 1.56 (s, 3H), 1.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.7, 167.1, 155.8, 152.9, 149.1, 144.8, 139.9, 139.8, 133.4, 129.9, 129.8, 128.7, 128.2, 128.2, 127.9, 126.9, 114.1, 90.8, 85.6, 83.7, 83.4, 70.4, 58.5, 55.8, 53.8, 52.1, 37.1, 27.1, 26.3, 25.3, 23.1. HRMS (ESI): calcd for C<sub>46</sub>H<sub>49</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 796.3823, found 796.3814.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Methyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(4-(<i>tert</i>-butoxy)-4-oxobutyl)amino)methyl)benzoate (<b>41</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 4-oxobutanoate <b>22</b> (29 mg, 0.18 mmol) and compound <b>30</b> (68 mg, 0.15 mmol) afforded compound <b>41</b> as a white powder (65 mg, 73% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (s, 1H), 7.85 (s, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 2H), 7.41 (d, <i>J</i> = 7.6 Hz, 1H), 7.23 (t, <i>J</i> = 7.6 Hz, 1H), 6.47 (s, 2H), 5.98 (d, <i>J</i> = 1.9 Hz, 1H), 5.33 (d, <i>J</i> = 6.4 Hz, 1H), 4.87 (m, 1H), 4.30 (m, 1H), 3.84 (s, 3H), 3.61–3.48 (m, 2H), 2.75–2.69 (m, 2H), 2.43 (m, 2H), 2.16–2.10 (m, 2H), 1.53 (s, 3H), 1.39–1.30 (m, 15H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 167.0, 155.8, 152.9, 148.9, 139.7, 139.6, 133.3, 129.9, 129.7, 128.2, 128.1, 120.0, 114.1, 114.1, 90.7, 85.4, 83.7, 83.3, 80.0, 61.6, 61.1, 58.6, 55.6, 53.4, 52.0, 32.9, 32.3, 28.0, 27.5, 27.0, 25.3, 22.3. HRMS (ESI): calcd for C<sub>30</sub>H<sub>40</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 597.3037, found 597.3037.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Methyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(5-(<i>tert</i>-butoxy)-5-oxopentyl)amino)methyl)benzoate (<b>42</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 5-oxopentanoate <b>23</b> (31 mg, 0.18 mmol) and compound <b>30</b> (68 mg, 0.15 mmol) afforded compound <b>42</b> as a white powder (56 mg, 61% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12 (s, 1H), 7.84 (s, 1H), 7.79 (d, <i>J</i> = 7.8 Hz, 2H), 7.39 (d, <i>J</i> = 7.5 Hz, 1H), 7.21 (t, <i>J</i> = 7.7 Hz, 1H), 6.52 (s, 2H), 5.97 (s, 1H), 5.36–5.30 (m, 1H), 4.86 (m, 1H), 4.33–4.26 (m, 1H), 3.82 (s, 3H), 3.58 (d, <i>J</i> = 13.8 Hz, 1H), 3.47 (d, <i>J</i> = 13.7 Hz, 1H), 2.69–2.56 (m, 2H), 2.43–2.35 (m, 2H), 2.07 (t, <i>J</i> = 6.8 Hz, 2H), 1.52 (s, 3H), 1.48–1.42 (m, 2H), 1.34 (s, 9H), 1.30 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 167.0, 155.8, 152.9, 149.0, 139.7, 139.7, 133.3, 129.9, 129.7, 128.2, 128.1, 128.1, 120.1, 114.1, 90.8, 85.5, 83.6, 83.5, 83.3, 79.9, 58.6, 55.6, 53.9, 52.0, 35.2, 28.0, 27.1, 26.2, 25.3, 22.7. HRMS (ESI): calcd for C<sub>31</sub>H<sub>42</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 611.3193, found 611.3182.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Methyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)((<i>S</i>)-4-(<i>tert</i>-butoxy)-2-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutyl)amino)methyl)benzoate (<b>43</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl (<i>R</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutanoate <b>27</b> (49 mg, 0.18 mmol) and compound <b>30</b> (68 mg, 0.15 mmol) afforded compound <b>43</b> as a white powder (62 mg, 58% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.19 (s, 1H), 7.87 (d, <i>J</i> = 6.5 Hz, 2H), 7.82 (s, 1H), 7.48 (d, <i>J</i> = 7.7 Hz, 1H), 7.30 (t, <i>J</i> = 7.9 Hz, 1H), 6.01 (s, 1H), 5.73 (s, 2H), 5.38 (m, 2H), 4.89 (m, 1H), 4.35 (m, 1H), 4.20–4.11 (m, 1H), 3.90 (s, 3H), 3.71–3.52 (m, 2H), 2.78 (m, 1H), 2.65 (m, 2H), 2.51 (m, 1H), 1.96 (s, 2H), 1.76 (m, 1H), 1.59 (s, 3H), 1.40 (m, 18H), 1.37 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.6, 167.0, 155.4, 155.4, 153.0, 149.1, 139.9, 139.2, 133.4, 130.0, 129.8, 128.4, 128.3, 120.3, 114.3, 90.7, 85.3, 83.8, 83.3, 81.7, 79.4, 58.6, 55.7, 52.7, 52.1, 50.5, 29.5, 28.3, 27.9, 27.1, 25.3. HRMS (ESI): calcd for C<sub>35</sub>H<sub>49</sub>N<sub>7</sub>O<sub>9</sub> [M + H]<sup>+</sup> 712.3670, found 712.3682.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Methyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(<i>iso</i>propyl)amino)methyl)benzoate (<b>44</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling dry acetone (5 mL, large excess) and compound <b>30</b> (68 mg, 0.15 mmol) afforded compound <b>44</b> as a white powder (42 mg, 57% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (s, 1H), 7.94 (s, 1H), 7.84 (d, <i>J</i> = 7.7 Hz, 1H), 7.77 (s, 1H), 7.52 (d, <i>J</i> = 7.6 Hz, 1H), 7.29 (t, <i>J</i> = 7.7 Hz, 1H), 5.96 (d, <i>J</i> = 2.4 Hz, 2H), 5.36 (dd, <i>J</i> = 6.4, 2.4 Hz, 1H), 4.87 (dd, <i>J</i> = 6.4, 3.0 Hz, 1H), 4.26–4.20 (m, 1H), 3.88 (s, 3H), 3.62 (d, <i>J</i> = 14.2 Hz, 1H), 3.54 (d, <i>J</i> = 14.2 Hz, 1H), 2.88 (p, <i>J</i> = 6.6 Hz, 1H), 2.73–2.59 (m, 2H), 1.53 (s, 3H), 1.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 167.1, 155.6, 152.9, 149.2, 141.0, 139.9, 133.2, 129.9, 129.6, 128.1, 128.1, 120.2, 114.0, 91.0, 86.1, 83.5, 83.2, 60.3, 54.3, 52.0, 51.4, 50.3, 27.1, 25.3, 21.0, 18.9, 16.8, 14.2. HRMS (ESI): calcd for C<sub>35</sub>H<sub>32</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 497.2512, found 497.2510.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>tert</i>-Butyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(4-oxo-4-(tritylamino)butyl)amino)methyl)benzoate (<b>45</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 4-oxo-<i>N</i>-tritylbutanamide <b>16</b> (62 mg, 0.18 mmol) and compound <b>31</b> (75 mg, 0.15 mmol) afforded compound <b>45</b> as a white powder (93 mg, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.23 (s, 1H), 7.90 (s, 1H), 7.84–7.79 (m, 2H), 7.43 (d, <i>J</i> = 7.6 Hz, 1H), 7.31–7.16 (m, 17H), 6.68 (s, 1H), 6.07 (s, 2H), 6.01 (d, <i>J</i> = 2.2 Hz, 1H), 5.39 (m, 1H), 4.89 (m, 1H), 4.37 (m, 1H), 3.66 (d, <i>J</i> = 13.9 Hz, 1H), 3.55 (d, <i>J</i> = 13.9 Hz, 1H), 2.76 (m, 1H), 2.66 (m, 1H), 2.47 (t, <i>J</i> = 6.8 Hz, 2H), 2.28 (m, 2H), 1.77 (m, 2H), 1.59 (s, 9H), 1.56 (s, 3H), 1.35 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.6, 165.7, 155.6, 153.0, 149.1, 144.8, 139.7, 139.4, 132.8, 131.9, 129.6, 128.7, 128.1, 128.0, 127.9, 126.9, 120.2, 114.2, 90.8, 85.4, 83.6, 83.4, 80.9, 70.4, 58.6, 55.7, 53.6, 34.9, 28.2, 27.1, 25.3, 22.7. HRMS (ESI): calcd for C<sub>49</sub>H<sub>53</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 824.4136, found 824.4123.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>tert</i>-Butyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)<i>-</i>6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(5-oxo-5-(tritylamino)pentyl)amino)methyl)benzoate (<b>46</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 5-oxo-<i>N</i>-tritylpentanamide <b>17</b> (64 mg, 0.18 mmol) and compound <b>31</b> (75 mg, 0.15 mmol) afforded compound <b>46</b> as a white powder (97 mg, 77% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.23 (d, <i>J</i> = 7.6 Hz, 1H), 7.90 (d, <i>J</i> = 9.6 Hz, 1H), 7.85–7.79 (m, 2H), 7.47 (d, <i>J</i> = 7.7 Hz, 1H), 7.32–7.15 (m, 16H), 6.71 (d, <i>J</i> = 8.4 Hz, 1H), 6.35 (d, <i>J</i> = 14.9 Hz, 2H), 6.03 (d, <i>J</i> = 2.1 Hz, 1H), 5.43 (m, 1H), 4.93 (m, 1H), 4.41–4.37 (m, 1H), 3.65 (d, <i>J</i> = 13.8 Hz, 1H), 3.54 (d, <i>J</i> = 13.8 Hz, 1H), 2.75–2.62 (m, 1H), 2.48–2.39 (m, 2H), 2.16 (t, <i>J</i> = 7.2 Hz, 2H), 1.59 (s, 12H), 1.45–1.37 (m, 2H), 1.36 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.7, 165.8, 155.8, 153.0, 149.1, 144.8, 144.8, 139.9, 139.6, 132.9, 131.8, 129.7, 128.7, 128.2, 128.1, 128.0, 128.0, 127.9, 126.9, 120.2, 114.1, 90.9, 90.8, 85.6, 83.7, 83.6, 83.4, 80.9, 70.4, 58.6, 58.6, 55.7, 53.8, 53.6, 37.1, 34.9, 28.2, 27.1, 27.1, 26.3, 25.3, 25.3, 23.1, 22.7. HRMS (ESI): calcd for C<sub>49</sub>H<sub>55</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 838.4292, found 838.4314.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(4-(<i>tert</i>-butoxy)-4-oxobutyl)amino)methyl)benzoate (<b>47</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 4-oxobutanoate <b>22</b> (29 mg, 0.18 mmol) and compound <b>31</b> (75 mg, 0.15 mmol) afforded compound <b>47</b> as a white powder (64 mg, 67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.21 (s, 1H), 7.86–7.77 (m, 3H), 7.42 (d, <i>J</i> = 7.6 Hz, 1H), 7.26 (d, <i>J</i> = 7.7 Hz, 1H), 6.15 (s, 2H), 5.99 (d, <i>J</i> = 2.2 Hz, 1H), 5.36 (m, 1H), 4.88 (m, 1H), 4.32 (m, 1H), 3.65 (d, <i>J</i> = 13.8 Hz, 1H), 3.50 (d, <i>J</i> = 13.8 Hz, 1H), 2.78–2.73 (m, 1H), 2.64–2.59 (m,1H), 2.42 (m, 2H), 2.22–2.09 (m, 2H), 1.55 (s, 12H), 1.36 (s, 9H), 1.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 165.7, 155.7, 153.0, 149.1, 139.8, 139.5, 132.8, 131.8, 129.6, 128.1, 128.0, 120.2, 114.2, 90.8, 85.5, 83.7, 83.3, 80.8, 80.0, 58.7, 55.6, 53.4, 33.0, 28.2, 28.0, 27.1, 25.3, 22.4. HRMS (ESI): calcd for C<sub>33</sub>H<sub>46</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 639.3506, found 639.3506.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(5-(<i>tert</i>-butoxy)-5-oxopentyl)amino)methyl)benzoate (<b>48</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 5-oxopentanoate <b>23</b> (31 mg, 0.18 mmol) and compound <b>31</b> (75 mg, 0.15 mmol) afforded compound <b>48</b> as a white powder (72 mg, 73% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (s, 1H), 7.84–7.77 (m, 3H), 7.42 (d, <i>J</i> = 7.6 Hz, 1H), 7.24 (t, <i>J</i> = 7.6 Hz, 1H), 6.19 (s, 2H), 5.99 (d, <i>J</i> = 2.2 Hz, 1H), 5.37 (m, 1H), 4.88 (m, 1H), 4.35–4.30 (m, 1H), 3.65–3.48 (1H), 2.71–2.59 (m, 1H), 2.46–2.38 (m, 2H), 2.10 (t, <i>J</i> = 7.1 Hz, 2H), 1.55 (s, 12H), 1.44 (m, 2H), 1.37 (s, 9H), 1.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.9, 165.7, 155.7, 153.0, 149.1, 139.7, 139.5, 132.9, 131.8, 129.6, 128.0, 128.0, 120.2, 114.1, 90.8, 85.5, 83.6, 83.3, 80.8, 79.9, 58.7, 55.6, 53.9, 35.2, 28.2, 28.1, 27.1, 26.2, 25.3, 22.7. HRMS (ESI): calcd for C<sub>34</sub>H<sub>48</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 653.3663, found 653.3669.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)((<i>S</i>)-4-(<i>tert</i>-butoxy)-3-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutyl)amino)methyl)benzoate (<b>49</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl (<i>R</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)-4-oxobutanoate <b>27</b> (49 mg, 0.18 mmol) and compound <b>31</b> (75 mg, 0.15 mmol) afforded compound <b>49</b> as a white powder (85 mg, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18 (s, 1H), 7.79 (d, <i>J</i> = 6.7 Hz, 3H), 7.44 (s, 1H), 7.28–7.23 (m, 1H), 6.20 (s, 2H), 5.99 (s, 1H), 5.50–5.43 (m, 1H), 5.34 (d, <i>J</i> = 5.6 Hz, 1H), 4.86 (m, 1H), 4.31 (m, 1H), 4.15–4.07 (m, 1H), 3.67 (br, 1H), 3.47 (br, 1H), 2.76 (br, 2H), 2.59 (m, 2H), 2.44 (m, 2H), 1.93 (m, 1H), 1.73 (m, 1H), 1.54 (s, 12H), 1.35 (m, 21H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.6, 165.6, 155.7, 155.7, 155.3, 153.0, 149.1, 139.8, 139.0, 132.9, 131.8, 129.6, 128.2, 128.2, 120.2, 114.3, 90.6, 85.3, 83.7, 83.3, 81.6, 80.9, 79.3, 58.8, 55.7, 52.7, 50.5, 29.4, 28.3, 28.2, 27.9, 27.1, 25.4. HRMS (ESI): calcd for C<sub>38</sub>H<sub>55</sub>N<sub>7</sub>O<sub>9</sub> [M + H]<sup>+</sup> 754.4140, found 754.4129.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl 3-(((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(isopropyl)amino)methyl)benzoate (<b>50</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 5 mL of dry acetone (large excess) and compound <b>31</b> (75 mg, 0.15 mmol) afforded compound <b>50</b> as a white powder (85 mg, 79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.26 (s, 1H), 7.90 (s, 1H), 7.80 (m, 2H), 7.51 (d, <i>J</i> = 7.6 Hz, 1H), 7.28 (t, <i>J</i> = 7.7 Hz, 1H), 5.97 (d, <i>J</i> = 2.4 Hz, 1H), 5.92 (s, 2H), 5.37 (m, 1H), 4.86 (m, 1H), 4.26–4.20 (m, 1H), 3.64 (br, 1H), 3.54 (br, 1H), 2.87 (m, 1H), 2.73–2.56 (br, 2H), 1.57 (s, 9H), 1.53 (s, 3H), 1.33 (s, 3H), 1.03 (d, <i>J</i> = 6.6 Hz, 3H), 0.89 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl3-<i>d</i>) δ 165.8, 155.5, 153.0, 149.2, 140.8, 139.9, 132.7, 131.8, 129.4, 128.0, 127.9, 120.2, 114.0, 91.0, 86.1, 83.4, 83.2, 80.8, 54.5, 51.3, 50.4, 28.2, 27.1, 25.3, 19.0, 16.7. HRMS (ESI): calcd for C<sub>28</sub>H<sub>38</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 539.2982, found 539.2982.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(naphthalen-2-ylmethyl)amino)-<i>N</i>-tritylbutanamide (<b>51</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 4-oxo-<i>N</i>-tritylbutanamide <b>16</b> (62 mg, 0.18 mmol) and compound <b>32</b> (67 mg, 0.15 mmol) afforded compound <b>51</b> as a white powder (85 mg, 73% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 7.79–7.73 (m, 2H), 7.72–7.66 (m, 2H), 7.61 (s, 1H), 7.46–7.38 (m, 3H), 7.28–7.12 (m, 15H), 6.59 (s, 1H), 5.97 (d, <i>J</i> = 2.2 Hz, 1H), 5.81 (s, 2H), 5.30 (m, 1H), 4.83 (m, 1H), 4.38 (s, 1H), 3.77 (d, <i>J</i> = 13.7 Hz, 1H), 3.63 (d, <i>J</i> = 13.7 Hz, 1H), 2.78–2.64 (m, 2H), 2.51 (t, <i>J</i> = 6.9 Hz, 2H), 2.30–2.20 (m, 2H), 1.79 (m, 2H), 1.52 (s, 3H), 1.31 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.6, 155.5, 153.0, 144.8, 139.7, 136.6, 133.2, 132.7, 128.7, 127.9, 127.8, 127.6, 127.6, 127.4, 127.2, 126.9, 126.0, 125.6, 114.2, 90.8, 85.4, 83.7, 83.4, 70.4, 59.1, 55.8, 53.8, 35.0, 27.0, 25.3, 22.8. HRMS (ESI): calcd for C<sub>47</sub>H<sub>47</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup> 774.3768, found 774.3769.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(naphthalen-2-ylmethyl)amino)-<i>N</i>-tritylpentanamide (<b>52</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 5-oxo-<i>N</i>-tritylpentanamide <b>17</b> (64 mg, 0.18 mmol) and compound <b>32</b> (67 mg, 0.15 mmol) afforded compound <b>52</b> as a white powder (85 mg, 64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12 (s, 1H), 7.84–7.55 (m, 5H), 7.42 (m, 3H), 7.28–7.16 (m, 14H), 6.57 (s, 1H), 5.98 (s, 1H), 5.76 (s, 2H), 5.35 (d, <i>J</i> = 6.3 Hz, 1H), 4.88 (d, <i>J</i> = 6.2 Hz, 1H), 4.39 (s, 1H), 3.75 (d, <i>J</i> = 13.6 Hz, 1H), 3.62 (d, <i>J</i> = 13.6 Hz, 1H), 2.77–2.62 (m, 2H), 2.52–2.37 (m, 2H), 2.16–2.09 (m, 2H), 1.56 (s, 3H), 1.45–1.38 (m, 2H), 1.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.7, 155.4, 152.9, 149.2, 144.8, 139.9, 136.8, 133.2, 132.7, 128.7, 128.4, 127.9, 127.8, 127.6, 127.4, 127.2, 127.0, 125.9, 125.5, 120.2, 114.1, 90.9, 85.7, 83.7, 83.5, 70.4, 59.1, 55.8, 53.8, 37.2, 27.1, 26.3, 25.3, 23.2. HRMS (ESI): calcd for C<sub>48</sub>H<sub>49</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup> 788.3924, found 788.3932.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>tert</i>-Butyl 4-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(naphthalen-2-ylmethyl)amino)butanoate (<b>53</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 4-oxobutanoate <b>22</b> (29 mg, 0.18 mmol) and compound <b>32</b> (67 mg, 0.15 mmol) afforded compound <b>53</b> as a white powder (67 mg, 76% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12 (s, 1H), 7.82 (s, 1H), 7.78–7.60 (m, 4H), 7.48–7.35 (m, 3H), 6.74 (s, 2H), 6.02 (s, 1H), 5.34 (m, 1H), 4.89 (m, 1H), 4.38 (m, 1H), 3.79 (d, <i>J</i> = 13.6 Hz, 1H), 3.60 (d, <i>J</i> = 13.6 Hz, 1H), 2.80 (m, 1H), 2.65 (m, 1H), 2.57–2.44 (m, 2H), 2.29–2.13 (m, 2H), 1.75 (p, <i>J</i> = 7.3 Hz, 2H), 1.57 (s, 3H), 1.40–1.08 (m, 12H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.9, 156.0, 152.9, 152.9, 149.0, 139.6, 136.7, 133.2, 132.7, 127.8, 127.6, 127.3, 127.2, 125.9, 125.5, 120.1, 114.1, 90.8, 85.5, 83.7, 83.5, 80.0, 59.2, 55.7, 53.6, 33.0, 28.0, 27.5, 27.1, 25.4, 22.4. HRMS (ESI): calcd for C<sub>32</sub>H<sub>40</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 589.3138, found 589.3143.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>tert</i>-Butyl 5-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(naphthalen-2-ylmethyl)amino)pentanoate (<b>54</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl 5-oxopentanoate <b>23</b> (31 mg, 0.18 mmol) and compound <b>32</b> (67 mg, 0.15 mmol) afforded compound <b>54</b> as a white powder (62 mg, 69% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 7.80 (d, <i>J</i> = 24.4 Hz, 2H), 7.73 (d, <i>J</i> = 8.4 Hz, 2H), 7.64 (s, 1H), 7.47–7.38 (m, 3H), 6.42 (s, 2H), 6.02 (s, 1H), 5.34 (d, <i>J</i> = 6.3 Hz, 1H), 4.90 (m, 1H), 4.42–4.36 (m, 1H), 3.80 (d, <i>J</i> = 13.6 Hz, 1H), 3.62 (d, <i>J</i> = 13.6 Hz, 1H), 2.77 (m, 1H), 2.70–2.62 (m, 1H), 2.54 (s, 2H), 2.15 (t, <i>J</i> = 6.7 Hz, 2H), 1.58 (s, 3H), 1.48 (d, <i>J</i> = 9.8 Hz, 2H), 1.41 (s, 9H), 1.35 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.9, 155.8, 152.9, 149.1, 139.7, 136.8, 133.2, 132.7, 127.7, 127.6, 127.5, 127.3, 127.2, 125.9, 125.5, 120.2, 114.1, 90.9, 85.5, 83.7, 83.6, 83.4, 79.9, 59.1, 55.7, 54.1, 35.3, 28.1, 28.0, 27.1, 26.3, 25.3, 22.8. HRMS (ESI): calcd for C<sub>33</sub>H<sub>42</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 603.3295, found 603.3311.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>tert</i>-Butyl (<i>R</i>)-4-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(naphthalen-2-ylmethyl)amino)-2-((<i>tert</i>-butoxycarbonyl)amino)butanoate (<b>55</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling <i>tert</i>-butyl (<i>R</i>)-2-((<i>tert-</i>butoxycarbonyl)amino)-4-oxobutanoate <b>27</b> (49 mg, 0.18 mmol) and compound <b>32</b> (67 mg, 0.15 mmol) afforded compound <b>55</b> as a white powder (72 mg, 68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (s, 1H), 7.87–7.67 (m, 4H), 7.61 (s, 1H), 7.54–7.39 (m, 3H), 6.27 (d, <i>J</i> = 11.3 Hz, 2H), 6.00 (s, 1H), 5.71–5.61 (m, 1H), 5.30 (d, <i>J</i> = 5.1 Hz, 1H), 4.84 (m, 1H), 4.39–4.34 (m, 1H), 4.23–4.14 (m, 1H), 3.84 (d, <i>J</i> = 13.5 Hz, 1H), 3.59 (d, <i>J</i> = 13.5 Hz, 1H), 2.82 (br, 2H), 2.65 (br, 2H), 2.57–2.51 (m, 1H), 2.06–1.94 (m, 1H), 1.86–1.78 (m, 1H), 1.57 (s, 3H), 1.50–1.18 (m, 21H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.7, 155.4, 152.9, 149.0, 139.7, 136.2, 133.2, 132.7, 127.9, 127.6, 127.6, 127.5, 127.2, 127.1, 125.9, 125.6, 120.1, 114.3, 90.7, 85.3, 83.7, 83.4, 81.6, 79.3, 59.2, 55.7, 52.9, 50.8, 29.4, 28.3, 27.9, 27.9, 27.1, 25.4. HRMS (ESI): calcd for C<sub>33</sub>H<sub>42</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 704.3772, found 704.3777.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 9-((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-((Isopropyl(naphthalen-2-ylmethyl)amino)methyl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)-9<i>H</i>-purin-6-amine (<b>56</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, coupling 5 mL of dry acetone (large excess) and compound <b>32</b> (67 mg, 0.15 mmol) afforded compound <b>56</b> as a white powder (35 mg, 48% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.21 (s, 1H), 7.83–7.68 (m, 5H), 7.53 (m, 1H), 7.47–7.39 (m, 2H), 6.26 (s, 2H), 5.98 (d, <i>J</i> = 2.3 Hz, 1H), 5.32 (m, 1H), 4.85 (m, 1H), 4.32–4.27 (m, 1H), 3.79 (d, <i>J</i> = 13.9 Hz, 1H), 3.64 (d, <i>J</i> = 14.0 Hz, 1H), 3.00–2.93 (m, 1H), 2.78 (m 1H), 2.64 (m, 1H), 1.53 (s, 3H), 1.31 (s, 3H), 1.09 (d, <i>J</i> = 6.6 Hz, 3H), 0.95 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.7, 152.9, 149.1, 139.7, 138.0, 133.2, 132.7, 127.7, 127.6, 127.5, 127.2, 127.0, 125.9, 125.4, 120.2, 113.9, 91.1, 86.2, 83.5, 83.3, 77.3, 54.9, 51.4, 50.4, 27.0, 25.3, 19.2, 16.6. HRMS (ESI): calcd for C<sub>27</sub>H<sub>32</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 489.2614, found 489.2611.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-(((4-Amino-4-oxobutyl)(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)amino)methyl)benzamide (<b>57</b>)</h3><div class="NLM_p last">To a solution of compound <b>33</b> (100 mg, 0.098 mmol) in 5 mL of CH<sub>2</sub>Cl<sub>2</sub> was added 5 mL of TFA, and the mixture was stirred at room temperature. After 2 h, 2 mL of H<sub>2</sub>O was added, and the mixture was stirred for 1 h at room temperature. The mixture was concentrated, and the crude product was purified by preparative HPLC affording compound <b>57</b> as a white powder. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.46–8.06 (m, 2H), 7.87–7.26 (m, 4H), 6.08 (br, 1H), 4.75–4.36 (m, 4H), 4.27 (br, 1H), 3.84–3.27 (m, 4H), 2.38 (br, 2H), 2.10 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 177.5, 162.8, 162.5, 149.6, 143.8, 134.8, 134.1, 132.7, 129.6, 129.1, 128.3, 118.9, 117.6, 114.7, 90.4, 77.7, 73.6, 71.5, 57.9, 54.8, 31.8, 19.0. HRMS (ESI): calcd for C<sub>22</sub>H<sub>28</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup> 485.2261, found 485.2265.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-(((5-Amino-5-oxopentyl)(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl)methyl)amino)methyl)benzamide (<b>58</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>34</b> (50 mg, 0.049 mmol) was deprotected to obtain compound <b>58</b> as a white powder (16 mg, 56% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.43–8.12 (m, 2H), 7.84–7.26 (m, 4H), 6.08 (br, 1H), 4.65–4.21 (m, 5H), 3.63–3.48 (m, 2H), 3.34 (br, 2H), 2.35 (br, 2H), 1.84 (br, 2H), 1.58 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 177.6, 170.6, 162.8, 149.6, 147.3, 143.8, 134.8, 129.7, 129.6, 129.4, 129.1, 128.3, 117.6, 114.7, 90.5, 77.8, 77.4, 71.6, 71.4, 57.8, 54.6, 32.6, 22.4, 21.0. HRMS (ESI): calcd for C<sub>23</sub>H<sub>30</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup> 499.2417, found 499.2420.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-carbamoylbenzyl)amino)butanoic Acid (<b>59</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>35</b> (50 mg, 0.060 mmol) was deprotected to obtain compound <b>59</b> as a white powder (21 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.38–8.06 (m, 2H), 7.71–7.26 (m, 4H), 6.05 (br, 1H), 4.64–4.21 (m, 5H), 3.53 (br, 2H), 3.35 (s, 2H), 2.41 (br, 2H), 2.02 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 176.4, 170.5, 149.6, 147.3, 143.8, 134.8, 132.7, 129.6, 129.5, 128.3, 117.5, 114.6, 90.4, 77.7, 73.5, 71.4, 57.8, 52.8, 38.6, 30.2, 18.4. HRMS (ESI): calcd for C<sub>22</sub>H<sub>28</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 486.2101, found 486.2103.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-carbamoylbenzyl)amino)pentanoic Acid (<b>60</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>36</b> (50 mg, 0.059 mmol) was deprotected to obtain compound <b>60</b> as a white powder (17 mg, 50% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.29 (br, 2H), 7.84–7.58 (m, 3H), 7.46 (br, 1H), 6.13 (br, 1H), 4.70–4.33 (m, 5H), 3.66 (br, 2H), 3.48–3.31 (m, 2H), 2.42 (br, 2H), 1.88 (s, 2H), 1.65 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 177.7, 170.8, 163.0, 150.5, 147.6, 145.1, 143.1, 134.5, 132.9, 129.7, 129.3, 128.4, 119.0, 117.7, 90.3, 77.7, 73.3, 32.8, 22.4, 21.0. HRMS (ESI): calcd for C<sub>23</sub>H<sub>30</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 500.2258, found 500.2267.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)methyl)benzamide (<b>61</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>38</b> (50 mg, 0.069 mmol) was deprotected to obtain compound <b>61</b> as a white powder (22 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>) δ 8.48–8.39 (m, 2H), 8.26 (br, 1H), 7.94 (d, <i>J</i> = 7.8 Hz, 1H), 7.9–7.73 (m, 2H), 7.46 (m, 1H), 6.81 (br, 1H), 6.13 (d, <i>J</i> = 3.4 Hz, 1H), 4.74 (br, 2H), 4.65 (s, 1H), 4.53 (br, 1H), 4.46 (br, 1H), 3.93–3.69 (m, 3H), 3.31 (s, 1H), 1.49–1.45 (m, 6H). <sup>13</sup>C NMR (101 MHz, acetone-<i>d</i><sub>6</sub>) δ 152.7, 148.4, 146.1, 142.5, 135.0, 134.0, 130.5, 130.2, 119.9, 90.6, 79.3, 73.5, 72.5, 55.6, 54.3, 54.0, 51.4, 16.6, 15.0. HRMS (ESI): calcd for C<sub>21</sub>H<sub>28</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup> 442.2203, found 442.2203.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Methyl 3-(((4-Amino-4-oxobutyl)(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)amino)methyl)benzoate (<b>62</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>39</b> (50 mg, 0.064 mmol) was deprotected to obtain compound <b>62</b> as a white powder (20 mg, 53% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.38–7.98 (m, 2H), 7.88–7.50 (m, 3H), 7.35 (br, 1H), 6.05 (br, 1H), 4.64–4.32 (m, 4H), 4.20 (br, 1H), 3.78 (s, 3H), 3.55 (br, 1H), 3.47–3.30 (m, 2H), 2.39 (br, 2H), 2.08 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 177.5, 167.3, 149.5, 147.2, 143.7, 143.6, 135.8, 134.6, 131.3, 130.7, 129.9, 129.8, 129.4, 129.1, 118.8, 90.6, 77.8, 77.4, 73.8, 73.1, 71.7, 71.4, 57.6, 56.9, 55.2, 54.8, 53.6, 52.7, 31.8, 19.0. HRMS (ESI): calcd for C<sub>23</sub>H<sub>29</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 500.2258, found 500.2265.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Methyl 3-(((5-Amino-5-oxopentyl)(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)amino)methyl)benzoate (<b>63</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>40</b> (50 mg, 0.063 mmol) was deprotected to obtain compound <b>63</b> as a white powder (21 mg, 55% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.44–8.07 (m, 2H), 7.96–7.34 (m, 4H), 6.12 (br, 1H), 4.50 (br, 4H), 4.32 (s, 1H), 3.86 (s, 3H), 3.62 (br, 1H), 3.52–3.34 (m, 2H), 2.32 (br, 2H), 1.89 (br, 2H), 1.68 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 178.7, 167.5, 162.6, 149.6, 143.8, 143.6, 135.9, 130.9, 130.0, 129.9, 129.5, 129.1, 117.6, 114.7, 111.8, 71.4, 52.7, 33.9, 22.4, 21.9. HRMS (ESI): calcd for C<sub>24</sub>H<sub>31</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 514.2414, found 514.2415.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(methoxycarbonyl)benzyl)amino)butanoic Acid (<b>64</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>41</b> (50 mg, 0.084 mmol) was deprotected to obtain compound <b>64</b> as a white powder (24 mg, 49% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.29 (s, 1H), 8.11 (s, 1H), 7.94–7.64 (m, 4H), 7.45 (t, <i>J</i> = 7.9 Hz, 1H), 6.09 (s, 1H), 4.62 (br, 4H), 4.49 (br, 1H), 3.88 (s, 3H), 3.67 (br, 2H), 3.55–3.41 (m, 6.9 Hz, 3H), 2.53 (t, <i>J</i> = 6.4 Hz, 2H), 2.18–2.09 (m, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 176.8, 167.6, 150.3, 147.4, 144.8, 143.3, 130.1, 129.8, 129.5, 129.2, 90.5, 77.7, 71.6, 57.7, 52.8, 30.6, 18.5. HRMS (ESI): calcd for C<sub>23</sub>H<sub>28</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 501.2098, found 501.2097.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 5-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(methoxycarbonyl)benzyl)amino)pentanoic Acid (<b>65</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>42</b> (50 mg, 0.082 mmol) was deprotected to obtain compound <b>65</b> as a white powder (30 mg, 59% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.22 (br, 2H), 7.86 (br, 2H), 7.67 (br, 1H), 7.46 (br, 1H), 6.08 (br, 1H), 4.55 (br, 4H), 4.35 (br, 1H), 3.88 (s, 3H), 3.64 (br, 1H), 3.43 (br, 2H), 2.45 (br, 2H), 1.90 (br, 2H), 1.67 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 178.1, 168.0, 150.3, 144.5, 143.8, 130.5, 130.2, 129.9, 129.6, 118.0, 115.1, 72.0, 53.1, 33.1, 23.6, 22.8, 21.4. HRMS (ESI): calcd for C<sub>24</sub>H<sub>30</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 515.2254, found 515.2257.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>S</i>)-2-Amino-4-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(methoxycarbonyl)benzyl)amino)butanoic Acid (<b>66</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>43</b> (50 mg, 0.070 mmol) was deprotected to obtain compound <b>66</b> as a white powder (26 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.24 (s, 1H), 8.01 (s, 1H), 7.72 (br, 1H), 7.64 (d, <i>J</i> = 7.8 Hz, 1H), 7.54 (d, <i>J</i> = 7.8 Hz, 1H), 7.31 (t, <i>J</i> = 7.8 Hz, 1H), 6.03 (s, 1H), 4.56–4.52 (m, 1H), 4.50–4.35 (m, 4H), 4.07 (m, 1H), 3.74 (s, 3H), 3.69–3.54 (m, 4H), 2.55–2.45 (m, 1H), 2.41–2.33 (m, 1H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 170.8, 167.2, 162.7, 162.3, 149.5, 147.2, 143.6, 143.6, 131.0, 130.0, 129.5, 129.3, 129.1, 118.8, 117.6, 114.7, 90.8, 77.5, 73.5, 71.4, 53.9, 50.7, 24.4. HRMS (ESI): calcd for C<sub>23</sub>H<sub>29</sub>N<sub>7</sub>O<sub>7</sub> [M + H]<sup>+</sup> 516.2207, found 516.2206.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 3-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)methyl)benzoate (<b>67</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>44</b> (50 mg, 0.101 mmol) was deprotected to obtain compound <b>67</b> as a white powder (33 mg, 59% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.19 (d, <i>J</i> = 3.9 Hz, 1H), 7.99–7.54 (m, 4H), 7.29 (t, <i>J</i> = 7.6 Hz, 1H), 5.91 (s, 1H), 4.62–4.46 (m, 3H), 4.33–4.25 (m, 1H), 4.20 (br, 1H), 3.87 (s, 3H), 3.79–3.62 (m, 2H), 3.39–3.28 (m, 1H), 1.54–1.37 (m, 6H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 167.6, 149.7, 147.3, 144.1, 143.3, 136.1, 131.3, 130.1, 129.7, 128.7, 118.7, 114.8, 90.6, 78.6, 73.6, 71.4, 58.7, 55.2, 52.7, 50.5, 16.2, 15.7. HRMS (ESI): calcd for C<sub>22</sub>H<sub>28</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 457.2199, found 457.2196.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-(((4-Amino-4-oxobutyl)(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)amino)methyl)benzoic Acid (<b>68</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>45</b> (50 mg, 0.061 mmol) was deprotected to obtain compound <b>68</b> as a white powder (15 mg, 42% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.21 (br, 2H), 7.86 (br, 2H), 7.65 (d, <i>J</i> = 7.6 Hz, 1H), 7.43 (br, 1H), 6.08 (br, 1H), 4.70–4.24 (m, 5H), 3.63 (br, 1H), 3.52–3.38 (m, 2H), 2.48 (br, 2H), 2.12 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 177.5, 149.8, 147.4, 144.0, 143.6, 131.2, 130.3, 129.9, 129.1, 117.7, 114.8, 90.5, 77.7, 71.5, 31.8, 19.1. HRMS (ESI): calcd for C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 486.2101, found 486.2089.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-(((5-Amino-5-oxopentyl)(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)amino)methyl)benzoic Acid (<b>69</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>46</b> (50 mg, 0.059 mmol) was deprotected to obtain compound <b>69</b> as a white powder (19 mg, 65% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.19 (br, 2H), 7.83 (br, 2H), 7.63 (br, 1H), 7.40 (br, 1H), 6.03 (br, 1H), 4.58–4.41 (m, 4H), 4.31 (br, 1H), 3.63 (br, 1H), 3.42 (d, <i>J</i> = 7.8 Hz, 2H), 2.34 (br, 2H), 1.90 (br, 2H), 1.68 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 178.7, 149.7, 143.9, 143.5, 130.3, 129.8, 129.8, 129.1, 120.6, 117.7, 114.8, 105.0, 77.9, 71.5, 33.9, 21.9. HRMS (ESI): calcd for C<sub>23</sub>H<sub>30</sub>N<sub>7</sub>O<sub>6</sub> [M + H]<sup>+</sup> 500.2258, found 500.2253.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 3-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-carboxypropyl)amino)methyl)benzoic Acid (<b>70</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>47</b> (50 mg, 0.078 mmol) was deprotected to obtain compound <b>70</b> as a white powder (21 mg, 46% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.27 (s, 1H), 8.14 (s, 1H), 7.85 (br, 2H), 7.64 (d, <i>J</i> = 7.7 Hz, 1H), 7.49–7.35 (m, 1H), 6.08 (br, 1H), 4.55 (br, 5H), 3.65 (br, 1H), 3.48–3.43 (m, 2H), 2.52 (br, 2H), 2.13 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 176.6, 168.8, 149.8, 147.4, 144.0, 143.5, 131.4, 130.4, 129.7, 129.1, 117.7, 114.8, 90.5, 77.7, 71.6, 30.4, 22.1, 18.5. HRMS (ESI): calcd for C<sub>22</sub>H<sub>27</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 487.1941, found 487.1945.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 3-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(4-carboxybutyl)amino)methyl)benzoic Acid (<b>71</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>48</b> (50 mg, 0.076 mmol) was deprotected to obtain compound <b>71</b> as a white powder (24 mg, 52% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.20 (br, 2H), 7.83 (br, 2H), 7.63 (d, <i>J</i> = 7.5 Hz, 1H), 7.42 (br, 1H), 6.05 (br, 1H), 4.53 (br, 4H), 4.31 (br, 1H), 3.63 (br, 1H), 3.49–3.32 (m, 2H), 2.42 (br, 2H), 1.88 (br, 2H), 1.66 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 177.7, 150.0, 144.3, 143.4, 131.4, 130.4, 130.1, 129.7, 129.1, 117.7, 114.8, 90.4, 77.7, 71.6, 32.7, 22.4, 21.0. HRMS (ESI): calcd for C<sub>23</sub>H<sub>29</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup> 501.2098, found 501.2096.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 3-((((<i>S</i>)-3-Amino-3-carboxypropyl)(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)amino)methyl)benzoic Acid (<b>72</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>49</b> (50 mg, 0.066 mmol) was deprotected to obtain compound <b>72</b> as a white powder (24 mg, 61% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.23 (bs, 1H), 8.06 (s, 1H), 7.76 (s, 1H), 7.69 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.33 (t, <i>J</i> = 7.8 Hz, 1H), 6.06–5.98 (m, 1H), 4.59–4.34 (m, 5H), 4.06 (m, 1H), 3.72–3.51 (m, 4H), 2.55–2.4 (m, 1H), 2.40–2.32 (m, 1H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 171.0, 168.4, 162.8, 162.4, 149.5, 147.3, 143.7, 143.5, 131.3, 130.3, 129.7, 129.5, 129.1, 118.9, 117.6, 114.7, 90.6, 77.5, 73.5, 71.5, 50.9, 24.4. HRMS (ESI): calcd for C<sub>22</sub>H<sub>27</sub>N<sub>7</sub>O<sub>7</sub> [M + H]<sup>+</sup> 502.2050, found 502.2048.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 3-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)methyl)benzoic Acid (<b>73</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>50</b> (50 mg, 0.093 mmol) was deprotected to obtain compound <b>73</b> as a white powder (27 mg, 54% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.21 (s, 1H), 8.16 (s, 1H), 7.90 (s, 1H), 7.58 (m, 2H), 7.27 (t, <i>J</i> = 7.3 Hz, 1H), 5.89 (s, 1H), 4.55 (t, <i>J</i> = 10.4 Hz, 2H), 4.31–4.15 (m, 2H), 3.98–3.90 (m, 1H), 3.78 (br, 1H), 3.32 (br, 1H), 1.50 (m, 6H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 215.3, 168.7, 149.9, 147.3, 144.4, 143.1, 136.1, 131.7, 129.9, 128.7, 118.7, 117.7, 114.8, 89.7, 78.5, 73.5, 71.4, 58.8, 55.3, 51.7, 30.1, 16.2, 15.7. HRMS (ESI): calcd for C<sub>21</sub>H<sub>26</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 443.2043, found 443.2040.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 4-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(naphthalen-2-ylmethyl)amino)butanamide (<b>74</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>51</b> (50 mg, 0.064 mmol) was deprotected to obtain compound <b>74</b> as a white powder (22 mg, 58% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.11 (br, 1H), 7.57–7.25 (m, 4H), 7.09 (d, <i>J</i> = 8.0 Hz, 1H), 5.89 (br, 1H), 4.35 (br, 4H), 3.94–3.63 (m, 1H), 3.49–3.22 (m, 3H), 2.44 (br, 2H), 2.13–1.82 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 177.5, 148.4, 146.0, 143.3, 142.3, 132.1, 131.6, 129.5, 128.0, 127.7, 127.2, 127.0, 126.8, 126.7, 125.1, 118.0, 90.6, 77.8, 74.1, 71.2, 58.0, 55.9, 54.9, 32.0, 19.0. HRMS (ESI): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup> 492.2359, found 492.2363.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 5-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(naphthalen-2-ylmethyl)amino)pentanamide (<b>75</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>52</b> (50 mg, 0.063 mmol) was deprotected to obtain compound <b>75</b> as a white powder (23 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.11 (s, 1H), 7.72–7.61 (m, 2H), 7.55–7.48 (m, 2H), 7.46–7.39 (m, 1H), 7.37–7.15 (m, 2H), 5.89 (br, 1H), 4.66–4.48 (m, 2H), 4.42–4.11 (m, 3H), 3.61–3.33 (m, 4H), 2.43–2.27 (m, 2H), 1.89 (d, <i>J</i> = 9.8 Hz, 2H), 1.77–1.61 (m, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 178.8, 148.6, 146.3, 143.8, 143.4, 142.7, 142.2, 132.4, 131.8, 129.9, 128.2, 127.8, 127.4, 126.8, 125.1, 90.7, 78.1, 74.2, 71.3, 58.6, 57.8, 55.8, 54.6, 34.0, 22.5, 22.0. HRMS (ESI): calcd for C<sub>26</sub>H<sub>31</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup> 506.2516, found 506.2520.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(naphthalen-2-ylmethyl)amino)butanoic Acid (<b>76</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>53</b> (50 mg, 0.085 mmol) was deprotected to obtain compound <b>76</b> as a white powder (30 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.14 (br, 1H), 7.75–7.23 (m, 8H), 5.95 (br, 1H), 4.62–4.54 (m, 1H), 4.43–4.26 (m, 4H), 3.69–3.53 (m, 2H), 3.45 (m, 2H), 2.54 (t, <i>J</i> = 6.5 Hz, 2H), 2.19–2.04 (m, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 179.8, 179.8, 152.0, 149.1, 146.3, 145.7, 134.9, 134.4, 132.5, 130.6, 129.9, 129.8, 129.3, 121.0, 120.2, 117.3, 93.3, 80.2, 74.2, 60.8, 33.6, 21.4. HRMS (ESI): calcd for C<sub>23</sub>H<sub>30</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup> 493.2199, found 493.2199.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 5-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(naphthalen-2-ylmethyl)amino)pentanoic Acid (<b>77</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>54</b> (50 mg, 0.083 mmol) was deprotected to obtain compound <b>77</b> as a white powder (31 mg, 61% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.27 (br, 2H), 7.86–7.55 (m, 5H), 7.52–7.47 (m, 1H), 7.40 (d, <i>J</i> = 7.7 Hz, 1H), 5.95 (s, 1H), 4.66–4.40 (m, 4H), 4.31 (br, 1H), 3.70–3.43 (m, 4H), 2.50 (br, 2H), 1.97 (br, 2H), 1.80–1.67 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 178.0, 163.0, 162.7, 149.5, 146.6, 143.8, 143.1, 132.4, 131.9, 130.0, 128.0, 127.3, 127.2, 126.8, 117.7, 38.6, 32.9, 21.2. HRMS (ESI): calcd for C<sub>26</sub>H<sub>28</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup> 507.2356, found 507.2355.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (<i>S</i>)-2-Amino-4-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(naphthalen-2-ylmethyl)amino)butanoic Acid (<b>78</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>55</b> (50 mg, 0.071 mmol) was deprotected to obtain compound <b>78</b> as a white powder (28 mg, 65% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.03 (bs, 2H), 7.54–6.97 (m, 7H), 5.83 (bs, 1H), 4.55–4.25 (m, 3H), 4.24–4.16 (m, 1H), 4.16–4.09 (m, 1H), 3.65 (s, 2H), 3.49 (s, 1H), 2.46 (br, 2H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 170.8, 148.3, 146.0, 143.3, 142.2, 132.0, 131.5, 129.7, 127.1, 126.9, 126.6, 126.3, 118.2, 117.6, 114.7, 90.9, 77.5, 73.8, 71.4, 50.7, 24.5. HRMS (ESI): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>7</sub>O<sub>5</sub> [M + H]<sup>+</sup> 508.2308, found 508.2309.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2-(6-Amino-9<i>H</i>-purin-9-yl)-5-((isopropyl(naphthalen-2-ylmethyl)amino)methyl)tetrahydrofuran-3,4-diol (<b>79</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>56</b> (50 mg, 0.102 mmol) was deprotected to obtain compound <b>79</b> as a white powder (36 mg, 65% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.86 (s, 1H), 7.64–7.47 (m, 2H), 7.42–7.10 (m, 6H), 5.58 (s, 1H), 4.41–4.35 (m, 1H), 4.29 (br, 1H), 4.16–4.04 (m, 2H), 3.92 (br, 1H), 3.80–3.73(m, 1H), 3.58 (br, 1H), 3.24 (m, 1H), 1.35 (m, 6H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 148.7, 146.3, 143.6, 143.0, 142.6, 132.2, 131.7, 130.4, 128.3, 127.5, 127.4, 118.0, 90.0, 77.5, 73.9, 71.9, 59.1, 51.7, 49.6, 17.4, 15.9. HRMS (ESI): calcd for C<sub>24</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 449.2301, found 449.2299.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>tert</i>-Butyl (<i>S</i>)<i>-</i>4-((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)<i>-</i>6-(6-Amino-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydro-furo-[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl)(naphthalen-2-ylmethyl)amino)-2-bis((<i>tert</i>-butoxycarbonyl)amino)pentanoate (<b>80</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>33</b>, <i>tert</i>-butyl (<i>R</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)-5-oxopentanoate <b>28</b> (312 mg, 0.80 mmol) and compound <b>32</b> (300 mg, 0.67 mmol) were coupled to obtain compound <b>80</b> as a white powder (319 mg, 58% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (s, 1H), 7.79 (s, 1H), 7.73 m, (1H), 7.68 (d, <i>J</i> = 8.6 Hz, 2H), 7.61 (s, 1H), 7.45–7.34 (m, 3H), 6.59 (s, 2H), 5.98 (d, <i>J</i> = 2.2 Hz, 1H), 5.27 (dd, <i>J</i> = 6.4, 2.2 Hz, 1H), 4.84 (dd, <i>J</i> = 6.4, 3.1 Hz, 1H), 4.69 (dd, <i>J</i> = 9.6, 5.2 Hz, 1H), 4.37 (m, 1H), 3.80 (br, 1H), 3.57 (br, 1H), 2.76 (m, 1H), 2.64–2.47 (m, 3H), 2.04 (m, 1H), 1.83 (m, 1H), 1.54 (s, 3H), 1.43 (s, 16H), 1.41 (s, 8H), 1.31 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.9, 152.9, 152.5, 139.5, 127.7, 127.5, 127.3, 127.2, 125.8, 125.5, 90.8, 85.4, 83.6, 83.41, 82.6, 81.0, 59.0, 55.6, 54.0, 28.0, 27.1, 27.0, 25.3, 23.8. HRMS (ESI): calcd for C<sub>43</sub>H<sub>59</sub>N<sub>7</sub>O<sub>9</sub> [M + H]<sup>+</sup> 818.4453, found 818.4458.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (<i>S</i>)-2-Amino-5-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(naphthalen-2-ylmethyl)amino)pentanoic Acid (<b>81</b>)</h3><div class="NLM_p last">Following the procedure described for compound <b>57</b>, compound <b>80</b> (120 mg, 0.15 mmol) was deprotected to obtain compound <b>81</b> as a white powder (58 mg, 63% yield). <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ 8.14 (br, 1H), 7.69–6.93 (m, 8H), 5.93 (br, 1H), 4.59–4.43 (m, 2H), 4.27 (br, 2H), 4.15–3.73 (m, 2H), 3.47 (m, 4H), 2.16–1.90 (m, 4H). <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ 171.6, 162.9, 162.7, 148.6, 131.8 127.3, 127.1, 126.8, 119.2, 117.3, 115.3, 90.7, 78.0, 74.3, 71.3, 58.8, 52.3, 26.9, 19.4. HRMS (ESI): calcd for C<sub>26</sub>H<sub>31</sub>N<sub>7</sub>O<sub>5</sub> [M + H]<sup>+</sup> 522.2465, found 522.2468.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Inhibition Studies</h3><div class="NLM_p">Expression and purification of full-length wild-type NNMT protein (NNMTwt) were performed as previously described.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The purity of the enzyme was confirmed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie blue staining, and NNMT identity was confirmed using SDS-PAGE and Western blotting. Catalytic activity of the recombinant protein was evaluated with 1 unit of enzyme activity representing the formation of 1 nmol of MNA/h of incubation at 37 °C. The specific activity of the batch used in the inhibitory activity assays was 18 665 units/mg of protein at a protein concentration of 0.56 mg/mL. NNMT was used at a final concentration of 100 nM diluted in assay buffer (50 mM Tris buffer (pH 8.4) and 1 mM dithiothreitol). The compounds were dissolved in DMSO and diluted with water to concentrations ranging from 0.1 to 500 μM (DMSO was kept constant at 1.25% final concentration). The compounds were incubated with the enzyme for 10 min at 37 °C before initiating the reaction with a mixture of NA and AdoMet at their <i>K</i><sub>M</sub> values of 200 and 8.5 μM, respectively. The formation of MNA was measured after 30 min at 37 °C. The reaction was quenched by addition of 15 μL of the sample to 70 μL of acetonitrile containing 50 nM deutero-methylated nicotinamide as internal standard. The enzymatic activity assays were performed using UHP-HILIC-MS/MS as previously described with minor modifications.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The UHP-HILIC-MS/MS system consisted of a binary ultra-HPLC system, consisting of two LC-30AD pumps, a SIL30-ACmp auto-sampler, a CTO-20AC column oven, and a DGU-20A5R degasser (all from Shimadzu, ’s-Hertogenbosch, The Netherlands). Isocratic elution was performed after 1 μL injections on a Waters Acquity BEH Amide HILIC column (3.0 × 100 mm, 1.7 μm particle size, Waters, Milford), using water containing 300 μM formic acid and 550 μM NH<sub>4</sub>OH (pH 9.2) at 40% v/v and acetonitrile at 60% v/v, with a runtime of 3 min. Calibration samples were prepared using 75 μL of internal standard <i>d</i><sub>3</sub>-MNA at 50 nM in acetonitrile and 25 μL of an aqueous solution of reference standard MNA with concentrations ranging from 2500 to 1.221 nM. For detection, a Sciex QTRAP 5500 triple quadrupole mass spectrometer, with Analyst 1.6.2 and MultiQuant 3.0.1 software (Sciex, Ontario, Canada), was used. Settings used for the ionization source were as follows: curtain gas, 40 psi; collision gas, “medium”; ionspray voltage, 5000 V; temperature, 600 °C; ion source gas 1, 60 psi; and ion source gas 2, 80 psi. Dwell times were 10 ms, and the entrance potential was set to 10 V; specific parameters of the compounds can be found in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The whole eluate was transferred to the electrospray probe from 1.0 till 2.8 min using the MS diverter valve. Ratios of the sums of the MNA and <i>d</i><sub>3</sub>-MNA transitions were calculated and plotted versus concentration.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Tuned MS/MS Parameters for All Quantified Components<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">Q1 (<i>m</i>/<i>z</i>)</th><th class="colsep0 rowsep0" align="center" char=".">Q3 (<i>m</i>/<i>z</i>)</th><th class="colsep0 rowsep0" align="center" char=".">DP</th><th class="colsep0 rowsep0" align="center" char=".">CE</th><th class="colsep0 rowsep0" align="center" char=".">CXP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MNA</td><td class="colsep0 rowsep0" align="char" char=".">137.101</td><td class="colsep0 rowsep0" align="char" char=".">94.0</td><td class="colsep0 rowsep0" align="char" char=".">136</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">92.0</td><td class="colsep0 rowsep0" align="char" char=".">136</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">78.0</td><td class="colsep0 rowsep0" align="char" char=".">136</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MNA-<i>d</i><sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">140.128</td><td class="colsep0 rowsep0" align="char" char=".">97.1</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">95.1</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">78.0</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The entrance potential was set at 10 V for all compounds, dwell time was 10 ms.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Q1: quadrupole 1, Q3: quadrupole 3, <i>z</i>: charge, DP: declustering potential, CE: collision energy, CXP: collision cell exit potential.</p></div></div></div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Isothermal Titration Calorimetry</h3><div class="NLM_p last">Expression and purification of full-length wild-type NNMT protein (NNMTwt) were performed as previously described.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Isothermal titration calorimetry (ITC) measurements were made at 25 °C on a MicroCal ITC200 Instrument (Malvern Instruments) with 2 μL injections. NNMTwt was diluted at 200 μM in ITC buffer [50 mM Tris (pH 8.0), 150 mM NaCl] supplemented with 4% DMSO. Compounds were dissolved in DMSO at 50 mM and diluted to 2 mM in ITC buffer with a final DMSO concentration of 4%. Binding constants were calculated by fitting the data using the ITC data analysis module in Origin 7.0 (OriginLab Corp.).</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Modeling Studies</h3><div class="NLM_p last">Docking computations were performed using Autodock 4.2.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compounds <b>1</b>, <b>2</b>, <b>78</b>, and <b>81</b> were docked into the catalytic pocket of the structure taken from PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ROD">3ROD</a>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Four molecular dynamic simulations were performed with GROMACS 2018.2<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> using the AMBER03 force field.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Each structure was immersed in a cubic box using TIP3P water molecules<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and neutralized with counter ions. A production step of 250 ns was carried out using the Parrinello–Rahman algorithm<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> for temperature and pressure control, with coupling constants of <i>T</i> = 0.1 ps and <i>P</i> = 2.0 ps, for compounds <b>1</b>, <b>2</b>, and <b>81</b> and extended to 450 ns for compound <b>78</b>, to reach equilibrium of the system. Coordinates were saved every 200 ps, and the protein/ligand binding energy was estimated using g_mmpbsa calculations<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> on the last 50 ns of each trajectory. The conformation of minimal energy in these 50 ns was extracted from the simulations and minimized to represent the interactions between the ligands and NNMT protein.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Enzyme Assay for Selectivity</h3><div class="NLM_p last">Methyltransferase inhibition assays were performed as described<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> by using commercially available chemiluminescent assay kits for PRMT1 and NSD2 (purchased from BPS Bioscience). The enzymatic reactions were conducted in duplicate at room temperature for 1 h (PRMT1) or 2 h (NSD2) in substrate-coated well plates at a final reaction volume of 50 μL containing the manufacturer’s proprietary assay buffer, AdoMet (at a concentration of 5 times the respective <i>K</i><sub>m</sub> value for each enzyme), the methyltransferase enzyme: PRMT1 (100 ng per reaction) and NSD2 (500 ng per reaction), and inhibitor <b>78</b>. Before addition of AdoMet, the enzyme was first incubated with the inhibitor for 15 min at room temperature. Positive controls were performed in the absence of the inhibitor using water to keep the final volume consistent. Blanks and substrate controls were performed in the absence of the enzyme and AdoMet, respectively. Following the enzymatic reactions, 100 μL of primary antibody (recognizing the respective immobilized methylated product) was added to each well, and the plate was incubated at room temperature for an additional 1 h. Then, 100 μL of secondary horseradish peroxidase (HRP)-conjugated antibody was added to each well, and the plate was incubated at room temperature for additional 30 min. Finally, 100 μL of an HRP substrate mixture was added to the wells, and the luminescence was measured directly by using a standard microplate reader. The luminescence data were normalized with the positive controls defined as 100% activity and blank defined as 0%.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Cell Culture and Treatment with Compounds</h3><div class="NLM_p">The HSC-2 human oral cancer cell line was purchased from the American Type Culture Collection (Rockville, MD) and cultured in Dulbecco’s modified Eagle’s medium/F12 medium, supplemented with 10% fetal bovine serum and 50 μg/mL gentamicin, at 37 °C in a humidified 5% CO<sub>2</sub> incubator. Compounds <b>1</b>, <b>2</b>, <b>78</b>, and <b>81</b> were tested for their inhibitory effect on cell proliferation of HSC-2 cells. Each compound was dissolved in DMSO at 100 mM concentration. This stock solution was then diluted in culture medium to final concentration values ranging between 1 and 100 μM. For each sample, DMSO was kept constant at 0.1% final concentration.</div><div class="NLM_p last">The day before starting treatment, cells were seeded in 96-well plates, at a density of 1 × 10<sup>3</sup> cells/well. Cells were allowed to attach overnight and then incubated with compounds at different final concentrations, or with only DMSO, for 24, 48, and 72 h. All experiments were performed in triplicate.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> MTT Assay</h3><div class="NLM_p last">Cell proliferation was determined using a colorimetric assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). The MTT assay measures the conversion of MTT to insoluble formazan by dehydrogenase enzymes of the intact mitochondria of living cells. HSC-2 cell proliferation was evaluated by measuring the conversion of the tetrazolium salt MTT to formazan crystals upon treatment with compounds or only DMSO for 24, 48, and 72 h. Briefly, cells were incubated for 2 h at 37 °C with 100 μL of fresh culture medium containing 5 μL of the MTT reagent (5 mg/mL in PBS). The medium was removed, and 200 μL of isopropanol were added. The amount of formazan crystals formed correlated directly with the number of viable cells. The reaction product was quantified by measuring the absorbance at 540 nm using an enzyme-linked immunosorbent assay plate reader. Experiments were repeated three times. Results were expressed as percentage of the control (control equals 100% and corresponds to the absorbance value of each sample at time zero) and presented as mean values ± standard deviation of three independent experiments performed in triplicate. Data were analyzed using GraphPad Prism software (GraphPad Software, San Diego, CA). Significant differences between groups were determined using the one-way analysis of variance. A <i>p</i> value <0.05 was considered as statistically significant.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Quantitative Measurements of MNA Levels in Cultured Cells</h3><div class="NLM_p last">The analysis was performed as previously described<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> with minor modifications. Cellular MNA levels were determined using the same UHP-HILIC-MS/MS employed for the inhibition studies, as described above. To determine the effect of compound <b>78</b> on NNMT activity in the HSC-2 oral cancer cell line, used cells were treated with <b>78</b> at 100 μM (final DMSO content 0.1%) and incubated for 24, 48, or 72 h. The day prior to starting treatment, cells were seeded in 6-well plates, at a density of 3 × 10<sup>4</sup> cells/well. Cells were allowed to attach overnight and were then incubated with compound <b>78</b>. All experiments were performed in duplicate. Following treatment, medium was removed, and adherent cells were trypsinized and harvested by centrifugation at 1000<i>g</i> for 3 min at 4 °C. Supernatant was then discarded and cell pellets were stored at −80 °C until further use. The extraction of MNA from the cell pellets was performed as previously described.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Briefly, 100 μL of acetonitrile containing 50 nM <i>d</i><sub>3</sub>-MNA (as internal control) was added to the cell pellets, and the cells were lyzed for 20 min at room temperature with mild shaking. Then, 50 μL of purified water was added, followed by mixing, and the resulting cell debris was centrifuged for 10 min at 5000 rpm. Then, 100 μL of the resulting supernatant was transferred to a 96-well plate and analyzed for MNA content.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00413" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00413" class="ext-link">10.1021/acs.jmedchem.9b00413</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Analytical data for all new compounds including <sup>1</sup>H and <sup>13</sup>C NMR spectra; supporting figures for enzyme inhibition curves, molecular modeling results, and cellular MNA determination; supporting tables for selectivity assays and estimated binding energies (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf">jm9b00413_si_001.pdf (7.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_002.csv">jm9b00413_si_002.csv (2.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00413" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathaniel I. Martin</span> - <span class="hlFld-Affiliation affiliation">Biological
Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg
72, 2333 BE Leiden, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8246-3006" title="Orcid link">http://orcid.org/0000-0001-8246-3006</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bed090d790d3dfcccad7d0fedcd7d1d2d1d9c790d2dbd7dadbd0cbd0d7c890d0d2"><span class="__cf_email__" data-cfemail="9af4b4f3b4f7fbe8eef3f4daf8f3f5f6f5fde3b4f6fff3fefff4eff4f3ecb4f4f6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongzhi Gao</span> - <span class="hlFld-Affiliation affiliation">Biological
Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg
72, 2333 BE Leiden, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthijs J. van Haren</span> - <span class="hlFld-Affiliation affiliation">Biological
Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg
72, 2333 BE Leiden, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ed E. Moret</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology &
Drug Discovery Group and , Utrecht Institute for
Pharmaceutical Sciences, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johannes J. M. Rood</span> - <span class="hlFld-Affiliation affiliation">Pharmacoepidemiology & Clinical
Pharmacology Group and , Utrecht Institute for
Pharmaceutical Sciences, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Davide Sartini</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Sciences, Universitá
Politecnica delle Marche, Via Ranieri 65, 60131 Ancona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessia Salvucci</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Sciences, Universitá
Politecnica delle Marche, Via Ranieri 65, 60131 Ancona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Emanuelli</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Sciences, Universitá
Politecnica delle Marche, Via Ranieri 65, 60131 Ancona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierrick Craveur</span> - <span class="hlFld-Affiliation affiliation"> Synsight, Genopole Entreprises, 4 Rue Pierre Fontaine, 91000 Évry, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Babault</span> - <span class="hlFld-Affiliation affiliation"> Synsight, Genopole Entreprises, 4 Rue Pierre Fontaine, 91000 Évry, France</span>; 
    <span class="hlFld-Affiliation affiliation">Center for
Chemical Biology and Drug Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Jin</span> - <span class="hlFld-Affiliation affiliation">Center for
Chemical Biology and Drug Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2387-3862" title="Orcid link">http://orcid.org/0000-0002-2387-3862</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.G. and M.J.v.H. contributed equally to this work.</p><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>Yongzhi Gao gratefully acknowledges the financial support provided by a scholarship from the Chinese Scholarship Council (CSC, file No. 201506270162). Jian Jin acknowledges support by grants R01CA218600, R01CA230854, R01GM122749 and R01HD088626 from the U.S. National Institutes of Health.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">DIBAL-H</td><td class="NLM_def"><p class="first last">diisobutylaluminum hydride</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>d</sub></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">MNA</td><td class="NLM_def"><p class="first last">1-methyl-nicotinamide</p></td></tr><tr><td class="NLM_term">NA</td><td class="NLM_def"><p class="first last">nicotinamide</p></td></tr><tr><td class="NLM_term">NNMT</td><td class="NLM_def"><p class="first last">nicotinamide <i>N</i>-methyltransferase</p></td></tr><tr><td class="NLM_term">NNMTwt</td><td class="NLM_def"><p class="first last">wild-type NNMT</p></td></tr><tr><td class="NLM_term">PDC</td><td class="NLM_def"><p class="first last">pyridinium dichromate</p></td></tr><tr><td class="NLM_term">SAH</td><td class="NLM_def"><p class="first last"><i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-homocysteine</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last"><i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine</p></td></tr><tr><td class="NLM_term">Trt</td><td class="NLM_def"><p class="first last">triphenylmethyl (trityl)</p></td></tr><tr><td class="NLM_term">UHP-HILIC</td><td class="NLM_def"><p class="first last">ultra-high-performance hydrophilic liquid interaction chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alston, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeles, R. H.</span></span> <span> </span><span class="NLM_article-title">Substrate Specificity of Nicotinamide Methyltransferase Isolated from Porcine Liver</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(88)90487-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2F0003-9861%2888%2990487-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=2963591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1elu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1988&pages=601-608&author=T.+A.+Alstonauthor=R.+H.+Abeles&title=Substrate+Specificity+of+Nicotinamide+Methyltransferase+Isolated+from+Porcine+Liver&doi=10.1016%2F0003-9861%2888%2990487-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of nicotinamide methyltransferase isolated from porcine liver</span></div><div class="casAuthors">Alston, Theodore A.; Abeles, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">601-8</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Nicotinamide methyltransferase (EC 2.1.1.1) was purified >1300-fold from porcine liver.  The enzyme is electrophoretically homogeneous, exhibiting a relative mol. wt. of 27,000.  In addn. to acting on nicotinamide and close structural analogs such as thionicotinamide and 3-acetylpyridine, the enzyme actively accommodates poor analogs such as quinoline, isoquinoline, and 1,2,3,4-tetrahydroisoquinoline as Me group acceptors.  Thus, the enzyme may detoxify numerous alkaloids in vivo.  In some cases, this enzyme might paradoxically increase toxicities of substrates, but the hepatotoxic antibiotic pyrazinamide, which is considered as a potential enzyme-activated electrophile, did not function detectably as a substrate for the isolated enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApJV903Z9o7Vg90H21EOLACvtfcHk0lgPU77yBuuAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1elu7c%253D&md5=ff4b08c064606a2373a4fa5164c837ba</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2888%2990487-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252888%252990487-0%26sid%3Dliteratum%253Aachs%26aulast%3DAlston%26aufirst%3DT.%2BA.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DSubstrate%2520Specificity%2520of%2520Nicotinamide%2520Methyltransferase%2520Isolated%2520from%2520Porcine%2520Liver%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1988%26volume%3D260%26spage%3D601%26epage%3D608%26doi%3D10.1016%2F0003-9861%2888%2990487-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toraño, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N -Methyltransferase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5307</span>– <span class="NLM_lpage">5315</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.6b00733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.6b00733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWntL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=5307-5315&author=M.+J.+van%0AHarenauthor=J.+S.+Tora%C3%B1oauthor=D.+Sartiniauthor=M.+Emanuelliauthor=R.+B.+Parsonsauthor=N.+I.+Martin&title=A+Rapid+and+Efficient+Assay+for+the+Characterization+of+Substrates+and+Inhibitors+of+Nicotinamide+N+-Methyltransferase&doi=10.1021%2Facs.biochem.6b00733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and efficient assay for the characterization of substrates and inhibitors of nicotinamide N-methyltransferase</span></div><div class="casAuthors">van Haren, Matthijs J.; Sastre Torano, Javier; Sartini, Davide; Emanuelli, Monica; Parsons, Richard B.; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5307-5315</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is one of the most abundant small mol. methyltransferases in the human body and is primarily responsible for the N-methylation of the nicotinamide (vitamin B3).  Employing the cofactor, S-adenosyl-L-methionine, NNMT transfers a Me group to the pyridine N atom of nicotinamide to generate N-methylnicotinamide.  Interestingly, NNMT is also able to N-methylate a variety of other pyridine-contg. small mols., suggesting a secondary role for the enzyme in the detoxification of xenobiotics.  A no. of recent studies have also revealed links between NNMT overexpression and a variety of diseases, including multiple cancers, Parkinson's disease, diabetes, and obesity.  Here, to facilitate further study of both the substrate scope and potential for inhibitor development, the authors describe the development of a new activity assay for human NNMT.  The assay makes use of ultra-high-performance hydrophilic interaction chromatog., allowing for the rapid sepn. of the reaction products, coupled with quadrupole time-of-flight mass spectrometric detection, providing for enhanced sensitivity and enabling high-throughput sample anal.  The authors successfully demonstrate the general applicability of the method by performing kinetic analyses of NNMT-mediated methylation for a range of pyridine-based substrates.  These findings also provide new insight into the diversity of substrate recognition by NNMT in a quant. manner.  In addn., the authors further established the suitability of the assay for the identification and characterization of small mol. inhibitors of NNMT.  To do so, the authors investigated the inhibition of NNMT by the nonspecific methyltransferase inhibitors, sinefungin and S-adenosyl-L-homocysteine, revealing IC50 values in the low micromolar range.  The results of these inhibition studies are particularly noteworthy as they will permit future efforts toward the development of new NNMT-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBC8U-yKb1brVg90H21EOLACvtfcHk0lgPU77yBuuAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWntL7O&md5=0ebb58b665b91dd5983b2bef91886c10</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.6b00733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.6b00733%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DTora%25C3%25B1o%26aufirst%3DJ.%2BS.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DA%2520Rapid%2520and%2520Efficient%2520Assay%2520for%2520the%2520Characterization%2520of%2520Substrates%2520and%2520Inhibitors%2520of%2520Nicotinamide%2520N%2520-Methyltransferase%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D5307%26epage%3D5315%26doi%3D10.1021%2Facs.biochem.6b00733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mountford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Catalyses the N-Methylation of the Endogenous-Carboline Norharman: Evidence for a Novel Detoxification Pathway</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>473</i></span>,  <span class="NLM_fpage">3253</span>– <span class="NLM_lpage">3267</span>, <span class="refDoi"> DOI: 10.1042/BCJ20160219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1042%2FBCJ20160219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=27389312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2016&pages=3253-3267&author=M.+G.+Thomasauthor=D.+Sartiniauthor=M.+Emanuelliauthor=M.+J.+van+Harenauthor=N.+I.+Martinauthor=D.+M.+Mountfordauthor=D.+J.+Barlowauthor=F.+Klamtauthor=D.+B.+Ramsdenauthor=M.+Rezaauthor=R.+B.+Parsons&title=Nicotinamide+N-Methyltransferase+Catalyses+the+N-Methylation+of+the+Endogenous-Carboline+Norharman%3A+Evidence+for+a+Novel+Detoxification+Pathway&doi=10.1042%2FBCJ20160219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase catalyses the N-methylation of the endogenous β-carboline norharman: evidence for a novel detoxification pathway</span></div><div class="casAuthors">Thomas, Martin G.; Sartini, Davide; Emanuelli, Monica; van Haren, Matthijs J.; Martin, Nathaniel I.; Mountford, David M.; Barlow, David J.; Klamt, Fabio; Ramsden, David B.; Reza, Madeehah; Parsons, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">473</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3253-3267</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is responsible for the N-methylation of nicotinamide to 1-methylnicotinamide.  Our recent studies have demonstrated that NNMT regulates cellular processes fundamental to the correct functioning and survival of the cell.  It has been proposed that NNMT may possess β-carboline (BC) N-methyltransferase activity, endogenously and exogenously produced pyridine-contg. compds. which, when N-methylated, are potent inhibitors of Complex I and have been proposed to have a role in the pathogenesis of Parkinson's disease.  We have investigated the ability of recombinant NNMT to N-methylate norharman (NH) to 2-N-methylnorharman (MeNH).  In addn., we have investigated the toxicity of the BC NH, its precursor 1,2,3,4-tetrahydronorharman (THNH) and its N-methylated metabolite MeNH, using our in vitro SH-SY5Y NNMT expression model.  Recombinant NNMT demonstrated NH 2N-methyltransferase activity, with a Km of 90 ± 20 μM, a kcat of 3 × 10-4 ± 2 × 10-5 s-1 and a specificity const. (kcat/Km) of 3±1s-1 M-1.  THNH was the least toxic of all three compds. investigated, whereas NH demonstrated the greatest, with no difference obsd. in terms of cell viability and cell death between NNMT-expressing and non-expressing cells.  In NNMT-expressing cells, MeNH increased cell viability and cellular ATP concn. in a dose-dependent manner after 72 and 120 h incubation, an effect that was not obsd. after 24 h incubation or in non-NNNT-expressing cells at any time point.  Taken together, these results suggest that NNMT may be a detoxification pathway for BCs such as NH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7D2JlLJSULVg90H21EOLACvtfcHk0limQwNOyJZzTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yltrc%253D&md5=e384674f954921b08016909ac0a503cb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBCJ20160219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBCJ20160219%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DMountford%26aufirst%3DD.%2BM.%26aulast%3DBarlow%26aufirst%3DD.%2BJ.%26aulast%3DKlamt%26aufirst%3DF.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DReza%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Catalyses%2520the%2520N-Methylation%2520of%2520the%2520Endogenous-Carboline%2520Norharman%253A%2520Evidence%2520for%2520a%2520Novel%2520Detoxification%2520Pathway%26jtitle%3DBiochem.%2520J.%26date%3D2016%26volume%3D473%26spage%3D3253%26epage%3D3267%26doi%3D10.1042%2FBCJ20160219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pissios, P.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N -Methyltransferase: More Than a Vitamin B3 Clearance Enzyme</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2017.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.tem.2017.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28291578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFehsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=340-353&author=P.+Pissios&title=Nicotinamide+N+-Methyltransferase%3A+More+Than+a+Vitamin+B3+Clearance+Enzyme&doi=10.1016%2Fj.tem.2017.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme</span></div><div class="casAuthors">Pissios, Pavlos</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">340-353</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide (NAM) N-methyltransferase (NNMT) was originally identified as the enzyme responsible for the methylation of NAM, one of the forms of vitamin B3.  Methylated NAM is eventually excreted from the body.  Recent evidence has expanded the role of NNMT beyond clearance of excess vitamin B3.  NNMT has been implicated in the regulation of multiple metabolic pathways in tissues such as adipose and liver as well as cancer cells through the consumption of Me donors and generation of active metabolites.  This review examines recent findings regarding the function of NNMT in physiol. and disease and highlights potential new avenues for therapeutic intervention.  Finally, key gaps in our knowledge about this enzymic system and future areas of investigation are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHRx9vhXz5LbVg90H21EOLACvtfcHk0limQwNOyJZzTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFehsrk%253D&md5=cf088bcc9434e006062d72de0c47c62a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2017.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2017.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DPissios%26aufirst%3DP.%26atitle%3DNicotinamide%2520N%2520-Methyltransferase%253A%2520More%2520Than%2520a%2520Vitamin%2520B3%2520Clearance%2520Enzyme%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2017%26volume%3D28%26spage%3D340%26epage%3D353%26doi%3D10.1016%2Fj.tem.2017.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoranart, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prager, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, J. N.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide Metabolism Regulates Glioblastoma Stem Cell Maintenance</span>. <i>JCI Insight</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1172/jci.insight.90019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1172%2Fjci.insight.90019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=1-23&author=J.+Jungauthor=L.+J.+Y.+Kimauthor=X.+Wangauthor=Q.+Wuauthor=T.+Sanvoranartauthor=C.+G.+Hubertauthor=B.+C.+Pragerauthor=L.+C.+Wallaceauthor=X.+Jinauthor=S.+C.+Mackauthor=J.+N.+Rich&title=Nicotinamide+Metabolism+Regulates+Glioblastoma+Stem+Cell+Maintenance&doi=10.1172%2Fjci.insight.90019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1172%2Fjci.insight.90019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci.insight.90019%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DL.%2BJ.%2BY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DSanvoranart%26aufirst%3DT.%26aulast%3DHubert%26aufirst%3DC.%2BG.%26aulast%3DPrager%26aufirst%3DB.%2BC.%26aulast%3DWallace%26aufirst%3DL.%2BC.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DMack%26aufirst%3DS.%2BC.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DNicotinamide%2520Metabolism%2520Regulates%2520Glioblastoma%2520Stem%2520Cell%2520Maintenance%26jtitle%3DJCI%2520Insight%26date%3D2017%26volume%3D2%26spage%3D1%26epage%3D23%26doi%3D10.1172%2Fjci.insight.90019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhonen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulinilkunnil, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigserver, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monia, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirinen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauve, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhanot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peroni, O. D.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Knockdown Protects against Diet-Induced Obesity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>508</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1038/nature13198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fnature13198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=24717514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2014&pages=258-262&author=B.+B.+Kahnauthor=L.+Alhonenauthor=T.+C.+Pulinilkunnilauthor=Y.+Cenauthor=P.+Puigserverauthor=Y.+Wangauthor=B.+P.+Moniaauthor=J.+M.+Asaraauthor=L.+Zhangauthor=D.+Kongauthor=J.+T.+Rodgersauthor=Q.+Yangauthor=F.+Gongauthor=E.+Pirinenauthor=A.+A.+Sauveauthor=S.+Bhanotauthor=A.+S.+Banksauthor=D.+Krausauthor=O.+D.+Peroni&title=Nicotinamide+N-Methyltransferase+Knockdown+Protects+against+Diet-Induced+Obesity&doi=10.1038%2Fnature13198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity</span></div><div class="casAuthors">Kraus, Daniel; Yang, Qin; Kong, Dong; Banks, Alexander S.; Zhang, Lin; Rodgers, Joseph T.; Pirinen, Eija; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Cen, Yana; Sauve, Anthony A.; Asara, John M.; Peroni, Odile D.; Monia, Brett P.; Bhanot, Sanjay; Alhonen, Leena; Puigserver, Pere; Kahn, Barbara B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">7495</span>),
    <span class="NLM_cas:pages">258-262</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In obesity and type 2 diabetes, Glut4 glucose transporter expression is decreased selectively in adipocytes.  Adipose-specific knockout or overexpression of Glut4 alters systemic insulin sensitivity.  Here we show, using DNA array analyses, that nicotinamide N-methyltransferase (Nnmt) is the most strongly reciprocally regulated gene when comparing gene expression in white adipose tissue (WAT) from adipose-specific Glut4-knockout or adipose-specific Glut4-overexpressing mice with their resp. controls.  NNMT methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a Me donor.  Nicotinamide is a precursor of NAD+, an important cofactor linking cellular redox states with energy metab.  SAM provides propylamine for polyamine biosynthesis and donates a Me group for histone methylation.  Polyamine flux including synthesis, catabolism and excretion, is controlled by the rate-limiting enzymes ornithine decarboxylase (ODC) and spermidine-spermine N1-acetyltransferase (SSAT; encoded by Sat1) and by polyamine oxidase (PAO), and has a major role in energy metab.  We report that NNMT expression is increased in WAT and liver of obese and diabetic mice.  Nnmt knockdown in WAT and liver protects against diet-induced obesity by augmenting cellular energy expenditure.  NNMT inhibition increases adipose SAM and NAD+ levels and upregulates ODC and SSAT activity as well as expression, owing to the effects of NNMT on histone H3 lysine 4 methylation in adipose tissue.  Direct evidence for increased polyamine flux resulting from NNMT inhibition includes elevated urinary excretion and adipocyte secretion of diacetylspermine, a product of polyamine metab.  NNMT inhibition in adipocytes increases oxygen consumption in an ODC-, SSAT- and PAO-dependent manner.  Thus, NNMT is a novel regulator of histone methylation, polyamine flux and NAD+-dependent SIRT1 signaling, and is a unique and attractive target for treating obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuWPUvPnIqLVg90H21EOLACvtfcHk0ljPkPTtYTpDRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWhsL8%253D&md5=c37b6137cd4537a0f6f1701a5a212dd6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature13198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13198%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DB.%2BB.%26aulast%3DAlhonen%26aufirst%3DL.%26aulast%3DPulinilkunnil%26aufirst%3DT.%2BC.%26aulast%3DCen%26aufirst%3DY.%26aulast%3DPuigserver%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMonia%26aufirst%3DB.%2BP.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DRodgers%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DPirinen%26aufirst%3DE.%26aulast%3DSauve%26aufirst%3DA.%2BA.%26aulast%3DBhanot%26aufirst%3DS.%26aulast%3DBanks%26aufirst%3DA.%2BS.%26aulast%3DKraus%26aufirst%3DD.%26aulast%3DPeroni%26aufirst%3DO.%2BD.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Knockdown%2520Protects%2520against%2520Diet-Induced%2520Obesity%26jtitle%3DNature%26date%3D2014%26volume%3D508%26spage%3D258%26epage%3D262%26doi%3D10.1038%2Fnature13198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ten
Klooster, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotiriou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vervoort, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, R.</span></span> <span> </span><span class="NLM_article-title">Type 2 Diabetes-Related Proteins Derived from an in Vitro Model of Inflamed Fat Tissue</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>644</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2018.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.abb.2018.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29526533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks12ksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=644&publication_year=2018&pages=81-92&author=J.+P.+ten%0AKloosterauthor=A.+Sotiriouauthor=S.+Boerenauthor=S.+Vaessenauthor=J.+Vervoortauthor=R.+Pieters&title=Type+2+Diabetes-Related+Proteins+Derived+from+an+in+Vitro+Model+of+Inflamed+Fat+Tissue&doi=10.1016%2Fj.abb.2018.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Type 2 diabetes-related proteins derived from an in vitro model of inflamed fat tissue</span></div><div class="casAuthors">ten Klooster, Jean Paul; Sotiriou, Alexandros; Boeren, Sjef; Vaessen, Stefan; Vervoort, Jacques; Pieters, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">644</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Currently, there is a worldwide increase of patients with type 2 diabetes (T2D).  During the progression of healthy obese to T2D status, there is an influx of immune cells, in particular macrophages, into visceral adipose tissue, accompanied by an increase of inflammatory cytokines, such as, IL6, TNFα and Hp.  To get a better insight in the underlying mechanisms, we performed a quant. LCMS anal. on a modified in vitro assay, combining 3T3L1 adipocytes and activated RAW264.7 macrophages, thus mimicking inflamed adipose tissue.  Clin. known proteins, e.g. IL6, TNFα, AdipoQ, complement factor C3, B and D were identified, thus confirming the assay.  In addn., we found 54 new proteins that can potentially be used for research into the mechanism of T2D.  Comparison of our results to a study on human visceral fat of obese non-diabetic and obese diabetic subjects, indicated that AUH, NAGK, pCYT2, NNMT, STK39 and CSNK2A2 might indeed be linked to insulin resistance in humans.  Moreover, the expression of some of these genes was also altered in human blood samples at early or later stages of insulin desensitization.  Overall, we conclude that the direct contact co-culture of 3T3L1 adipocytes with activated macrophages could be a mechanistically relevant and partially translational model of inflamed visceral adipose tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz8iBuxCNAALVg90H21EOLACvtfcHk0ljPkPTtYTpDRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks12ksb4%253D&md5=4779e2ded5fda5d65a4cb285899ccaa3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2018.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2018.03.003%26sid%3Dliteratum%253Aachs%26aulast%3Dten%2BKlooster%26aufirst%3DJ.%2BP.%26aulast%3DSotiriou%26aufirst%3DA.%26aulast%3DBoeren%26aufirst%3DS.%26aulast%3DVaessen%26aufirst%3DS.%26aulast%3DVervoort%26aufirst%3DJ.%26aulast%3DPieters%26aufirst%3DR.%26atitle%3DType%25202%2520Diabetes-Related%2520Proteins%2520Derived%2520from%2520an%2520in%2520Vitro%2520Model%2520of%2520Inflamed%2520Fat%2520Tissue%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2018%26volume%3D644%26spage%3D81%26epage%3D92%26doi%3D10.1016%2Fj.abb.2018.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span> <span> </span><span class="NLM_article-title">Methyltransferases: Key Regulators in Cardiovascular Development and Disease</span>. <i>Ann. Vasc. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=1032-1039&author=E.+M.+Khalilauthor=B.+D.+Mackieauthor=Y.+Mao&title=Methyltransferases%3A+Key+Regulators+in+Cardiovascular+Development+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhalil%26aufirst%3DE.%2BM.%26aulast%3DMackie%26aufirst%3DB.%2BD.%26aulast%3DMao%26aufirst%3DY.%26atitle%3DMethyltransferases%253A%2520Key%2520Regulators%2520in%2520Cardiovascular%2520Development%2520and%2520Disease%26jtitle%3DAnn.%2520Vasc.%2520Med.%2520Res.%26date%3D2016%26volume%3D3%26spage%3D1032%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateuszuk, Ł.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skórka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutryb-Zając, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łomnicka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Słomińska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chlopicki, S.</span></span> <span> </span><span class="NLM_article-title">Activation of the Nicotinamide N-Methyltransferase (NNMT)-1-Methylnicotinamide (MNA) Pathway in Pulmonary Hypertension</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">108</span> <span class="refDoi"> DOI: 10.1186/s12931-016-0423-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1186%2Fs12931-016-0423-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=27581040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGkt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&author=A.+Fedorowiczauthor=%C5%81.+Mateuszukauthor=G.+Kopecauthor=T.+Sk%C3%B3rkaauthor=B.+Kutryb-Zaj%C4%85cauthor=A.+Zakrzewskaauthor=M.+Walczakauthor=A.+Jakubowskiauthor=M.+%C5%81omnickaauthor=E.+S%C5%82omi%C5%84skaauthor=S.+Chlopicki&title=Activation+of+the+Nicotinamide+N-Methyltransferase+%28NNMT%29-1-Methylnicotinamide+%28MNA%29+Pathway+in+Pulmonary+Hypertension&doi=10.1186%2Fs12931-016-0423-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension</span></div><div class="casAuthors">Fedorowicz, Andrzej; Mateuszuk, Lukasz; Kopec, Grzegorz; Skorka, Tomasz; Kutryb-Zajac, Barbara; Zakrzewska, Agnieszka; Walczak, Maria; Jakubowski, Andrzej; Lomnicka, Magdalena; Slominska, Ewa; Chlopicki, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108/1-108/13</span>CODEN:
                <span class="NLM_cas:coden">RREEBZ</span>;
        ISSN:<span class="NLM_cas:issn">1465-993X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Pulmonary arterial hypertension (PAH) is assocd. with inflammatory response but it is unknown whether it is assocd. with alterations in NNMT activity and MNA plasma concn.  Here we examd. changes in NNMT-MNA pathway in PAH in rats and humans.  Methods: PAH in rats was induced by a single s.c. injection of MCT (60 mg/kg).  Changes in NNMT activity in the lungs and liver (assessed as the rate of conversion of nicotinamide (NA) to MNA), changes in plasma concn. of MNA and its metabolites (analyzed by LC/MS) were analyzed in relation to PAH progression.  PAH was characterized by right ventricular hypertrophy (gross morphol.), cardiac dysfunction (by MRI), lung histopathol., lung ultrastructure, and ET-1 concn. in plasma.  NO-dependent and PGI2-dependent function in isolated lungs was analyzed.  In naive patients with idiopathic pulmonary hypertension (IPAH) characterized by hemodynamic and biochem. parameters MNA and its metabolites in plasma were also measured.  Results: MCT-injected rats developed hypertrophy and functional impairment of the right ventricle, hypertrophy of the pulmonary arteries, endothelial ultrastructural defects and a progressive increase in ET-1 plasma concn.-findings all consistent with PAH development.  In isolated lung, NO-dependent regulation of hypoxic pulmonary vasoconstriction was impaired, while PGI2 prodn. (6-keto-PGF1α) was increased.  NNMT activity increased progressively in the liver and in the lungs following MCT injection, and NNMT response was assocd. with an increase in MNA and 6-keto-PGF1α concn. in plasma.  In IPAH patients plasma concn. of MNA was elevated as compared with healthy controls.  Conclusions: Progression of pulmonary hypertension is assocd. with the activation of the NNMT-MNA pathway in rats and humans.  Given the vasoprotective activity of exogenous MNA, which was previously ascribed to PGI2 release, the activation of the endogenous NNMT-MNA pathway may play a compensatory role in PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobPtnz-72kOLVg90H21EOLACvtfcHk0ljPkPTtYTpDRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGkt7%252FF&md5=8e1d65f9921b81968b70609dd4d8a623</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2Fs12931-016-0423-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12931-016-0423-7%26sid%3Dliteratum%253Aachs%26aulast%3DFedorowicz%26aufirst%3DA.%26aulast%3DMateuszuk%26aufirst%3D%25C5%2581.%26aulast%3DKopec%26aufirst%3DG.%26aulast%3DSk%25C3%25B3rka%26aufirst%3DT.%26aulast%3DKutryb-Zaj%25C4%2585c%26aufirst%3DB.%26aulast%3DZakrzewska%26aufirst%3DA.%26aulast%3DWalczak%26aufirst%3DM.%26aulast%3DJakubowski%26aufirst%3DA.%26aulast%3D%25C5%2581omnicka%26aufirst%3DM.%26aulast%3DS%25C5%2582omi%25C5%2584ska%26aufirst%3DE.%26aulast%3DChlopicki%26aufirst%3DS.%26atitle%3DActivation%2520of%2520the%2520Nicotinamide%2520N-Methyltransferase%2520%2528NNMT%2529-1-Methylnicotinamide%2520%2528MNA%2529%2520Pathway%2520in%2520Pulmonary%2520Hypertension%26jtitle%3DRespir.%2520Res.%26date%3D2016%26volume%3D17%26doi%3D10.1186%2Fs12931-016-0423-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulanovskaya, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuhl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">NNMT Promotes Epigenetic Remodeling in Cancer by Creating a Metabolic Methylation Sink</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fnchembio.1204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=23455543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlKnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=300-306&author=O.+A.+Ulanovskayaauthor=A.+M.+Zuhlauthor=B.+F.+Cravatt&title=NNMT+Promotes+Epigenetic+Remodeling+in+Cancer+by+Creating+a+Metabolic+Methylation+Sink&doi=10.1038%2Fnchembio.1204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink</span></div><div class="casAuthors">Ulanovskaya, Olesya A.; Zuhl, Andrea M.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">300-306</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is overexpressed in a variety of human cancers, where it contributes to tumorigenesis by a mechanism that is still poorly understood.  Here we show using metabolomics that NNMT impairs the methylation potential of cancer cells by consuming Me units from S-adenosyl methionine to create the stable metabolic product 1-methylnicotinamide.  As a result, NNMT-expressing cancer cells have an altered epigenetic state that includes hypomethylated histones and other cancer-related proteins combined with heightened expression of protumorigenic gene products.  Our findings thus point to a direct mechanistic link between the deregulation of a metabolic enzyme and widespread changes in the methylation landscape of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsOQPNFxw5kbVg90H21EOLACvtfcHk0liEeHgyGcX-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlKnsbs%253D&md5=8775d8b27fba0d039b0f6da7244d28a4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1204%26sid%3Dliteratum%253Aachs%26aulast%3DUlanovskaya%26aufirst%3DO.%2BA.%26aulast%3DZuhl%26aufirst%3DA.%2BM.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DNNMT%2520Promotes%2520Epigenetic%2520Remodeling%2520in%2520Cancer%2520by%2520Creating%2520a%2520Metabolic%2520Methylation%2520Sink%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D300%26epage%3D306%26doi%3D10.1038%2Fnchembio.1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palanichamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirumoorthy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litzenberg, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span> <span> </span><span class="NLM_article-title">NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2334</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1158%2F1078-0432.CCR-16-1323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=27810903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=2325-2334&author=K.+Palanichamyauthor=S.+Kanjiauthor=N.+Gordonauthor=K.+Thirumoorthyauthor=J.+R.+Jacobauthor=K.+T.+Litzenbergauthor=D.+Patelauthor=A.+Chakravarti&title=NNMT+Silencing+Activates+Tumor+Suppressor+PP2A%2C+Inactivates+Oncogenic+STKs%2C+and+Inhibits+Tumor+Forming+Ability&doi=10.1158%2F1078-0432.CCR-16-1323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability</span></div><div class="casAuthors">Palanichamy, Kamalakannan; Kanji, Suman; Gordon, Nicolaus; Thirumoorthy, Krishnan; Jacob, John R.; Litzenberg, Kevin T.; Patel, Disha; Chakravarti, Arnab</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2325-2334</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To identify potential mol. hubs that regulate oncogenic kinases and target them to improve treatment outcomes for glioblastoma patients.  Exptl. Design: Data mining of The Cancer Genome Atlas datasets identified nicotinamide-N-Me transferase (NNMT) as a prognostic marker for glioblastoma, an enzyme linked to the reorganization of the methylome.  We tested our hypothesis that NNMT plays a crucial role by modulating protein methylation, leading to inactivation of tumor suppressors and activation of oncogenes.  Further expts. were performed to understand the underlying biochem. mechanisms using glioblastoma patient samples, established, primary, and isogenic cells.  Results: We demonstrate that NNMT outcompetes leucine carboxyl Me transferase 1 (LCMT1) for Me transfer from principal Me donor SAM in biol. systems.  Inhibiting NNMT increased the availability of Me groups for LCMT1 to methylate PP2A, resulting in the inhibition of oncogenic serine/threonine kinases (STK).  Further, NNMT inhibition retained the radiosensitizer nicotinamide and enhanced radiation sensitivity.  We have provided the biochem. rationale of how NNMT plays a vital role in inhibiting tumor suppressor PP2A while concomitantly activating STKs.  Conclusions: We report the intricate novel mechanism in which NNMT inhibits tumor suppressor PP2A by reorganizing the methylome both at epigenome and proteome levels and concomitantly activating prosurvival STKs.  In glioblastoma tumors with NNMT expression, activation of PP2A can be accomplished by FDA approved perphenazine (PPZ), which is currently used to treat mood disorders such as schizophrenia, bipolar disorder, etc.  This study forms a foundation for further glioblastoma clin. trials using PPZ with std. of care treatment.  Clin Cancer Res; 23(9); 2325-34. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqIwv0424CHbVg90H21EOLACvtfcHk0liEeHgyGcX-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFehuro%253D&md5=dafd3575d75a59c87f691b37e8dbcd8f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1323%26sid%3Dliteratum%253Aachs%26aulast%3DPalanichamy%26aufirst%3DK.%26aulast%3DKanji%26aufirst%3DS.%26aulast%3DGordon%26aufirst%3DN.%26aulast%3DThirumoorthy%26aufirst%3DK.%26aulast%3DJacob%26aufirst%3DJ.%2BR.%26aulast%3DLitzenberg%26aufirst%3DK.%2BT.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DChakravarti%26aufirst%3DA.%26atitle%3DNNMT%2520Silencing%2520Activates%2520Tumor%2520Suppressor%2520PP2A%252C%2520Inactivates%2520Oncogenic%2520STKs%252C%2520and%2520Inhibits%2520Tumor%2520Forming%2520Ability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D2325%26epage%3D2334%26doi%3D10.1158%2F1078-0432.CCR-16-1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">Down-Regulation of Nicotinamide N-Methyltransferase Induces Apoptosis in Human Breast Cancer Cells via the Mitochondria-Mediated Pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e89202</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0089202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1371%2Fjournal.pone.0089202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=24558488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKjs73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=J.+Zhangauthor=Y.+Wangauthor=G.+Liauthor=H.+Yuauthor=X.+Xie&title=Down-Regulation+of+Nicotinamide+N-Methyltransferase+Induces+Apoptosis+in+Human+Breast+Cancer+Cells+via+the+Mitochondria-Mediated+Pathway&doi=10.1371%2Fjournal.pone.0089202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway</span></div><div class="casAuthors">Zhang, Jun; Wang, Yanzhong; Li, Guiling; Yu, Haitao; Xie, Xinyou</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e89202/1-e89202/17, 17 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) has been found involved in cell proliferation of several malignancies.  However, the functional role of NNMT in breast cancer has not been elucidated.  In the present study, we showed that NNMT was selectively expressed in some breast cancer cell lines, down-regulation of NNMT expression in Bcap-37 and MDA-MB-231 cell lines by NNMT shRNA significantly inhibited cell growth in vitro, decreased tumorigenicity in mice and induced apoptosis.  The silencing reciprocal effect of NNMT was confirmed by over-expressing NNMT in the MCF-7 and SK-BR-3 breast cancer cell lines which lack constitutive expression of NNMT.  In addn., down-regulation of NNMT expression resulted in reducing expression of Bcl-2 and Bcl-xL, up-regulation of Bax, Puma, cleaved caspase-9, cleaved caspase-3 and cleaved PARP, increasing reactive oxygen species prodn. and release of cytochrome c from mitochondria, and decreasing the phosphorylation of Akt and ERK1/2.  These data suggest that down-regulation of NNMT induces apoptosis via the mitochondria-mediated pathway in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxw6YRvrhclrVg90H21EOLACvtfcHk0liEeHgyGcX-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKjs73O&md5=ba37d01dcc59df8ec842da9895bd3e57</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0089202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0089202%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DDown-Regulation%2520of%2520Nicotinamide%2520N-Methyltransferase%2520Induces%2520Apoptosis%2520in%2520Human%2520Breast%2520Cancer%2520Cells%2520via%2520the%2520Mitochondria-Mediated%2520Pathway%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0089202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzzonigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanese, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Nicotinamide N-Methyltransferase as a Novel Tumor Marker for Renal Clear Cell Carcinoma</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">2248</span>– <span class="NLM_lpage">2254</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2006.07.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.juro.2006.07.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=17070307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=2248-2254&author=D.+Sartiniauthor=G.+Muzzonigroauthor=G.+Milaneseauthor=F.+Pierellaauthor=V.+Rossiauthor=M.+Emanuelli&title=Identification+of+Nicotinamide+N-Methyltransferase+as+a+Novel+Tumor+Marker+for+Renal+Clear+Cell+Carcinoma&doi=10.1016%2Fj.juro.2006.07.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma</span></div><div class="casAuthors">Sartini, Davide; Muzzonigro, Giovanni; Milanese, Giulio; Pierella, Francesca; Rossi, Valentina; Emanuelli, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2248-2254</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To explore the involvement of enzymes of drug metab. in renal cell carcinoma we analyzed the gene expression profiles of tumor and nontumor tissues from the same patient by DNA macroarray.  The enzyme nicotinamide N-methyl-transferase was selected for further evaluation.  Nicotinamide N-methyltransferase mRNA expression was investigated in paired tissue samples from cancerous and noncancerous parts of the kidneys of 30 patients with clear cell renal cell carcinoma who underwent tumor nephrectomy.  Measurements were performed by semiquant. reverse transcriptase-polymerase chain reaction and quant. real-time polymerase chain reaction.  Paired tissue samples were also obtained from 1 patient with chromophobe renal cell carcinoma and from another with oncocytoma to compare the specificity of changes in nicotinamide N-methyltransferase expression among tumors that are related to different renal epithelial cell types.  Western blot anal. and catalytic activity assay were also performed to study nicotinamide N-methyltransferase expression.  Expression correlated with tumor characteristics.  A marked increased expression in tumor tissue was found for nicotinamide N-methyltransferase, which is an enzyme involved in the biotransformation of many drugs and xenobiotic compds.  Differential gene expression measurements in tumor vs normal tissue revealed up-regulation in all clear cell renal cell carcinomas at between 3 and 294-fold (mean 41).  In contrast, in chromophobe renal cell carcinoma and oncocytoma nicotinamide N-methyltransferase expression did not increase.  In addn., nicotinamide N-methyltransferase expression significantly correlated inversely with tumor size.  The results indicate that a marked nicotinamide N-methyltransferase increase is a peculiar feature of clear cell renal cell carcinoma.  Addnl. studies may establish the role of nicotinamide N-methyltransferase in tumor formation and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2PjugEWTlgLVg90H21EOLACvtfcHk0liIaZh4PCl2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbJ&md5=12e39e079588b666bd40af85e4919f39</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.07.046%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DMuzzonigro%26aufirst%3DG.%26aulast%3DMilanese%26aufirst%3DG.%26aulast%3DPierella%26aufirst%3DF.%26aulast%3DRossi%26aufirst%3DV.%26aulast%3DEmanuelli%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Nicotinamide%2520N-Methyltransferase%2520as%2520a%2520Novel%2520Tumor%2520Marker%2520for%2520Renal%2520Clear%2520Cell%2520Carcinoma%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D2248%26epage%3D2254%26doi%3D10.1016%2Fj.juro.2006.07.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Upregulation Inversely Correlates with Lymph Node Metastasis in Oral Squamous Cell Carcinoma</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.2119/2007-00035.Sartini</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.2119%2F2007-00035.Sartini" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=17622326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVynsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=415-421&author=D.+Sartiniauthor=A.+Santarelli&title=Nicotinamide+N-Methyltransferase+Upregulation+Inversely+Correlates+with+Lymph+Node+Metastasis+in+Oral+Squamous+Cell+Carcinoma&doi=10.2119%2F2007-00035.Sartini"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma</span></div><div class="casAuthors">Sartini, Davide; Santarelli, Andrea; Rossi, Valentina; Goteri, Gaia; Rubini, Corrado; Ciavarella, Domenico; Lo Muzio, Lorenzo; Emanuelli, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">415-421</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">We investigated expression levels of Nicotinamide N-Methyltransferase (NNMT), an enzyme involved in the biotransformation of many drugs and xenobiotic compds., in oral squamous cell carcinoma (OSCC).  Measurements were performed by semi-quant. RT-PCR and quant. real-time PCR in tumor and matched adjacent healthy tissue.  Interestingly, NNMT was up-regulated in most of the favorable OSCCs, while no marked NNMT expression alterations between tumor and normal mucosa were detected in most of the unfavorable OSCCs.  Western blot and immunohistochem. analyses also were performed and the relationship between tumor characteristics and NNMT levels in OSCC were studied to evaluate the effectiveness of NNMT as a prognostic marker in the squamous cell carcinoma of the oral cavity.  In summary, the present study suggests that NNMT may have potential as a biomarker and a therapeutic target for OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg_Vx2wEahmbVg90H21EOLACvtfcHk0liIaZh4PCl2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVynsrjL&md5=9b78d16ea787bc3d544faffed81822aa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2119%2F2007-00035.Sartini&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252F2007-00035.Sartini%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DSantarelli%26aufirst%3DA.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Upregulation%2520Inversely%2520Correlates%2520with%2520Lymph%2520Node%2520Metastasis%2520in%2520Oral%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DMol.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D415%26epage%3D421%26doi%3D10.2119%2F2007-00035.Sartini" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span> <span> </span><span class="NLM_article-title">High Expression of Nicotinamide N-Methyltransferase in Patients with Idiopathic Parkinson’s Disease</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(03)00218-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2FS0304-3940%2803%2900218-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=12727306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2003&pages=13-16&author=R.+B.+Parsonsauthor=S.+W.+Smithauthor=R.+H.+Waringauthor=A.+C.+Williamsauthor=D.+B.+Ramsden&title=High+Expression+of+Nicotinamide+N-Methyltransferase+in+Patients+with+Idiopathic+Parkinson%E2%80%99s+Disease&doi=10.1016%2FS0304-3940%2803%2900218-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease</span></div><div class="casAuthors">Parsons, Richard B.; Smith, Stuart W.; Waring, Rosemary H.; Williams, Adrian C.; Ramsden, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">13-16</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">We have previously speculated that elevated levels of nicotinamide N-methyltransferase (NNMT), the primary catabolic enzyme of nicotinamide, may result in reduced Complex I activity in idiopathic Parkinson's disease (IPD) in two ways: (1) redn. in the levels of nicotinamide available for NAD synthesis; and (2) increased methylation of compds. such as tetrahydroisoquinolines and β-carbolines, which are potent Complex I inhibitors.  Expression of NNMT was assessed in 91 cerebella (53 IPD, 38 control) using immunohistochem. coupled with quant. digital image anal.  Control cerebella showed a distribution of expression ascribed to low, intermediate and high expressors with ratios of 1:2:1 categories.  Expression in the parkinsonian cerebella was significantly higher than in the control group (control group median expression 17%, mean expression 16.6%, range 0-51%, std. deviation 11.4%, std. error 1.9%; IPD group median expression 46%, mean expression 53.7%, range 21-100%, std. deviation 23.4%, std. error 3.2%; P<0.0001; unpaired t-test with Welch correction (parametric) and Mann-Whitney U-test (non-parametric)).  These results confirm that NNMT expression is elevated in IPD, which may ultimately lead to neurodegeneration via a redn. in Complex I activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeSxNViswvA7Vg90H21EOLACvtfcHk0liIaZh4PCl2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohs74%253D&md5=62fe20b57152b3e88745f11de6f8b844</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2803%2900218-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252803%252900218-0%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BW.%26aulast%3DWaring%26aufirst%3DR.%2BH.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26atitle%3DHigh%2520Expression%2520of%2520Nicotinamide%2520N-Methyltransferase%2520in%2520Patients%2520with%2520Idiopathic%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D342%26spage%3D13%26epage%3D16%26doi%3D10.1016%2FS0304-3940%2803%2900218-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.-L.</span></span> <span> </span><span class="NLM_article-title">Expression of Nicotinamide N-Methyltransferase (E.C. 2.1.1.1) in the Parkinsonian Brain</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1093/jnen/61.2.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1093%2Fjnen%2F61.2.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=11853016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFOku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=111-124&author=R.+B.+Parsonsauthor=A.+C.+Williamsauthor=R.+H.+Waringauthor=D.+B.+Ramsdenauthor=M.-L.+Smith&title=Expression+of+Nicotinamide+N-Methyltransferase+%28E.C.+2.1.1.1%29+in+the+Parkinsonian+Brain&doi=10.1093%2Fjnen%2F61.2.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain</span></div><div class="casAuthors">Parsons, Richard B.; Smith, Marie-Louise; Williams, Adrian C.; Waring, Rosemary H.; Ramsden, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-124</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) has been proposed as a link between the environmental and genetic factors of Parkinson disease (PD).  Therefore, we explored the hypothesis that high levels of NNMT expression may predispose to the development of PD.  Regions of high mRNA expression were shown in the spinal cord, medulla, and temporal lobe, with lowest expression in the cerebellum, subthalamic nucleus, and caudate nucleus.  Using 2 NNMT antibodies, the protein was shown to be expressed in multipolar neurons in the temporal lobe, caudate nucleus, and spinal cord, granular neurons of the cerebellum, dopaminergic neurons in the substantia nigra, and in the axons of the third nerve.  Expression of NNMT was compared in PD and non-PD control cerebella and caudate nucleus.  PD tissue exhibited significantly increased levels of NNMT protein and activity.  PD disease duration was inversely correlated with the level of expression in cerebellum.  This is the first demonstration that patients with PD have higher levels of NNMT activity and protein in brain tissue than those without PD and that NNMT expression is assocd. with neurons that degenerate in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTQojjaTnox7Vg90H21EOLACvtfcHk0lgT6KAdzmf-SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFOku7w%253D&md5=ac3a0e25e3ae442fc9d3e81df1757949</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjnen%2F61.2.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnen%252F61.2.111%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DWaring%26aufirst%3DR.%2BH.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DSmith%26aufirst%3DM.-L.%26atitle%3DExpression%2520of%2520Nicotinamide%2520N-Methyltransferase%2520%2528E.C.%25202.1.1.1%2529%2520in%2520the%2520Parkinsonian%2520Brain%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2002%26volume%3D61%26spage%3D111%26epage%3D124%26doi%3D10.1093%2Fjnen%2F61.2.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saldanha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Expression in SH-SY5Y Neuroblastoma and N27 Mesencephalic Neurones Induces Changes in Cell Morphology via Ephrin-B2 and Akt Signalling</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e669</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fcddis.2013.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=23764850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyrs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=M.+G.+Thomasauthor=M.+Saldanhaauthor=R.+J.+Mistryauthor=D.+T.+Dexterauthor=D.+B.+Ramsdenauthor=R.+B.+Parsons&title=Nicotinamide+N-Methyltransferase+Expression+in+SH-SY5Y+Neuroblastoma+and+N27+Mesencephalic+Neurones+Induces+Changes+in+Cell+Morphology+via+Ephrin-B2+and+Akt+Signalling&doi=10.1038%2Fcddis.2013.200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling</span></div><div class="casAuthors">Thomas, M. G.; Saldanha, M.; Mistry, R. J.; Dexter, D. T.; Ramsden, D. B.; Parsons, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">e669</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT, E.C. 2.1.1.1) N-methylates nicotinamide to produce 1-methylnicotinamide (MeN).  We have previously shown that NNMT expression protected against neurotoxin-mediated cell death by increasing Complex I (CxI) activity, resulting in increased ATP synthesis.  This was mediated via protection of the NDUFS3 subunit of CxI from degrdn. by increased MeN prodn.  In the present study, we have investigated the effects of NNMT expression on neuron morphol. and differentiation.  Expression of NNMT in SH-SY5Y human neuroblastoma and N27 rat mesencephalic dopaminergic neurons increased neurite branching, synaptophysin expression and dopamine accumulation and release. siRNA gene silencing of ephrin B2 (EFNB2), and inhibition of Akt phosphorylation using LY294002, demonstrated that their sequential activation was responsible for the increases obsd.  Incubation of SH-SY5Y with increasing concns. of MeN also increased neurite branching, suggesting that the effects of NNMT may be mediated by MeN.  NNMT had no significant effect on the expression of phenotypic and post-mitotic markers, suggesting that NNMT is not involved in detg. phenotypic fate or differentiation status.  These results demonstrate that NNMT expression regulates neuron morphol. in vitro via the sequential activation of the EFNB2 and Akt cellular signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp-UTjIACPwrVg90H21EOLACvtfcHk0lgT6KAdzmf-SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyrs7zI&md5=ffe0b9b462503399935f6dd73697f077</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.200%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DSaldanha%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DR.%2BJ.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Expression%2520in%2520SH-SY5Y%2520Neuroblastoma%2520and%2520N27%2520Mesencephalic%2520Neurones%2520Induces%2520Changes%2520in%2520Cell%2520Morphology%2520via%2520Ephrin-B2%2520and%2520Akt%2520Signalling%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span> <span> </span><span class="NLM_article-title">The Kinetic Analysis of the N-Methylation of 4-Phenylpyridine by Nicotinamide N-Methyltransferase: Evidence for a Novel Mechanism of Substrate Inhibition</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2018.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.biocel.2018.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29549048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=127-136&author=M.+J.+van%0AHarenauthor=M.+G.+Thomasauthor=D.+Sartiniauthor=D.+J.+Barlowauthor=D.+B.+Ramsdenauthor=M.+Emanuelliauthor=F.+Klamtauthor=N.+I.+Martinauthor=R.+B.+Parsons&title=The+Kinetic+Analysis+of+the+N-Methylation+of+4-Phenylpyridine+by+Nicotinamide+N-Methyltransferase%3A+Evidence+for+a+Novel+Mechanism+of+Substrate+Inhibition&doi=10.1016%2Fj.biocel.2018.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic analysis of the N-methylation of 4-phenylpyridine by nicotinamide N-methyltransferase: Evidence for a novel mechanism of substrate inhibition</span></div><div class="casAuthors">van Haren, Matthijs J.; Thomas, Martin G.; Sartini, Davide; Barlow, David J.; Ramsden, David B.; Emanuelli, Monica; Klamt, Fabio; Martin, Nathaniel I.; Parsons, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The N-methylation of 4-phenylpyridine produces the neurotoxin 1-methyl-4-phenylpyridinium ion (MPP+).  We investigated the kinetics of 4-phenylpyridine N-methylation by nicotinamide N-methyltransferase (NNMT) and its effect upon 4-phenylpyridine toxicity in vitro.  Human recombinant NNMT possessed 4-phenylpyridine N-methyltransferase activity, with a specific activity of 1.7 ± 0.03 nmol MPP+ produced/h/mg NNMT.  Although the Km for 4-phenylpyridine was similar to that reported for nicotinamide, its kcat of 9.3 × 10-5 ± 2 × 10-5 s-1 and specificity const., kcat/Km, of 0.8 ± 0.8 s-1 M-1 were less than 0.15% of the resp. values for nicotinamide, demonstrating that 4-phenylpyridine is a poor substrate for NNMT.  At low (<2.5 mM) substrate concn., 4-phenylpyridine N-methylation was competitively inhibited by dimethylsulfoxide, with a Ki of 34 ± 8 mM.  At high (>2.5 mM) substrate concn., enzyme activity followed substrate inhibition kinetics, with a Ki of 4 ± 1 mM.  In silico mol. docking suggested that 4-phenylpyridine binds to the active site of NNMT in two non-redundant poses, one a substrate binding mode and the other an inhibitory mode.  Finally, the expression of NNMT in the SH-SY5Y cell-line had no effect cell death, viability, ATP content or mitochondrial membrane potential.  These data demonstrate that 4-phenylpyridine N-methylation by NNMT is unlikely to serve as a source of MPP+.  The possibility for competitive inhibition by dimethylsulfoxide should be considered in NNMT-based drug discovery studies.  The potential for 4-phenylpyridine to bind to the active site in two binding orientations using the same active site residues is a novel mechanism of substrate inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwe1BBHtPRF7Vg90H21EOLACvtfcHk0lhIBDEXxuB_Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOntr4%253D&md5=adce60fb9957a6f3588fe863c0a8318b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2018.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2018.03.010%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DBarlow%26aufirst%3DD.%2BJ.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DKlamt%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26atitle%3DThe%2520Kinetic%2520Analysis%2520of%2520the%2520N-Methylation%2520of%25204-Phenylpyridine%2520by%2520Nicotinamide%2520N-Methyltransferase%253A%2520Evidence%2520for%2520a%2520Novel%2520Mechanism%2520of%2520Substrate%2520Inhibition%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2018%26volume%3D98%26spage%3D127%26epage%3D136%26doi%3D10.1016%2Fj.biocel.2018.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aksoy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szumlanski, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinshilboum, R. M.</span></span> <span> </span><span class="NLM_article-title">Human Liver Nicotinamide N-Methyltransferase. CDNA Cloning, Expression, and Biochemical Characterization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">14835</span>– <span class="NLM_lpage">14840</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=8182091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaK2cXkslCqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=14835-14840&author=S.+Aksoyauthor=C.+L.+Szumlanskiauthor=R.+M.+Weinshilboum&title=Human+Liver+Nicotinamide+N-Methyltransferase.+CDNA+Cloning%2C+Expression%2C+and+Biochemical+Characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization</span></div><div class="casAuthors">Aksoy, Saime; Szumlanski, Carol L.; Weinshilboum, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14835-40</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide and other pyridines.  Human liver NNMT activity has a bimodal frequency distribution, an observation which raises the possibility that this enzyme might be regulated by a genetic polymorphism, a polymorphism that could have functional implications for individual differences in drug and xenobiotic toxicity.  As a first step toward testing this hypothesis, the authors set out to clone and express a cDNA for human liver NNMT.  Human liver NNMT was partially purified, photoaffinity-labeled, subjected to limited proteolysis, and partial amino acid sequence information was obtained.  The polymerase chain reaction was then used to amplify a 550-nucleotide sequence with human liver cDNA as template and primers designed on the basis of the NNMT amino acid sequence.  The 5'- and 3'-ends of a human liver NNMT cDNA were obtained by use of the rapid amplification of cDNA ends.  The combined use of these approaches resulted in the isolation of a human liver NNMT cDNA that was 969 nucleotides in length, with a 792-nucleotide open reading frame that encoded a 264-amino acid protein with a calcd. mol. mass of 29.6 kDa.  The human liver NNMT cDNA was transcribed in vitro and translated with a reticulocyte lysate system to yield a protein with a mol. mass of approx. 29 kDa that comigrated during SDS-polyacrylamide gel electrophoresis with photoaffinity-labeled human liver NNMT.  The NNMT cDNA was also subcloned into the eukaryotic expression vector p91023(B).  COS-1 cells transfected with this construct expressed a high level of NNMT enzymic activity, and the biochem. properties of this activity were similar to those of human liver NNMT.  Human liver NNMT and transfected COS-1 cell NNMT had apparent Km values for the two cosubstrates for the reaction, nicotinamide and S-adenosyl-L-methionine, of 0.43 and 0.38 mM and of 1.8 and 2.2 μM, resp.  IC50 values for the inhibition of NNMT by N1-methylnicotinamide were 60 and 30 μM for human liver and COS-1 cell-expressed NNMT, resp.  Cloning of a cDNA for human liver NNMT should make it possible to test the hypothesis that inheritance may play a role in the regulation of individual differences in human liver NNMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZRn3_QD5atbVg90H21EOLACvtfcHk0lhIBDEXxuB_Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslCqtro%253D&md5=d5d9edf09cb329ecc01b49fd819fad47</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAksoy%26aufirst%3DS.%26aulast%3DSzumlanski%26aufirst%3DC.%2BL.%26aulast%3DWeinshilboum%26aufirst%3DR.%2BM.%26atitle%3DHuman%2520Liver%2520Nicotinamide%2520N-Methyltransferase.%2520CDNA%2520Cloning%252C%2520Expression%252C%2520and%2520Biochemical%2520Characterization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D14835%26epage%3D14840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suciu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadiri, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulanovskaya, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Chemical Proteomic Profiling of Human Methyltransferases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">13335</span>– <span class="NLM_lpage">13343</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b07830</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b07830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFymu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=13335-13343&author=B.+D.+Horningauthor=R.+M.+Suciuauthor=D.+A.+Ghadiriauthor=O.+A.+Ulanovskayaauthor=M.+L.+Matthewsauthor=K.+M.+Lumauthor=K.+M.+Backusauthor=S.+J.+Brownauthor=H.+Rosenauthor=B.+F.+Cravatt&title=Chemical+Proteomic+Profiling+of+Human+Methyltransferases&doi=10.1021%2Fjacs.6b07830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Proteomic Profiling of Human Methyltransferases</span></div><div class="casAuthors">Horning, Benjamin D.; Suciu, Radu M.; Ghadiri, Darian A.; Ulanovskaya, Olesya A.; Matthews, Megan L.; Lum, Kenneth M.; Backus, Keriann M.; Brown, Steven J.; Rosen, Hugh; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">13335-13343</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methylation is a fundamental mechanism used in Nature to modify the structure and function of biomols., including proteins, DNA, RNA, and metabolites.  Me groups are predominantly installed into biomols. by a large and diverse class of S-adenosyl methionine (SAM)-dependent methyltransferases (MTs), of which there are ∼200 known or putative members in the human proteome.  Deregulated MT activity contributes to numerous diseases, including cancer, and several MT inhibitors are in clin. development.  Nonetheless, a large fraction of the human MT family remains poorly characterized, underscoring the need for new technologies to characterize MTs and their inhibitors in native biol. systems.  Here, the authors describe a suite of S-adenosyl homocysteine (SAH) photoreactive probes and their application in chem. proteomic expts. to profile and enrich a large no. of MTs (>50) from human cancer cell lysates with remarkable specificity over other classes of proteins.  The authors further demonstrate that the SAH probes can enrich MT-assocd. proteins and be used to screen for and assess the selectivity of MT inhibitors, leading to the discovery of a covalent inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cancer and metabolic disorders.  The chem. proteomics probes and methods for their utilization reported herein should prove of value for the functional characterization of MTs, MT complexes, and MT inhibitors in mammalian biol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJsKzvFF-e7Vg90H21EOLACvtfcHk0li4bcBD5OWjGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFymu7bP&md5=0e07845e59e33381f3149beae7500e18</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b07830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b07830%26sid%3Dliteratum%253Aachs%26aulast%3DHorning%26aufirst%3DB.%2BD.%26aulast%3DSuciu%26aufirst%3DR.%2BM.%26aulast%3DGhadiri%26aufirst%3DD.%2BA.%26aulast%3DUlanovskaya%26aufirst%3DO.%2BA.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DChemical%2520Proteomic%2520Profiling%2520of%2520Human%2520Methyltransferases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D13335%26epage%3D13343%26doi%3D10.1021%2Fjacs.6b07830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallur, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchan, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swamy, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugesan, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhulu, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putta, V. P. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mane, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadnur, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhamidipati, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreuder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullangi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakshinamoorthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span> <span> </span><span class="NLM_article-title">Novel Nicotinamide Analog as Inhibitor of Nicotinamide N-Methyltransferase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">925</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2018.01.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29433927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=922-925&author=S.+Rufauthor=M.+S.+Hallurauthor=N.+K.+Anchanauthor=I.+N.+Swamyauthor=K.+R.+Murugesanauthor=S.+Sarkarauthor=L.+K.+Narasimhuluauthor=V.+P.+R.+K.+Puttaauthor=S.+Shaikauthor=D.+V.+Chandrasekarauthor=V.+S.+Maneauthor=S.+V.+Kadnurauthor=J.+Sureshauthor=R.+K.+Bhamidipatiauthor=M.+Singhauthor=R.+R.+Burriauthor=R.+Kristamauthor=H.+Schreuderauthor=J.+Czechauthor=C.+Rudolphauthor=A.+Markerauthor=T.+Langerauthor=R.+Mullangiauthor=T.+Yuraauthor=R.+Gosuauthor=A.+Kanntauthor=S.+Dhakshinamoorthyauthor=S.+Rajagopal&title=Novel+Nicotinamide+Analog+as+Inhibitor+of+Nicotinamide+N-Methyltransferase&doi=10.1016%2Fj.bmcl.2018.01.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase</span></div><div class="casAuthors">Ruf, Sven; Hallur, Mahanandeesha Siddappa; Anchan, Nisha K.; Swamy, Indu N.; Murugesan, Karthikai Raj; Sarkar, Sayantani; Narasimhulu, Lokesh Kananti; Putta, V. P. Rama Kishore; Shaik, Shama; Chandrasekar, Devaraj Venkatapura; Mane, Vishal Subhash; Kadnur, Sanjay Venkatachalapathi; Suresh, Juluri; Bhamidipati, Ravi Kanth; Singh, Manvi; Burri, Raghunadha Reddy; Kristam, Rajendra; Schreuder, Herman; Czech, Joerg; Rudolph, Christine; Marker, Alexander; Langer, Thomas; Mullangi, Ramesh; Yura, Takeshi; Gosu, Ramachandraiah; Kannt, Aimo; Dhakshinamoorthy, Saravanakumar; Rajagopal, Sridharan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">922-925</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) has been linked to obesity and diabetes.  We have identified a novel nicotinamide (NA) analog, compd. I that inhibited NNMT enzymic activity and reduced the formation of 1-methyl-nicotinamide (MNA), the primary metabolite of NA by ∼80% at 2 h when dosed in mice orally at 50 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxeiU30o2tybVg90H21EOLACvtfcHk0li4bcBD5OWjGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCmsb0%253D&md5=06345ee6c292c482711d62639fac9a16</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DHallur%26aufirst%3DM.%2BS.%26aulast%3DAnchan%26aufirst%3DN.%2BK.%26aulast%3DSwamy%26aufirst%3DI.%2BN.%26aulast%3DMurugesan%26aufirst%3DK.%2BR.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DNarasimhulu%26aufirst%3DL.%2BK.%26aulast%3DPutta%26aufirst%3DV.%2BP.%2BR.%2BK.%26aulast%3DShaik%26aufirst%3DS.%26aulast%3DChandrasekar%26aufirst%3DD.%2BV.%26aulast%3DMane%26aufirst%3DV.%2BS.%26aulast%3DKadnur%26aufirst%3DS.%2BV.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DR.%2BK.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DBurri%26aufirst%3DR.%2BR.%26aulast%3DKristam%26aufirst%3DR.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DCzech%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DC.%26aulast%3DMarker%26aufirst%3DA.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DMullangi%26aufirst%3DR.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DDhakshinamoorthy%26aufirst%3DS.%26aulast%3DRajagopal%26aufirst%3DS.%26atitle%3DNovel%2520Nicotinamide%2520Analog%2520as%2520Inhibitor%2520of%2520Nicotinamide%2520N-Methyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D922%26epage%3D925%26doi%3D10.1016%2Fj.bmcl.2018.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadnur, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhamidipati, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallur, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfenninger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreuder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mane, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birudukota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zope, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parveen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullangi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakshinamoorthy, S.</span></span> <span> </span><span class="NLM_article-title">A Small Molecule Inhibitor of Nicotinamide N-Methyltransferase for the Treatment of Metabolic Disorders</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">3660</span> <span class="refDoi"> DOI: 10.1038/s41598-018-22081-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fs41598-018-22081-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29483571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrls1ahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&author=A.+Kanntauthor=S.+Rajagopalauthor=S.+V.+Kadnurauthor=J.+Sureshauthor=R.+K.+Bhamidipatiauthor=S.+Swaminathanauthor=M.+S.+Hallurauthor=R.+Kristamauthor=R.+Elvertauthor=J.+Czechauthor=A.+Pfenningerauthor=C.+Rudolphauthor=H.+Schreuderauthor=D.+V.+Chandrasekarauthor=V.+S.+Maneauthor=S.+Birudukotaauthor=S.+Shaikauthor=B.+R.+Zopeauthor=R.+R.+Burriauthor=N.+N.+Anandauthor=M.+K.+Thakurauthor=M.+Singhauthor=R.+Parveenauthor=S.+Kandanauthor=R.+Mullangiauthor=T.+Yuraauthor=R.+Gosuauthor=S.+Rufauthor=S.+Dhakshinamoorthy&title=A+Small+Molecule+Inhibitor+of+Nicotinamide+N-Methyltransferase+for+the+Treatment+of+Metabolic+Disorders&doi=10.1038%2Fs41598-018-22081-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders</span></div><div class="casAuthors">Kannt Aimo; Elvert Ralf; Czech Jorg; Pfenninger Anja; Rudolph Christine; Schreuder Herman; Ruf Sven; Kannt Aimo; Rajagopal Sridharan; Kadnur Sanjay Venkatachalapathi; Suresh Juluri; Bhamidipati Ravi Kanth; Swaminathan Srinivasan; Hallur Mahanandeesha Siddappa; Kristam Rajendra; Chandrasekar Devaraj Venkatapura; Mane Vishal Subhash; Birudukota Swarnakumari; Shaik Shama; Zope Bharat Ravindra; Burri Raghunadha Reddy; Anand Niranjan Naranapura; Thakur Manish Kumar; Singh Manvi; Parveen Reejuana; Kandan Saravanan; Mullangi Ramesh; Yura Takeshi; Gosu Ramachandraiah; Dhakshinamoorthy Saravanakumar</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3660</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from the co-factor S-adenosyl-L-methionine (SAM) onto the substrate, nicotinamide (NA) to form 1-methyl-nicotinamide (MNA).  Higher NNMT expression and MNA concentrations have been associated with obesity and type-2 diabetes.  Here we report a small molecule analog of NA, JBSNF-000088, that inhibits NNMT activity, reduces MNA levels and drives insulin sensitization, glucose modulation and body weight reduction in animal models of metabolic disease.  In mice with high fat diet (HFD)-induced obesity, JBSNF-000088 treatment caused a reduction in body weight, improved insulin sensitivity and normalized glucose tolerance to the level of lean control mice.  These effects were not seen in NNMT knockout mice on HFD, confirming specificity of JBSNF-000088.  The compound also improved glucose handling in ob/ob and db/db mice albeit to a lesser extent and in the absence of weight loss.  Co-crystal structure analysis revealed the presence of the N-methylated product of JBSNF-000088 bound to the NNMT protein.  The N-methylated product was also detected in the plasma of mice treated with JBSNF-000088.  Hence, JBSNF-000088 may act as a slow-turnover substrate analog, driving the observed metabolic benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdHZ3bviJkhgaK-_ZudimnfW6udTcc2eYD99bof-v8R7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrls1ahtw%253D%253D&md5=3f2306da18e0ab2a41a57f08ea9384fb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-22081-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-22081-7%26sid%3Dliteratum%253Aachs%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DKadnur%26aufirst%3DS.%2BV.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DR.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DHallur%26aufirst%3DM.%2BS.%26aulast%3DKristam%26aufirst%3DR.%26aulast%3DElvert%26aufirst%3DR.%26aulast%3DCzech%26aufirst%3DJ.%26aulast%3DPfenninger%26aufirst%3DA.%26aulast%3DRudolph%26aufirst%3DC.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DChandrasekar%26aufirst%3DD.%2BV.%26aulast%3DMane%26aufirst%3DV.%2BS.%26aulast%3DBirudukota%26aufirst%3DS.%26aulast%3DShaik%26aufirst%3DS.%26aulast%3DZope%26aufirst%3DB.%2BR.%26aulast%3DBurri%26aufirst%3DR.%2BR.%26aulast%3DAnand%26aufirst%3DN.%2BN.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DParveen%26aufirst%3DR.%26aulast%3DKandan%26aufirst%3DS.%26aulast%3DMullangi%26aufirst%3DR.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DDhakshinamoorthy%26aufirst%3DS.%26atitle%3DA%2520Small%2520Molecule%2520Inhibitor%2520of%2520Nicotinamide%2520N-Methyltransferase%2520for%2520the%2520Treatment%2520of%2520Metabolic%2520Disorders%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26doi%3D10.1038%2Fs41598-018-22081-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watowich, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5015</span>– <span class="NLM_lpage">5028</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Sgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5015-5028&author=H.+Neelakantanauthor=H.+Y.+Wangauthor=V.+Vanceauthor=J.+D.+Hommelauthor=S.+F.+McHardyauthor=S.+J.+Watowich&title=Structure-Activity+Relationship+for+Small+Molecule+Inhibitors+of+Nicotinamide+N-Methyltransferase&doi=10.1021%2Facs.jmedchem.7b00389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase</span></div><div class="casAuthors">Neelakantan, Harshini; Wang, Hua-Yu; Vance, Virginia; Hommel, Jonathan D.; McHardy, Stanton F.; Watowich, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5015-5028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is a fundamental cytosolic biotransforming enzyme that catalyzes the N-methylation of endogenous and exogenous xenobiotics.  We have identified small mol. inhibitors of NNMT with >1000-fold range of activity and developed comprehensive structure-activity relationships (SARs) for NNMT inhibitors.  Screening of N-methylated quinolinium, isoquinolinium, pyrididium, and benzimidazolium/benzothiazolium analogs resulted in the identification of quinoliniums as a promising scaffold with very low micromolar (IC50 ∼ 1 μM) NNMT inhibition.  Computer-based docking of inhibitors to the NNMT substrate (nicotinamide)-binding site produced a robust correlation between ligand-enzyme interaction docking scores and exptl. calcd. IC50 values.  Predicted binding orientation of the quinolinium analogs revealed selective binding to the NNMT substrate-binding site residues and essential chem. features driving protein-ligand intermol. interactions and NNMT inhibition.  The development of this new series of small mol. NNMT inhibitors direct the future design of lead drug-like inhibitors to treat several metabolic and chronic disease conditions characterized by abnormal NNMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxYy3poogIbVg90H21EOLACvtfcHk0lhTncskGkOo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Sgtrc%253D&md5=2cd7159b9e15569221849168e49e39cd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00389%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DVance%26aufirst%3DV.%26aulast%3DHommel%26aufirst%3DJ.%2BD.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26atitle%3DStructure-Activity%2520Relationship%2520for%2520Small%2520Molecule%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5015%26epage%3D5028%26doi%3D10.1021%2Facs.jmedchem.7b00389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre Toraño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moret, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Nicotinamide N-Methyltransferase Designed to Mimic the Methylation Reaction Transition State</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6656</span>– <span class="NLM_lpage">6667</span>, <span class="refDoi"> DOI: 10.1039/C7OB01357D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1039%2FC7OB01357D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28758655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1aktLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=6656-6667&author=M.+J.+van%0AHarenauthor=R.+Taigauthor=J.+Kuppensauthor=J.+Sastre+Tora%C3%B1oauthor=E.+E.+Moretauthor=R.+B.+Parsonsauthor=D.+Sartiniauthor=M.+Emanuelliauthor=N.+I.+Martin&title=Inhibitors+of+Nicotinamide+N-Methyltransferase+Designed+to+Mimic+the+Methylation+Reaction+Transition+State&doi=10.1039%2FC7OB01357D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state</span></div><div class="casAuthors">van Haren, Matthijs J.; Taig, Rebecca; Kuppens, Jilles; Sastre Torano, Javier; Moret, Ed E.; Parsons, Richard B.; Sartini, Davide; Emanuelli, Monica; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6656-6667</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is an enzyme that catalyzes the methylation of nicotinamide to form N'-methylnicotinamide.  Both NNMT and its methylated product have recently been linked to a variety of diseases, suggesting a role for the enzyme as a therapeutic target beyond its previously ascribed metabolic function in detoxification.  We here describe the systematic development of NNMT inhibitors derived from the structures of the substrates involved in the methylation reaction.  By covalently linking fragments of the NNMT substrates a diverse library of bisubstrate-like compds. was prepd.  The ability of these compds. to inhibit NNMT was evaluated providing valuable insights into the structural tolerances of the enzyme active site.  These studies led to the identification of new NNMT inhibitors that mimic the transition state of the methylation reaction and inhibit the enzyme with activity on par with established methyltransferase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwrd9fP8Bf7Vg90H21EOLACvtfcHk0lhTncskGkOo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1aktLfI&md5=74280c50135611d361ab81b8fc55fa89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7OB01357D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB01357D%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DTaig%26aufirst%3DR.%26aulast%3DKuppens%26aufirst%3DJ.%26aulast%3DSastre%2BTora%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMoret%26aufirst%3DE.%2BE.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DInhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520Designed%2520to%2520Mimic%2520the%2520Methylation%2520Reaction%2520Transition%2520State%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26spage%3D6656%26epage%3D6667%26doi%3D10.1039%2FC7OB01357D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masjost, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gramlich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob-Roetne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zürcher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Bisubstrate Inhibitors for the Enzyme Catechol-O-Methyltransferase (COMT): Influence of Inhibitor Preorganisation and Linker Length between the Two Substrate Moieties on Binding Affinity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1039/B208690P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1039%2FB208690P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=12929389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=42-49&author=C.+Lernerauthor=B.+Masjostauthor=A.+Rufauthor=V.+Gramlichauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+Inhibitors+for+the+Enzyme+Catechol-O-Methyltransferase+%28COMT%29%3A+Influence+of+Inhibitor+Preorganisation+and+Linker+Length+between+the+Two+Substrate+Moieties+on+Binding+Affinity&doi=10.1039%2FB208690P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): Influence of inhibitor preorganization and linker length between the two substrate moieties on binding affinity</span></div><div class="casAuthors">Lerner, Christian; Masjost, Birgit; Ruf, Armin; Gramlich, Volker; Jakob-Roetne, Roland; Zurcher, Gerhard; Borroni, Edilio; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-49</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of the enzyme catechol-O-methyltransferase (COMT) is an important approach in the treatment of Parkinson's disease.  A series of new potent bisubstrate inhibitors for COMT, resulting from X-ray structure-based design and featuring adenosine and catechol moieties have been synthesized.  Biol. results show a large dependence of binding affinity on inhibitor preorganization and the length of the linker between nucleoside and catechol moieties.  The most potent bisubstrate inhibitor for COMT has an IC50 value of 9 nM.  It exhibits competitive kinetics for the SAM and mixed inhibition kinetics for the catechol binding site.  Its bisubstrate binding mode was confirmed by X-ray structure anal. of the ternary complex formed by the inhibitor, COMT and a Mg2· ion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMuhnQD9t-zLVg90H21EOLACvtfcHk0ljI4DZl0yRkSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCgsb8%253D&md5=978732f0d825272d41748365a8dadf13</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FB208690P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB208690P%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520Inhibitors%2520for%2520the%2520Enzyme%2520Catechol-O-Methyltransferase%2520%2528COMT%2529%253A%2520Influence%2520of%2520Inhibitor%2520Preorganisation%2520and%2520Linker%2520Length%2520between%2520the%2520Two%2520Substrate%2520Moieties%2520on%2520Binding%2520Affinity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D42%26epage%3D49%26doi%3D10.1039%2FB208690P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trindler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brändli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob-Roetne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zürcher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Bisubstrate Inhibitors of Catechol O-Methyltransferase (COMT): The Crucial Role of the Ribose Structural Unit for Inhibitor Binding Affinity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200500065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1002%2Fcmdc.200500065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=16892369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD28XislKrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=340-357&author=R.+Pauliniauthor=C.+Trindlerauthor=C.+Lernerauthor=L.+Br%C3%A4ndliauthor=W.+B.+Schweizerauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+Inhibitors+of+Catechol+O-Methyltransferase+%28COMT%29%3A+The+Crucial+Role+of+the+Ribose+Structural+Unit+for+Inhibitor+Binding+Affinity&doi=10.1002%2Fcmdc.200500065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bisubstrate inhibitors of catechol O-methyltransferase (COMT): the crucial role of the ribose structural unit for inhibitor binding affinity</span></div><div class="casAuthors">Paulini, Ralph; Trindler, Christian; Lerner, Christian; Brandli, Lukas; Schweizer, W. Bernd; Jakob-Roetne, Roland; Zurcher, Gerhard; Borroni, Edilio; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">340-357</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Inhibition of the enzyme catechol O-methyltransferase offers a therapeutic handle to regulate the catabolism of catecholamine neurotransmitters, providing valuable assistance in the treatment of CNS disorders such as Parkinson's disease.  A series of ribose-modified bisubstrate inhibitors of COMT featuring 2'-deoxy-, 3'-deoxy-, 2'-aminodeoxy-3'-deoxy-, and 2'-deoxy-3'-aminodeoxyribose-derived central moieties and analogs contg. the carbocyclic skeleton of the natural product aristeromycin were synthesized and evaluated to investigate the mol. recognition properties of the ribose binding site in the enzyme.  Key synthetic intermediates in the ribose-derived series were obtained by deoxygenative [1,2]-hydride shift rearrangement of adenosine derivs.; highlights in the synthesis of carbocyclic aristeromycin analogs include a diastereoselective cyclopropanation step and nucleobase introduction with a modified Mitsunobu protocol.  In vitro biol. evaluation and kinetic studies revealed dramatic effects of the ribose modification on binding affinity: 3'-deoxygenation of the ribose gave potent inhibitors (IC50 values in the nanomolar range), which stands in sharp contrast to the remarkable decrease in potency obsd. for 2'-deoxy derivs. (IC50 values in the micromolar range).  Aminodeoxy analogs were only weakly active, whereas the change of the THF skeleton to a carbocycle unexpectedly led to a complete loss of biol. activity.  These results confirm that the ribose structural unit of the bisubstrate inhibitors of COMT is a key element of mol. recognition and that modifications thereof are delicate and may lead to surprises.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpynXbZNC6PY7Vg90H21EOLACvtfcHk0ljI4DZl0yRkSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislKrsr4%253D&md5=dfb854add9f8db09c6181b68d135d634</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200500065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200500065%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DTrindler%26aufirst%3DC.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBr%25C3%25A4ndli%26aufirst%3DL.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520Inhibitors%2520of%2520Catechol%2520O-Methyltransferase%2520%2528COMT%2529%253A%2520The%2520Crucial%2520Role%2520of%2520the%2520Ribose%2520Structural%2520Unit%2520for%2520Inhibitor%2520Binding%2520Affinity%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D340%26epage%3D357%26doi%3D10.1002%2Fcmdc.200500065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Bisubstrate-Type Inhibitors of Histone Methyltransferase SET7/9</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">8158</span>– <span class="NLM_lpage">8166</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmc.2010.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=21036620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsValurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=8158-8166&author=S.+Moriauthor=K.+Iwaseauthor=N.+Iwanamiauthor=Y.+Tanakaauthor=H.+Kagechikaauthor=T.+Hirano&title=Development+of+Novel+Bisubstrate-Type+Inhibitors+of+Histone+Methyltransferase+SET7%2F9&doi=10.1016%2Fj.bmc.2010.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9</span></div><div class="casAuthors">Mori, Shuichi; Iwase, Kenta; Iwanami, Naoko; Tanaka, Yujiro; Kagechika, Hiroyuki; Hirano, Tomoya</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8158-8166</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone modification, for example, by histone deacetylase (HDAC) and histone lysine methyltransferase (HMT), plays an important role in regulating gene expression.  To obtain novel inhibitors as tools for investigating the physiol. function of members of the HMT family, we designed and synthesized novel inhibitors, which are amine analogs of adenosylmethionine (AdoMet; the cofactor utilized in the methylation reaction) bearing various alkylamino groups coupled via an ethylene linker.  The inhibitory activities of these compds. towards SET7/9, an HMT, were evaluated.  It was found that introduction of an alkylamino group increased the inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUp7neuWTg1rVg90H21EOLACvtfcHk0ljI4DZl0yRkSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsValurrL&md5=76faa42f957d02ed47458c348b324929</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DS.%26aulast%3DIwase%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520Novel%2520Bisubstrate-Type%2520Inhibitors%2520of%2520Histone%2520Methyltransferase%2520SET7%252F9%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D8158%26epage%3D8166%26doi%3D10.1016%2Fj.bmc.2010.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. G.</span></span> <span> </span><span class="NLM_article-title">Toward the Development of Potent and Selective Bisubstrate Inhibitors of Protein Arginine Methyltransferases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2103</span>– <span class="NLM_lpage">2105</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2010.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=20219369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslGmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2103-2105&author=J.+Dowdenauthor=W.+Hongauthor=R.+V.+Parryauthor=R.+A.+Pikeauthor=S.+G.+Ward&title=Toward+the+Development+of+Potent+and+Selective+Bisubstrate+Inhibitors+of+Protein+Arginine+Methyltransferases&doi=10.1016%2Fj.bmcl.2010.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases</span></div><div class="casAuthors">Dowden, James; Hong, Wei; Parry, Richard V.; Pike, Richard A.; Ward, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2103-2105</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prototype inhibitors of protein arginine methyltransferases (PRMTs) have been constructed by attaching guanidine functionality via a variable linker to non-reactive amine analogs of the cellular co-factor (S)-adenosyl methionine (AdoMet).  Potent inhibition of PRMT1 (IC50 of ∼3-6 μM) combined with weak inhibition of the lysine methyltransferase SET7 (∼50% of activity at 100 μM) was obsd. for two such compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj5FdIemXEXrVg90H21EOLACvtfcHk0liIfddWuuNRiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslGmsb4%253D&md5=6401f6157aa931ae23ac27928d4bf1d1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DDowden%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DW.%26aulast%3DParry%26aufirst%3DR.%2BV.%26aulast%3DPike%26aufirst%3DR.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BG.%26atitle%3DToward%2520the%2520Development%2520of%2520Potent%2520and%2520Selective%2520Bisubstrate%2520Inhibitors%2520of%2520Protein%2520Arginine%2520Methyltransferases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2103%26epage%3D2105%26doi%3D10.1016%2Fj.bmcl.2010.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Haren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ufford, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moret, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Protein Arginine N-Methyltransferase Inhibitors Designed to Simultaneously Occupy Both Substrate Binding Sites</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1039/C4OB01734J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1039%2FC4OB01734J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=25380215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSiu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=549-560&author=M.+Van%0AHarenauthor=L.+Q.+Van+Uffordauthor=E.+E.+Moretauthor=N.+I.+Martin&title=Synthesis+and+Evaluation+of+Protein+Arginine+N-Methyltransferase+Inhibitors+Designed+to+Simultaneously+Occupy+Both+Substrate+Binding+Sites&doi=10.1039%2FC4OB01734J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites</span></div><div class="casAuthors">van Haren, Matthijs; van Ufford, Linda Quarles; Moret, Ed E.; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The protein arginine N-methyltransferases (PRMTs) are a family of enzymes that function by specifically transferring a Me group from the cofactor S-adenosyl-L-methionine (AdoMet) to the guanidine group of arginine residues in target proteins.  The most notable is the PRMT-mediated methylation of arginine residues that are present in histone proteins which can lead to chromatin remodelling and influence gene transcription.  A growing body of evidence now implicates dysregulated PRMT activity in a no. of diseases including various forms of cancer.  The development of PRMT inhibitors may therefore hold potential as a means of developing new therapeutics.  We here report the synthesis and evaluation of a series of small mol. PRMT inhibitors designed to simultaneously occupy the binding sites of both the guanidino substrate and AdoMet cofactor.  Potent inhibition and surprising selectivity were obsd. when testing these compds. against a panel of methyltransferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcFfPMCcpn97Vg90H21EOLACvtfcHk0liIfddWuuNRiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSiu77N&md5=62b07b10e6cc1c288168e8bd0ef4d9f5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC4OB01734J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01734J%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHaren%26aufirst%3DM.%26aulast%3DVan%2BUfford%26aufirst%3DL.%2BQ.%26aulast%3DMoret%26aufirst%3DE.%2BE.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Protein%2520Arginine%2520N-Methyltransferase%2520Inhibitors%2520Designed%2520to%2520Simultaneously%2520Occupy%2520Both%2520Substrate%2520Binding%2520Sites%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D549%26epage%3D560%26doi%3D10.1039%2FC4OB01734J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbardella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troffer-Charlier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marechal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavarelli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianciulli, A.</span></span> <span> </span><span class="NLM_article-title">Transition State Mimics Are Valuable Mechanistic Probes for Structural Studies with the Arginine Methyltransferase CARM1</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3625</span>– <span class="NLM_lpage">3630</span>, <span class="refDoi"> DOI: 10.1073/pnas.1618401114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1073%2Fpnas.1618401114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28330993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslShs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3625-3630&author=M.+J.+van%0AHarenauthor=G.+Sbardellaauthor=N.+I.+Martinauthor=N.+Troffer-Charlierauthor=N.+Marechalauthor=J.+Cavarelliauthor=A.+Cianciulli&title=Transition+State+Mimics+Are+Valuable+Mechanistic+Probes+for+Structural+Studies+with+the+Arginine+Methyltransferase+CARM1&doi=10.1073%2Fpnas.1618401114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1</span></div><div class="casAuthors">van Haren, Matthijs J.; Marechal, Nils; Troffer-Charlier, Nathalie; Cianciulli, Agostino; Sbardella, Gianluca; Cavarelli, Jean; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3625-3630</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coactivator-assocd. arginine methyltransferase 1 (CARM1) is a member of the protein arginine methyltransferase (PRMT) family and methylates a range of proteins in eukaryotic cells.  Overexpression of CARM1 is implicated in a no. of cancers, and it is therefore seen as a potential therapeutic target.  Peptide sequences derived from the well-defined CARM1 substrate, poly(A)-binding protein 1 (PABP1), were covalently linked to an adenosine moiety as in the AdoMet cofactor to generate transition state mimics.  These constructs were found to be potent CARM1 inhibitors and also formed stable complexes with the enzyme.  High-resoln. crystal structures of CARM1 complexed with these compds. confirmed a mode of binding that was indeed reflective of the transition state at the CARM1 active site.  Given the transient nature of PRMT-substrate complexes, such transition state mimics represent valuable chem. tools for structural studies aimed at deciphering the regulation of arginine methylation mediated by the family of arginine methyltransferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQP8dnoWBD5bVg90H21EOLACvtfcHk0liIfddWuuNRiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslShs7g%253D&md5=67a38bf8b8d382eec5bd8689b0ed2764</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1618401114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1618401114%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DTroffer-Charlier%26aufirst%3DN.%26aulast%3DMarechal%26aufirst%3DN.%26aulast%3DCavarelli%26aufirst%3DJ.%26aulast%3DCianciulli%26aufirst%3DA.%26atitle%3DTransition%2520State%2520Mimics%2520Are%2520Valuable%2520Mechanistic%2520Probes%2520for%2520Structural%2520Studies%2520with%2520the%2520Arginine%2520Methyltransferase%2520CARM1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2017%26volume%3D114%26spage%3D3625%26epage%3D3630%26doi%3D10.1073%2Fpnas.1618401114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babault, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-Hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1541</span>– <span class="NLM_lpage">1551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01422</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01422" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1541-1551&author=N.+Babaultauthor=A.+Allali-Hassaniauthor=F.+Liauthor=J.+Fanauthor=A.+Yueauthor=K.+Juauthor=F.+Liuauthor=M.+Vedadiauthor=J.+Liuauthor=J.+Jin&title=Discovery+of+Bisubstrate+Inhibitors+of+Nicotinamide+N-Methyltransferase+%28NNMT%29&doi=10.1021%2Facs.jmedchem.7b01422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)</span></div><div class="casAuthors">Babault, Nicolas; Allali-Hassani, Abdellah; Li, Fengling; Fan, Jie; Yue, Alex; Ju, Kevin; Liu, Feng; Vedadi, Masoud; Liu, Jing; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1541-1551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of pyridine-contg. compds. using the cofactor S-5'-adenosyl-L-methionine (SAM) as the Me group donor.  Through the regulation of the levels of its substrates, cofactor, and products, NNMT plays important role in physiol. and pathophysiol.  Overexpression of NNMT has been implicated in various human diseases.  Potent and selective small-mol. NNMT inhibitors are valuable chem. tools for testing biol. and therapeutic hypotheses.  However, very few NNMT inhibitors have been reported.  Here, we describe the discovery of a bisubstrate NNMT inhibitor MS2734 (6), and characterization of this inhibitor in biochem., biophys., kinetic, and structural studies.  Importantly, we obtained the first crystal structure of human NNMT in complex with a small-mol. inhibitor.  The structure of the NNMT-6 complex has unambiguously demonstrated that 6 occupied both substrate and cofactor binding sites.  The findings paved the way for developing more potent and selective NNMT inhibitors in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ThNiA1GTwLVg90H21EOLACvtfcHk0ljQxb-H2Klp7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVOruw%253D%253D&md5=50e23e5f60beb64c184f6eadc6a75883</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01422%26sid%3Dliteratum%253Aachs%26aulast%3DBabault%26aufirst%3DN.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYue%26aufirst%3DA.%26aulast%3DJu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Bisubstrate%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520%2528NNMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1541%26epage%3D1551%26doi%3D10.1021%2Facs.jmedchem.7b01422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, V. C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">7800</span>– <span class="NLM_lpage">7808</span>, <span class="refDoi"> DOI: 10.1021/bi2007614</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2007614" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtValsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=7800-7808&author=Y.+Pengauthor=D.+Sartiniauthor=V.+Pozziauthor=D.+Wilkauthor=M.+Emanuelliauthor=V.+C.+Yee&title=Structural+Basis+of+Substrate+Recognition+in+Human+Nicotinamide+N-Methyltransferase&doi=10.1021%2Fbi2007614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of substrate recognition in human nicotinamide N-methyltransferase</span></div><div class="casAuthors">Peng, Yi; Sartini, Davide; Pozzi, Valentina; Wilk, Dennis; Emanuelli, Monica; Yee, Vivien C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">7800-7808</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide, pyridines, and other analogs using S-adenosyl-L-methionine as donor.  NNMT plays a significant role in the regulation of metabolic pathways and is expressed at markedly high levels in several kinds of cancers, presenting it as a potential mol. target for cancer therapy.  Here, the authors detd. the crystal structure of human NNMT as a ternary complex bound to both the demethylated donor, S-adenosyl-L-homocysteine, and the acceptor substrate, nicotinamide, to 2.7 Å resoln.  These studies reveal the structural basis for nicotinamide binding and highlight several residues in the active site which may play roles in nicotinamide recognition and NNMT catalysis.  The functional importance of these residues was probed by mutagenesis.  Of three residues near the nicotinamide's amide group, substitution of S201 and S213 had no effect on enzyme activity while replacement of D197 dramatically decreased activity.  Substitutions of Y20, whose side chain hydroxyl interacts with both the nicotinamide arom. ring and AdoHcy carboxylate, also compromised activity.  Enzyme kinetics anal. revealed kcat/Km decreases of 2-3 orders of magnitude for the D197A and Y20A mutants, confirming the functional importance of these active site residues.  The mutants exhibited substantially increased Km for both NCA and AdoMet and modestly decreased kcat.  MD simulations revealed long-range conformational effects which provide an explanation for the large increase in Km(AdoMet) for the D197A mutant, which interacts directly only with nicotinamide in the ternary complex crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh1yxD6WIJFLVg90H21EOLACvtfcHk0ljQxb-H2Klp7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtValsbnF&md5=926af50d2464e21094ffb17205793d19</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi2007614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2007614%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DPozzi%26aufirst%3DV.%26aulast%3DWilk%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DYee%26aufirst%3DV.%2BC.%26atitle%3DStructural%2520Basis%2520of%2520Substrate%2520Recognition%2520in%2520Human%2520Nicotinamide%2520N-Methyltransferase%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D7800%26epage%3D7808%26doi%3D10.1021%2Fbi2007614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1007/s13318-017-0404-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1007%2Fs13318-017-0404-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28229434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtFKls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=891-901&author=N.+J.+Waters&title=Preclinical+Pharmacokinetics+and+Pharmacodynamics+of+Pinometostat+%28EPZ-5676%29%2C+a+First-in-Class%2C+Small+Molecule+S-Adenosyl+Methionine+Competitive+Inhibitor+of+DOT1L&doi=10.1007%2Fs13318-017-0404-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L</span></div><div class="casAuthors">Waters, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">891-901</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Acute leukemias bearing mixed lineage leukemia (MLL) rearrangements are aggressive diseases characterized by a poor overall prognosis despite multi-agent chemotherapy.  Aberrant fusion proteins involving the MLL histone methyltransferase (HMT) lead to recruitment of DOT1L, to a multi-protein complex resulting in aberrant methylation of histone H3 lysine 79 at MLL target genes, and ultimately enhanced expression of crit. genes for hematopoietic differentiation, including HOXA9 and MEIS1, and as such defines the established mechanism for leukemogenesis in MLL-rearrangement (MLL-r) leukemias.  Pinometostat is a first-in-class, small mol. inhibitor of DOT1L with sub-nanomolar affinity and >37,000 fold selectivity against non-MLL HMTs, and was the first member of the novel HMT inhibitor class to enter Phase 1 clin. trials in both adult and pediatric MLL-r leukemia patients.  In this article, the preclin. pharmacokinetics/pharmacodynamics and drug disposition of pinometostat are reviewed including discussion of how these data were used to inform early clin. studies, and how they translated to the clin. experience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxU8juCNJnELVg90H21EOLACvtfcHk0ljQxb-H2Klp7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtFKls7c%253D&md5=edacbc0f25f056f736705ae7c6f184cf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs13318-017-0404-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-017-0404-3%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520Pharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520Pinometostat%2520%2528EPZ-5676%2529%252C%2520a%2520First-in-Class%252C%2520Small%2520Molecule%2520S-Adenosyl%2520Methionine%2520Competitive%2520Inhibitor%2520of%2520DOT1L%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2017%26volume%3D42%26spage%3D891%26epage%3D901%26doi%3D10.1007%2Fs13318-017-0404-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">af
Gennäs, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekokoski, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuominen, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yli-Kauhaluoma, J.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Isophthalic Acid Derivatives Targeted to the C1 Domain of Protein Kinase C</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3969</span>– <span class="NLM_lpage">3981</span>, <span class="refDoi"> DOI: 10.1021/jm900229p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900229p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3969-3981&author=G.+B.+af%0AGenn%C3%A4sauthor=V.+Talmanauthor=O.+Aitioauthor=E.+Ekokoskiauthor=M.+Finelauthor=R.+K.+Tuominenauthor=J.+Yli-Kauhaluoma&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Isophthalic+Acid+Derivatives+Targeted+to+the+C1+Domain+of+Protein+Kinase+C&doi=10.1021%2Fjm900229p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm900229p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900229p%26sid%3Dliteratum%253Aachs%26aulast%3Daf%2BGenn%25C3%25A4s%26aufirst%3DG.%2BB.%26aulast%3DTalman%26aufirst%3DV.%26aulast%3DAitio%26aufirst%3DO.%26aulast%3DEkokoski%26aufirst%3DE.%26aulast%3DFinel%26aufirst%3DM.%26aulast%3DTuominen%26aufirst%3DR.%2BK.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Isophthalic%2520Acid%2520Derivatives%2520Targeted%2520to%2520the%2520C1%2520Domain%2520of%2520Protein%2520Kinase%2520C%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3969%26epage%3D3981%26doi%3D10.1021%2Fjm900229p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, Y. J.</span></span> <span> </span><span class="NLM_article-title">Facile Reduction of Carboxylic Acids, Esters, Acid Chlorides, Amides and Nitriles to Alcohols or Amines Using NaBH<sub>4</sub>/BF<sub>3</sub>·Et<sub>2</sub>O</span>. <i>Bull. Korean Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.5012/bkcs.2004.25.3.407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.5012%2Fbkcs.2004.25.3.407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVymu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=407-409&author=S.+D.+Choauthor=Y.+D.+Parkauthor=J.+J.+Kimauthor=J.+R.+Falckauthor=Y.+J.+Yoon&title=Facile+Reduction+of+Carboxylic+Acids%2C+Esters%2C+Acid+Chlorides%2C+Amides+and+Nitriles+to+Alcohols+or+Amines+Using+NaBH4%2FBF3%C2%B7Et2O&doi=10.5012%2Fbkcs.2004.25.3.407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Facile reduction of carboxylic acids, esters, acid chlorides, amides and nitriles to alcohols or amines using NaBH4/BF3.Et2O</span></div><div class="casAuthors">Cho, Su-Dong; Park, Yong-Dae; Kim, Jeum-Jong; Falck, J. R.; Yoon, Yong-Jin</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-409</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">The system NaBH4/BF3.Et2O is an inexpensive and highly versatile reducing system for a wide variety of carbonyls, acid chlorides, carboxylic acids, esters, amides and nitriles.  Among the 16 products prepd. were 98% 5-nitrofurfuryl alc., 97% PhCH2OH, 94% 3-(hydroxymethyl)pyridine and 89% 2,6-difluorobenzylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGLUCGfrNUBLVg90H21EOLACvtfcHk0lgclsWMxOcJuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVymu7o%253D&md5=4a4e4707d02fe60d040b7266fbd2dcfa</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2004.25.3.407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2004.25.3.407%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DPark%26aufirst%3DY.%2BD.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DYoon%26aufirst%3DY.%2BJ.%26atitle%3DFacile%2520Reduction%2520of%2520Carboxylic%2520Acids%252C%2520Esters%252C%2520Acid%2520Chlorides%252C%2520Amides%2520and%2520Nitriles%2520to%2520Alcohols%2520or%2520Amines%2520Using%2520NaBH4%252FBF3%25C2%25B7Et2O%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2004%26volume%3D25%26spage%3D407%26epage%3D409%26doi%3D10.5012%2Fbkcs.2004.25.3.407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imajo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomimori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span> <span> </span><span class="NLM_article-title">Development of 6-Benzyl Substituted 4-Aminocarbonyl-1,4-Diazepane-2,5-Diones as Orally Active Human Chymase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3439</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2007.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=17434735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtValsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3435-3439&author=H.+Maruokaauthor=T.+Mutoauthor=T.+Tanakaauthor=S.+Imajoauthor=Y.+Tomimoriauthor=Y.+Fukudaauthor=T.+Nakatsuka&title=Development+of+6-Benzyl+Substituted+4-Aminocarbonyl-1%2C4-Diazepane-2%2C5-Diones+as+Orally+Active+Human+Chymase+Inhibitors&doi=10.1016%2Fj.bmcl.2007.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 6-benzyl-substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors</span></div><div class="casAuthors">Maruoka, Hiroshi; Muto, Tsuyoshi; Tanaka, Taisaku; Imajo, Seiichi; Tomimori, Yoshiaki; Fukuda, Yoshiaki; Nakatsuka, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3435-3439</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A novel series of 6-benzyl-substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones I (R1 = H, R2 = PhCH2, PhCH2CH2, PhCHMe, Ph2CH, etc.; R1 = Me, R2 = PhCH2) was designed, synthesized, and evaluated as human chymase inhibitors.  From this series, several compds. which were effective, via oral administration, in a mouse model of chronic dermatitis were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgXKgcOk71rVg90H21EOLACvtfcHk0lgclsWMxOcJuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtValsLs%253D&md5=e6893b5973e9c22f575bbe2238703251</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DMaruoka%26aufirst%3DH.%26aulast%3DMuto%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DImajo%26aufirst%3DS.%26aulast%3DTomimori%26aufirst%3DY.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DNakatsuka%26aufirst%3DT.%26atitle%3DDevelopment%2520of%25206-Benzyl%2520Substituted%25204-Aminocarbonyl-1%252C4-Diazepane-2%252C5-Diones%2520as%2520Orally%2520Active%2520Human%2520Chymase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3435%26epage%3D3439%26doi%3D10.1016%2Fj.bmcl.2007.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Pola
Chemical Industries Inc.</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, K.</span>; <span class="NLM_string-name">Kimura, M.</span>; <span class="NLM_string-name">Tamai, M.</span>; <span class="NLM_string-name">Saitoh, Y.</span>; <span class="NLM_string-name">Kato, T.</span>; <span class="NLM_string-name">Ikeda, Y.</span></span> <span> </span><span class="NLM_article-title">Melanin Production Inhibitor</span>. U.S. Patent <span class="NLM_patent">8,846,012</span>, Sept 30, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Pola%0AChemical+Industries+Inc.author=K.+Yokoyama&author=M.+Kimura&author=M.+Tamai&author=Y.+Saitoh&author=T.+Kato&author=Y.+Ikeda&title=Melanin+Production+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3D%26aulast%3DYokoyama%26aufirst%3DK.%26atitle%3DMelanin%2520Production%2520Inhibitor%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, V. P.</span></span> <span> </span><span class="NLM_article-title">The Lithium Aluminum Hydride Reduction of Some N-Substituted Succinimides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1744</span>– <span class="NLM_lpage">1747</span>, <span class="refDoi"> DOI: 10.1021/jo01065a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01065a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Chsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=1744-1747&author=K.+C.+Schreiberauthor=V.+P.+Fernandez&title=The+Lithium+Aluminum+Hydride+Reduction+of+Some+N-Substituted+Succinimides&doi=10.1021%2Fjo01065a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium aluminium hydride reduction of some N-substituted succinimides</span></div><div class="casAuthors">Schreiber, Kurt C.; Fernandez, Vincent P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1744-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The redn. of N-substituted succinimides with LiAlH4 was studied.  In all but one case redn. to the N-substituted pyrrolidines occurred smoothly.  N-Benzhydryl (I), N-tert-butyl (II), and N-phenylsuccinimides (III) underwent ring opening to yield the resp. amino alcs. in addn. to the normal redn. product.  N-Tritylsuccinimide (IV) gave only N-trityl-4-hydroxybutyramide (V).  Several succinamic acids were reduced to the resp. amino alcs.  All the succinimides except IV were prepd. by heating a mixt. of succinic anhydride and the corresponding amino for 24 hrs.  Isopropylsuccinimide (VI), obtained in 84% yield, m. 64-5°.  II, obtained in 25% yield, m. 49-50°.  No attempt was made to det. the structure of this compd.  II was obtained in 46% yield by refluxing 40 g. tert-butylsuccinamic acid (VII) in 2 l. PhMe for 48 hrs. and collecting the H2O in a trap.  III, obtained in 86% yield, m. 153°, benzylsuccinimide, in 89% yield, m. 103%, I, in 56% yield, m. 131-2°(alc.).  In addn. to the imide there was formed some higher melting material, m. 248-50°, putative N,N'-dibenzhydrylsuccinimide.  The 2 compds. were sepd. by extn. with hot alc.  IV was prepd. by refluxing an equimolar mixt. of trityl bromide and N-bromosuccinimide in dry CHCl3 3-4 hrs., the mixt. washed, evapd., and the product isolated in 67% yield, m. 203-4°.  N-Substituted succinamic acids were obtained by a known procedure (R, % yield, and m.p. given): iso-Pr, 86, 105-7°; Me3C, 90, 134-5°; Ph, 85, 147-8°; Ph2CH, 92, 189-90°.  Tritylsuccinamic acid was obtained by hydrolysis of IV, m. 222-3°.  N-Tritylacetamide, m. 214-15°, was prepd. in 89% yield in the same way as IV by using an equimolar ratio of trityl bromide and N-bromoacetamide.  In an alkali-resistant flask, 3 g. tritylacetamide in 100 ml. C6H6 and 1 g. NaH refluxed 48 hrs., the mixt. cooled, then refluxed 6 hrs. with 2 ml. MeI, filtered, the solvent removed, and product recrystd. gave 2.4 g. N-methyl-N-tritylacetamide, m. 147-8°.  A typical run for the redn. of the N-substituted succinimides was as follows.  LiAlH4 (9 g.) in 100 ml. tetrahydrofuran (THF) treated dropwise with 0.1 mole of the imide in THF so as to maintain reflux, the soln. refluxed 72 hrs., and decompd. gave the product.  The following results were obtained (N-substituent, % yield of pyrrolidine, m.p. or b.p., m.p. of picrate, % yield of RNH(CH2)4OH, and b.p. given): Me2CH, 66, 121°, 200-1°, 0, -; Me3C, 78, 146°, decompn. 245°, 1, 41-2°; Ph, 57, 81°/0.45 mm., 115-16°, 10, 134°/0.7 mm.; PhCH2, 65, 63°/0.45 mm., 128°, 0, -; Ph2CH, 48, 84-5°, 194-5°, 36, 201-5°/1 mm.  With IV the product which was obtained after 3 hrs. reflux was V.  Refluxing the mixt. for the usual period of 72 hrs. gave only a viscous material from which no solid could be obtained.  Since iso-PrCl did not apparently react with pyrrolidine even after 24 hrs. reflux, the alkyl iodide was used.  N-Tritylpyrrolidine, m. 126-7°, was obtained in 49% yield; picrate m. 133° (decompn.).  N-Substituted succinamic acids were reduced in a similar manner.  The following results were obtained (R of the product RNH-(CH2)4OH, b.p., % yield given): Me2CH, 85°/1 mm., 64; Me3C, 89-19°/1 mm. (m.41-2°), 61; Ph, 134°/0.7 mm., 50; Ph2CH, 201-5°/1 mm., 50-60°.  N-Tritylsuccinamic acid (5 g.) refluxed with 2 g. LiAlH4 was similarly reduced to give 4.6 g. V.  V (6.2 g.) in 100 ml. C6H6 and 1 g. Na refluxed 36 hrs., the mixt. treated with 4 g. MeI, stirred 2 hrs., and the product sepd. gave 4.2 g. N-trityl-γ-methoxybutyramide, m. 165°.  N-Tritylacetamide (3 g.) in 100 ml. THF treated 3 hrs. under reflux with 1 g. LiAlH4 gave 2.8 g. unchanged material.  Refluxing 72 hrs. did not effect any redn.  LiAlH4 (2 g.) in 100 ml. THF and 6.5 g. N-methyl-N-tritylacetamide in 100 ml. THF refluxed 72 hrs. gave 1.7 g. ethylmethyltritylamine, m. 81-2°; picrate m. 105-6° (decompn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd_JrqjBlnarVg90H21EOLACvtfcHk0ljNtgPtEFDdqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Chsbc%253D&md5=38fa1f923820077ff3928c61b190a0f8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo01065a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01065a012%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DK.%2BC.%26aulast%3DFernandez%26aufirst%3DV.%2BP.%26atitle%3DThe%2520Lithium%2520Aluminum%2520Hydride%2520Reduction%2520of%2520Some%2520N-Substituted%2520Succinimides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D1744%26epage%3D1747%26doi%3D10.1021%2Fjo01065a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingozzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belvisi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piarulli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carenini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castiglioni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanziani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine–Glycine–Aspartate (RGD) Peptidomimetic–Paclitaxel Conjugates Targeting Integrin AVβ3</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10460</span>– <span class="NLM_lpage">10474</span>, <span class="refDoi"> DOI: 10.1021/jm301058f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301058f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GlsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10460-10474&author=R.+Colomboauthor=M.+Mingozziauthor=L.+Belvisiauthor=D.+Arosioauthor=U.+Piarulliauthor=N.+Careniniauthor=P.+Peregoauthor=N.+Zaffaroniauthor=M.+De+Cesareauthor=V.+Castiglioniauthor=E.+Scanzianiauthor=C.+Gennari&title=Synthesis+and+Biological+Evaluation+%28in+Vitro+and+in+Vivo%29+of+Cyclic+Arginine%E2%80%93Glycine%E2%80%93Aspartate+%28RGD%29+Peptidomimetic%E2%80%93Paclitaxel+Conjugates+Targeting+Integrin+AV%CE%B23&doi=10.1021%2Fjm301058f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine-Glycine-Aspartate (RGD) Peptidomimetic-Paclitaxel Conjugates Targeting Integrin αVβ3</span></div><div class="casAuthors">Colombo, Raffaele; Mingozzi, Michele; Belvisi, Laura; Arosio, Daniela; Piarulli, Umberto; Carenini, Nives; Perego, Paola; Zaffaroni, Nadia; De Cesare, Michelandrea; Castiglioni, Vittoria; Scanziani, Eugenio; Gennari, Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10460-10474</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small library of integrin ligand-paclitaxel conjugates 10-13 was synthesized with the aim of using the tumor-homing cyclo[DKP-RGD] peptidomimetics for site-directed delivery of the cytotoxic drug.  All the paclitaxel-RGD constructs 10-13 inhibited biotinylated vitronectin binding to the purified αVβ3 integrin receptor at low nanomolar concn. and showed in vitro cytotoxic activity against a panel of human tumor cell lines similar to that of paclitaxel.  Among the cell lines, the cisplatin-resistant IGROV-1/Pt1 cells expressed high levels of integrin αVβ3, making them attractive to be tested in in vivo models. cyclo[DKP-f3-RGD]-PTX 11 displayed sufficient stability in physiol. soln. and in both human and murine plasma to be a good candidate for in vivo testing.  In tumor-targeting expts. against the IGROV-1/Pt1 human ovarian carcinoma xenotransplanted in nude mice, compd. 11 exhibited a superior activity compared with paclitaxel, despite the lower (about half) molar dosage used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7QwGoS6oKH7Vg90H21EOLACvtfcHk0ljNtgPtEFDdqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GlsrvL&md5=e7c777bc1bce4e2533cb056db63ada2e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301058f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301058f%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DMingozzi%26aufirst%3DM.%26aulast%3DBelvisi%26aufirst%3DL.%26aulast%3DArosio%26aufirst%3DD.%26aulast%3DPiarulli%26aufirst%3DU.%26aulast%3DCarenini%26aufirst%3DN.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DCastiglioni%26aufirst%3DV.%26aulast%3DScanziani%26aufirst%3DE.%26aulast%3DGennari%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520%2528in%2520Vitro%2520and%2520in%2520Vivo%2529%2520of%2520Cyclic%2520Arginine%25E2%2580%2593Glycine%25E2%2580%2593Aspartate%2520%2528RGD%2529%2520Peptidomimetic%25E2%2580%2593Paclitaxel%2520Conjugates%2520Targeting%2520Integrin%2520AV%25CE%25B23%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10460%26epage%3D10474%26doi%3D10.1021%2Fjm301058f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Practical Synthesis of Enantiomerically Pure β 2-Amino Acids via Proline-Catalyzed Diastereoselective Aminomethylation of Aldehydes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">6050</span>– <span class="NLM_lpage">6055</span>, <span class="refDoi"> DOI: 10.1021/ja070063i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja070063i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1ShsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=6050-6055&author=Y.+Chiauthor=E.+P.+Englishauthor=W.+C.+Pomerantzauthor=W.+S.+Horneauthor=L.+A.+Joyceauthor=L.+R.+Alexanderauthor=W.+S.+Flemingauthor=E.+A.+Hopkinsauthor=S.+H.+Gellman&title=Practical+Synthesis+of+Enantiomerically+Pure+%CE%B2+2-Amino+Acids+via+Proline-Catalyzed+Diastereoselective+Aminomethylation+of+Aldehydes&doi=10.1021%2Fja070063i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis of enantiomerically pure β2-amino acids via proline-catalyzed diastereoselective aminomethylation of aldehydes</span></div><div class="casAuthors">Chi, Yonggui; English, Emily P.; Pomerantz, William C.; Horne, W. Seth; Joyce, Leo A.; Alexander, Lane R.; Fleming, William S.; Hopkins, Elizabeth A.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6050-6055</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proline-catalyzed diastereoselective aminomethylation of aldehydes using a chiral iminium ion, generated from a readily prepd. precursor, provides α-substituted-β-amino aldehydes with 85:15 to 90:10 dr.  The α-substituted-β-amino aldehydes can be reduced to β-substituted-γ-amino alcs., the major diastereomer of which can be isolated via crystn. or column chromatog.  The amino alcs. are efficiently transformed to protected β2-amino acids, which are valuable building blocks for β-peptides, natural products, and other interesting mols.  Because conditions for the aminomethylation and subsequent reactions are mild, β2-amino acid derivs. with protected functional groups in the side chain, such as β2-homoglutamic acid, β2-homotyrosine, and β2-homolysine, can be prepd. in this way.  The synthetic route is short, and purifications are simple; therefore, this method enables the prepn. of protected β2-amino acids in useful quantities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-9yCpoP2hvLVg90H21EOLACvtfcHk0ljNtgPtEFDdqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1ShsLs%253D&md5=dfb968ca03d869e049750514c2256100</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja070063i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja070063i%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DY.%26aulast%3DEnglish%26aufirst%3DE.%2BP.%26aulast%3DPomerantz%26aufirst%3DW.%2BC.%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DAlexander%26aufirst%3DL.%2BR.%26aulast%3DFleming%26aufirst%3DW.%2BS.%26aulast%3DHopkins%26aufirst%3DE.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DPractical%2520Synthesis%2520of%2520Enantiomerically%2520Pure%2520%25CE%25B2%25202-Amino%2520Acids%2520via%2520Proline-Catalyzed%2520Diastereoselective%2520Aminomethylation%2520of%2520Aldehydes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D6050%26epage%3D6055%26doi%3D10.1021%2Fja070063i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wernic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMaio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span> <span> </span><span class="NLM_article-title">Enantiospecific Synthesis of L-.Alpha.-Aminosuberic Acid. Synthetic Applications in Preparation of Atrial Natriuretic Factor Analogs</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4224</span>– <span class="NLM_lpage">4228</span>, <span class="refDoi"> DOI: 10.1021/jo00278a046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00278a046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaL1MXltFGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=4224-4228&author=D.+Wernicauthor=J.+DiMaioauthor=J.+Adams&title=Enantiospecific+Synthesis+of+L-.Alpha.-Aminosuberic+Acid.+Synthetic+Applications+in+Preparation+of+Atrial+Natriuretic+Factor+Analogs&doi=10.1021%2Fjo00278a046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiospecific synthesis of L-α-aminosuberic acid. Synthetic applications in preparation of atrial natriuretic factor analogs</span></div><div class="casAuthors">Wernic, Dominik; DiMaio, John; Adams, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4224-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">L-α-Aminosuberic acid, RNHCH(CO2H)(CH2)5CO2R1 (I, R = R1 = H), and L-α-amino-γ,δ-(Z)-dehydrosuberic acid, RNHCH(CO2H)CH2CH:CHCH2CH2CO2R1 (II, R = R1 = H), were synthesized enantiospecifically as orthogonally protected derivs. I and II (R = Me3CO2C, R1 = 9-fluorenylmethyl), which are convenient for peptide synthesis.  Both products were utilized as isosteres for the cysteine-cysteine disulfide linkage in atrial natriuretic factor analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl3HTWcqFriLVg90H21EOLACvtfcHk0lggxGp6NLCMYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltFGksbw%253D&md5=0eccef5b3e26409fb0b955c1900d3a05</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo00278a046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00278a046%26sid%3Dliteratum%253Aachs%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DDiMaio%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DEnantiospecific%2520Synthesis%2520of%2520L-.Alpha.-Aminosuberic%2520Acid.%2520Synthetic%2520Applications%2520in%2520Preparation%2520of%2520Atrial%2520Natriuretic%2520Factor%2520Analogs%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D4224%26epage%3D4228%26doi%3D10.1021%2Fjo00278a046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascitti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumarola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Muzio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Nicotinamide N-Methyltransferase in HSC-2 OSCC Cell Line: Effect on Apoptosis and Cell Proliferation</span>. <i>Clin. Oral Investig.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1007/s00784-018-2497-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1007%2Fs00784-018-2497-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29882109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A280%3ADC%252BC1Mblt12gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=829-838&author=R.+Setaauthor=M.+Mascittiauthor=R.+Campagnaauthor=D.+Sartiniauthor=S.+Fumarolaauthor=A.+Santarelliauthor=M.+Giulianiauthor=M.+Cecatiauthor=L.+Lo+Muzioauthor=M.+Emanuelli&title=Overexpression+of+Nicotinamide+N-Methyltransferase+in+HSC-2+OSCC+Cell+Line%3A+Effect+on+Apoptosis+and+Cell+Proliferation&doi=10.1007%2Fs00784-018-2497-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation</span></div><div class="casAuthors">Seta Riccardo; Mascitti Marco; Campagna Roberto; Sartini Davide; Fumarola Stefania; Santarelli Andrea; Cecati Monia; Emanuelli Monica; Giuliani Michele; Muzio Lorenzo Lo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oral investigations</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">829-838</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Oral squamous cell carcinoma (OSCC) is the most common malignancy of oral cavity.  Despite advances in therapeutic approaches, the 5-year survival rate for oral cancer has not improved in the last three decades.  Therefore, new molecular targets for early diagnosis and treatment of OSCC are needed.  In the present study, we focused on the enzyme nicotinamide N-methyltransferase (NNMT).  We have previously shown that enzyme expression is upregulated in OSCC and NNMT knockdown in PE/CA PJ-15 cells significantly decreased cell growth in vitro and tumorigenicity in vivo.  MATERIAL AND METHODS:  To further explore the role of the enzyme in oral cancer cell metabolism, HSC-2 cells were transfected with the NNMT expression vector (pcDNA3-NNMT) and the effect of enzyme upregulation on cell proliferation was evaluated by MTT assay.  Subsequently, we investigated at molecular level the role of NNMT on apoptosis and cell proliferation, by exploring the expression of β-catenin, survivin, and Ki-67 by real-time PCR.  Moreover, we performed immunohistochemistry on 20 OSCC tissue samples to explore the expression level of NNMT and survivin ΔEx3 isoform.  RESULTS:  Enzyme upregulation significantly increased cell growth in vitro.  Moreover, a positive correlation between NNMT and survivin ΔEx3 isoform expression levels was found both in HSC-2 cells and in OSCC tissue samples.  CONCLUSION:  Taken together, our results indicate a possible involvement of NNMT in the proliferation and tumorigenic capacity of OSCC cells and seem to suggest that the enzyme could represent a potential target for the treatment of oral cancer.  CLINICAL RELEVANCE:  The involvement of NNMT in cell growth and anti-apoptotic mechanisms seems to suggest that this enzyme could be a new therapeutic target to improve the survival of OSCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZ7QZTOXwtZG52AMpI4GK2fW6udTcc2eZ0jkdk7zOf6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mblt12gsw%253D%253D&md5=f4495f592b308457437236b629d62f1d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00784-018-2497-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00784-018-2497-8%26sid%3Dliteratum%253Aachs%26aulast%3DSeta%26aufirst%3DR.%26aulast%3DMascitti%26aufirst%3DM.%26aulast%3DCampagna%26aufirst%3DR.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DFumarola%26aufirst%3DS.%26aulast%3DSantarelli%26aufirst%3DA.%26aulast%3DGiuliani%26aufirst%3DM.%26aulast%3DCecati%26aufirst%3DM.%26aulast%3DLo%2BMuzio%26aufirst%3DL.%26aulast%3DEmanuelli%26aufirst%3DM.%26atitle%3DOverexpression%2520of%2520Nicotinamide%2520N-Methyltransferase%2520in%2520HSC-2%2520OSCC%2520Cell%2520Line%253A%2520Effect%2520on%2520Apoptosis%2520and%2520Cell%2520Proliferation%26jtitle%3DClin.%2520Oral%2520Investig.%26date%3D2019%26volume%3D23%26spage%3D829%26epage%3D838%26doi%3D10.1007%2Fs00784-018-2497-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.-H.</span>; <span class="NLM_string-name">Chun, K.</span>; <span class="NLM_string-name">Choi, J.-W.</span>; <span class="NLM_string-name">Joe, B.-Y.</span>; <span class="NLM_string-name">Park, S.-W.</span>; <span class="NLM_string-name">Kim, K. H.</span>; <span class="NLM_string-name">Oh, B.-K.</span>; <span class="NLM_string-name">Choi, J.-H.</span></span> <span> </span><span class="NLM_article-title">Tricyclic Derivatives or Pharmaceutically Acceptable Salts Thereof, Their Preparations and Pharmaceutical Compositions Containing Them</span>. U.S. Patent <span class="NLM_patent">2007/0179143A1</span>, Aug 2, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.-H.+Kim&author=K.+Chun&author=J.-W.+Choi&author=B.-Y.+Joe&author=S.-W.+Park&author=K.+H.+Kim&author=B.-K.+Oh&author=J.-H.+Choi&title=Tricyclic+Derivatives+or+Pharmaceutically+Acceptable+Salts+Thereof%2C+Their+Preparations+and+Pharmaceutical+Compositions+Containing+Them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.-H.%26atitle%3DTricyclic%2520Derivatives%2520or%2520Pharmaceutically%2520Acceptable%2520Salts%2520Thereof%252C%2520Their%2520Preparations%2520and%2520Pharmaceutical%2520Compositions%2520Containing%2520Them%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ewa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIej, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzegorz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michał, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Józef, O.</span></span> <span> </span><span class="NLM_article-title">The Development of First Staphylococcus Aureus SplB Protease Inhibitors: Phosphonic Analogues of Glutamine</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5574</span>– <span class="NLM_lpage">5578</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2012.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=22858096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A280%3ADC%252BC38fltFWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5574-5578&author=B.+Ewaauthor=W.+MacIejauthor=S.+Marcinauthor=D.+Grzegorzauthor=Z.+Micha%C5%82author=P.+Janauthor=O.+J%C3%B3zef&title=The+Development+of+First+Staphylococcus+Aureus+SplB+Protease+Inhibitors%3A+Phosphonic+Analogues+of+Glutamine&doi=10.1016%2Fj.bmcl.2012.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The development of first Staphylococcus aureus SplB protease inhibitors: phosphonic analogues of glutamine</span></div><div class="casAuthors">Ewa Burchacka; Maciej Walczak; Marcin Sienczyk; Grzegorz Dubin; Michal Zdzalik; Jan Potempa; Jozef Oleksyszyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5574-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Produced by Staphylococcus aureus, SplB belongs to the chymotrypsin-like serine protease family.  Since the biological role of SplB protease is unknown, the design and application of its specific inhibitors may help to reveal the function of this enzyme.  Until now no SplB inhibitors have been reported.  Herein, we present the design and synthesis of novel α-aminophosphonic analogues of glutamine, as well as their peptidyl derivatives.  The inhibitory effects of these compounds towards the newly discovered SplB serine protease from S. aureus are characterized.  We have also investigated the influence of aromatic ester substituents on inhibitory potency towards SplB.  One of the compounds-Cbz-Glu-Leu-Gln(P)(OC(6)H(4)-4-O-CH(3))(2)-displayed an apparent second-order inhibition rate value of 1400 M(-1)s(-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3RTMScVEaKRdUSIfHIn4FfW6udTcc2eb0gvjhLcBUfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fltFWhtg%253D%253D&md5=a0e775442a8a4add9d207b7121d045d2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DEwa%26aufirst%3DB.%26aulast%3DMacIej%26aufirst%3DW.%26aulast%3DMarcin%26aufirst%3DS.%26aulast%3DGrzegorz%26aufirst%3DD.%26aulast%3DMicha%25C5%2582%26aufirst%3DZ.%26aulast%3DJan%26aufirst%3DP.%26aulast%3DJ%25C3%25B3zef%26aufirst%3DO.%26atitle%3DThe%2520Development%2520of%2520First%2520Staphylococcus%2520Aureus%2520SplB%2520Protease%2520Inhibitors%253A%2520Phosphonic%2520Analogues%2520of%2520Glutamine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5574%26epage%3D5578%26doi%3D10.1016%2Fj.bmcl.2012.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1021/bc9005656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9005656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=979-987&author=S.+Chenauthor=X.+Zhaoauthor=J.+Chenauthor=J.+Chenauthor=L.+Kuznetsovaauthor=S.+S.+Wongauthor=I.+Ojima&title=Mechanism-Based+Tumor-Targeting+Drug+Delivery+System.+Validation+of+Efficient+Vitamin+Receptor-Mediated+Endocytosis+and+Drug+Release&doi=10.1021%2Fbc9005656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release</span></div><div class="casAuthors">Chen, Shuyi; Zhao, Xianrui; Chen, Jingyi; Chen, Jin; Kuznetsova, Larisa; Wong, Stanislaus S.; Ojima, Iwao</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">979-987</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient mechanism-based tumor-targeting drug delivery system, based on tumor-specific vitamin-receptor mediated endocytosis, has been developed.  The tumor-targeting drug delivery system is a conjugate of a tumor-targeting mol. (biotin: vitamin H or vitamin B-7), a mechanism-based self-immolative linker and a second-generation taxoid (SB-T-1214) as the cytotoxic agent.  This conjugate (I) is designed to be (i) specific to the vitamin receptors overexpressed on tumor cell surface and (ii) internalized efficiently through receptor-mediated endocytosis, followed by smooth drug release via glutathione-triggered self-immolation of the linker.  In order to monitor and validate the sequence of events hypothesized, i.e., receptor-mediated endocytosis of the conjugate, drug release, and drug-binding to the target protein (microtubules), three fluorescent/fluorogenic mol. probes were designed and synthesized.  The actual occurrence of these processes was unambiguously confirmed by means of confocal fluorescence microscopy (CFM) and flow cytometry using L1210FR leukemia cells, overexpressing biotin receptors.  The mol. probe bearing the taxoid linked to fluorescein, was also used to examine the cell specificity (i.e., efficacy of receptor-based cell targeting) for three cell lines, L1210FR (biotin receptors overexpressed), L1210 (biotin receptors not overexpressed), and WI38 (normal human lung fibroblast, biotin receptor neg.).  As anticipated, the mol. probe exhibited high specificity only to L1210FR.  To confirm the direct correlation between the cell-specific drug delivery and anticancer activity of the fluorescein-linked taxoid probe, its cytotoxicity against these three cell lines was also examd.  The results clearly showed a good correlation between the two methods.  In the same manner, excellent cell-specific cytotoxicity of the conjugate I (without fluorescein attachment to the taxoid) against the same three cell lines was confirmed.  This mechanism-based tumor-targeting drug delivery system will find a range of applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUIQMoFwAzy7Vg90H21EOLACvtfcHk0lh3qK38DJzXig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSks7o%253D&md5=697f734ab904bc8117bef139150e1938</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbc9005656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9005656%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKuznetsova%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DS.%2BS.%26aulast%3DOjima%26aufirst%3DI.%26atitle%3DMechanism-Based%2520Tumor-Targeting%2520Drug%2520Delivery%2520System.%2520Validation%2520of%2520Efficient%2520Vitamin%2520Receptor-Mediated%2520Endocytosis%2520and%2520Drug%2520Release%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D979%26epage%3D987%26doi%3D10.1021%2Fbc9005656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berk, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">A Catalytic Method for the Reduction of Esters to Alcohols</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">5093</span>– <span class="NLM_lpage">5095</span>, <span class="refDoi"> DOI: 10.1021/ja00013a074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00013a074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1ygtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=5093-5095&author=S.+C.+Berkauthor=K.+A.+Kreutzerauthor=S.+L.+Buchwald&title=A+Catalytic+Method+for+the+Reduction+of+Esters+to+Alcohols&doi=10.1021%2Fja00013a074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A catalytic method for the reduction of esters to alcohols</span></div><div class="casAuthors">Berk, Scott C.; Kreutzer, Kristina A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5093-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new titanium-catalyzed hydrosilylation of esters is described.  The procedure is exptl. simple and efficient, and it uses inexpensive materials to convert esters into their corresponding primary alcs.  Thus, a hexane soln. of BuLi was added to a slurry of titanocene dichloride at -78° to give a catalyst.  BzOMe and (EtO)3SiH were added to the catalyst soln. and the mixt. warmed to room temp. and subsequently treated with concd. HCl to give 93% PhCH2OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7hBEqbQRZSrVg90H21EOLACvtfcHk0lh3qK38DJzXig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1ygtrw%253D&md5=bcdbbb89058788e8d73f932f97e36290</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja00013a074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00013a074%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DS.%2BC.%26aulast%3DKreutzer%26aufirst%3DK.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520Catalytic%2520Method%2520for%2520the%2520Reduction%2520of%2520Esters%2520to%2520Alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D5093%26epage%3D5095%26doi%3D10.1021%2Fja00013a074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a New Conformation-Constrained L-Tyrosine Analogue as a Potential Scaffold for SH2 Domain Ligands</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">6679</span>– <span class="NLM_lpage">6684</span>, <span class="refDoi"> DOI: 10.1021/jo0340152</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0340152" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1egs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=6679-6684&author=F.+Liuauthor=H.+Y.+Zhaauthor=Z.+J.+Yao&title=Synthesis+of+a+New+Conformation-Constrained+L-Tyrosine+Analogue+as+a+Potential+Scaffold+for+SH2+Domain+Ligands&doi=10.1021%2Fjo0340152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a New Conformation-Constrained L-Tyrosine Analogue as a Potential Scaffold for SH2 Domain Ligands</span></div><div class="casAuthors">Liu, Fa; Zha, Hui-Yan; Yao, Zhu-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6679-6684</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enantioselective synthesis of a new tricyclic tyrosine analog I is reported.  I, conformation-constrained SH2 domain ligand scaffold, was designed on the basis of the natural ligand, whose structure contains the elements of a tyrosine moiety having χ1 and χ2 angles constrained to values obsd. for a phosphotyrosyl (pTyr) residue bound to the p56lck SH2 domain.  It represents a unique, highly constrained amino acid, which may be of value in signal transduction studies.  Three key steps, an asym. tandem Michael addn., an intramol. Friedel-Crafts reaction, and an intramol. Mannich reaction, were successfully applied in the presented synthetic route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhyckVoIIDWrVg90H21EOLACvtfcHk0lh3qK38DJzXig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1egs7s%253D&md5=abfea2649a8418b5fc12fbfb82c92e82</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo0340152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0340152%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DZha%26aufirst%3DH.%2BY.%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26atitle%3DSynthesis%2520of%2520a%2520New%2520Conformation-Constrained%2520L-Tyrosine%2520Analogue%2520as%2520a%2520Potential%2520Scaffold%2520for%2520SH2%2520Domain%2520Ligands%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D6679%26epage%3D6684%26doi%3D10.1021%2Fjo0340152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayakrishnan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeppe, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Thiyl Glycosylate of Olefinic Proteins: S-Linked Glycoconjugate Synthesis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7798</span>– <span class="NLM_lpage">7802</span>, <span class="refDoi"> DOI: 10.1002/anie.200903135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1002%2Fanie.200903135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ektL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7798-7802&author=N.+Floydauthor=B.+Vijayakrishnanauthor=J.+R.+Koeppeauthor=B.+G.+Davis&title=Thiyl+Glycosylate+of+Olefinic+Proteins%3A+S-Linked+Glycoconjugate+Synthesis&doi=10.1002%2Fanie.200903135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Thiyl Glycosylation of Olefinic Proteins: S-Linked Glycoconjugate Synthesis</span></div><div class="casAuthors">Floyd, Nicola; Vijayakrishnan, Balakumar; Koeppe, Julia R.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">7798-7802, S7798/1-S7798/72</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe the development of a convergent approach for the synthesis of a novel class of S-linked glycoconjugate proteins through the site-specific ligation of 1-glycosylthiols to proteins.  The strategy exploits nonnatural amino acid incorporation for the introduction of L-homoallylglycine (L-Hag) into a protein and free-radical addn. hydrothiolation reactions, under conditions mild enough to retain protein activity throughout.  In this way, Hag functions as a new tag combined here with a new modification as part of a general "tag-modify" strategy for synthetic-protein construction.  While 1-thioglycoside formation by the free-radical addn. of 1-glycosylthiols to alkenes has been reported for the synthesis of small mols., to date this method has not been applied to the synthesis of S-linked glycoproteins or bioconjugates.  The unique reactivity profile of L-Hag, with an olefinic sidechain compared to the natural amino acids characteristically found in proteins, allows for a chemoselective chem. reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjW9T2A8yjC7Vg90H21EOLACvtfcHk0liJJ-81-BHSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ektL%252FN&md5=5de684052119bc60b41972eb8d09467a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.200903135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200903135%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DN.%26aulast%3DVijayakrishnan%26aufirst%3DB.%26aulast%3DKoeppe%26aufirst%3DJ.%2BR.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DThiyl%2520Glycosylate%2520of%2520Olefinic%2520Proteins%253A%2520S-Linked%2520Glycoconjugate%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D7798%26epage%3D7802%26doi%3D10.1002%2Fanie.200903135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0liJJ-81-BHSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS: High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers</span>. <i>SoftwareX</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1–2</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.softx.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.softx.2015.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=2015&pages=19-25&author=M.+J.+Abrahamauthor=T.+Murtolaauthor=R.+Schulzauthor=S.+P%C3%A1llauthor=J.+C.+Smithauthor=B.+Hessauthor=E.+Lindahl&title=GROMACS%3A+High+Performance+Molecular+Simulations+through+Multi-Level+Parallelism+from+Laptops+to+Supercomputers&doi=10.1016%2Fj.softx.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.softx.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.softx.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BJ.%26aulast%3DMurtola%26aufirst%3DT.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DP%25C3%25A1ll%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%253A%2520High%2520Performance%2520Molecular%2520Simulations%2520through%2520Multi-Level%2520Parallelism%2520from%2520Laptops%2520to%2520Supercomputers%26jtitle%3DSoftwareX%26date%3D2015%26volume%3D1%25E2%2580%25932%26spage%3D19%26epage%3D25%26doi%3D10.1016%2Fj.softx.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponder, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Force Fields for Protein Simulations</span>. <i>Adv. Protein Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/S0065-3233(03)66002-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2FS0065-3233%2803%2966002-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=14631816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1yhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=27-85&author=J.+W.+Ponderauthor=D.+A.+Case&title=Force+Fields+for+Protein+Simulations&doi=10.1016%2FS0065-3233%2803%2966002-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Force fields for protein simulations</span></div><div class="casAuthors">Ponder, Jay W.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Protein Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">Protein Simulations</span>),
    <span class="NLM_cas:pages">27-85, 1 plate</span>CODEN:
                <span class="NLM_cas:coden">APCHA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-3233</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review on history, performance and development of force fields for protein simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraAF5aG_QoCrVg90H21EOLACvtfcHk0lhPhMrCbLrYpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1yhsQ%253D%253D&md5=8e6a69c961b621868dbcf4698b3c813a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0065-3233%2803%2966002-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3233%252803%252966002-X%26sid%3Dliteratum%253Aachs%26aulast%3DPonder%26aufirst%3DJ.%2BW.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DForce%2520Fields%2520for%2520Protein%2520Simulations%26jtitle%3DAdv.%2520Protein%2520Chem.%26date%3D2003%26volume%3D66%26spage%3D27%26epage%3D85%26doi%3D10.1016%2FS0065-3233%2803%2966002-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">A Five-Site Model for Liquid Water and the Reproduction of the Density Anomaly by Rigid, Nonpolarizable Potential Functions</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">8910</span>– <span class="NLM_lpage">8922</span>, <span class="refDoi"> DOI: 10.1063/1.481505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1063%2F1.481505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2000&pages=8910-8922&author=M.+W.+Mahoneyauthor=W.+L.+Jorgensen&title=A+Five-Site+Model+for+Liquid+Water+and+the+Reproduction+of+the+Density+Anomaly+by+Rigid%2C+Nonpolarizable+Potential+Functions&doi=10.1063%2F1.481505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions</span></div><div class="casAuthors">Mahoney, Michael W.; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8910-8922</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The ability of simple potential functions to reproduce accurately the d. of liq. water from -37 to 100 °C at 1 to 10 000 atm has been further explored.  The result is the five-site TIP5P model, which yields significantly improved results; the av. error in the d. over the 100° temp. range from -37.5 to 62.5 °C at 1 atm is only 0.006 g cm-3.  Classical Monte Carlo statistical mechanics calcns. have been performed to optimize the parameters, esp. the position of the neg. charges along the lone-pair directions.  Initial calcns. with 216 mols. in the NPT ensemble at 1 atm focused on finding a model that reproduced the shape of the liq. d. curve as a function of temp.  Calcns. performed for 512 mols. with the final TIP5P model demonstrate that the d. max. near 4 °C at 1 atm is reproduced, while high-quality structural and thermodn. results are maintained.  Attainment of high precision for the low-temp. runs required sampling for more than 1 billion Monte Carlo configurations.  In addn., the dielec. const. was computed from the response to an applied elec. field; the result is 81.5±1.5 at 25 °C and the exptl. curve is mirrored from 0-100 °C at 1 atm.  The TIP5P model is also found to perform well as a function of pressure; the d. of liq. water at 25 °C is reproduced with an av. error of ∼2% over the range from 1 to 10 000 atm, and the shift of the temp. of max. d. to lower temp. with increasing pressure is also obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreTL07agP8GbVg90H21EOLACvtfcHk0lhPhMrCbLrYpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFCltr0%253D&md5=368765bd00124153b0c65d95b81e951a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1063%2F1.481505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.481505%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DA%2520Five-Site%2520Model%2520for%2520Liquid%2520Water%2520and%2520the%2520Reproduction%2520of%2520the%2520Density%2520Anomaly%2520by%2520Rigid%252C%2520Nonpolarizable%2520Potential%2520Functions%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2000%26volume%3D112%26spage%3D8910%26epage%3D8922%26doi%3D10.1063%2F1.481505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parrinello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span> <span> </span><span class="NLM_article-title">Polymorphic Transitions in Single Crystals: A New Molecular Dynamics Method</span>. <i>J. Appl. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7182</span>– <span class="NLM_lpage">7190</span>, <span class="refDoi"> DOI: 10.1063/1.328693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1063%2F1.328693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaL38XislSnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1981&pages=7182-7190&author=M.+Parrinelloauthor=A.+Rahman&title=Polymorphic+Transitions+in+Single+Crystals%3A+A+New+Molecular+Dynamics+Method&doi=10.1063%2F1.328693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphic transitions in single crystals:  A new molecular dynamics method</span></div><div class="casAuthors">Parrinello, M.; Rahman, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Physics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7182-90</span>CODEN:
                <span class="NLM_cas:coden">JAPIAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8979</span>.
    </div><div class="casAbstract">A Lagrangian formulation is introduced; it can be used to make mol. dynamics (MD) calcns. on systems under the most general, externally applied, conditions of stress.  In this formulation the MD cell shape and size can change according to dynamic equations given by this Lagrangian.  This MD technique was used to the study of structural transitions of a Ni single crystal under uniform uniaxial compressive and tensile loads.  Some results regarding the stress-strain relation obtained by static calcns. are invalid at finite temp.  Under compressive loading, the model of Ni shows a bifurcation in its stress-strain relation; this bifurcation provides a link in configuration space between cubic and hexagonal close packing.  Such a transition could perhaps be obsd. exptl. under extreme conditions of shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2_UQSeiXXPbVg90H21EOLACvtfcHk0lhPhMrCbLrYpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XislSnuw%253D%253D&md5=a0a5617389f6cabbf2a405c649aadf03</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1063%2F1.328693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.328693%26sid%3Dliteratum%253Aachs%26aulast%3DParrinello%26aufirst%3DM.%26aulast%3DRahman%26aufirst%3DA.%26atitle%3DPolymorphic%2520Transitions%2520in%2520Single%2520Crystals%253A%2520A%2520New%2520Molecular%2520Dynamics%2520Method%26jtitle%3DJ.%2520Appl.%2520Phys.%26date%3D1981%26volume%3D52%26spage%3D7182%26epage%3D7190%26doi%3D10.1063%2F1.328693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynn, A.</span></span> <span> </span><span class="NLM_article-title">G_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1951</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1021/ci500020m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500020m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlWiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1951-1962&author=R.+Kumariauthor=R.+Kumarauthor=A.+Lynn&title=G_mmpbsa%E2%80%94A+GROMACS+Tool+for+High-Throughput+MM-PBSA+Calculations&doi=10.1021%2Fci500020m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations</span></div><div class="casAuthors">Kumari, Rashmi; Kumar, Rajendra; Lynn, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1951-1962</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics Poisson-Boltzmann surface area (MM-PBSA), a method to est. interaction free energies, has been increasingly used in the study of biomol. interactions.  Recently, this method has also been applied as a scoring function in computational drug design.  Here a new tool g_mmpbsa, which implements the MM-PBSA approach using subroutines written inhouse or sourced from the GROMACS and APBS packages is described. g_mmpbsa was developed as part of the Open Source Drug Discovery (OSDD) consortium.  Its aim is to integrate high-throughput mol. dynamics (MD) simulations with binding energy calcns.  The tool provides options to select alternative at. radii and different nonpolar solvation models including models based on the solvent accessible surface area (SASA), solvent accessible vol. (SAV), and a model which contains both repulsive (SASA-SAV) and attractive components (described using a Weeks-Chandler-Andersen like integral method).  We showcase the effectiveness of the tool by comparing the calcd. interaction energy of 37 structurally diverse HIV-1 protease inhibitor complexes with their exptl. binding free energies.  The effect of varying several combinations of input parameters such as at. radii, dielec. const., grid resoln., solute-solvent dielec. boundary definition, and nonpolar models was investigated. g_mmpbsa can also be used to est. the energy contribution per residue to the binding energy.  It has been used to identify those residues in HIV-1 protease that are most crit. for binding a range of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrckNA7gLtUGrVg90H21EOLACvtfcHk0lhPhMrCbLrYpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlWiu7o%253D&md5=e70a138b71eed07054d58f91ba1a227f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fci500020m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500020m%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DLynn%26aufirst%3DA.%26atitle%3DG_mmpbsa%25E2%2580%2594A%2520GROMACS%2520Tool%2520for%2520High-Throughput%2520MM-PBSA%2520Calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1951%26epage%3D1962%26doi%3D10.1021%2Fci500020m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sept, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span> <span> </span><span class="NLM_article-title">Electrostatics of Nanosystems: Application to Microtubules and the Ribosome</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10037</span>– <span class="NLM_lpage">10041</span>, <span class="refDoi"> DOI: 10.1073/pnas.181342398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1073%2Fpnas.181342398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=11517324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10037-10041&author=N.+A.+Bakerauthor=D.+Septauthor=S.+Josephauthor=M.+J.+Holstauthor=J.+A.+McCammon&title=Electrostatics+of+Nanosystems%3A+Application+to+Microtubules+and+the+Ribosome&doi=10.1073%2Fpnas.181342398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Electrostatics of nanosystems: application to microtubules and the ribosome</span></div><div class="casAuthors">Baker, Nathan A.; Sept, David; Joseph, Simpson; Holst, Michael J.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10037-10041</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Evaluation of the electrostatic properties of biomols. has become a std. practice in mol. biophysics.  Foremost among the models used to elucidate the electrostatic potential is the Poisson-Boltzmann equation; however, existing methods for solving this equation have limited the scope of accurate electrostatic calcns. to relatively small biomol. systems.  Here we present the application of numerical methods to enable the trivially parallel soln. of the Poisson-Boltzmann equation for supramol. structures that are orders of magnitude larger in size.  As a demonstration of this methodol., electrostatic potentials have been calcd. for large microtubule and ribosome structures.  The results point to the likely role of electrostatics in a variety of activities of these structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA_CAlhE0uX7Vg90H21EOLACvtfcHk0ljR8GC0BObjJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D&md5=1b861999ef12c6972e82e8ada0f387cb</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.181342398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.181342398%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BA.%26aulast%3DSept%26aufirst%3DD.%26aulast%3DJoseph%26aufirst%3DS.%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DElectrostatics%2520of%2520Nanosystems%253A%2520Application%2520to%2520Microtubules%2520and%2520the%2520Ribosome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2001%26volume%3D98%26spage%3D10037%26epage%3D10041%26doi%3D10.1073%2Fpnas.181342398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsyte-lovejoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rival-gervier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labrie, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigle, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMaggio, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasney, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siarheyeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattenden, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kireev, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petronis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">A Chemical Probe Selectively Inhibits G9a and GLP Methyltransferase and Genanylgeranyltransferase I with Antitumor Activity against Brest Cancer in Vivo</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1038/nchembio.599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fnchembio.599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=21743462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=566-574&author=M.+Vedadiauthor=D.+Barsyte-lovejoyauthor=F.+Liuauthor=S.+Rival-gervierauthor=A.+Allali-hassaniauthor=V.+Labrieauthor=T.+J.+Wigleauthor=P.+A.+DiMaggioauthor=G.+A.+Wasneyauthor=A.+Siarheyevaauthor=A.+Dongauthor=W.+Tempelauthor=S.-C.+Wangauthor=X.+Chenauthor=I.+Chauauthor=T.+J.+Manganoauthor=X.-p.+Huangauthor=C.+D.+Simpsonauthor=S.+G.+Pattendenauthor=J.+L.+Norrisauthor=D.+B.+Kireevauthor=A.+Tripathyauthor=B.+L.+Rothauthor=W.+P.+Janzenauthor=B.+A.+Garciaauthor=A.+Petronisauthor=J.+Ellisauthor=P.+J.+Brownauthor=S.+V.+Fryeauthor=C.+H.+Arrowsmithauthor=J.+Jin&title=A+Chemical+Probe+Selectively+Inhibits+G9a+and+GLP+Methyltransferase+and+Genanylgeranyltransferase+I+with+Antitumor+Activity+against+Brest+Cancer+in+Vivo&doi=10.1038%2Fnchembio.599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells</span></div><div class="casAuthors">Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Liu, Feng; Rival-Gervier, Sylvie; Allali-Hassani, Abdellah; Labrie, Viviane; Wigle, Tim J.; DiMaggio, Peter A.; Wasney, Gregory A.; Siarheyeva, Alena; Dong, Aiping; Tempel, Wolfram; Wang, Sun-Chong; Chen, Xin; Chau, Irene; Mangano, Thomas J.; Huang, Xi-ping; Simpson, Catherine D.; Pattenden, Samantha G.; Norris, Jacqueline L.; Kireev, Dmitri B.; Tripathy, Ashutosh; Edwards, Aled; Roth, Bryan L.; Janzen, William P.; Garcia, Benjamin A.; Petronis, Arturas; Ellis, James; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">566-574</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein lysine methyltransferases G9a and GLP modulate the transcriptional repression of a variety of genes via dimethylation of Lys9 on histone H3 (H3K9me2) as well as dimethylation of non-histone targets.  Here we report the discovery of UNC0638, an inhibitor of G9a and GLP with excellent potency and selectivity over a wide range of epigenetic and non-epigenetic targets.  UNC0638 treatment of a variety of cell lines resulted in lower global H3K9me2 levels, equiv. to levels obsd. for small hairpin RNA knockdown of G9a and GLP with the functional potency of UNC0638 being well sepd. from its toxicity.  UNC0638 markedly reduced the clonogenicity of MCF7 cells, reduced the abundance of H3K9me2 marks at promoters of known G9a-regulated endogenous genes and disproportionately affected several genomic loci encoding microRNAs.  In mouse embryonic stem cells, UNC0638 reactivated G9a-silenced genes and a retroviral reporter gene in a concn.-dependent manner without promoting differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphv-2bZcBqwLVg90H21EOLACvtfcHk0ljR8GC0BObjJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OmtLs%253D&md5=a944e99a910194c1a15240fc6dc8f852</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.599%26sid%3Dliteratum%253Aachs%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DBarsyte-lovejoy%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRival-gervier%26aufirst%3DS.%26aulast%3DAllali-hassani%26aufirst%3DA.%26aulast%3DLabrie%26aufirst%3DV.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DDiMaggio%26aufirst%3DP.%2BA.%26aulast%3DWasney%26aufirst%3DG.%2BA.%26aulast%3DSiarheyeva%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.-C.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DMangano%26aufirst%3DT.%2BJ.%26aulast%3DHuang%26aufirst%3DX.-p.%26aulast%3DSimpson%26aufirst%3DC.%2BD.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DNorris%26aufirst%3DJ.%2BL.%26aulast%3DKireev%26aufirst%3DD.%2BB.%26aulast%3DTripathy%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DPetronis%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DA%2520Chemical%2520Probe%2520Selectively%2520Inhibits%2520G9a%2520and%2520GLP%2520Methyltransferase%2520and%2520Genanylgeranyltransferase%2520I%2520with%2520Antitumor%2520Activity%2520against%2520Brest%2520Cancer%2520in%2520Vivo%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D566%26epage%3D574%26doi%3D10.1038%2Fnchembio.599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerty, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watowich, S. J.</span></span> <span> </span><span class="NLM_article-title">Selective and Membrane-Permeable Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Reverse High Fat Diet-Induced Obesity in Mice</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bcp.2017.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29155147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVegu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2018&pages=141-152&author=H.+Neelakantanauthor=V.+Vanceauthor=M.+D.+Wetzelauthor=H.-Y.+L.+Wangauthor=S.+F.+McHardyauthor=C.+C.+Finnertyauthor=J.+D.+Hommelauthor=S.+J.+Watowich&title=Selective+and+Membrane-Permeable+Small+Molecule+Inhibitors+of+Nicotinamide+N-Methyltransferase+Reverse+High+Fat+Diet-Induced+Obesity+in+Mice&doi=10.1016%2Fj.bcp.2017.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice</span></div><div class="casAuthors">Neelakantan, Harshini; Vance, Virginia; Wetzel, Michael D.; Wang, Hua-Yu Leo; McHardy, Stanton F.; Finnerty, Celeste C.; Hommel, Jonathan D.; Watowich, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-152</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is a crit. need for new mechanism-of-action drugs that reduce the burden of obesity and assocd. chronic metabolic comorbidities.  A potentially novel target to treat obesity and type 2 diabetes is nicotinamide-N-methyltransferase (NNMT), a cytosolic enzyme with newly identified roles in cellular metab. and energy homeostasis.  To validate NNMT as an anti-obesity drug target, the authors investigated the permeability, selectivity, mechanistic, and physiol. properties of a series of small mol. NNMT inhibitors.  Membrane permeability of NNMT inhibitors was characterized using parallel artificial membrane permeability and Caco-2 cell assays.  Selectivity was tested against structurally-related methyltransferases and NAD (NAD+) salvage pathway enzymes.  Effects of NNMT inhibitors on lipogenesis and intracellular levels of metabolites, including NNMT reaction product 1-methylnicotianamide (1-MNA) were evaluated in cultured adipocytes.  Effects of a potent NNMT inhibitor on obesity measures and plasma lipid were assessed in diet-induced obese mice fed a high-fat diet.  Methylquinolinium scaffolds with primary amine substitutions displayed high permeability from passive and active transport across membranes.  Importantly, methylquinolinium analogs displayed high selectivity, not inhibiting related SAM-dependent methyltransferases or enzymes in the NAD+ salvage pathway.  NNMT inhibitors reduced intracellular 1-MNA, increased intracellular NAD+ and S-(5'-adenosyl)-L-methionine (SAM), and suppressed lipogenesis in adipocytes.  Treatment of diet-induced obese mice systemically with a potent NNMT inhibitor significantly reduced body wt. and white adipose mass, decreased adipocyte size, and lowered plasma total cholesterol levels.  Notably, administration of NNMT inhibitors did not impact total food intake nor produce any observable adverse effects.  These results support development of small mol. NNMT inhibitors as therapeutics to reverse diet-induced obesity and validate NNMT as a viable target to treat obesity and related metabolic conditions.  Increased flux of key cellular energy regulators, including NAD+ and SAM, may potentially define the therapeutic mechanism-of-action of NNMT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0K0OY6S9HhbVg90H21EOLACvtfcHk0liuqPAIBbPZvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVegu7vL&md5=4a798e5f69cf9989b8d7a9d0584f872d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DH.%26aulast%3DVance%26aufirst%3DV.%26aulast%3DWetzel%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DH.-Y.%2BL.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DFinnerty%26aufirst%3DC.%2BC.%26aulast%3DHommel%26aufirst%3DJ.%2BD.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26atitle%3DSelective%2520and%2520Membrane-Permeable%2520Small%2520Molecule%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520Reverse%2520High%2520Fat%2520Diet-Induced%2520Obesity%2520in%2520Mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D147%26spage%3D141%26epage%3D152%26doi%3D10.1016%2Fj.bcp.2017.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Policarpo, R.</span>; <span class="NLM_string-name">Decultot, L.</span>; <span class="NLM_string-name">May, E.</span>; <span class="NLM_string-name">Kuzmic, P.</span>; <span class="NLM_string-name">Carlson, S.</span>; <span class="NLM_string-name">Huang, D.</span>; <span class="NLM_string-name">Chu, V.</span>; <span class="NLM_string-name">Wright, B.</span>; <span class="NLM_string-name">Dhakshinamoorthy, S.</span>; <span class="NLM_string-name">Kannt, A.</span>; <span class="NLM_string-name">Rani, S.</span>; <span class="NLM_string-name">Dittakavi, S.</span>; <span class="NLM_string-name">Gaudet, R.</span>; <span class="NLM_string-name">Shair, M.</span></span> <span> </span><span class="NLM_article-title">High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)</span>. <span class="NLM_year">2019</span>, chemrxiv.org e-Print archive. <a href="https://chemrxiv.org/articles/High-Affinity_Alkynyl_Bisubstrate_Inhibitors_of_Nicotinamide_N-Methyltransferase_NNMT_/8010302/1" class="extLink">https://chemrxiv.org/articles/High-Affinity_Alkynyl_Bisubstrate_Inhibitors_of_Nicotinamide_N-Methyltransferase_NNMT_/8010302/1</a> <span class="refDoi"> DOI: 10.26434/chemrxiv.8010302.v1</span>  (accessed May 28, 2019).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.26434%2Fchemrxiv.8010302.v1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=R.+Policarpo&author=L.+Decultot&author=E.+May&author=P.+Kuzmic&author=S.+Carlson&author=D.+Huang&author=V.+Chu&author=B.+Wright&author=S.+Dhakshinamoorthy&author=A.+Kannt&author=S.+Rani&author=S.+Dittakavi&author=R.+Gaudet&author=M.+Shair&title=High-Affinity+Alkynyl+Bisubstrate+Inhibitors+of+Nicotinamide+N-Methyltransferase+%28NNMT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.26434%2Fchemrxiv.8010302.v1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.26434%252Fchemrxiv.8010302.v1%26sid%3Dliteratum%253Aachs%26aulast%3DPolicarpo%26aufirst%3DR.%26atitle%3DHigh-Affinity%2520Alkynyl%2520Bisubstrate%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520%2528NNMT%2529%26date%3D2019%26doi%3D10.26434%2Fchemrxiv.8010302.v1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kyohei Hayashi, Shota Uehara, Shiho Yamamoto, Douglas R. Cary, Junichi Nishikawa, Taichi Ueda, Hiroki Ozasa, Kousuke Mihara, Norito Yoshimura, Taeko Kawai, Takashi Ono, Saki Yamamoto, Masataka Fumoto, <span class="NLM_string-name hlFld-ContribAuthor">Hidenori Mikamiyama</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1093-1101. <a href="https://doi.org/10.1021/acsmedchemlett.1c00134" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00134%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMacrocyclic%252BPeptides%252Bas%252Ba%252BNovel%252BClass%252Bof%252BNNMT%252BInhibitors%25253A%252BA%252BSAR%252BStudy%252BAimed%252Bat%252BInhibitory%252BActivity%252Bin%252Bthe%252BCell%26aulast%3DHayashi%26aufirst%3DKyohei%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05032021%26date%3D24052021%26date%3D02062021%26volume%3D12%26issue%3D7%26spage%3D1093%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Silvia Vera, Ana Vázquez, Ricardo Rodriguez, Sandra del Pozo, Iñaki Urruzuno, Abel de Cózar, Antonia Mielgo, <span class="NLM_string-name hlFld-ContribAuthor">Claudio Palomo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of β-Hydroxy α-Amino Acids Through Brønsted Base-Catalyzed syn-Selective Direct Aldol Reaction of Schiff Bases of Glycine o-Nitroanilide. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (11)
                                     , 7757-7772. <a href="https://doi.org/10.1021/acs.joc.1c00406" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00406%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B2-Hydroxy%252B%2525CE%2525B1-Amino%252BAcids%252BThrough%252BBr%2525C3%2525B8nsted%252BBase-Catalyzed%252Bsyn-Selective%252BDirect%252BAldol%252BReaction%252Bof%252BSchiff%252BBases%252Bof%252BGlycine%252Bo-Nitroanilide%26aulast%3DVera%26aufirst%3DSilvia%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18022021%26date%3D16052021%26volume%3D86%26issue%3D11%26spage%3D7757%26epage%3D7772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jian Lu, Aaron G. Bart, Qian Wu, Kevin R. Criscione, Michael J. McLeish, Emily E. Scott, <span class="NLM_string-name hlFld-ContribAuthor">Gary L. Grunewald</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13878-13898. <a href="https://doi.org/10.1021/acs.jmedchem.0c01475" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01475%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDrug%252BDesign%252Bof%252BBisubstrate%252BInhibitors%252Bof%252BPhenylethanolamine%252BN-Methyltransferase%252BPossessing%252BLow%252BNanomolar%252BAffinity%252Bat%252BBoth%252BSubstrate%252BBinding%252BDomains1%26aulast%3DLu%26aufirst%3DJian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D04112020%26volume%3D63%26issue%3D22%26spage%3D13878%26epage%3D13898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rocco
L. Policarpo, Ludovic Decultot, Elizabeth May, Petr Kuzmič, Samuel Carlson, Danny Huang, Vincent Chu, Brandon A. Wright, Saravanakumar Dhakshinamoorthy, Aimo Kannt, Shilpa Rani, Sreekanth Dittakavi, Joseph D. Panarese, Rachelle Gaudet, <span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Shair</span>. </span><span class="cited-content_cbyCitation_article-title">High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9837-9873. <a href="https://doi.org/10.1021/acs.jmedchem.9b01238" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01238%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Affinity%252BAlkynyl%252BBisubstrate%252BInhibitors%252Bof%252BNicotinamide%252BN-Methyltransferase%252B%252528NNMT%252529%26aulast%3DPolicarpo%26aufirst%3DRocco%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05082019%26date%3D25102019%26date%3D07102019%26volume%3D62%26issue%3D21%26spage%3D9837%26epage%3D9873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie-Ru  Liu</span>, <span class="hlFld-ContribAuthor ">Zhao-Hui  Deng</span>, <span class="hlFld-ContribAuthor ">Xiao-Juan  Zhu</span>, <span class="hlFld-ContribAuthor ">Yu-Rong  Zeng</span>, <span class="hlFld-ContribAuthor ">Xiang-Xiang  Guan</span>, <span class="hlFld-ContribAuthor ">Jiang-Hua  Li</span>, . </span><span class="cited-content_cbyCitation_article-title">Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2021,</strong> <em>2021 </em>, 1-8. <a href="https://doi.org/10.1155/2021/9924314" title="DOI URL">https://doi.org/10.1155/2021/9924314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/9924314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F9924314%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DRoles%252Bof%252BNicotinamide%252BN-Methyltransferase%252Bin%252BObesity%252Band%252BType%252B2%252BDiabetes%26aulast%3DLiu%26aufirst%3DJie-Ru%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan C.  García-Cañaveras</span>, <span class="hlFld-ContribAuthor ">Agustín  Lahoz</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Microenvironment-Derived Metabolites: A Guide to Find New Metabolic Therapeutic Targets and Biomarkers. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (13)
                                     , 3230. <a href="https://doi.org/10.3390/cancers13133230" title="DOI URL">https://doi.org/10.3390/cancers13133230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13133230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13133230%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTumor%252BMicroenvironment-Derived%252BMetabolites%25253A%252BA%252BGuide%252Bto%252BFind%252BNew%252BMetabolic%252BTherapeutic%252BTargets%252Band%252BBiomarkers%26aulast%3DGarc%25C3%25ADa-Ca%25C3%25B1averas%26aufirst%3DJuan%2BC.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D13%26spage%3D3230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongzhi  Gao</span>, <span class="hlFld-ContribAuthor ">Nathaniel I.  Martin</span>, <span class="hlFld-ContribAuthor ">Matthijs J.  van Haren</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide N-methyl transferase (NNMT): An emerging therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.1016/j.drudis.2021.05.011" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DNicotinamide%252BN-methyl%252Btransferase%252B%252528NNMT%252529%25253A%252BAn%252Bemerging%252Btherapeutic%252Btarget%26aulast%3DGao%26aufirst%3DYongzhi%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Altin  Kocinaj</span>, <span class="hlFld-ContribAuthor ">Tabassum  Chaudhury</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Uddin</span>, <span class="hlFld-ContribAuthor ">Rashad R.  Junaid</span>, <span class="hlFld-ContribAuthor ">David B.  Ramsden</span>, <span class="hlFld-ContribAuthor ">Geshanthi  Hondhamuni</span>, <span class="hlFld-ContribAuthor ">Fábio  Klamt</span>, <span class="hlFld-ContribAuthor ">Linda  Parsons</span>, <span class="hlFld-ContribAuthor ">Richard B.  Parsons</span>. </span><span class="cited-content_cbyCitation_article-title">High Expression of Nicotinamide N-Methyltransferase in Patients with Sporadic Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2021,</strong> <em>58 </em>
                                    (4)
                                     , 1769-1781. <a href="https://doi.org/10.1007/s12035-020-02259-9" title="DOI URL">https://doi.org/10.1007/s12035-020-02259-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-020-02259-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-020-02259-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DHigh%252BExpression%252Bof%252BNicotinamide%252BN-Methyltransferase%252Bin%252BPatients%252Bwith%252BSporadic%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DKocinaj%26aufirst%3DAltin%26date%3D2021%26date%3D2021%26volume%3D58%26issue%3D4%26spage%3D1769%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aimo  Kannt</span>, <span class="hlFld-ContribAuthor ">Sridharan  Rajagopal</span>, <span class="hlFld-ContribAuthor ">Mahanandeesha S.  Hallur</span>, <span class="hlFld-ContribAuthor ">Indu  Swamy</span>, <span class="hlFld-ContribAuthor ">Rajendra  Kristam</span>, <span class="hlFld-ContribAuthor ">Saravanakumar  Dhakshinamoorthy</span>, <span class="hlFld-ContribAuthor ">Joerg  Czech</span>, <span class="hlFld-ContribAuthor ">Gernot  Zech</span>, <span class="hlFld-ContribAuthor ">Herman  Schreuder</span>, <span class="hlFld-ContribAuthor ">Sven  Ruf</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 991. <a href="https://doi.org/10.3390/molecules26040991" title="DOI URL">https://doi.org/10.3390/molecules26040991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26040991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26040991%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BInhibitors%252Bof%252BNicotinamide-N-Methyltransferase%252Bfor%252Bthe%252BTreatment%252Bof%252BMetabolic%252BDisorders%26aulast%3DKannt%26aufirst%3DAimo%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iredia D.  Iyamu</span>, <span class="hlFld-ContribAuthor ">Rong  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms and inhibitors of nicotinamide
              N
              -methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>28 </em><a href="https://doi.org/10.1039/D1MD00016K" title="DOI URL">https://doi.org/10.1039/D1MD00016K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00016K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00016K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DMechanisms%252Band%252Binhibitors%252Bof%252Bnicotinamide%252BN%252B-methyltransferase%26aulast%3DIyamu%26aufirst%3DIredia%2BD.%26date%3D2021%26date%3D2021%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuping  Li</span>, <span class="hlFld-ContribAuthor ">Yali  Zhang</span>, <span class="hlFld-ContribAuthor ">Yiting  Cheng</span>, <span class="hlFld-ContribAuthor ">Tianshu  Du</span>, <span class="hlFld-ContribAuthor ">Jianyu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent inhibition profiles and inverse solvent isotope effects for enzymatic methyl transfer catalyzed by nicotinamide
              N
              ‐methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physical Organic Chemistry</span><span> <strong>2020,</strong> <em>33 </em>
                                    (10)
                                     <a href="https://doi.org/10.1002/poc.4093" title="DOI URL">https://doi.org/10.1002/poc.4093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/poc.4093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpoc.4093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physical%2520Organic%2520Chemistry%26atitle%3DSolvent%252Binhibition%252Bprofiles%252Band%252Binverse%252Bsolvent%252Bisotope%252Beffects%252Bfor%252Benzymatic%252Bmethyl%252Btransfer%252Bcatalyzed%252Bby%252Bnicotinamide%252BN%252B%2525E2%252580%252590methyltransferase%26aulast%3DLi%26aufirst%3DYuping%26date%3D2020%26date%3D2020%26volume%3D33%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iredia D.  Iyamu</span>, <span class="hlFld-ContribAuthor ">Rong  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of fluorescence polarization-based competition assay for nicotinamide N-methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2020,</strong> <em>604 </em>, 113833. <a href="https://doi.org/10.1016/j.ab.2020.113833" title="DOI URL">https://doi.org/10.1016/j.ab.2020.113833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2020.113833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2020.113833%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DDevelopment%252Bof%252Bfluorescence%252Bpolarization-based%252Bcompetition%252Bassay%252Bfor%252Bnicotinamide%252BN-methyltransferase%26aulast%3DIyamu%26aufirst%3DIredia%2BD.%26date%3D2020%26volume%3D604%26spage%3D113833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanyan  Cui</span>, <span class="hlFld-ContribAuthor ">Dawei  Yang</span>, <span class="hlFld-ContribAuthor ">Wenjie  Wang</span>, <span class="hlFld-ContribAuthor ">Luyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongtao  Liu</span>, <span class="hlFld-ContribAuthor ">Shanshan  Ma</span>, <span class="hlFld-ContribAuthor ">Wenna  Guo</span>, <span class="hlFld-ContribAuthor ">Minghao  Yao</span>, <span class="hlFld-ContribAuthor ">Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Wencai  Li</span>, <span class="hlFld-ContribAuthor ">Yanting  Zhang</span>, <span class="hlFld-ContribAuthor ">Fangxia  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide N‐methyltransferase decreases 5‐fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect. </span><span class="cited-content_cbyCitation_journal-name">Molecular Carcinogenesis</span><span> <strong>2020,</strong> <em>59 </em>
                                    (8)
                                     , 940-954. <a href="https://doi.org/10.1002/mc.23209" title="DOI URL">https://doi.org/10.1002/mc.23209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mc.23209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmc.23209%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Carcinogenesis%26atitle%3DNicotinamide%252BN%2525E2%252580%252590methyltransferase%252Bdecreases%252B5%2525E2%252580%252590fluorouracil%252Bsensitivity%252Bin%252Bhuman%252Besophageal%252Bsquamous%252Bcell%252Bcarcinoma%252Bthrough%252Bmetabolic%252Breprogramming%252Band%252Bpromoting%252Bthe%252BWarburg%252Beffect%26aulast%3DCui%26aufirst%3DYanyan%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D8%26spage%3D940%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatemeh  Rajabi</span>, <span class="hlFld-ContribAuthor ">Christian  Wilhelm</span>, <span class="hlFld-ContribAuthor ">Werner R.  Thiel</span>. </span><span class="cited-content_cbyCitation_article-title">A Brønsted acidic, ionic liquid containing, heteropolyacid functionalized polysiloxane network as a highly selective catalyst for the esterification of dicarboxylic acids. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (14)
                                     , 4438-4444. <a href="https://doi.org/10.1039/D0GC01354D" title="DOI URL">https://doi.org/10.1039/D0GC01354D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC01354D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC01354D%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DA%252BBr%2525C3%2525B8nsted%252Bacidic%25252C%252Bionic%252Bliquid%252Bcontaining%25252C%252Bheteropolyacid%252Bfunctionalized%252Bpolysiloxane%252Bnetwork%252Bas%252Ba%252Bhighly%252Bselective%252Bcatalyst%252Bfor%252Bthe%252Besterification%252Bof%252Bdicarboxylic%252Bacids%26aulast%3DRajabi%26aufirst%3DFatemeh%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D14%26spage%3D4438%26epage%3D4444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryotaro  Yagita</span>, <span class="hlFld-ContribAuthor ">Kazuma  Murakami</span>, <span class="hlFld-ContribAuthor ">Hisafumi  Ikeda</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Irie</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and physicochemical properties of 20-mer peptide nucleic acid conjugates with testosterone 17β-carboxylic acid. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (17)
                                     , 151781. <a href="https://doi.org/10.1016/j.tetlet.2020.151781" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151781%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Band%252Bphysicochemical%252Bproperties%252Bof%252B20-mer%252Bpeptide%252Bnucleic%252Bacid%252Bconjugates%252Bwith%252Btestosterone%252B17%2525CE%2525B2-carboxylic%252Bacid%26aulast%3DYagita%26aufirst%3DRyotaro%26date%3D2020%26volume%3D61%26issue%3D17%26spage%3D151781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic overview of the design strategy of the second generation of inhibitors based on trivalent bisubstrate compounds 1<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and 2.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Aldehydes <b>6</b>, <b>8</b>, and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, MeOH, room temperature (rt), 16 h (95%); (b) (i) SOCl<sub>2</sub>, reflux, 2 h, (ii) tritylamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h (72%); (c) diisobutylaluminum hydride (DIBAL-H), −78 °C to rt, 2 h (85%); (d) pyridinium dichromate (PDC), CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (53–64%); (e) NaBH<sub>4</sub>, BF<sub>3</sub>.Et<sub>2</sub>O, tetrahydrofuran (THF), 0 °C to rt, 2 h (89%); (f) LiOH, THF/H<sub>2</sub>O (2:1); (g) 2-<i>tert</i>-butyl-1,3-diisopropylisourea, CH<sub>2</sub>Cl<sub>2</sub>, <i>tert</i>-butanol (39% over two steps).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Aldehydes <b>16</b>, <b>17</b>, <b>22</b>, and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TrtCl, CH<sub>3</sub>CN, K<sub>2</sub>CO<sub>3</sub>, rt, 48 h (20–28%); (b) KOH, EtOH, reflux, overnight (37–93%) (c) NaBH<sub>4</sub>, BF<sub>3</sub>·Et<sub>2</sub>O, THF, 0 °C to rt, 2 h (64–81%); (d) PDC, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (65–78%); (e) <i>tert</i>-butanol, 4-dimethylaminopyridine (DMAP), <i>N</i>-hydroxysuccinimide, Et<sub>3</sub>N, toluene, overnight (25–93%).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Aldehydes <b>27</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>3</sub>NHOCH<sub>3</sub>·HCl, BOP, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (85–88%); (b) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub> (94%); (c) DIBAL-H in hexanes (1 M), THF, −78 °C, assumed quant.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Intermediate Compounds <b>29</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH(OAc)<sub>3</sub>, AcOH, 1,2-dichloroethane (DCE), rt, overnight (50–74%).</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Representative Scheme for the Synthesis of the Final Compounds; Shown for Compounds <b>1</b> and <b>57</b>–<b>61</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>The same procedure was used starting from aldehydes <b>30</b>–<b>32</b> to form intermediate compounds <b>39</b>–<b>56</b> and <b>80</b> and final compounds <b>62</b>–<b>79</b> and <b>81</b> as detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Reagents and conditions: (a) aldehyde, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, overnight (49–77%); (b) (i) trifluoroacetyl (TFA), CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, (ii) H<sub>2</sub>O, rt, 30 min (47–73%).</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of the reference compounds used in NNMT inhibition studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ITC isotherms and thermograms including thermodynamic binding parameters measured for compounds <b>1</b>, <b>66</b>, <b>72</b>, and <b>78</b> with human NNMT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Modeling results for compound <b>78</b> in the NNMT active site (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ROD">3ROD</a>). Molecular dynamics simulation indicates the presence of an intramolecular hydrogen bond (2.7 Å, shown in cyan) specific to compound <b>78</b> (in green) that would be expected to reduce the entropic energy of the ligand and potentially stabilize binding to NNMT (in white). Proposed intermolecular hydrogen bond network (in yellow) and π–π stacking interactions with Tyr residues (in purple) stabilize compound <b>78</b> in the NNMT active site (hydrogens omitted for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/medium/jm-2019-00413d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Results of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) cell viability assay on HSC-2 human oral cancer cells. Only compound <b>78</b> showed a significant effect on cell proliferation after 48 and 72 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00413/20190827/images/large/jm-2019-00413d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00413&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alston, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeles, R. H.</span></span> <span> </span><span class="NLM_article-title">Substrate Specificity of Nicotinamide Methyltransferase Isolated from Porcine Liver</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(88)90487-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2F0003-9861%2888%2990487-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=2963591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1elu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1988&pages=601-608&author=T.+A.+Alstonauthor=R.+H.+Abeles&title=Substrate+Specificity+of+Nicotinamide+Methyltransferase+Isolated+from+Porcine+Liver&doi=10.1016%2F0003-9861%2888%2990487-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of nicotinamide methyltransferase isolated from porcine liver</span></div><div class="casAuthors">Alston, Theodore A.; Abeles, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">601-8</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Nicotinamide methyltransferase (EC 2.1.1.1) was purified >1300-fold from porcine liver.  The enzyme is electrophoretically homogeneous, exhibiting a relative mol. wt. of 27,000.  In addn. to acting on nicotinamide and close structural analogs such as thionicotinamide and 3-acetylpyridine, the enzyme actively accommodates poor analogs such as quinoline, isoquinoline, and 1,2,3,4-tetrahydroisoquinoline as Me group acceptors.  Thus, the enzyme may detoxify numerous alkaloids in vivo.  In some cases, this enzyme might paradoxically increase toxicities of substrates, but the hepatotoxic antibiotic pyrazinamide, which is considered as a potential enzyme-activated electrophile, did not function detectably as a substrate for the isolated enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApJV903Z9o7Vg90H21EOLACvtfcHk0ljIZGt7RqVc4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1elu7c%253D&md5=ff4b08c064606a2373a4fa5164c837ba</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2888%2990487-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252888%252990487-0%26sid%3Dliteratum%253Aachs%26aulast%3DAlston%26aufirst%3DT.%2BA.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DSubstrate%2520Specificity%2520of%2520Nicotinamide%2520Methyltransferase%2520Isolated%2520from%2520Porcine%2520Liver%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1988%26volume%3D260%26spage%3D601%26epage%3D608%26doi%3D10.1016%2F0003-9861%2888%2990487-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toraño, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N -Methyltransferase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5307</span>– <span class="NLM_lpage">5315</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.6b00733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.6b00733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWntL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=5307-5315&author=M.+J.+van%0AHarenauthor=J.+S.+Tora%C3%B1oauthor=D.+Sartiniauthor=M.+Emanuelliauthor=R.+B.+Parsonsauthor=N.+I.+Martin&title=A+Rapid+and+Efficient+Assay+for+the+Characterization+of+Substrates+and+Inhibitors+of+Nicotinamide+N+-Methyltransferase&doi=10.1021%2Facs.biochem.6b00733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and efficient assay for the characterization of substrates and inhibitors of nicotinamide N-methyltransferase</span></div><div class="casAuthors">van Haren, Matthijs J.; Sastre Torano, Javier; Sartini, Davide; Emanuelli, Monica; Parsons, Richard B.; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5307-5315</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is one of the most abundant small mol. methyltransferases in the human body and is primarily responsible for the N-methylation of the nicotinamide (vitamin B3).  Employing the cofactor, S-adenosyl-L-methionine, NNMT transfers a Me group to the pyridine N atom of nicotinamide to generate N-methylnicotinamide.  Interestingly, NNMT is also able to N-methylate a variety of other pyridine-contg. small mols., suggesting a secondary role for the enzyme in the detoxification of xenobiotics.  A no. of recent studies have also revealed links between NNMT overexpression and a variety of diseases, including multiple cancers, Parkinson's disease, diabetes, and obesity.  Here, to facilitate further study of both the substrate scope and potential for inhibitor development, the authors describe the development of a new activity assay for human NNMT.  The assay makes use of ultra-high-performance hydrophilic interaction chromatog., allowing for the rapid sepn. of the reaction products, coupled with quadrupole time-of-flight mass spectrometric detection, providing for enhanced sensitivity and enabling high-throughput sample anal.  The authors successfully demonstrate the general applicability of the method by performing kinetic analyses of NNMT-mediated methylation for a range of pyridine-based substrates.  These findings also provide new insight into the diversity of substrate recognition by NNMT in a quant. manner.  In addn., the authors further established the suitability of the assay for the identification and characterization of small mol. inhibitors of NNMT.  To do so, the authors investigated the inhibition of NNMT by the nonspecific methyltransferase inhibitors, sinefungin and S-adenosyl-L-homocysteine, revealing IC50 values in the low micromolar range.  The results of these inhibition studies are particularly noteworthy as they will permit future efforts toward the development of new NNMT-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBC8U-yKb1brVg90H21EOLACvtfcHk0liqJa8nrNErlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWntL7O&md5=0ebb58b665b91dd5983b2bef91886c10</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.6b00733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.6b00733%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DTora%25C3%25B1o%26aufirst%3DJ.%2BS.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DA%2520Rapid%2520and%2520Efficient%2520Assay%2520for%2520the%2520Characterization%2520of%2520Substrates%2520and%2520Inhibitors%2520of%2520Nicotinamide%2520N%2520-Methyltransferase%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D5307%26epage%3D5315%26doi%3D10.1021%2Facs.biochem.6b00733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mountford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Catalyses the N-Methylation of the Endogenous-Carboline Norharman: Evidence for a Novel Detoxification Pathway</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>473</i></span>,  <span class="NLM_fpage">3253</span>– <span class="NLM_lpage">3267</span>, <span class="refDoi"> DOI: 10.1042/BCJ20160219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1042%2FBCJ20160219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=27389312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2016&pages=3253-3267&author=M.+G.+Thomasauthor=D.+Sartiniauthor=M.+Emanuelliauthor=M.+J.+van+Harenauthor=N.+I.+Martinauthor=D.+M.+Mountfordauthor=D.+J.+Barlowauthor=F.+Klamtauthor=D.+B.+Ramsdenauthor=M.+Rezaauthor=R.+B.+Parsons&title=Nicotinamide+N-Methyltransferase+Catalyses+the+N-Methylation+of+the+Endogenous-Carboline+Norharman%3A+Evidence+for+a+Novel+Detoxification+Pathway&doi=10.1042%2FBCJ20160219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase catalyses the N-methylation of the endogenous β-carboline norharman: evidence for a novel detoxification pathway</span></div><div class="casAuthors">Thomas, Martin G.; Sartini, Davide; Emanuelli, Monica; van Haren, Matthijs J.; Martin, Nathaniel I.; Mountford, David M.; Barlow, David J.; Klamt, Fabio; Ramsden, David B.; Reza, Madeehah; Parsons, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">473</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3253-3267</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is responsible for the N-methylation of nicotinamide to 1-methylnicotinamide.  Our recent studies have demonstrated that NNMT regulates cellular processes fundamental to the correct functioning and survival of the cell.  It has been proposed that NNMT may possess β-carboline (BC) N-methyltransferase activity, endogenously and exogenously produced pyridine-contg. compds. which, when N-methylated, are potent inhibitors of Complex I and have been proposed to have a role in the pathogenesis of Parkinson's disease.  We have investigated the ability of recombinant NNMT to N-methylate norharman (NH) to 2-N-methylnorharman (MeNH).  In addn., we have investigated the toxicity of the BC NH, its precursor 1,2,3,4-tetrahydronorharman (THNH) and its N-methylated metabolite MeNH, using our in vitro SH-SY5Y NNMT expression model.  Recombinant NNMT demonstrated NH 2N-methyltransferase activity, with a Km of 90 ± 20 μM, a kcat of 3 × 10-4 ± 2 × 10-5 s-1 and a specificity const. (kcat/Km) of 3±1s-1 M-1.  THNH was the least toxic of all three compds. investigated, whereas NH demonstrated the greatest, with no difference obsd. in terms of cell viability and cell death between NNMT-expressing and non-expressing cells.  In NNMT-expressing cells, MeNH increased cell viability and cellular ATP concn. in a dose-dependent manner after 72 and 120 h incubation, an effect that was not obsd. after 24 h incubation or in non-NNNT-expressing cells at any time point.  Taken together, these results suggest that NNMT may be a detoxification pathway for BCs such as NH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7D2JlLJSULVg90H21EOLACvtfcHk0liqJa8nrNErlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yltrc%253D&md5=e384674f954921b08016909ac0a503cb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBCJ20160219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBCJ20160219%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DMountford%26aufirst%3DD.%2BM.%26aulast%3DBarlow%26aufirst%3DD.%2BJ.%26aulast%3DKlamt%26aufirst%3DF.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DReza%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Catalyses%2520the%2520N-Methylation%2520of%2520the%2520Endogenous-Carboline%2520Norharman%253A%2520Evidence%2520for%2520a%2520Novel%2520Detoxification%2520Pathway%26jtitle%3DBiochem.%2520J.%26date%3D2016%26volume%3D473%26spage%3D3253%26epage%3D3267%26doi%3D10.1042%2FBCJ20160219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pissios, P.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N -Methyltransferase: More Than a Vitamin B3 Clearance Enzyme</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2017.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.tem.2017.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28291578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFehsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=340-353&author=P.+Pissios&title=Nicotinamide+N+-Methyltransferase%3A+More+Than+a+Vitamin+B3+Clearance+Enzyme&doi=10.1016%2Fj.tem.2017.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme</span></div><div class="casAuthors">Pissios, Pavlos</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">340-353</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide (NAM) N-methyltransferase (NNMT) was originally identified as the enzyme responsible for the methylation of NAM, one of the forms of vitamin B3.  Methylated NAM is eventually excreted from the body.  Recent evidence has expanded the role of NNMT beyond clearance of excess vitamin B3.  NNMT has been implicated in the regulation of multiple metabolic pathways in tissues such as adipose and liver as well as cancer cells through the consumption of Me donors and generation of active metabolites.  This review examines recent findings regarding the function of NNMT in physiol. and disease and highlights potential new avenues for therapeutic intervention.  Finally, key gaps in our knowledge about this enzymic system and future areas of investigation are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHRx9vhXz5LbVg90H21EOLACvtfcHk0liqJa8nrNErlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFehsrk%253D&md5=cf088bcc9434e006062d72de0c47c62a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2017.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2017.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DPissios%26aufirst%3DP.%26atitle%3DNicotinamide%2520N%2520-Methyltransferase%253A%2520More%2520Than%2520a%2520Vitamin%2520B3%2520Clearance%2520Enzyme%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2017%26volume%3D28%26spage%3D340%26epage%3D353%26doi%3D10.1016%2Fj.tem.2017.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoranart, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prager, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, J. N.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide Metabolism Regulates Glioblastoma Stem Cell Maintenance</span>. <i>JCI Insight</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1172/jci.insight.90019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1172%2Fjci.insight.90019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=1-23&author=J.+Jungauthor=L.+J.+Y.+Kimauthor=X.+Wangauthor=Q.+Wuauthor=T.+Sanvoranartauthor=C.+G.+Hubertauthor=B.+C.+Pragerauthor=L.+C.+Wallaceauthor=X.+Jinauthor=S.+C.+Mackauthor=J.+N.+Rich&title=Nicotinamide+Metabolism+Regulates+Glioblastoma+Stem+Cell+Maintenance&doi=10.1172%2Fjci.insight.90019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1172%2Fjci.insight.90019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci.insight.90019%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DL.%2BJ.%2BY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DSanvoranart%26aufirst%3DT.%26aulast%3DHubert%26aufirst%3DC.%2BG.%26aulast%3DPrager%26aufirst%3DB.%2BC.%26aulast%3DWallace%26aufirst%3DL.%2BC.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DMack%26aufirst%3DS.%2BC.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DNicotinamide%2520Metabolism%2520Regulates%2520Glioblastoma%2520Stem%2520Cell%2520Maintenance%26jtitle%3DJCI%2520Insight%26date%3D2017%26volume%3D2%26spage%3D1%26epage%3D23%26doi%3D10.1172%2Fjci.insight.90019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhonen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulinilkunnil, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigserver, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monia, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirinen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauve, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhanot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peroni, O. D.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Knockdown Protects against Diet-Induced Obesity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>508</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1038/nature13198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fnature13198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=24717514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2014&pages=258-262&author=B.+B.+Kahnauthor=L.+Alhonenauthor=T.+C.+Pulinilkunnilauthor=Y.+Cenauthor=P.+Puigserverauthor=Y.+Wangauthor=B.+P.+Moniaauthor=J.+M.+Asaraauthor=L.+Zhangauthor=D.+Kongauthor=J.+T.+Rodgersauthor=Q.+Yangauthor=F.+Gongauthor=E.+Pirinenauthor=A.+A.+Sauveauthor=S.+Bhanotauthor=A.+S.+Banksauthor=D.+Krausauthor=O.+D.+Peroni&title=Nicotinamide+N-Methyltransferase+Knockdown+Protects+against+Diet-Induced+Obesity&doi=10.1038%2Fnature13198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity</span></div><div class="casAuthors">Kraus, Daniel; Yang, Qin; Kong, Dong; Banks, Alexander S.; Zhang, Lin; Rodgers, Joseph T.; Pirinen, Eija; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Cen, Yana; Sauve, Anthony A.; Asara, John M.; Peroni, Odile D.; Monia, Brett P.; Bhanot, Sanjay; Alhonen, Leena; Puigserver, Pere; Kahn, Barbara B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">7495</span>),
    <span class="NLM_cas:pages">258-262</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In obesity and type 2 diabetes, Glut4 glucose transporter expression is decreased selectively in adipocytes.  Adipose-specific knockout or overexpression of Glut4 alters systemic insulin sensitivity.  Here we show, using DNA array analyses, that nicotinamide N-methyltransferase (Nnmt) is the most strongly reciprocally regulated gene when comparing gene expression in white adipose tissue (WAT) from adipose-specific Glut4-knockout or adipose-specific Glut4-overexpressing mice with their resp. controls.  NNMT methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a Me donor.  Nicotinamide is a precursor of NAD+, an important cofactor linking cellular redox states with energy metab.  SAM provides propylamine for polyamine biosynthesis and donates a Me group for histone methylation.  Polyamine flux including synthesis, catabolism and excretion, is controlled by the rate-limiting enzymes ornithine decarboxylase (ODC) and spermidine-spermine N1-acetyltransferase (SSAT; encoded by Sat1) and by polyamine oxidase (PAO), and has a major role in energy metab.  We report that NNMT expression is increased in WAT and liver of obese and diabetic mice.  Nnmt knockdown in WAT and liver protects against diet-induced obesity by augmenting cellular energy expenditure.  NNMT inhibition increases adipose SAM and NAD+ levels and upregulates ODC and SSAT activity as well as expression, owing to the effects of NNMT on histone H3 lysine 4 methylation in adipose tissue.  Direct evidence for increased polyamine flux resulting from NNMT inhibition includes elevated urinary excretion and adipocyte secretion of diacetylspermine, a product of polyamine metab.  NNMT inhibition in adipocytes increases oxygen consumption in an ODC-, SSAT- and PAO-dependent manner.  Thus, NNMT is a novel regulator of histone methylation, polyamine flux and NAD+-dependent SIRT1 signaling, and is a unique and attractive target for treating obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuWPUvPnIqLVg90H21EOLACvtfcHk0lgoDFWMT-nkRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWhsL8%253D&md5=c37b6137cd4537a0f6f1701a5a212dd6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature13198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13198%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DB.%2BB.%26aulast%3DAlhonen%26aufirst%3DL.%26aulast%3DPulinilkunnil%26aufirst%3DT.%2BC.%26aulast%3DCen%26aufirst%3DY.%26aulast%3DPuigserver%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMonia%26aufirst%3DB.%2BP.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DRodgers%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DPirinen%26aufirst%3DE.%26aulast%3DSauve%26aufirst%3DA.%2BA.%26aulast%3DBhanot%26aufirst%3DS.%26aulast%3DBanks%26aufirst%3DA.%2BS.%26aulast%3DKraus%26aufirst%3DD.%26aulast%3DPeroni%26aufirst%3DO.%2BD.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Knockdown%2520Protects%2520against%2520Diet-Induced%2520Obesity%26jtitle%3DNature%26date%3D2014%26volume%3D508%26spage%3D258%26epage%3D262%26doi%3D10.1038%2Fnature13198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ten
Klooster, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotiriou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vervoort, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, R.</span></span> <span> </span><span class="NLM_article-title">Type 2 Diabetes-Related Proteins Derived from an in Vitro Model of Inflamed Fat Tissue</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>644</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2018.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.abb.2018.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29526533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks12ksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=644&publication_year=2018&pages=81-92&author=J.+P.+ten%0AKloosterauthor=A.+Sotiriouauthor=S.+Boerenauthor=S.+Vaessenauthor=J.+Vervoortauthor=R.+Pieters&title=Type+2+Diabetes-Related+Proteins+Derived+from+an+in+Vitro+Model+of+Inflamed+Fat+Tissue&doi=10.1016%2Fj.abb.2018.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Type 2 diabetes-related proteins derived from an in vitro model of inflamed fat tissue</span></div><div class="casAuthors">ten Klooster, Jean Paul; Sotiriou, Alexandros; Boeren, Sjef; Vaessen, Stefan; Vervoort, Jacques; Pieters, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">644</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Currently, there is a worldwide increase of patients with type 2 diabetes (T2D).  During the progression of healthy obese to T2D status, there is an influx of immune cells, in particular macrophages, into visceral adipose tissue, accompanied by an increase of inflammatory cytokines, such as, IL6, TNFα and Hp.  To get a better insight in the underlying mechanisms, we performed a quant. LCMS anal. on a modified in vitro assay, combining 3T3L1 adipocytes and activated RAW264.7 macrophages, thus mimicking inflamed adipose tissue.  Clin. known proteins, e.g. IL6, TNFα, AdipoQ, complement factor C3, B and D were identified, thus confirming the assay.  In addn., we found 54 new proteins that can potentially be used for research into the mechanism of T2D.  Comparison of our results to a study on human visceral fat of obese non-diabetic and obese diabetic subjects, indicated that AUH, NAGK, pCYT2, NNMT, STK39 and CSNK2A2 might indeed be linked to insulin resistance in humans.  Moreover, the expression of some of these genes was also altered in human blood samples at early or later stages of insulin desensitization.  Overall, we conclude that the direct contact co-culture of 3T3L1 adipocytes with activated macrophages could be a mechanistically relevant and partially translational model of inflamed visceral adipose tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz8iBuxCNAALVg90H21EOLACvtfcHk0lgoDFWMT-nkRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks12ksb4%253D&md5=4779e2ded5fda5d65a4cb285899ccaa3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2018.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2018.03.003%26sid%3Dliteratum%253Aachs%26aulast%3Dten%2BKlooster%26aufirst%3DJ.%2BP.%26aulast%3DSotiriou%26aufirst%3DA.%26aulast%3DBoeren%26aufirst%3DS.%26aulast%3DVaessen%26aufirst%3DS.%26aulast%3DVervoort%26aufirst%3DJ.%26aulast%3DPieters%26aufirst%3DR.%26atitle%3DType%25202%2520Diabetes-Related%2520Proteins%2520Derived%2520from%2520an%2520in%2520Vitro%2520Model%2520of%2520Inflamed%2520Fat%2520Tissue%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2018%26volume%3D644%26spage%3D81%26epage%3D92%26doi%3D10.1016%2Fj.abb.2018.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span> <span> </span><span class="NLM_article-title">Methyltransferases: Key Regulators in Cardiovascular Development and Disease</span>. <i>Ann. Vasc. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=1032-1039&author=E.+M.+Khalilauthor=B.+D.+Mackieauthor=Y.+Mao&title=Methyltransferases%3A+Key+Regulators+in+Cardiovascular+Development+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhalil%26aufirst%3DE.%2BM.%26aulast%3DMackie%26aufirst%3DB.%2BD.%26aulast%3DMao%26aufirst%3DY.%26atitle%3DMethyltransferases%253A%2520Key%2520Regulators%2520in%2520Cardiovascular%2520Development%2520and%2520Disease%26jtitle%3DAnn.%2520Vasc.%2520Med.%2520Res.%26date%3D2016%26volume%3D3%26spage%3D1032%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateuszuk, Ł.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skórka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutryb-Zając, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łomnicka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Słomińska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chlopicki, S.</span></span> <span> </span><span class="NLM_article-title">Activation of the Nicotinamide N-Methyltransferase (NNMT)-1-Methylnicotinamide (MNA) Pathway in Pulmonary Hypertension</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">108</span> <span class="refDoi"> DOI: 10.1186/s12931-016-0423-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1186%2Fs12931-016-0423-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=27581040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGkt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&author=A.+Fedorowiczauthor=%C5%81.+Mateuszukauthor=G.+Kopecauthor=T.+Sk%C3%B3rkaauthor=B.+Kutryb-Zaj%C4%85cauthor=A.+Zakrzewskaauthor=M.+Walczakauthor=A.+Jakubowskiauthor=M.+%C5%81omnickaauthor=E.+S%C5%82omi%C5%84skaauthor=S.+Chlopicki&title=Activation+of+the+Nicotinamide+N-Methyltransferase+%28NNMT%29-1-Methylnicotinamide+%28MNA%29+Pathway+in+Pulmonary+Hypertension&doi=10.1186%2Fs12931-016-0423-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension</span></div><div class="casAuthors">Fedorowicz, Andrzej; Mateuszuk, Lukasz; Kopec, Grzegorz; Skorka, Tomasz; Kutryb-Zajac, Barbara; Zakrzewska, Agnieszka; Walczak, Maria; Jakubowski, Andrzej; Lomnicka, Magdalena; Slominska, Ewa; Chlopicki, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108/1-108/13</span>CODEN:
                <span class="NLM_cas:coden">RREEBZ</span>;
        ISSN:<span class="NLM_cas:issn">1465-993X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Pulmonary arterial hypertension (PAH) is assocd. with inflammatory response but it is unknown whether it is assocd. with alterations in NNMT activity and MNA plasma concn.  Here we examd. changes in NNMT-MNA pathway in PAH in rats and humans.  Methods: PAH in rats was induced by a single s.c. injection of MCT (60 mg/kg).  Changes in NNMT activity in the lungs and liver (assessed as the rate of conversion of nicotinamide (NA) to MNA), changes in plasma concn. of MNA and its metabolites (analyzed by LC/MS) were analyzed in relation to PAH progression.  PAH was characterized by right ventricular hypertrophy (gross morphol.), cardiac dysfunction (by MRI), lung histopathol., lung ultrastructure, and ET-1 concn. in plasma.  NO-dependent and PGI2-dependent function in isolated lungs was analyzed.  In naive patients with idiopathic pulmonary hypertension (IPAH) characterized by hemodynamic and biochem. parameters MNA and its metabolites in plasma were also measured.  Results: MCT-injected rats developed hypertrophy and functional impairment of the right ventricle, hypertrophy of the pulmonary arteries, endothelial ultrastructural defects and a progressive increase in ET-1 plasma concn.-findings all consistent with PAH development.  In isolated lung, NO-dependent regulation of hypoxic pulmonary vasoconstriction was impaired, while PGI2 prodn. (6-keto-PGF1α) was increased.  NNMT activity increased progressively in the liver and in the lungs following MCT injection, and NNMT response was assocd. with an increase in MNA and 6-keto-PGF1α concn. in plasma.  In IPAH patients plasma concn. of MNA was elevated as compared with healthy controls.  Conclusions: Progression of pulmonary hypertension is assocd. with the activation of the NNMT-MNA pathway in rats and humans.  Given the vasoprotective activity of exogenous MNA, which was previously ascribed to PGI2 release, the activation of the endogenous NNMT-MNA pathway may play a compensatory role in PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobPtnz-72kOLVg90H21EOLACvtfcHk0lhlmoZoFj4-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGkt7%252FF&md5=8e1d65f9921b81968b70609dd4d8a623</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2Fs12931-016-0423-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12931-016-0423-7%26sid%3Dliteratum%253Aachs%26aulast%3DFedorowicz%26aufirst%3DA.%26aulast%3DMateuszuk%26aufirst%3D%25C5%2581.%26aulast%3DKopec%26aufirst%3DG.%26aulast%3DSk%25C3%25B3rka%26aufirst%3DT.%26aulast%3DKutryb-Zaj%25C4%2585c%26aufirst%3DB.%26aulast%3DZakrzewska%26aufirst%3DA.%26aulast%3DWalczak%26aufirst%3DM.%26aulast%3DJakubowski%26aufirst%3DA.%26aulast%3D%25C5%2581omnicka%26aufirst%3DM.%26aulast%3DS%25C5%2582omi%25C5%2584ska%26aufirst%3DE.%26aulast%3DChlopicki%26aufirst%3DS.%26atitle%3DActivation%2520of%2520the%2520Nicotinamide%2520N-Methyltransferase%2520%2528NNMT%2529-1-Methylnicotinamide%2520%2528MNA%2529%2520Pathway%2520in%2520Pulmonary%2520Hypertension%26jtitle%3DRespir.%2520Res.%26date%3D2016%26volume%3D17%26doi%3D10.1186%2Fs12931-016-0423-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulanovskaya, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuhl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">NNMT Promotes Epigenetic Remodeling in Cancer by Creating a Metabolic Methylation Sink</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fnchembio.1204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=23455543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlKnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=300-306&author=O.+A.+Ulanovskayaauthor=A.+M.+Zuhlauthor=B.+F.+Cravatt&title=NNMT+Promotes+Epigenetic+Remodeling+in+Cancer+by+Creating+a+Metabolic+Methylation+Sink&doi=10.1038%2Fnchembio.1204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink</span></div><div class="casAuthors">Ulanovskaya, Olesya A.; Zuhl, Andrea M.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">300-306</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is overexpressed in a variety of human cancers, where it contributes to tumorigenesis by a mechanism that is still poorly understood.  Here we show using metabolomics that NNMT impairs the methylation potential of cancer cells by consuming Me units from S-adenosyl methionine to create the stable metabolic product 1-methylnicotinamide.  As a result, NNMT-expressing cancer cells have an altered epigenetic state that includes hypomethylated histones and other cancer-related proteins combined with heightened expression of protumorigenic gene products.  Our findings thus point to a direct mechanistic link between the deregulation of a metabolic enzyme and widespread changes in the methylation landscape of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsOQPNFxw5kbVg90H21EOLACvtfcHk0lhlmoZoFj4-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlKnsbs%253D&md5=8775d8b27fba0d039b0f6da7244d28a4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1204%26sid%3Dliteratum%253Aachs%26aulast%3DUlanovskaya%26aufirst%3DO.%2BA.%26aulast%3DZuhl%26aufirst%3DA.%2BM.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DNNMT%2520Promotes%2520Epigenetic%2520Remodeling%2520in%2520Cancer%2520by%2520Creating%2520a%2520Metabolic%2520Methylation%2520Sink%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D300%26epage%3D306%26doi%3D10.1038%2Fnchembio.1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palanichamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirumoorthy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litzenberg, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span> <span> </span><span class="NLM_article-title">NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2334</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1158%2F1078-0432.CCR-16-1323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=27810903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=2325-2334&author=K.+Palanichamyauthor=S.+Kanjiauthor=N.+Gordonauthor=K.+Thirumoorthyauthor=J.+R.+Jacobauthor=K.+T.+Litzenbergauthor=D.+Patelauthor=A.+Chakravarti&title=NNMT+Silencing+Activates+Tumor+Suppressor+PP2A%2C+Inactivates+Oncogenic+STKs%2C+and+Inhibits+Tumor+Forming+Ability&doi=10.1158%2F1078-0432.CCR-16-1323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability</span></div><div class="casAuthors">Palanichamy, Kamalakannan; Kanji, Suman; Gordon, Nicolaus; Thirumoorthy, Krishnan; Jacob, John R.; Litzenberg, Kevin T.; Patel, Disha; Chakravarti, Arnab</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2325-2334</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To identify potential mol. hubs that regulate oncogenic kinases and target them to improve treatment outcomes for glioblastoma patients.  Exptl. Design: Data mining of The Cancer Genome Atlas datasets identified nicotinamide-N-Me transferase (NNMT) as a prognostic marker for glioblastoma, an enzyme linked to the reorganization of the methylome.  We tested our hypothesis that NNMT plays a crucial role by modulating protein methylation, leading to inactivation of tumor suppressors and activation of oncogenes.  Further expts. were performed to understand the underlying biochem. mechanisms using glioblastoma patient samples, established, primary, and isogenic cells.  Results: We demonstrate that NNMT outcompetes leucine carboxyl Me transferase 1 (LCMT1) for Me transfer from principal Me donor SAM in biol. systems.  Inhibiting NNMT increased the availability of Me groups for LCMT1 to methylate PP2A, resulting in the inhibition of oncogenic serine/threonine kinases (STK).  Further, NNMT inhibition retained the radiosensitizer nicotinamide and enhanced radiation sensitivity.  We have provided the biochem. rationale of how NNMT plays a vital role in inhibiting tumor suppressor PP2A while concomitantly activating STKs.  Conclusions: We report the intricate novel mechanism in which NNMT inhibits tumor suppressor PP2A by reorganizing the methylome both at epigenome and proteome levels and concomitantly activating prosurvival STKs.  In glioblastoma tumors with NNMT expression, activation of PP2A can be accomplished by FDA approved perphenazine (PPZ), which is currently used to treat mood disorders such as schizophrenia, bipolar disorder, etc.  This study forms a foundation for further glioblastoma clin. trials using PPZ with std. of care treatment.  Clin Cancer Res; 23(9); 2325-34. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqIwv0424CHbVg90H21EOLACvtfcHk0lhlmoZoFj4-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFehuro%253D&md5=dafd3575d75a59c87f691b37e8dbcd8f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1323%26sid%3Dliteratum%253Aachs%26aulast%3DPalanichamy%26aufirst%3DK.%26aulast%3DKanji%26aufirst%3DS.%26aulast%3DGordon%26aufirst%3DN.%26aulast%3DThirumoorthy%26aufirst%3DK.%26aulast%3DJacob%26aufirst%3DJ.%2BR.%26aulast%3DLitzenberg%26aufirst%3DK.%2BT.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DChakravarti%26aufirst%3DA.%26atitle%3DNNMT%2520Silencing%2520Activates%2520Tumor%2520Suppressor%2520PP2A%252C%2520Inactivates%2520Oncogenic%2520STKs%252C%2520and%2520Inhibits%2520Tumor%2520Forming%2520Ability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D2325%26epage%3D2334%26doi%3D10.1158%2F1078-0432.CCR-16-1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">Down-Regulation of Nicotinamide N-Methyltransferase Induces Apoptosis in Human Breast Cancer Cells via the Mitochondria-Mediated Pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e89202</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0089202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1371%2Fjournal.pone.0089202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=24558488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKjs73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=J.+Zhangauthor=Y.+Wangauthor=G.+Liauthor=H.+Yuauthor=X.+Xie&title=Down-Regulation+of+Nicotinamide+N-Methyltransferase+Induces+Apoptosis+in+Human+Breast+Cancer+Cells+via+the+Mitochondria-Mediated+Pathway&doi=10.1371%2Fjournal.pone.0089202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway</span></div><div class="casAuthors">Zhang, Jun; Wang, Yanzhong; Li, Guiling; Yu, Haitao; Xie, Xinyou</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e89202/1-e89202/17, 17 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) has been found involved in cell proliferation of several malignancies.  However, the functional role of NNMT in breast cancer has not been elucidated.  In the present study, we showed that NNMT was selectively expressed in some breast cancer cell lines, down-regulation of NNMT expression in Bcap-37 and MDA-MB-231 cell lines by NNMT shRNA significantly inhibited cell growth in vitro, decreased tumorigenicity in mice and induced apoptosis.  The silencing reciprocal effect of NNMT was confirmed by over-expressing NNMT in the MCF-7 and SK-BR-3 breast cancer cell lines which lack constitutive expression of NNMT.  In addn., down-regulation of NNMT expression resulted in reducing expression of Bcl-2 and Bcl-xL, up-regulation of Bax, Puma, cleaved caspase-9, cleaved caspase-3 and cleaved PARP, increasing reactive oxygen species prodn. and release of cytochrome c from mitochondria, and decreasing the phosphorylation of Akt and ERK1/2.  These data suggest that down-regulation of NNMT induces apoptosis via the mitochondria-mediated pathway in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxw6YRvrhclrVg90H21EOLACvtfcHk0lhlmoZoFj4-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKjs73O&md5=ba37d01dcc59df8ec842da9895bd3e57</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0089202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0089202%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DDown-Regulation%2520of%2520Nicotinamide%2520N-Methyltransferase%2520Induces%2520Apoptosis%2520in%2520Human%2520Breast%2520Cancer%2520Cells%2520via%2520the%2520Mitochondria-Mediated%2520Pathway%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0089202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzzonigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanese, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierella, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Nicotinamide N-Methyltransferase as a Novel Tumor Marker for Renal Clear Cell Carcinoma</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">2248</span>– <span class="NLM_lpage">2254</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2006.07.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.juro.2006.07.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=17070307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=2248-2254&author=D.+Sartiniauthor=G.+Muzzonigroauthor=G.+Milaneseauthor=F.+Pierellaauthor=V.+Rossiauthor=M.+Emanuelli&title=Identification+of+Nicotinamide+N-Methyltransferase+as+a+Novel+Tumor+Marker+for+Renal+Clear+Cell+Carcinoma&doi=10.1016%2Fj.juro.2006.07.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma</span></div><div class="casAuthors">Sartini, Davide; Muzzonigro, Giovanni; Milanese, Giulio; Pierella, Francesca; Rossi, Valentina; Emanuelli, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2248-2254</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To explore the involvement of enzymes of drug metab. in renal cell carcinoma we analyzed the gene expression profiles of tumor and nontumor tissues from the same patient by DNA macroarray.  The enzyme nicotinamide N-methyl-transferase was selected for further evaluation.  Nicotinamide N-methyltransferase mRNA expression was investigated in paired tissue samples from cancerous and noncancerous parts of the kidneys of 30 patients with clear cell renal cell carcinoma who underwent tumor nephrectomy.  Measurements were performed by semiquant. reverse transcriptase-polymerase chain reaction and quant. real-time polymerase chain reaction.  Paired tissue samples were also obtained from 1 patient with chromophobe renal cell carcinoma and from another with oncocytoma to compare the specificity of changes in nicotinamide N-methyltransferase expression among tumors that are related to different renal epithelial cell types.  Western blot anal. and catalytic activity assay were also performed to study nicotinamide N-methyltransferase expression.  Expression correlated with tumor characteristics.  A marked increased expression in tumor tissue was found for nicotinamide N-methyltransferase, which is an enzyme involved in the biotransformation of many drugs and xenobiotic compds.  Differential gene expression measurements in tumor vs normal tissue revealed up-regulation in all clear cell renal cell carcinomas at between 3 and 294-fold (mean 41).  In contrast, in chromophobe renal cell carcinoma and oncocytoma nicotinamide N-methyltransferase expression did not increase.  In addn., nicotinamide N-methyltransferase expression significantly correlated inversely with tumor size.  The results indicate that a marked nicotinamide N-methyltransferase increase is a peculiar feature of clear cell renal cell carcinoma.  Addnl. studies may establish the role of nicotinamide N-methyltransferase in tumor formation and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2PjugEWTlgLVg90H21EOLACvtfcHk0lhmT2AoYkW7gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbJ&md5=12e39e079588b666bd40af85e4919f39</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.07.046%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DMuzzonigro%26aufirst%3DG.%26aulast%3DMilanese%26aufirst%3DG.%26aulast%3DPierella%26aufirst%3DF.%26aulast%3DRossi%26aufirst%3DV.%26aulast%3DEmanuelli%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Nicotinamide%2520N-Methyltransferase%2520as%2520a%2520Novel%2520Tumor%2520Marker%2520for%2520Renal%2520Clear%2520Cell%2520Carcinoma%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D2248%26epage%3D2254%26doi%3D10.1016%2Fj.juro.2006.07.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Upregulation Inversely Correlates with Lymph Node Metastasis in Oral Squamous Cell Carcinoma</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.2119/2007-00035.Sartini</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.2119%2F2007-00035.Sartini" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=17622326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVynsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=415-421&author=D.+Sartiniauthor=A.+Santarelli&title=Nicotinamide+N-Methyltransferase+Upregulation+Inversely+Correlates+with+Lymph+Node+Metastasis+in+Oral+Squamous+Cell+Carcinoma&doi=10.2119%2F2007-00035.Sartini"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma</span></div><div class="casAuthors">Sartini, Davide; Santarelli, Andrea; Rossi, Valentina; Goteri, Gaia; Rubini, Corrado; Ciavarella, Domenico; Lo Muzio, Lorenzo; Emanuelli, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">415-421</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">We investigated expression levels of Nicotinamide N-Methyltransferase (NNMT), an enzyme involved in the biotransformation of many drugs and xenobiotic compds., in oral squamous cell carcinoma (OSCC).  Measurements were performed by semi-quant. RT-PCR and quant. real-time PCR in tumor and matched adjacent healthy tissue.  Interestingly, NNMT was up-regulated in most of the favorable OSCCs, while no marked NNMT expression alterations between tumor and normal mucosa were detected in most of the unfavorable OSCCs.  Western blot and immunohistochem. analyses also were performed and the relationship between tumor characteristics and NNMT levels in OSCC were studied to evaluate the effectiveness of NNMT as a prognostic marker in the squamous cell carcinoma of the oral cavity.  In summary, the present study suggests that NNMT may have potential as a biomarker and a therapeutic target for OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg_Vx2wEahmbVg90H21EOLACvtfcHk0lhmT2AoYkW7gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVynsrjL&md5=9b78d16ea787bc3d544faffed81822aa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2119%2F2007-00035.Sartini&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252F2007-00035.Sartini%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DSantarelli%26aufirst%3DA.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Upregulation%2520Inversely%2520Correlates%2520with%2520Lymph%2520Node%2520Metastasis%2520in%2520Oral%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DMol.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D415%26epage%3D421%26doi%3D10.2119%2F2007-00035.Sartini" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span> <span> </span><span class="NLM_article-title">High Expression of Nicotinamide N-Methyltransferase in Patients with Idiopathic Parkinson’s Disease</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(03)00218-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2FS0304-3940%2803%2900218-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=12727306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2003&pages=13-16&author=R.+B.+Parsonsauthor=S.+W.+Smithauthor=R.+H.+Waringauthor=A.+C.+Williamsauthor=D.+B.+Ramsden&title=High+Expression+of+Nicotinamide+N-Methyltransferase+in+Patients+with+Idiopathic+Parkinson%E2%80%99s+Disease&doi=10.1016%2FS0304-3940%2803%2900218-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease</span></div><div class="casAuthors">Parsons, Richard B.; Smith, Stuart W.; Waring, Rosemary H.; Williams, Adrian C.; Ramsden, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">13-16</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">We have previously speculated that elevated levels of nicotinamide N-methyltransferase (NNMT), the primary catabolic enzyme of nicotinamide, may result in reduced Complex I activity in idiopathic Parkinson's disease (IPD) in two ways: (1) redn. in the levels of nicotinamide available for NAD synthesis; and (2) increased methylation of compds. such as tetrahydroisoquinolines and β-carbolines, which are potent Complex I inhibitors.  Expression of NNMT was assessed in 91 cerebella (53 IPD, 38 control) using immunohistochem. coupled with quant. digital image anal.  Control cerebella showed a distribution of expression ascribed to low, intermediate and high expressors with ratios of 1:2:1 categories.  Expression in the parkinsonian cerebella was significantly higher than in the control group (control group median expression 17%, mean expression 16.6%, range 0-51%, std. deviation 11.4%, std. error 1.9%; IPD group median expression 46%, mean expression 53.7%, range 21-100%, std. deviation 23.4%, std. error 3.2%; P<0.0001; unpaired t-test with Welch correction (parametric) and Mann-Whitney U-test (non-parametric)).  These results confirm that NNMT expression is elevated in IPD, which may ultimately lead to neurodegeneration via a redn. in Complex I activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeSxNViswvA7Vg90H21EOLACvtfcHk0lhmT2AoYkW7gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohs74%253D&md5=62fe20b57152b3e88745f11de6f8b844</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2803%2900218-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252803%252900218-0%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BW.%26aulast%3DWaring%26aufirst%3DR.%2BH.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26atitle%3DHigh%2520Expression%2520of%2520Nicotinamide%2520N-Methyltransferase%2520in%2520Patients%2520with%2520Idiopathic%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D342%26spage%3D13%26epage%3D16%26doi%3D10.1016%2FS0304-3940%2803%2900218-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.-L.</span></span> <span> </span><span class="NLM_article-title">Expression of Nicotinamide N-Methyltransferase (E.C. 2.1.1.1) in the Parkinsonian Brain</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1093/jnen/61.2.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1093%2Fjnen%2F61.2.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=11853016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFOku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=111-124&author=R.+B.+Parsonsauthor=A.+C.+Williamsauthor=R.+H.+Waringauthor=D.+B.+Ramsdenauthor=M.-L.+Smith&title=Expression+of+Nicotinamide+N-Methyltransferase+%28E.C.+2.1.1.1%29+in+the+Parkinsonian+Brain&doi=10.1093%2Fjnen%2F61.2.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain</span></div><div class="casAuthors">Parsons, Richard B.; Smith, Marie-Louise; Williams, Adrian C.; Waring, Rosemary H.; Ramsden, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-124</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) has been proposed as a link between the environmental and genetic factors of Parkinson disease (PD).  Therefore, we explored the hypothesis that high levels of NNMT expression may predispose to the development of PD.  Regions of high mRNA expression were shown in the spinal cord, medulla, and temporal lobe, with lowest expression in the cerebellum, subthalamic nucleus, and caudate nucleus.  Using 2 NNMT antibodies, the protein was shown to be expressed in multipolar neurons in the temporal lobe, caudate nucleus, and spinal cord, granular neurons of the cerebellum, dopaminergic neurons in the substantia nigra, and in the axons of the third nerve.  Expression of NNMT was compared in PD and non-PD control cerebella and caudate nucleus.  PD tissue exhibited significantly increased levels of NNMT protein and activity.  PD disease duration was inversely correlated with the level of expression in cerebellum.  This is the first demonstration that patients with PD have higher levels of NNMT activity and protein in brain tissue than those without PD and that NNMT expression is assocd. with neurons that degenerate in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTQojjaTnox7Vg90H21EOLACvtfcHk0lguf_Hh44yWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFOku7w%253D&md5=ac3a0e25e3ae442fc9d3e81df1757949</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjnen%2F61.2.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnen%252F61.2.111%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DWaring%26aufirst%3DR.%2BH.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DSmith%26aufirst%3DM.-L.%26atitle%3DExpression%2520of%2520Nicotinamide%2520N-Methyltransferase%2520%2528E.C.%25202.1.1.1%2529%2520in%2520the%2520Parkinsonian%2520Brain%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2002%26volume%3D61%26spage%3D111%26epage%3D124%26doi%3D10.1093%2Fjnen%2F61.2.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saldanha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide N-Methyltransferase Expression in SH-SY5Y Neuroblastoma and N27 Mesencephalic Neurones Induces Changes in Cell Morphology via Ephrin-B2 and Akt Signalling</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e669</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fcddis.2013.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=23764850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyrs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=M.+G.+Thomasauthor=M.+Saldanhaauthor=R.+J.+Mistryauthor=D.+T.+Dexterauthor=D.+B.+Ramsdenauthor=R.+B.+Parsons&title=Nicotinamide+N-Methyltransferase+Expression+in+SH-SY5Y+Neuroblastoma+and+N27+Mesencephalic+Neurones+Induces+Changes+in+Cell+Morphology+via+Ephrin-B2+and+Akt+Signalling&doi=10.1038%2Fcddis.2013.200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling</span></div><div class="casAuthors">Thomas, M. G.; Saldanha, M.; Mistry, R. J.; Dexter, D. T.; Ramsden, D. B.; Parsons, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">e669</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT, E.C. 2.1.1.1) N-methylates nicotinamide to produce 1-methylnicotinamide (MeN).  We have previously shown that NNMT expression protected against neurotoxin-mediated cell death by increasing Complex I (CxI) activity, resulting in increased ATP synthesis.  This was mediated via protection of the NDUFS3 subunit of CxI from degrdn. by increased MeN prodn.  In the present study, we have investigated the effects of NNMT expression on neuron morphol. and differentiation.  Expression of NNMT in SH-SY5Y human neuroblastoma and N27 rat mesencephalic dopaminergic neurons increased neurite branching, synaptophysin expression and dopamine accumulation and release. siRNA gene silencing of ephrin B2 (EFNB2), and inhibition of Akt phosphorylation using LY294002, demonstrated that their sequential activation was responsible for the increases obsd.  Incubation of SH-SY5Y with increasing concns. of MeN also increased neurite branching, suggesting that the effects of NNMT may be mediated by MeN.  NNMT had no significant effect on the expression of phenotypic and post-mitotic markers, suggesting that NNMT is not involved in detg. phenotypic fate or differentiation status.  These results demonstrate that NNMT expression regulates neuron morphol. in vitro via the sequential activation of the EFNB2 and Akt cellular signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp-UTjIACPwrVg90H21EOLACvtfcHk0lguf_Hh44yWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyrs7zI&md5=ffe0b9b462503399935f6dd73697f077</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.200%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DSaldanha%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DR.%2BJ.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26atitle%3DNicotinamide%2520N-Methyltransferase%2520Expression%2520in%2520SH-SY5Y%2520Neuroblastoma%2520and%2520N27%2520Mesencephalic%2520Neurones%2520Induces%2520Changes%2520in%2520Cell%2520Morphology%2520via%2520Ephrin-B2%2520and%2520Akt%2520Signalling%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span> <span> </span><span class="NLM_article-title">The Kinetic Analysis of the N-Methylation of 4-Phenylpyridine by Nicotinamide N-Methyltransferase: Evidence for a Novel Mechanism of Substrate Inhibition</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2018.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.biocel.2018.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29549048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=127-136&author=M.+J.+van%0AHarenauthor=M.+G.+Thomasauthor=D.+Sartiniauthor=D.+J.+Barlowauthor=D.+B.+Ramsdenauthor=M.+Emanuelliauthor=F.+Klamtauthor=N.+I.+Martinauthor=R.+B.+Parsons&title=The+Kinetic+Analysis+of+the+N-Methylation+of+4-Phenylpyridine+by+Nicotinamide+N-Methyltransferase%3A+Evidence+for+a+Novel+Mechanism+of+Substrate+Inhibition&doi=10.1016%2Fj.biocel.2018.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic analysis of the N-methylation of 4-phenylpyridine by nicotinamide N-methyltransferase: Evidence for a novel mechanism of substrate inhibition</span></div><div class="casAuthors">van Haren, Matthijs J.; Thomas, Martin G.; Sartini, Davide; Barlow, David J.; Ramsden, David B.; Emanuelli, Monica; Klamt, Fabio; Martin, Nathaniel I.; Parsons, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The N-methylation of 4-phenylpyridine produces the neurotoxin 1-methyl-4-phenylpyridinium ion (MPP+).  We investigated the kinetics of 4-phenylpyridine N-methylation by nicotinamide N-methyltransferase (NNMT) and its effect upon 4-phenylpyridine toxicity in vitro.  Human recombinant NNMT possessed 4-phenylpyridine N-methyltransferase activity, with a specific activity of 1.7 ± 0.03 nmol MPP+ produced/h/mg NNMT.  Although the Km for 4-phenylpyridine was similar to that reported for nicotinamide, its kcat of 9.3 × 10-5 ± 2 × 10-5 s-1 and specificity const., kcat/Km, of 0.8 ± 0.8 s-1 M-1 were less than 0.15% of the resp. values for nicotinamide, demonstrating that 4-phenylpyridine is a poor substrate for NNMT.  At low (<2.5 mM) substrate concn., 4-phenylpyridine N-methylation was competitively inhibited by dimethylsulfoxide, with a Ki of 34 ± 8 mM.  At high (>2.5 mM) substrate concn., enzyme activity followed substrate inhibition kinetics, with a Ki of 4 ± 1 mM.  In silico mol. docking suggested that 4-phenylpyridine binds to the active site of NNMT in two non-redundant poses, one a substrate binding mode and the other an inhibitory mode.  Finally, the expression of NNMT in the SH-SY5Y cell-line had no effect cell death, viability, ATP content or mitochondrial membrane potential.  These data demonstrate that 4-phenylpyridine N-methylation by NNMT is unlikely to serve as a source of MPP+.  The possibility for competitive inhibition by dimethylsulfoxide should be considered in NNMT-based drug discovery studies.  The potential for 4-phenylpyridine to bind to the active site in two binding orientations using the same active site residues is a novel mechanism of substrate inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwe1BBHtPRF7Vg90H21EOLACvtfcHk0lguf_Hh44yWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOntr4%253D&md5=adce60fb9957a6f3588fe863c0a8318b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2018.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2018.03.010%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DBarlow%26aufirst%3DD.%2BJ.%26aulast%3DRamsden%26aufirst%3DD.%2BB.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DKlamt%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26atitle%3DThe%2520Kinetic%2520Analysis%2520of%2520the%2520N-Methylation%2520of%25204-Phenylpyridine%2520by%2520Nicotinamide%2520N-Methyltransferase%253A%2520Evidence%2520for%2520a%2520Novel%2520Mechanism%2520of%2520Substrate%2520Inhibition%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2018%26volume%3D98%26spage%3D127%26epage%3D136%26doi%3D10.1016%2Fj.biocel.2018.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aksoy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szumlanski, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinshilboum, R. M.</span></span> <span> </span><span class="NLM_article-title">Human Liver Nicotinamide N-Methyltransferase. CDNA Cloning, Expression, and Biochemical Characterization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">14835</span>– <span class="NLM_lpage">14840</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=8182091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaK2cXkslCqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=14835-14840&author=S.+Aksoyauthor=C.+L.+Szumlanskiauthor=R.+M.+Weinshilboum&title=Human+Liver+Nicotinamide+N-Methyltransferase.+CDNA+Cloning%2C+Expression%2C+and+Biochemical+Characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization</span></div><div class="casAuthors">Aksoy, Saime; Szumlanski, Carol L.; Weinshilboum, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14835-40</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide and other pyridines.  Human liver NNMT activity has a bimodal frequency distribution, an observation which raises the possibility that this enzyme might be regulated by a genetic polymorphism, a polymorphism that could have functional implications for individual differences in drug and xenobiotic toxicity.  As a first step toward testing this hypothesis, the authors set out to clone and express a cDNA for human liver NNMT.  Human liver NNMT was partially purified, photoaffinity-labeled, subjected to limited proteolysis, and partial amino acid sequence information was obtained.  The polymerase chain reaction was then used to amplify a 550-nucleotide sequence with human liver cDNA as template and primers designed on the basis of the NNMT amino acid sequence.  The 5'- and 3'-ends of a human liver NNMT cDNA were obtained by use of the rapid amplification of cDNA ends.  The combined use of these approaches resulted in the isolation of a human liver NNMT cDNA that was 969 nucleotides in length, with a 792-nucleotide open reading frame that encoded a 264-amino acid protein with a calcd. mol. mass of 29.6 kDa.  The human liver NNMT cDNA was transcribed in vitro and translated with a reticulocyte lysate system to yield a protein with a mol. mass of approx. 29 kDa that comigrated during SDS-polyacrylamide gel electrophoresis with photoaffinity-labeled human liver NNMT.  The NNMT cDNA was also subcloned into the eukaryotic expression vector p91023(B).  COS-1 cells transfected with this construct expressed a high level of NNMT enzymic activity, and the biochem. properties of this activity were similar to those of human liver NNMT.  Human liver NNMT and transfected COS-1 cell NNMT had apparent Km values for the two cosubstrates for the reaction, nicotinamide and S-adenosyl-L-methionine, of 0.43 and 0.38 mM and of 1.8 and 2.2 μM, resp.  IC50 values for the inhibition of NNMT by N1-methylnicotinamide were 60 and 30 μM for human liver and COS-1 cell-expressed NNMT, resp.  Cloning of a cDNA for human liver NNMT should make it possible to test the hypothesis that inheritance may play a role in the regulation of individual differences in human liver NNMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZRn3_QD5atbVg90H21EOLACvtfcHk0lgOIfZROXVJVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslCqtro%253D&md5=d5d9edf09cb329ecc01b49fd819fad47</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAksoy%26aufirst%3DS.%26aulast%3DSzumlanski%26aufirst%3DC.%2BL.%26aulast%3DWeinshilboum%26aufirst%3DR.%2BM.%26atitle%3DHuman%2520Liver%2520Nicotinamide%2520N-Methyltransferase.%2520CDNA%2520Cloning%252C%2520Expression%252C%2520and%2520Biochemical%2520Characterization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D14835%26epage%3D14840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suciu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadiri, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulanovskaya, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Chemical Proteomic Profiling of Human Methyltransferases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">13335</span>– <span class="NLM_lpage">13343</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b07830</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b07830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFymu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=13335-13343&author=B.+D.+Horningauthor=R.+M.+Suciuauthor=D.+A.+Ghadiriauthor=O.+A.+Ulanovskayaauthor=M.+L.+Matthewsauthor=K.+M.+Lumauthor=K.+M.+Backusauthor=S.+J.+Brownauthor=H.+Rosenauthor=B.+F.+Cravatt&title=Chemical+Proteomic+Profiling+of+Human+Methyltransferases&doi=10.1021%2Fjacs.6b07830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Proteomic Profiling of Human Methyltransferases</span></div><div class="casAuthors">Horning, Benjamin D.; Suciu, Radu M.; Ghadiri, Darian A.; Ulanovskaya, Olesya A.; Matthews, Megan L.; Lum, Kenneth M.; Backus, Keriann M.; Brown, Steven J.; Rosen, Hugh; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">13335-13343</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methylation is a fundamental mechanism used in Nature to modify the structure and function of biomols., including proteins, DNA, RNA, and metabolites.  Me groups are predominantly installed into biomols. by a large and diverse class of S-adenosyl methionine (SAM)-dependent methyltransferases (MTs), of which there are ∼200 known or putative members in the human proteome.  Deregulated MT activity contributes to numerous diseases, including cancer, and several MT inhibitors are in clin. development.  Nonetheless, a large fraction of the human MT family remains poorly characterized, underscoring the need for new technologies to characterize MTs and their inhibitors in native biol. systems.  Here, the authors describe a suite of S-adenosyl homocysteine (SAH) photoreactive probes and their application in chem. proteomic expts. to profile and enrich a large no. of MTs (>50) from human cancer cell lysates with remarkable specificity over other classes of proteins.  The authors further demonstrate that the SAH probes can enrich MT-assocd. proteins and be used to screen for and assess the selectivity of MT inhibitors, leading to the discovery of a covalent inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cancer and metabolic disorders.  The chem. proteomics probes and methods for their utilization reported herein should prove of value for the functional characterization of MTs, MT complexes, and MT inhibitors in mammalian biol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJsKzvFF-e7Vg90H21EOLACvtfcHk0lgOIfZROXVJVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFymu7bP&md5=0e07845e59e33381f3149beae7500e18</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b07830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b07830%26sid%3Dliteratum%253Aachs%26aulast%3DHorning%26aufirst%3DB.%2BD.%26aulast%3DSuciu%26aufirst%3DR.%2BM.%26aulast%3DGhadiri%26aufirst%3DD.%2BA.%26aulast%3DUlanovskaya%26aufirst%3DO.%2BA.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DChemical%2520Proteomic%2520Profiling%2520of%2520Human%2520Methyltransferases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D13335%26epage%3D13343%26doi%3D10.1021%2Fjacs.6b07830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallur, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchan, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swamy, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugesan, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhulu, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putta, V. P. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mane, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadnur, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhamidipati, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreuder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullangi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakshinamoorthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span> <span> </span><span class="NLM_article-title">Novel Nicotinamide Analog as Inhibitor of Nicotinamide N-Methyltransferase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">925</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2018.01.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29433927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=922-925&author=S.+Rufauthor=M.+S.+Hallurauthor=N.+K.+Anchanauthor=I.+N.+Swamyauthor=K.+R.+Murugesanauthor=S.+Sarkarauthor=L.+K.+Narasimhuluauthor=V.+P.+R.+K.+Puttaauthor=S.+Shaikauthor=D.+V.+Chandrasekarauthor=V.+S.+Maneauthor=S.+V.+Kadnurauthor=J.+Sureshauthor=R.+K.+Bhamidipatiauthor=M.+Singhauthor=R.+R.+Burriauthor=R.+Kristamauthor=H.+Schreuderauthor=J.+Czechauthor=C.+Rudolphauthor=A.+Markerauthor=T.+Langerauthor=R.+Mullangiauthor=T.+Yuraauthor=R.+Gosuauthor=A.+Kanntauthor=S.+Dhakshinamoorthyauthor=S.+Rajagopal&title=Novel+Nicotinamide+Analog+as+Inhibitor+of+Nicotinamide+N-Methyltransferase&doi=10.1016%2Fj.bmcl.2018.01.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase</span></div><div class="casAuthors">Ruf, Sven; Hallur, Mahanandeesha Siddappa; Anchan, Nisha K.; Swamy, Indu N.; Murugesan, Karthikai Raj; Sarkar, Sayantani; Narasimhulu, Lokesh Kananti; Putta, V. P. Rama Kishore; Shaik, Shama; Chandrasekar, Devaraj Venkatapura; Mane, Vishal Subhash; Kadnur, Sanjay Venkatachalapathi; Suresh, Juluri; Bhamidipati, Ravi Kanth; Singh, Manvi; Burri, Raghunadha Reddy; Kristam, Rajendra; Schreuder, Herman; Czech, Joerg; Rudolph, Christine; Marker, Alexander; Langer, Thomas; Mullangi, Ramesh; Yura, Takeshi; Gosu, Ramachandraiah; Kannt, Aimo; Dhakshinamoorthy, Saravanakumar; Rajagopal, Sridharan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">922-925</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) has been linked to obesity and diabetes.  We have identified a novel nicotinamide (NA) analog, compd. I that inhibited NNMT enzymic activity and reduced the formation of 1-methyl-nicotinamide (MNA), the primary metabolite of NA by ∼80% at 2 h when dosed in mice orally at 50 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxeiU30o2tybVg90H21EOLACvtfcHk0lgOIfZROXVJVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCmsb0%253D&md5=06345ee6c292c482711d62639fac9a16</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DHallur%26aufirst%3DM.%2BS.%26aulast%3DAnchan%26aufirst%3DN.%2BK.%26aulast%3DSwamy%26aufirst%3DI.%2BN.%26aulast%3DMurugesan%26aufirst%3DK.%2BR.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DNarasimhulu%26aufirst%3DL.%2BK.%26aulast%3DPutta%26aufirst%3DV.%2BP.%2BR.%2BK.%26aulast%3DShaik%26aufirst%3DS.%26aulast%3DChandrasekar%26aufirst%3DD.%2BV.%26aulast%3DMane%26aufirst%3DV.%2BS.%26aulast%3DKadnur%26aufirst%3DS.%2BV.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DR.%2BK.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DBurri%26aufirst%3DR.%2BR.%26aulast%3DKristam%26aufirst%3DR.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DCzech%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DC.%26aulast%3DMarker%26aufirst%3DA.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DMullangi%26aufirst%3DR.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DDhakshinamoorthy%26aufirst%3DS.%26aulast%3DRajagopal%26aufirst%3DS.%26atitle%3DNovel%2520Nicotinamide%2520Analog%2520as%2520Inhibitor%2520of%2520Nicotinamide%2520N-Methyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D922%26epage%3D925%26doi%3D10.1016%2Fj.bmcl.2018.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadnur, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhamidipati, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallur, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfenninger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreuder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mane, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birudukota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zope, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parveen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullangi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakshinamoorthy, S.</span></span> <span> </span><span class="NLM_article-title">A Small Molecule Inhibitor of Nicotinamide N-Methyltransferase for the Treatment of Metabolic Disorders</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">3660</span> <span class="refDoi"> DOI: 10.1038/s41598-018-22081-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fs41598-018-22081-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29483571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrls1ahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&author=A.+Kanntauthor=S.+Rajagopalauthor=S.+V.+Kadnurauthor=J.+Sureshauthor=R.+K.+Bhamidipatiauthor=S.+Swaminathanauthor=M.+S.+Hallurauthor=R.+Kristamauthor=R.+Elvertauthor=J.+Czechauthor=A.+Pfenningerauthor=C.+Rudolphauthor=H.+Schreuderauthor=D.+V.+Chandrasekarauthor=V.+S.+Maneauthor=S.+Birudukotaauthor=S.+Shaikauthor=B.+R.+Zopeauthor=R.+R.+Burriauthor=N.+N.+Anandauthor=M.+K.+Thakurauthor=M.+Singhauthor=R.+Parveenauthor=S.+Kandanauthor=R.+Mullangiauthor=T.+Yuraauthor=R.+Gosuauthor=S.+Rufauthor=S.+Dhakshinamoorthy&title=A+Small+Molecule+Inhibitor+of+Nicotinamide+N-Methyltransferase+for+the+Treatment+of+Metabolic+Disorders&doi=10.1038%2Fs41598-018-22081-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders</span></div><div class="casAuthors">Kannt Aimo; Elvert Ralf; Czech Jorg; Pfenninger Anja; Rudolph Christine; Schreuder Herman; Ruf Sven; Kannt Aimo; Rajagopal Sridharan; Kadnur Sanjay Venkatachalapathi; Suresh Juluri; Bhamidipati Ravi Kanth; Swaminathan Srinivasan; Hallur Mahanandeesha Siddappa; Kristam Rajendra; Chandrasekar Devaraj Venkatapura; Mane Vishal Subhash; Birudukota Swarnakumari; Shaik Shama; Zope Bharat Ravindra; Burri Raghunadha Reddy; Anand Niranjan Naranapura; Thakur Manish Kumar; Singh Manvi; Parveen Reejuana; Kandan Saravanan; Mullangi Ramesh; Yura Takeshi; Gosu Ramachandraiah; Dhakshinamoorthy Saravanakumar</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3660</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from the co-factor S-adenosyl-L-methionine (SAM) onto the substrate, nicotinamide (NA) to form 1-methyl-nicotinamide (MNA).  Higher NNMT expression and MNA concentrations have been associated with obesity and type-2 diabetes.  Here we report a small molecule analog of NA, JBSNF-000088, that inhibits NNMT activity, reduces MNA levels and drives insulin sensitization, glucose modulation and body weight reduction in animal models of metabolic disease.  In mice with high fat diet (HFD)-induced obesity, JBSNF-000088 treatment caused a reduction in body weight, improved insulin sensitivity and normalized glucose tolerance to the level of lean control mice.  These effects were not seen in NNMT knockout mice on HFD, confirming specificity of JBSNF-000088.  The compound also improved glucose handling in ob/ob and db/db mice albeit to a lesser extent and in the absence of weight loss.  Co-crystal structure analysis revealed the presence of the N-methylated product of JBSNF-000088 bound to the NNMT protein.  The N-methylated product was also detected in the plasma of mice treated with JBSNF-000088.  Hence, JBSNF-000088 may act as a slow-turnover substrate analog, driving the observed metabolic benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdHZ3bviJkhgaK-_ZudimnfW6udTcc2eaMnj-9fwYvnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrls1ahtw%253D%253D&md5=3f2306da18e0ab2a41a57f08ea9384fb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-22081-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-22081-7%26sid%3Dliteratum%253Aachs%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DKadnur%26aufirst%3DS.%2BV.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DR.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DHallur%26aufirst%3DM.%2BS.%26aulast%3DKristam%26aufirst%3DR.%26aulast%3DElvert%26aufirst%3DR.%26aulast%3DCzech%26aufirst%3DJ.%26aulast%3DPfenninger%26aufirst%3DA.%26aulast%3DRudolph%26aufirst%3DC.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DChandrasekar%26aufirst%3DD.%2BV.%26aulast%3DMane%26aufirst%3DV.%2BS.%26aulast%3DBirudukota%26aufirst%3DS.%26aulast%3DShaik%26aufirst%3DS.%26aulast%3DZope%26aufirst%3DB.%2BR.%26aulast%3DBurri%26aufirst%3DR.%2BR.%26aulast%3DAnand%26aufirst%3DN.%2BN.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DParveen%26aufirst%3DR.%26aulast%3DKandan%26aufirst%3DS.%26aulast%3DMullangi%26aufirst%3DR.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DDhakshinamoorthy%26aufirst%3DS.%26atitle%3DA%2520Small%2520Molecule%2520Inhibitor%2520of%2520Nicotinamide%2520N-Methyltransferase%2520for%2520the%2520Treatment%2520of%2520Metabolic%2520Disorders%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26doi%3D10.1038%2Fs41598-018-22081-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watowich, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5015</span>– <span class="NLM_lpage">5028</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Sgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5015-5028&author=H.+Neelakantanauthor=H.+Y.+Wangauthor=V.+Vanceauthor=J.+D.+Hommelauthor=S.+F.+McHardyauthor=S.+J.+Watowich&title=Structure-Activity+Relationship+for+Small+Molecule+Inhibitors+of+Nicotinamide+N-Methyltransferase&doi=10.1021%2Facs.jmedchem.7b00389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase</span></div><div class="casAuthors">Neelakantan, Harshini; Wang, Hua-Yu; Vance, Virginia; Hommel, Jonathan D.; McHardy, Stanton F.; Watowich, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5015-5028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is a fundamental cytosolic biotransforming enzyme that catalyzes the N-methylation of endogenous and exogenous xenobiotics.  We have identified small mol. inhibitors of NNMT with >1000-fold range of activity and developed comprehensive structure-activity relationships (SARs) for NNMT inhibitors.  Screening of N-methylated quinolinium, isoquinolinium, pyrididium, and benzimidazolium/benzothiazolium analogs resulted in the identification of quinoliniums as a promising scaffold with very low micromolar (IC50 ∼ 1 μM) NNMT inhibition.  Computer-based docking of inhibitors to the NNMT substrate (nicotinamide)-binding site produced a robust correlation between ligand-enzyme interaction docking scores and exptl. calcd. IC50 values.  Predicted binding orientation of the quinolinium analogs revealed selective binding to the NNMT substrate-binding site residues and essential chem. features driving protein-ligand intermol. interactions and NNMT inhibition.  The development of this new series of small mol. NNMT inhibitors direct the future design of lead drug-like inhibitors to treat several metabolic and chronic disease conditions characterized by abnormal NNMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxYy3poogIbVg90H21EOLACvtfcHk0lhfgE1OPP_3gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Sgtrc%253D&md5=2cd7159b9e15569221849168e49e39cd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00389%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DVance%26aufirst%3DV.%26aulast%3DHommel%26aufirst%3DJ.%2BD.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26atitle%3DStructure-Activity%2520Relationship%2520for%2520Small%2520Molecule%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5015%26epage%3D5028%26doi%3D10.1021%2Facs.jmedchem.7b00389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre Toraño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moret, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Nicotinamide N-Methyltransferase Designed to Mimic the Methylation Reaction Transition State</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6656</span>– <span class="NLM_lpage">6667</span>, <span class="refDoi"> DOI: 10.1039/C7OB01357D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1039%2FC7OB01357D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28758655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1aktLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=6656-6667&author=M.+J.+van%0AHarenauthor=R.+Taigauthor=J.+Kuppensauthor=J.+Sastre+Tora%C3%B1oauthor=E.+E.+Moretauthor=R.+B.+Parsonsauthor=D.+Sartiniauthor=M.+Emanuelliauthor=N.+I.+Martin&title=Inhibitors+of+Nicotinamide+N-Methyltransferase+Designed+to+Mimic+the+Methylation+Reaction+Transition+State&doi=10.1039%2FC7OB01357D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state</span></div><div class="casAuthors">van Haren, Matthijs J.; Taig, Rebecca; Kuppens, Jilles; Sastre Torano, Javier; Moret, Ed E.; Parsons, Richard B.; Sartini, Davide; Emanuelli, Monica; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6656-6667</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) is an enzyme that catalyzes the methylation of nicotinamide to form N'-methylnicotinamide.  Both NNMT and its methylated product have recently been linked to a variety of diseases, suggesting a role for the enzyme as a therapeutic target beyond its previously ascribed metabolic function in detoxification.  We here describe the systematic development of NNMT inhibitors derived from the structures of the substrates involved in the methylation reaction.  By covalently linking fragments of the NNMT substrates a diverse library of bisubstrate-like compds. was prepd.  The ability of these compds. to inhibit NNMT was evaluated providing valuable insights into the structural tolerances of the enzyme active site.  These studies led to the identification of new NNMT inhibitors that mimic the transition state of the methylation reaction and inhibit the enzyme with activity on par with established methyltransferase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwrd9fP8Bf7Vg90H21EOLACvtfcHk0liQjqo-gknWow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1aktLfI&md5=74280c50135611d361ab81b8fc55fa89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7OB01357D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB01357D%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DTaig%26aufirst%3DR.%26aulast%3DKuppens%26aufirst%3DJ.%26aulast%3DSastre%2BTora%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMoret%26aufirst%3DE.%2BE.%26aulast%3DParsons%26aufirst%3DR.%2BB.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DInhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520Designed%2520to%2520Mimic%2520the%2520Methylation%2520Reaction%2520Transition%2520State%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26spage%3D6656%26epage%3D6667%26doi%3D10.1039%2FC7OB01357D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masjost, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gramlich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob-Roetne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zürcher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Bisubstrate Inhibitors for the Enzyme Catechol-O-Methyltransferase (COMT): Influence of Inhibitor Preorganisation and Linker Length between the Two Substrate Moieties on Binding Affinity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1039/B208690P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1039%2FB208690P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=12929389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=42-49&author=C.+Lernerauthor=B.+Masjostauthor=A.+Rufauthor=V.+Gramlichauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+Inhibitors+for+the+Enzyme+Catechol-O-Methyltransferase+%28COMT%29%3A+Influence+of+Inhibitor+Preorganisation+and+Linker+Length+between+the+Two+Substrate+Moieties+on+Binding+Affinity&doi=10.1039%2FB208690P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): Influence of inhibitor preorganization and linker length between the two substrate moieties on binding affinity</span></div><div class="casAuthors">Lerner, Christian; Masjost, Birgit; Ruf, Armin; Gramlich, Volker; Jakob-Roetne, Roland; Zurcher, Gerhard; Borroni, Edilio; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-49</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of the enzyme catechol-O-methyltransferase (COMT) is an important approach in the treatment of Parkinson's disease.  A series of new potent bisubstrate inhibitors for COMT, resulting from X-ray structure-based design and featuring adenosine and catechol moieties have been synthesized.  Biol. results show a large dependence of binding affinity on inhibitor preorganization and the length of the linker between nucleoside and catechol moieties.  The most potent bisubstrate inhibitor for COMT has an IC50 value of 9 nM.  It exhibits competitive kinetics for the SAM and mixed inhibition kinetics for the catechol binding site.  Its bisubstrate binding mode was confirmed by X-ray structure anal. of the ternary complex formed by the inhibitor, COMT and a Mg2· ion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMuhnQD9t-zLVg90H21EOLACvtfcHk0liQjqo-gknWow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCgsb8%253D&md5=978732f0d825272d41748365a8dadf13</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FB208690P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB208690P%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520Inhibitors%2520for%2520the%2520Enzyme%2520Catechol-O-Methyltransferase%2520%2528COMT%2529%253A%2520Influence%2520of%2520Inhibitor%2520Preorganisation%2520and%2520Linker%2520Length%2520between%2520the%2520Two%2520Substrate%2520Moieties%2520on%2520Binding%2520Affinity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D42%26epage%3D49%26doi%3D10.1039%2FB208690P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trindler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brändli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob-Roetne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zürcher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Bisubstrate Inhibitors of Catechol O-Methyltransferase (COMT): The Crucial Role of the Ribose Structural Unit for Inhibitor Binding Affinity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200500065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1002%2Fcmdc.200500065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=16892369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD28XislKrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=340-357&author=R.+Pauliniauthor=C.+Trindlerauthor=C.+Lernerauthor=L.+Br%C3%A4ndliauthor=W.+B.+Schweizerauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+Inhibitors+of+Catechol+O-Methyltransferase+%28COMT%29%3A+The+Crucial+Role+of+the+Ribose+Structural+Unit+for+Inhibitor+Binding+Affinity&doi=10.1002%2Fcmdc.200500065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bisubstrate inhibitors of catechol O-methyltransferase (COMT): the crucial role of the ribose structural unit for inhibitor binding affinity</span></div><div class="casAuthors">Paulini, Ralph; Trindler, Christian; Lerner, Christian; Brandli, Lukas; Schweizer, W. Bernd; Jakob-Roetne, Roland; Zurcher, Gerhard; Borroni, Edilio; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">340-357</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Inhibition of the enzyme catechol O-methyltransferase offers a therapeutic handle to regulate the catabolism of catecholamine neurotransmitters, providing valuable assistance in the treatment of CNS disorders such as Parkinson's disease.  A series of ribose-modified bisubstrate inhibitors of COMT featuring 2'-deoxy-, 3'-deoxy-, 2'-aminodeoxy-3'-deoxy-, and 2'-deoxy-3'-aminodeoxyribose-derived central moieties and analogs contg. the carbocyclic skeleton of the natural product aristeromycin were synthesized and evaluated to investigate the mol. recognition properties of the ribose binding site in the enzyme.  Key synthetic intermediates in the ribose-derived series were obtained by deoxygenative [1,2]-hydride shift rearrangement of adenosine derivs.; highlights in the synthesis of carbocyclic aristeromycin analogs include a diastereoselective cyclopropanation step and nucleobase introduction with a modified Mitsunobu protocol.  In vitro biol. evaluation and kinetic studies revealed dramatic effects of the ribose modification on binding affinity: 3'-deoxygenation of the ribose gave potent inhibitors (IC50 values in the nanomolar range), which stands in sharp contrast to the remarkable decrease in potency obsd. for 2'-deoxy derivs. (IC50 values in the micromolar range).  Aminodeoxy analogs were only weakly active, whereas the change of the THF skeleton to a carbocycle unexpectedly led to a complete loss of biol. activity.  These results confirm that the ribose structural unit of the bisubstrate inhibitors of COMT is a key element of mol. recognition and that modifications thereof are delicate and may lead to surprises.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpynXbZNC6PY7Vg90H21EOLACvtfcHk0liQjqo-gknWow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislKrsr4%253D&md5=dfb854add9f8db09c6181b68d135d634</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200500065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200500065%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DTrindler%26aufirst%3DC.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBr%25C3%25A4ndli%26aufirst%3DL.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520Inhibitors%2520of%2520Catechol%2520O-Methyltransferase%2520%2528COMT%2529%253A%2520The%2520Crucial%2520Role%2520of%2520the%2520Ribose%2520Structural%2520Unit%2520for%2520Inhibitor%2520Binding%2520Affinity%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D340%26epage%3D357%26doi%3D10.1002%2Fcmdc.200500065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Bisubstrate-Type Inhibitors of Histone Methyltransferase SET7/9</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">8158</span>– <span class="NLM_lpage">8166</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmc.2010.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=21036620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsValurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=8158-8166&author=S.+Moriauthor=K.+Iwaseauthor=N.+Iwanamiauthor=Y.+Tanakaauthor=H.+Kagechikaauthor=T.+Hirano&title=Development+of+Novel+Bisubstrate-Type+Inhibitors+of+Histone+Methyltransferase+SET7%2F9&doi=10.1016%2Fj.bmc.2010.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9</span></div><div class="casAuthors">Mori, Shuichi; Iwase, Kenta; Iwanami, Naoko; Tanaka, Yujiro; Kagechika, Hiroyuki; Hirano, Tomoya</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8158-8166</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone modification, for example, by histone deacetylase (HDAC) and histone lysine methyltransferase (HMT), plays an important role in regulating gene expression.  To obtain novel inhibitors as tools for investigating the physiol. function of members of the HMT family, we designed and synthesized novel inhibitors, which are amine analogs of adenosylmethionine (AdoMet; the cofactor utilized in the methylation reaction) bearing various alkylamino groups coupled via an ethylene linker.  The inhibitory activities of these compds. towards SET7/9, an HMT, were evaluated.  It was found that introduction of an alkylamino group increased the inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUp7neuWTg1rVg90H21EOLACvtfcHk0lh7AApFiMWLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsValurrL&md5=76faa42f957d02ed47458c348b324929</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DS.%26aulast%3DIwase%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520Novel%2520Bisubstrate-Type%2520Inhibitors%2520of%2520Histone%2520Methyltransferase%2520SET7%252F9%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D8158%26epage%3D8166%26doi%3D10.1016%2Fj.bmc.2010.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. G.</span></span> <span> </span><span class="NLM_article-title">Toward the Development of Potent and Selective Bisubstrate Inhibitors of Protein Arginine Methyltransferases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2103</span>– <span class="NLM_lpage">2105</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2010.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=20219369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslGmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2103-2105&author=J.+Dowdenauthor=W.+Hongauthor=R.+V.+Parryauthor=R.+A.+Pikeauthor=S.+G.+Ward&title=Toward+the+Development+of+Potent+and+Selective+Bisubstrate+Inhibitors+of+Protein+Arginine+Methyltransferases&doi=10.1016%2Fj.bmcl.2010.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases</span></div><div class="casAuthors">Dowden, James; Hong, Wei; Parry, Richard V.; Pike, Richard A.; Ward, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2103-2105</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prototype inhibitors of protein arginine methyltransferases (PRMTs) have been constructed by attaching guanidine functionality via a variable linker to non-reactive amine analogs of the cellular co-factor (S)-adenosyl methionine (AdoMet).  Potent inhibition of PRMT1 (IC50 of ∼3-6 μM) combined with weak inhibition of the lysine methyltransferase SET7 (∼50% of activity at 100 μM) was obsd. for two such compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj5FdIemXEXrVg90H21EOLACvtfcHk0lh7AApFiMWLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslGmsb4%253D&md5=6401f6157aa931ae23ac27928d4bf1d1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DDowden%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DW.%26aulast%3DParry%26aufirst%3DR.%2BV.%26aulast%3DPike%26aufirst%3DR.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BG.%26atitle%3DToward%2520the%2520Development%2520of%2520Potent%2520and%2520Selective%2520Bisubstrate%2520Inhibitors%2520of%2520Protein%2520Arginine%2520Methyltransferases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2103%26epage%3D2105%26doi%3D10.1016%2Fj.bmcl.2010.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Haren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ufford, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moret, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Protein Arginine N-Methyltransferase Inhibitors Designed to Simultaneously Occupy Both Substrate Binding Sites</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1039/C4OB01734J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1039%2FC4OB01734J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=25380215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSiu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=549-560&author=M.+Van%0AHarenauthor=L.+Q.+Van+Uffordauthor=E.+E.+Moretauthor=N.+I.+Martin&title=Synthesis+and+Evaluation+of+Protein+Arginine+N-Methyltransferase+Inhibitors+Designed+to+Simultaneously+Occupy+Both+Substrate+Binding+Sites&doi=10.1039%2FC4OB01734J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites</span></div><div class="casAuthors">van Haren, Matthijs; van Ufford, Linda Quarles; Moret, Ed E.; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The protein arginine N-methyltransferases (PRMTs) are a family of enzymes that function by specifically transferring a Me group from the cofactor S-adenosyl-L-methionine (AdoMet) to the guanidine group of arginine residues in target proteins.  The most notable is the PRMT-mediated methylation of arginine residues that are present in histone proteins which can lead to chromatin remodelling and influence gene transcription.  A growing body of evidence now implicates dysregulated PRMT activity in a no. of diseases including various forms of cancer.  The development of PRMT inhibitors may therefore hold potential as a means of developing new therapeutics.  We here report the synthesis and evaluation of a series of small mol. PRMT inhibitors designed to simultaneously occupy the binding sites of both the guanidino substrate and AdoMet cofactor.  Potent inhibition and surprising selectivity were obsd. when testing these compds. against a panel of methyltransferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcFfPMCcpn97Vg90H21EOLACvtfcHk0lh7AApFiMWLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSiu77N&md5=62b07b10e6cc1c288168e8bd0ef4d9f5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC4OB01734J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01734J%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHaren%26aufirst%3DM.%26aulast%3DVan%2BUfford%26aufirst%3DL.%2BQ.%26aulast%3DMoret%26aufirst%3DE.%2BE.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Protein%2520Arginine%2520N-Methyltransferase%2520Inhibitors%2520Designed%2520to%2520Simultaneously%2520Occupy%2520Both%2520Substrate%2520Binding%2520Sites%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D549%26epage%3D560%26doi%3D10.1039%2FC4OB01734J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Haren, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbardella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troffer-Charlier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marechal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavarelli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianciulli, A.</span></span> <span> </span><span class="NLM_article-title">Transition State Mimics Are Valuable Mechanistic Probes for Structural Studies with the Arginine Methyltransferase CARM1</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3625</span>– <span class="NLM_lpage">3630</span>, <span class="refDoi"> DOI: 10.1073/pnas.1618401114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1073%2Fpnas.1618401114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28330993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslShs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3625-3630&author=M.+J.+van%0AHarenauthor=G.+Sbardellaauthor=N.+I.+Martinauthor=N.+Troffer-Charlierauthor=N.+Marechalauthor=J.+Cavarelliauthor=A.+Cianciulli&title=Transition+State+Mimics+Are+Valuable+Mechanistic+Probes+for+Structural+Studies+with+the+Arginine+Methyltransferase+CARM1&doi=10.1073%2Fpnas.1618401114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1</span></div><div class="casAuthors">van Haren, Matthijs J.; Marechal, Nils; Troffer-Charlier, Nathalie; Cianciulli, Agostino; Sbardella, Gianluca; Cavarelli, Jean; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3625-3630</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coactivator-assocd. arginine methyltransferase 1 (CARM1) is a member of the protein arginine methyltransferase (PRMT) family and methylates a range of proteins in eukaryotic cells.  Overexpression of CARM1 is implicated in a no. of cancers, and it is therefore seen as a potential therapeutic target.  Peptide sequences derived from the well-defined CARM1 substrate, poly(A)-binding protein 1 (PABP1), were covalently linked to an adenosine moiety as in the AdoMet cofactor to generate transition state mimics.  These constructs were found to be potent CARM1 inhibitors and also formed stable complexes with the enzyme.  High-resoln. crystal structures of CARM1 complexed with these compds. confirmed a mode of binding that was indeed reflective of the transition state at the CARM1 active site.  Given the transient nature of PRMT-substrate complexes, such transition state mimics represent valuable chem. tools for structural studies aimed at deciphering the regulation of arginine methylation mediated by the family of arginine methyltransferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQP8dnoWBD5bVg90H21EOLACvtfcHk0lh7AApFiMWLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslShs7g%253D&md5=67a38bf8b8d382eec5bd8689b0ed2764</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1618401114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1618401114%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHaren%26aufirst%3DM.%2BJ.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DTroffer-Charlier%26aufirst%3DN.%26aulast%3DMarechal%26aufirst%3DN.%26aulast%3DCavarelli%26aufirst%3DJ.%26aulast%3DCianciulli%26aufirst%3DA.%26atitle%3DTransition%2520State%2520Mimics%2520Are%2520Valuable%2520Mechanistic%2520Probes%2520for%2520Structural%2520Studies%2520with%2520the%2520Arginine%2520Methyltransferase%2520CARM1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2017%26volume%3D114%26spage%3D3625%26epage%3D3630%26doi%3D10.1073%2Fpnas.1618401114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babault, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-Hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1541</span>– <span class="NLM_lpage">1551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01422</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01422" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1541-1551&author=N.+Babaultauthor=A.+Allali-Hassaniauthor=F.+Liauthor=J.+Fanauthor=A.+Yueauthor=K.+Juauthor=F.+Liuauthor=M.+Vedadiauthor=J.+Liuauthor=J.+Jin&title=Discovery+of+Bisubstrate+Inhibitors+of+Nicotinamide+N-Methyltransferase+%28NNMT%29&doi=10.1021%2Facs.jmedchem.7b01422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)</span></div><div class="casAuthors">Babault, Nicolas; Allali-Hassani, Abdellah; Li, Fengling; Fan, Jie; Yue, Alex; Ju, Kevin; Liu, Feng; Vedadi, Masoud; Liu, Jing; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1541-1551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of pyridine-contg. compds. using the cofactor S-5'-adenosyl-L-methionine (SAM) as the Me group donor.  Through the regulation of the levels of its substrates, cofactor, and products, NNMT plays important role in physiol. and pathophysiol.  Overexpression of NNMT has been implicated in various human diseases.  Potent and selective small-mol. NNMT inhibitors are valuable chem. tools for testing biol. and therapeutic hypotheses.  However, very few NNMT inhibitors have been reported.  Here, we describe the discovery of a bisubstrate NNMT inhibitor MS2734 (6), and characterization of this inhibitor in biochem., biophys., kinetic, and structural studies.  Importantly, we obtained the first crystal structure of human NNMT in complex with a small-mol. inhibitor.  The structure of the NNMT-6 complex has unambiguously demonstrated that 6 occupied both substrate and cofactor binding sites.  The findings paved the way for developing more potent and selective NNMT inhibitors in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ThNiA1GTwLVg90H21EOLACvtfcHk0ljmbqjgM0UHKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVOruw%253D%253D&md5=50e23e5f60beb64c184f6eadc6a75883</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01422%26sid%3Dliteratum%253Aachs%26aulast%3DBabault%26aufirst%3DN.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYue%26aufirst%3DA.%26aulast%3DJu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Bisubstrate%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520%2528NNMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1541%26epage%3D1551%26doi%3D10.1021%2Facs.jmedchem.7b01422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, V. C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">7800</span>– <span class="NLM_lpage">7808</span>, <span class="refDoi"> DOI: 10.1021/bi2007614</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2007614" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtValsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=7800-7808&author=Y.+Pengauthor=D.+Sartiniauthor=V.+Pozziauthor=D.+Wilkauthor=M.+Emanuelliauthor=V.+C.+Yee&title=Structural+Basis+of+Substrate+Recognition+in+Human+Nicotinamide+N-Methyltransferase&doi=10.1021%2Fbi2007614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of substrate recognition in human nicotinamide N-methyltransferase</span></div><div class="casAuthors">Peng, Yi; Sartini, Davide; Pozzi, Valentina; Wilk, Dennis; Emanuelli, Monica; Yee, Vivien C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">7800-7808</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide, pyridines, and other analogs using S-adenosyl-L-methionine as donor.  NNMT plays a significant role in the regulation of metabolic pathways and is expressed at markedly high levels in several kinds of cancers, presenting it as a potential mol. target for cancer therapy.  Here, the authors detd. the crystal structure of human NNMT as a ternary complex bound to both the demethylated donor, S-adenosyl-L-homocysteine, and the acceptor substrate, nicotinamide, to 2.7 Å resoln.  These studies reveal the structural basis for nicotinamide binding and highlight several residues in the active site which may play roles in nicotinamide recognition and NNMT catalysis.  The functional importance of these residues was probed by mutagenesis.  Of three residues near the nicotinamide's amide group, substitution of S201 and S213 had no effect on enzyme activity while replacement of D197 dramatically decreased activity.  Substitutions of Y20, whose side chain hydroxyl interacts with both the nicotinamide arom. ring and AdoHcy carboxylate, also compromised activity.  Enzyme kinetics anal. revealed kcat/Km decreases of 2-3 orders of magnitude for the D197A and Y20A mutants, confirming the functional importance of these active site residues.  The mutants exhibited substantially increased Km for both NCA and AdoMet and modestly decreased kcat.  MD simulations revealed long-range conformational effects which provide an explanation for the large increase in Km(AdoMet) for the D197A mutant, which interacts directly only with nicotinamide in the ternary complex crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh1yxD6WIJFLVg90H21EOLACvtfcHk0ljmbqjgM0UHKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtValsbnF&md5=926af50d2464e21094ffb17205793d19</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi2007614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2007614%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DPozzi%26aufirst%3DV.%26aulast%3DWilk%26aufirst%3DD.%26aulast%3DEmanuelli%26aufirst%3DM.%26aulast%3DYee%26aufirst%3DV.%2BC.%26atitle%3DStructural%2520Basis%2520of%2520Substrate%2520Recognition%2520in%2520Human%2520Nicotinamide%2520N-Methyltransferase%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D7800%26epage%3D7808%26doi%3D10.1021%2Fbi2007614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1007/s13318-017-0404-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1007%2Fs13318-017-0404-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=28229434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtFKls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=891-901&author=N.+J.+Waters&title=Preclinical+Pharmacokinetics+and+Pharmacodynamics+of+Pinometostat+%28EPZ-5676%29%2C+a+First-in-Class%2C+Small+Molecule+S-Adenosyl+Methionine+Competitive+Inhibitor+of+DOT1L&doi=10.1007%2Fs13318-017-0404-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L</span></div><div class="casAuthors">Waters, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">891-901</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Acute leukemias bearing mixed lineage leukemia (MLL) rearrangements are aggressive diseases characterized by a poor overall prognosis despite multi-agent chemotherapy.  Aberrant fusion proteins involving the MLL histone methyltransferase (HMT) lead to recruitment of DOT1L, to a multi-protein complex resulting in aberrant methylation of histone H3 lysine 79 at MLL target genes, and ultimately enhanced expression of crit. genes for hematopoietic differentiation, including HOXA9 and MEIS1, and as such defines the established mechanism for leukemogenesis in MLL-rearrangement (MLL-r) leukemias.  Pinometostat is a first-in-class, small mol. inhibitor of DOT1L with sub-nanomolar affinity and >37,000 fold selectivity against non-MLL HMTs, and was the first member of the novel HMT inhibitor class to enter Phase 1 clin. trials in both adult and pediatric MLL-r leukemia patients.  In this article, the preclin. pharmacokinetics/pharmacodynamics and drug disposition of pinometostat are reviewed including discussion of how these data were used to inform early clin. studies, and how they translated to the clin. experience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxU8juCNJnELVg90H21EOLACvtfcHk0ljmbqjgM0UHKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtFKls7c%253D&md5=edacbc0f25f056f736705ae7c6f184cf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs13318-017-0404-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-017-0404-3%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520Pharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520Pinometostat%2520%2528EPZ-5676%2529%252C%2520a%2520First-in-Class%252C%2520Small%2520Molecule%2520S-Adenosyl%2520Methionine%2520Competitive%2520Inhibitor%2520of%2520DOT1L%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2017%26volume%3D42%26spage%3D891%26epage%3D901%26doi%3D10.1007%2Fs13318-017-0404-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">af
Gennäs, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekokoski, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuominen, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yli-Kauhaluoma, J.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Isophthalic Acid Derivatives Targeted to the C1 Domain of Protein Kinase C</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3969</span>– <span class="NLM_lpage">3981</span>, <span class="refDoi"> DOI: 10.1021/jm900229p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900229p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3969-3981&author=G.+B.+af%0AGenn%C3%A4sauthor=V.+Talmanauthor=O.+Aitioauthor=E.+Ekokoskiauthor=M.+Finelauthor=R.+K.+Tuominenauthor=J.+Yli-Kauhaluoma&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Isophthalic+Acid+Derivatives+Targeted+to+the+C1+Domain+of+Protein+Kinase+C&doi=10.1021%2Fjm900229p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm900229p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900229p%26sid%3Dliteratum%253Aachs%26aulast%3Daf%2BGenn%25C3%25A4s%26aufirst%3DG.%2BB.%26aulast%3DTalman%26aufirst%3DV.%26aulast%3DAitio%26aufirst%3DO.%26aulast%3DEkokoski%26aufirst%3DE.%26aulast%3DFinel%26aufirst%3DM.%26aulast%3DTuominen%26aufirst%3DR.%2BK.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Isophthalic%2520Acid%2520Derivatives%2520Targeted%2520to%2520the%2520C1%2520Domain%2520of%2520Protein%2520Kinase%2520C%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3969%26epage%3D3981%26doi%3D10.1021%2Fjm900229p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, Y. J.</span></span> <span> </span><span class="NLM_article-title">Facile Reduction of Carboxylic Acids, Esters, Acid Chlorides, Amides and Nitriles to Alcohols or Amines Using NaBH<sub>4</sub>/BF<sub>3</sub>·Et<sub>2</sub>O</span>. <i>Bull. Korean Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.5012/bkcs.2004.25.3.407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.5012%2Fbkcs.2004.25.3.407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVymu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=407-409&author=S.+D.+Choauthor=Y.+D.+Parkauthor=J.+J.+Kimauthor=J.+R.+Falckauthor=Y.+J.+Yoon&title=Facile+Reduction+of+Carboxylic+Acids%2C+Esters%2C+Acid+Chlorides%2C+Amides+and+Nitriles+to+Alcohols+or+Amines+Using+NaBH4%2FBF3%C2%B7Et2O&doi=10.5012%2Fbkcs.2004.25.3.407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Facile reduction of carboxylic acids, esters, acid chlorides, amides and nitriles to alcohols or amines using NaBH4/BF3.Et2O</span></div><div class="casAuthors">Cho, Su-Dong; Park, Yong-Dae; Kim, Jeum-Jong; Falck, J. R.; Yoon, Yong-Jin</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-409</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">The system NaBH4/BF3.Et2O is an inexpensive and highly versatile reducing system for a wide variety of carbonyls, acid chlorides, carboxylic acids, esters, amides and nitriles.  Among the 16 products prepd. were 98% 5-nitrofurfuryl alc., 97% PhCH2OH, 94% 3-(hydroxymethyl)pyridine and 89% 2,6-difluorobenzylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGLUCGfrNUBLVg90H21EOLACvtfcHk0liZXVfDgrW-AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVymu7o%253D&md5=4a4e4707d02fe60d040b7266fbd2dcfa</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2004.25.3.407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2004.25.3.407%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DPark%26aufirst%3DY.%2BD.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DYoon%26aufirst%3DY.%2BJ.%26atitle%3DFacile%2520Reduction%2520of%2520Carboxylic%2520Acids%252C%2520Esters%252C%2520Acid%2520Chlorides%252C%2520Amides%2520and%2520Nitriles%2520to%2520Alcohols%2520or%2520Amines%2520Using%2520NaBH4%252FBF3%25C2%25B7Et2O%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2004%26volume%3D25%26spage%3D407%26epage%3D409%26doi%3D10.5012%2Fbkcs.2004.25.3.407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imajo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomimori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span> <span> </span><span class="NLM_article-title">Development of 6-Benzyl Substituted 4-Aminocarbonyl-1,4-Diazepane-2,5-Diones as Orally Active Human Chymase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3439</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2007.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=17434735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtValsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3435-3439&author=H.+Maruokaauthor=T.+Mutoauthor=T.+Tanakaauthor=S.+Imajoauthor=Y.+Tomimoriauthor=Y.+Fukudaauthor=T.+Nakatsuka&title=Development+of+6-Benzyl+Substituted+4-Aminocarbonyl-1%2C4-Diazepane-2%2C5-Diones+as+Orally+Active+Human+Chymase+Inhibitors&doi=10.1016%2Fj.bmcl.2007.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 6-benzyl-substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors</span></div><div class="casAuthors">Maruoka, Hiroshi; Muto, Tsuyoshi; Tanaka, Taisaku; Imajo, Seiichi; Tomimori, Yoshiaki; Fukuda, Yoshiaki; Nakatsuka, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3435-3439</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A novel series of 6-benzyl-substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones I (R1 = H, R2 = PhCH2, PhCH2CH2, PhCHMe, Ph2CH, etc.; R1 = Me, R2 = PhCH2) was designed, synthesized, and evaluated as human chymase inhibitors.  From this series, several compds. which were effective, via oral administration, in a mouse model of chronic dermatitis were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgXKgcOk71rVg90H21EOLACvtfcHk0liZXVfDgrW-AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtValsLs%253D&md5=e6893b5973e9c22f575bbe2238703251</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DMaruoka%26aufirst%3DH.%26aulast%3DMuto%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DImajo%26aufirst%3DS.%26aulast%3DTomimori%26aufirst%3DY.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DNakatsuka%26aufirst%3DT.%26atitle%3DDevelopment%2520of%25206-Benzyl%2520Substituted%25204-Aminocarbonyl-1%252C4-Diazepane-2%252C5-Diones%2520as%2520Orally%2520Active%2520Human%2520Chymase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3435%26epage%3D3439%26doi%3D10.1016%2Fj.bmcl.2007.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Pola
Chemical Industries Inc.</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, K.</span>; <span class="NLM_string-name">Kimura, M.</span>; <span class="NLM_string-name">Tamai, M.</span>; <span class="NLM_string-name">Saitoh, Y.</span>; <span class="NLM_string-name">Kato, T.</span>; <span class="NLM_string-name">Ikeda, Y.</span></span> <span> </span><span class="NLM_article-title">Melanin Production Inhibitor</span>. U.S. Patent <span class="NLM_patent">8,846,012</span>, Sept 30, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Pola%0AChemical+Industries+Inc.author=K.+Yokoyama&author=M.+Kimura&author=M.+Tamai&author=Y.+Saitoh&author=T.+Kato&author=Y.+Ikeda&title=Melanin+Production+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3D%26aulast%3DYokoyama%26aufirst%3DK.%26atitle%3DMelanin%2520Production%2520Inhibitor%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, V. P.</span></span> <span> </span><span class="NLM_article-title">The Lithium Aluminum Hydride Reduction of Some N-Substituted Succinimides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1744</span>– <span class="NLM_lpage">1747</span>, <span class="refDoi"> DOI: 10.1021/jo01065a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01065a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Chsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=1744-1747&author=K.+C.+Schreiberauthor=V.+P.+Fernandez&title=The+Lithium+Aluminum+Hydride+Reduction+of+Some+N-Substituted+Succinimides&doi=10.1021%2Fjo01065a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium aluminium hydride reduction of some N-substituted succinimides</span></div><div class="casAuthors">Schreiber, Kurt C.; Fernandez, Vincent P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1744-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The redn. of N-substituted succinimides with LiAlH4 was studied.  In all but one case redn. to the N-substituted pyrrolidines occurred smoothly.  N-Benzhydryl (I), N-tert-butyl (II), and N-phenylsuccinimides (III) underwent ring opening to yield the resp. amino alcs. in addn. to the normal redn. product.  N-Tritylsuccinimide (IV) gave only N-trityl-4-hydroxybutyramide (V).  Several succinamic acids were reduced to the resp. amino alcs.  All the succinimides except IV were prepd. by heating a mixt. of succinic anhydride and the corresponding amino for 24 hrs.  Isopropylsuccinimide (VI), obtained in 84% yield, m. 64-5°.  II, obtained in 25% yield, m. 49-50°.  No attempt was made to det. the structure of this compd.  II was obtained in 46% yield by refluxing 40 g. tert-butylsuccinamic acid (VII) in 2 l. PhMe for 48 hrs. and collecting the H2O in a trap.  III, obtained in 86% yield, m. 153°, benzylsuccinimide, in 89% yield, m. 103%, I, in 56% yield, m. 131-2°(alc.).  In addn. to the imide there was formed some higher melting material, m. 248-50°, putative N,N'-dibenzhydrylsuccinimide.  The 2 compds. were sepd. by extn. with hot alc.  IV was prepd. by refluxing an equimolar mixt. of trityl bromide and N-bromosuccinimide in dry CHCl3 3-4 hrs., the mixt. washed, evapd., and the product isolated in 67% yield, m. 203-4°.  N-Substituted succinamic acids were obtained by a known procedure (R, % yield, and m.p. given): iso-Pr, 86, 105-7°; Me3C, 90, 134-5°; Ph, 85, 147-8°; Ph2CH, 92, 189-90°.  Tritylsuccinamic acid was obtained by hydrolysis of IV, m. 222-3°.  N-Tritylacetamide, m. 214-15°, was prepd. in 89% yield in the same way as IV by using an equimolar ratio of trityl bromide and N-bromoacetamide.  In an alkali-resistant flask, 3 g. tritylacetamide in 100 ml. C6H6 and 1 g. NaH refluxed 48 hrs., the mixt. cooled, then refluxed 6 hrs. with 2 ml. MeI, filtered, the solvent removed, and product recrystd. gave 2.4 g. N-methyl-N-tritylacetamide, m. 147-8°.  A typical run for the redn. of the N-substituted succinimides was as follows.  LiAlH4 (9 g.) in 100 ml. tetrahydrofuran (THF) treated dropwise with 0.1 mole of the imide in THF so as to maintain reflux, the soln. refluxed 72 hrs., and decompd. gave the product.  The following results were obtained (N-substituent, % yield of pyrrolidine, m.p. or b.p., m.p. of picrate, % yield of RNH(CH2)4OH, and b.p. given): Me2CH, 66, 121°, 200-1°, 0, -; Me3C, 78, 146°, decompn. 245°, 1, 41-2°; Ph, 57, 81°/0.45 mm., 115-16°, 10, 134°/0.7 mm.; PhCH2, 65, 63°/0.45 mm., 128°, 0, -; Ph2CH, 48, 84-5°, 194-5°, 36, 201-5°/1 mm.  With IV the product which was obtained after 3 hrs. reflux was V.  Refluxing the mixt. for the usual period of 72 hrs. gave only a viscous material from which no solid could be obtained.  Since iso-PrCl did not apparently react with pyrrolidine even after 24 hrs. reflux, the alkyl iodide was used.  N-Tritylpyrrolidine, m. 126-7°, was obtained in 49% yield; picrate m. 133° (decompn.).  N-Substituted succinamic acids were reduced in a similar manner.  The following results were obtained (R of the product RNH-(CH2)4OH, b.p., % yield given): Me2CH, 85°/1 mm., 64; Me3C, 89-19°/1 mm. (m.41-2°), 61; Ph, 134°/0.7 mm., 50; Ph2CH, 201-5°/1 mm., 50-60°.  N-Tritylsuccinamic acid (5 g.) refluxed with 2 g. LiAlH4 was similarly reduced to give 4.6 g. V.  V (6.2 g.) in 100 ml. C6H6 and 1 g. Na refluxed 36 hrs., the mixt. treated with 4 g. MeI, stirred 2 hrs., and the product sepd. gave 4.2 g. N-trityl-γ-methoxybutyramide, m. 165°.  N-Tritylacetamide (3 g.) in 100 ml. THF treated 3 hrs. under reflux with 1 g. LiAlH4 gave 2.8 g. unchanged material.  Refluxing 72 hrs. did not effect any redn.  LiAlH4 (2 g.) in 100 ml. THF and 6.5 g. N-methyl-N-tritylacetamide in 100 ml. THF refluxed 72 hrs. gave 1.7 g. ethylmethyltritylamine, m. 81-2°; picrate m. 105-6° (decompn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd_JrqjBlnarVg90H21EOLACvtfcHk0lgk8giCRlKn_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Chsbc%253D&md5=38fa1f923820077ff3928c61b190a0f8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo01065a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01065a012%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DK.%2BC.%26aulast%3DFernandez%26aufirst%3DV.%2BP.%26atitle%3DThe%2520Lithium%2520Aluminum%2520Hydride%2520Reduction%2520of%2520Some%2520N-Substituted%2520Succinimides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D1744%26epage%3D1747%26doi%3D10.1021%2Fjo01065a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingozzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belvisi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piarulli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carenini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castiglioni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanziani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine–Glycine–Aspartate (RGD) Peptidomimetic–Paclitaxel Conjugates Targeting Integrin AVβ3</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10460</span>– <span class="NLM_lpage">10474</span>, <span class="refDoi"> DOI: 10.1021/jm301058f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301058f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GlsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10460-10474&author=R.+Colomboauthor=M.+Mingozziauthor=L.+Belvisiauthor=D.+Arosioauthor=U.+Piarulliauthor=N.+Careniniauthor=P.+Peregoauthor=N.+Zaffaroniauthor=M.+De+Cesareauthor=V.+Castiglioniauthor=E.+Scanzianiauthor=C.+Gennari&title=Synthesis+and+Biological+Evaluation+%28in+Vitro+and+in+Vivo%29+of+Cyclic+Arginine%E2%80%93Glycine%E2%80%93Aspartate+%28RGD%29+Peptidomimetic%E2%80%93Paclitaxel+Conjugates+Targeting+Integrin+AV%CE%B23&doi=10.1021%2Fjm301058f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine-Glycine-Aspartate (RGD) Peptidomimetic-Paclitaxel Conjugates Targeting Integrin αVβ3</span></div><div class="casAuthors">Colombo, Raffaele; Mingozzi, Michele; Belvisi, Laura; Arosio, Daniela; Piarulli, Umberto; Carenini, Nives; Perego, Paola; Zaffaroni, Nadia; De Cesare, Michelandrea; Castiglioni, Vittoria; Scanziani, Eugenio; Gennari, Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10460-10474</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small library of integrin ligand-paclitaxel conjugates 10-13 was synthesized with the aim of using the tumor-homing cyclo[DKP-RGD] peptidomimetics for site-directed delivery of the cytotoxic drug.  All the paclitaxel-RGD constructs 10-13 inhibited biotinylated vitronectin binding to the purified αVβ3 integrin receptor at low nanomolar concn. and showed in vitro cytotoxic activity against a panel of human tumor cell lines similar to that of paclitaxel.  Among the cell lines, the cisplatin-resistant IGROV-1/Pt1 cells expressed high levels of integrin αVβ3, making them attractive to be tested in in vivo models. cyclo[DKP-f3-RGD]-PTX 11 displayed sufficient stability in physiol. soln. and in both human and murine plasma to be a good candidate for in vivo testing.  In tumor-targeting expts. against the IGROV-1/Pt1 human ovarian carcinoma xenotransplanted in nude mice, compd. 11 exhibited a superior activity compared with paclitaxel, despite the lower (about half) molar dosage used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7QwGoS6oKH7Vg90H21EOLACvtfcHk0lgk8giCRlKn_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GlsrvL&md5=e7c777bc1bce4e2533cb056db63ada2e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301058f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301058f%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DMingozzi%26aufirst%3DM.%26aulast%3DBelvisi%26aufirst%3DL.%26aulast%3DArosio%26aufirst%3DD.%26aulast%3DPiarulli%26aufirst%3DU.%26aulast%3DCarenini%26aufirst%3DN.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DCastiglioni%26aufirst%3DV.%26aulast%3DScanziani%26aufirst%3DE.%26aulast%3DGennari%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520%2528in%2520Vitro%2520and%2520in%2520Vivo%2529%2520of%2520Cyclic%2520Arginine%25E2%2580%2593Glycine%25E2%2580%2593Aspartate%2520%2528RGD%2529%2520Peptidomimetic%25E2%2580%2593Paclitaxel%2520Conjugates%2520Targeting%2520Integrin%2520AV%25CE%25B23%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10460%26epage%3D10474%26doi%3D10.1021%2Fjm301058f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Practical Synthesis of Enantiomerically Pure β 2-Amino Acids via Proline-Catalyzed Diastereoselective Aminomethylation of Aldehydes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">6050</span>– <span class="NLM_lpage">6055</span>, <span class="refDoi"> DOI: 10.1021/ja070063i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja070063i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1ShsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=6050-6055&author=Y.+Chiauthor=E.+P.+Englishauthor=W.+C.+Pomerantzauthor=W.+S.+Horneauthor=L.+A.+Joyceauthor=L.+R.+Alexanderauthor=W.+S.+Flemingauthor=E.+A.+Hopkinsauthor=S.+H.+Gellman&title=Practical+Synthesis+of+Enantiomerically+Pure+%CE%B2+2-Amino+Acids+via+Proline-Catalyzed+Diastereoselective+Aminomethylation+of+Aldehydes&doi=10.1021%2Fja070063i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis of enantiomerically pure β2-amino acids via proline-catalyzed diastereoselective aminomethylation of aldehydes</span></div><div class="casAuthors">Chi, Yonggui; English, Emily P.; Pomerantz, William C.; Horne, W. Seth; Joyce, Leo A.; Alexander, Lane R.; Fleming, William S.; Hopkins, Elizabeth A.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6050-6055</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proline-catalyzed diastereoselective aminomethylation of aldehydes using a chiral iminium ion, generated from a readily prepd. precursor, provides α-substituted-β-amino aldehydes with 85:15 to 90:10 dr.  The α-substituted-β-amino aldehydes can be reduced to β-substituted-γ-amino alcs., the major diastereomer of which can be isolated via crystn. or column chromatog.  The amino alcs. are efficiently transformed to protected β2-amino acids, which are valuable building blocks for β-peptides, natural products, and other interesting mols.  Because conditions for the aminomethylation and subsequent reactions are mild, β2-amino acid derivs. with protected functional groups in the side chain, such as β2-homoglutamic acid, β2-homotyrosine, and β2-homolysine, can be prepd. in this way.  The synthetic route is short, and purifications are simple; therefore, this method enables the prepn. of protected β2-amino acids in useful quantities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-9yCpoP2hvLVg90H21EOLACvtfcHk0lgk8giCRlKn_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1ShsLs%253D&md5=dfb968ca03d869e049750514c2256100</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja070063i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja070063i%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DY.%26aulast%3DEnglish%26aufirst%3DE.%2BP.%26aulast%3DPomerantz%26aufirst%3DW.%2BC.%26aulast%3DHorne%26aufirst%3DW.%2BS.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DAlexander%26aufirst%3DL.%2BR.%26aulast%3DFleming%26aufirst%3DW.%2BS.%26aulast%3DHopkins%26aufirst%3DE.%2BA.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DPractical%2520Synthesis%2520of%2520Enantiomerically%2520Pure%2520%25CE%25B2%25202-Amino%2520Acids%2520via%2520Proline-Catalyzed%2520Diastereoselective%2520Aminomethylation%2520of%2520Aldehydes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D6050%26epage%3D6055%26doi%3D10.1021%2Fja070063i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wernic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMaio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span> <span> </span><span class="NLM_article-title">Enantiospecific Synthesis of L-.Alpha.-Aminosuberic Acid. Synthetic Applications in Preparation of Atrial Natriuretic Factor Analogs</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4224</span>– <span class="NLM_lpage">4228</span>, <span class="refDoi"> DOI: 10.1021/jo00278a046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00278a046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaL1MXltFGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=4224-4228&author=D.+Wernicauthor=J.+DiMaioauthor=J.+Adams&title=Enantiospecific+Synthesis+of+L-.Alpha.-Aminosuberic+Acid.+Synthetic+Applications+in+Preparation+of+Atrial+Natriuretic+Factor+Analogs&doi=10.1021%2Fjo00278a046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiospecific synthesis of L-α-aminosuberic acid. Synthetic applications in preparation of atrial natriuretic factor analogs</span></div><div class="casAuthors">Wernic, Dominik; DiMaio, John; Adams, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4224-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">L-α-Aminosuberic acid, RNHCH(CO2H)(CH2)5CO2R1 (I, R = R1 = H), and L-α-amino-γ,δ-(Z)-dehydrosuberic acid, RNHCH(CO2H)CH2CH:CHCH2CH2CO2R1 (II, R = R1 = H), were synthesized enantiospecifically as orthogonally protected derivs. I and II (R = Me3CO2C, R1 = 9-fluorenylmethyl), which are convenient for peptide synthesis.  Both products were utilized as isosteres for the cysteine-cysteine disulfide linkage in atrial natriuretic factor analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl3HTWcqFriLVg90H21EOLACvtfcHk0lgk8giCRlKn_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltFGksbw%253D&md5=0eccef5b3e26409fb0b955c1900d3a05</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo00278a046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00278a046%26sid%3Dliteratum%253Aachs%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DDiMaio%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DEnantiospecific%2520Synthesis%2520of%2520L-.Alpha.-Aminosuberic%2520Acid.%2520Synthetic%2520Applications%2520in%2520Preparation%2520of%2520Atrial%2520Natriuretic%2520Factor%2520Analogs%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D4224%26epage%3D4228%26doi%3D10.1021%2Fjo00278a046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascitti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumarola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Muzio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuelli, M.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Nicotinamide N-Methyltransferase in HSC-2 OSCC Cell Line: Effect on Apoptosis and Cell Proliferation</span>. <i>Clin. Oral Investig.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1007/s00784-018-2497-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1007%2Fs00784-018-2497-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29882109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A280%3ADC%252BC1Mblt12gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=829-838&author=R.+Setaauthor=M.+Mascittiauthor=R.+Campagnaauthor=D.+Sartiniauthor=S.+Fumarolaauthor=A.+Santarelliauthor=M.+Giulianiauthor=M.+Cecatiauthor=L.+Lo+Muzioauthor=M.+Emanuelli&title=Overexpression+of+Nicotinamide+N-Methyltransferase+in+HSC-2+OSCC+Cell+Line%3A+Effect+on+Apoptosis+and+Cell+Proliferation&doi=10.1007%2Fs00784-018-2497-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation</span></div><div class="casAuthors">Seta Riccardo; Mascitti Marco; Campagna Roberto; Sartini Davide; Fumarola Stefania; Santarelli Andrea; Cecati Monia; Emanuelli Monica; Giuliani Michele; Muzio Lorenzo Lo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oral investigations</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">829-838</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Oral squamous cell carcinoma (OSCC) is the most common malignancy of oral cavity.  Despite advances in therapeutic approaches, the 5-year survival rate for oral cancer has not improved in the last three decades.  Therefore, new molecular targets for early diagnosis and treatment of OSCC are needed.  In the present study, we focused on the enzyme nicotinamide N-methyltransferase (NNMT).  We have previously shown that enzyme expression is upregulated in OSCC and NNMT knockdown in PE/CA PJ-15 cells significantly decreased cell growth in vitro and tumorigenicity in vivo.  MATERIAL AND METHODS:  To further explore the role of the enzyme in oral cancer cell metabolism, HSC-2 cells were transfected with the NNMT expression vector (pcDNA3-NNMT) and the effect of enzyme upregulation on cell proliferation was evaluated by MTT assay.  Subsequently, we investigated at molecular level the role of NNMT on apoptosis and cell proliferation, by exploring the expression of β-catenin, survivin, and Ki-67 by real-time PCR.  Moreover, we performed immunohistochemistry on 20 OSCC tissue samples to explore the expression level of NNMT and survivin ΔEx3 isoform.  RESULTS:  Enzyme upregulation significantly increased cell growth in vitro.  Moreover, a positive correlation between NNMT and survivin ΔEx3 isoform expression levels was found both in HSC-2 cells and in OSCC tissue samples.  CONCLUSION:  Taken together, our results indicate a possible involvement of NNMT in the proliferation and tumorigenic capacity of OSCC cells and seem to suggest that the enzyme could represent a potential target for the treatment of oral cancer.  CLINICAL RELEVANCE:  The involvement of NNMT in cell growth and anti-apoptotic mechanisms seems to suggest that this enzyme could be a new therapeutic target to improve the survival of OSCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZ7QZTOXwtZG52AMpI4GK2fW6udTcc2eYX1SIsnDSE7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mblt12gsw%253D%253D&md5=f4495f592b308457437236b629d62f1d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00784-018-2497-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00784-018-2497-8%26sid%3Dliteratum%253Aachs%26aulast%3DSeta%26aufirst%3DR.%26aulast%3DMascitti%26aufirst%3DM.%26aulast%3DCampagna%26aufirst%3DR.%26aulast%3DSartini%26aufirst%3DD.%26aulast%3DFumarola%26aufirst%3DS.%26aulast%3DSantarelli%26aufirst%3DA.%26aulast%3DGiuliani%26aufirst%3DM.%26aulast%3DCecati%26aufirst%3DM.%26aulast%3DLo%2BMuzio%26aufirst%3DL.%26aulast%3DEmanuelli%26aufirst%3DM.%26atitle%3DOverexpression%2520of%2520Nicotinamide%2520N-Methyltransferase%2520in%2520HSC-2%2520OSCC%2520Cell%2520Line%253A%2520Effect%2520on%2520Apoptosis%2520and%2520Cell%2520Proliferation%26jtitle%3DClin.%2520Oral%2520Investig.%26date%3D2019%26volume%3D23%26spage%3D829%26epage%3D838%26doi%3D10.1007%2Fs00784-018-2497-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.-H.</span>; <span class="NLM_string-name">Chun, K.</span>; <span class="NLM_string-name">Choi, J.-W.</span>; <span class="NLM_string-name">Joe, B.-Y.</span>; <span class="NLM_string-name">Park, S.-W.</span>; <span class="NLM_string-name">Kim, K. H.</span>; <span class="NLM_string-name">Oh, B.-K.</span>; <span class="NLM_string-name">Choi, J.-H.</span></span> <span> </span><span class="NLM_article-title">Tricyclic Derivatives or Pharmaceutically Acceptable Salts Thereof, Their Preparations and Pharmaceutical Compositions Containing Them</span>. U.S. Patent <span class="NLM_patent">2007/0179143A1</span>, Aug 2, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.-H.+Kim&author=K.+Chun&author=J.-W.+Choi&author=B.-Y.+Joe&author=S.-W.+Park&author=K.+H.+Kim&author=B.-K.+Oh&author=J.-H.+Choi&title=Tricyclic+Derivatives+or+Pharmaceutically+Acceptable+Salts+Thereof%2C+Their+Preparations+and+Pharmaceutical+Compositions+Containing+Them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.-H.%26atitle%3DTricyclic%2520Derivatives%2520or%2520Pharmaceutically%2520Acceptable%2520Salts%2520Thereof%252C%2520Their%2520Preparations%2520and%2520Pharmaceutical%2520Compositions%2520Containing%2520Them%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ewa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIej, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzegorz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michał, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Józef, O.</span></span> <span> </span><span class="NLM_article-title">The Development of First Staphylococcus Aureus SplB Protease Inhibitors: Phosphonic Analogues of Glutamine</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5574</span>– <span class="NLM_lpage">5578</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bmcl.2012.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=22858096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A280%3ADC%252BC38fltFWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5574-5578&author=B.+Ewaauthor=W.+MacIejauthor=S.+Marcinauthor=D.+Grzegorzauthor=Z.+Micha%C5%82author=P.+Janauthor=O.+J%C3%B3zef&title=The+Development+of+First+Staphylococcus+Aureus+SplB+Protease+Inhibitors%3A+Phosphonic+Analogues+of+Glutamine&doi=10.1016%2Fj.bmcl.2012.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The development of first Staphylococcus aureus SplB protease inhibitors: phosphonic analogues of glutamine</span></div><div class="casAuthors">Ewa Burchacka; Maciej Walczak; Marcin Sienczyk; Grzegorz Dubin; Michal Zdzalik; Jan Potempa; Jozef Oleksyszyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5574-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Produced by Staphylococcus aureus, SplB belongs to the chymotrypsin-like serine protease family.  Since the biological role of SplB protease is unknown, the design and application of its specific inhibitors may help to reveal the function of this enzyme.  Until now no SplB inhibitors have been reported.  Herein, we present the design and synthesis of novel α-aminophosphonic analogues of glutamine, as well as their peptidyl derivatives.  The inhibitory effects of these compounds towards the newly discovered SplB serine protease from S. aureus are characterized.  We have also investigated the influence of aromatic ester substituents on inhibitory potency towards SplB.  One of the compounds-Cbz-Glu-Leu-Gln(P)(OC(6)H(4)-4-O-CH(3))(2)-displayed an apparent second-order inhibition rate value of 1400 M(-1)s(-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3RTMScVEaKRdUSIfHIn4FfW6udTcc2eYX1SIsnDSE7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fltFWhtg%253D%253D&md5=a0e775442a8a4add9d207b7121d045d2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DEwa%26aufirst%3DB.%26aulast%3DMacIej%26aufirst%3DW.%26aulast%3DMarcin%26aufirst%3DS.%26aulast%3DGrzegorz%26aufirst%3DD.%26aulast%3DMicha%25C5%2582%26aufirst%3DZ.%26aulast%3DJan%26aufirst%3DP.%26aulast%3DJ%25C3%25B3zef%26aufirst%3DO.%26atitle%3DThe%2520Development%2520of%2520First%2520Staphylococcus%2520Aureus%2520SplB%2520Protease%2520Inhibitors%253A%2520Phosphonic%2520Analogues%2520of%2520Glutamine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5574%26epage%3D5578%26doi%3D10.1016%2Fj.bmcl.2012.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1021/bc9005656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9005656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=979-987&author=S.+Chenauthor=X.+Zhaoauthor=J.+Chenauthor=J.+Chenauthor=L.+Kuznetsovaauthor=S.+S.+Wongauthor=I.+Ojima&title=Mechanism-Based+Tumor-Targeting+Drug+Delivery+System.+Validation+of+Efficient+Vitamin+Receptor-Mediated+Endocytosis+and+Drug+Release&doi=10.1021%2Fbc9005656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release</span></div><div class="casAuthors">Chen, Shuyi; Zhao, Xianrui; Chen, Jingyi; Chen, Jin; Kuznetsova, Larisa; Wong, Stanislaus S.; Ojima, Iwao</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">979-987</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient mechanism-based tumor-targeting drug delivery system, based on tumor-specific vitamin-receptor mediated endocytosis, has been developed.  The tumor-targeting drug delivery system is a conjugate of a tumor-targeting mol. (biotin: vitamin H or vitamin B-7), a mechanism-based self-immolative linker and a second-generation taxoid (SB-T-1214) as the cytotoxic agent.  This conjugate (I) is designed to be (i) specific to the vitamin receptors overexpressed on tumor cell surface and (ii) internalized efficiently through receptor-mediated endocytosis, followed by smooth drug release via glutathione-triggered self-immolation of the linker.  In order to monitor and validate the sequence of events hypothesized, i.e., receptor-mediated endocytosis of the conjugate, drug release, and drug-binding to the target protein (microtubules), three fluorescent/fluorogenic mol. probes were designed and synthesized.  The actual occurrence of these processes was unambiguously confirmed by means of confocal fluorescence microscopy (CFM) and flow cytometry using L1210FR leukemia cells, overexpressing biotin receptors.  The mol. probe bearing the taxoid linked to fluorescein, was also used to examine the cell specificity (i.e., efficacy of receptor-based cell targeting) for three cell lines, L1210FR (biotin receptors overexpressed), L1210 (biotin receptors not overexpressed), and WI38 (normal human lung fibroblast, biotin receptor neg.).  As anticipated, the mol. probe exhibited high specificity only to L1210FR.  To confirm the direct correlation between the cell-specific drug delivery and anticancer activity of the fluorescein-linked taxoid probe, its cytotoxicity against these three cell lines was also examd.  The results clearly showed a good correlation between the two methods.  In the same manner, excellent cell-specific cytotoxicity of the conjugate I (without fluorescein attachment to the taxoid) against the same three cell lines was confirmed.  This mechanism-based tumor-targeting drug delivery system will find a range of applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUIQMoFwAzy7Vg90H21EOLACvtfcHk0lgoVtCQ-oU12w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSks7o%253D&md5=697f734ab904bc8117bef139150e1938</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbc9005656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9005656%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKuznetsova%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DS.%2BS.%26aulast%3DOjima%26aufirst%3DI.%26atitle%3DMechanism-Based%2520Tumor-Targeting%2520Drug%2520Delivery%2520System.%2520Validation%2520of%2520Efficient%2520Vitamin%2520Receptor-Mediated%2520Endocytosis%2520and%2520Drug%2520Release%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D979%26epage%3D987%26doi%3D10.1021%2Fbc9005656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berk, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">A Catalytic Method for the Reduction of Esters to Alcohols</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">5093</span>– <span class="NLM_lpage">5095</span>, <span class="refDoi"> DOI: 10.1021/ja00013a074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00013a074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1ygtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=5093-5095&author=S.+C.+Berkauthor=K.+A.+Kreutzerauthor=S.+L.+Buchwald&title=A+Catalytic+Method+for+the+Reduction+of+Esters+to+Alcohols&doi=10.1021%2Fja00013a074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A catalytic method for the reduction of esters to alcohols</span></div><div class="casAuthors">Berk, Scott C.; Kreutzer, Kristina A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5093-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new titanium-catalyzed hydrosilylation of esters is described.  The procedure is exptl. simple and efficient, and it uses inexpensive materials to convert esters into their corresponding primary alcs.  Thus, a hexane soln. of BuLi was added to a slurry of titanocene dichloride at -78° to give a catalyst.  BzOMe and (EtO)3SiH were added to the catalyst soln. and the mixt. warmed to room temp. and subsequently treated with concd. HCl to give 93% PhCH2OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7hBEqbQRZSrVg90H21EOLACvtfcHk0lgoVtCQ-oU12w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1ygtrw%253D&md5=bcdbbb89058788e8d73f932f97e36290</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja00013a074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00013a074%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DS.%2BC.%26aulast%3DKreutzer%26aufirst%3DK.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520Catalytic%2520Method%2520for%2520the%2520Reduction%2520of%2520Esters%2520to%2520Alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D5093%26epage%3D5095%26doi%3D10.1021%2Fja00013a074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a New Conformation-Constrained L-Tyrosine Analogue as a Potential Scaffold for SH2 Domain Ligands</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">6679</span>– <span class="NLM_lpage">6684</span>, <span class="refDoi"> DOI: 10.1021/jo0340152</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0340152" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1egs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=6679-6684&author=F.+Liuauthor=H.+Y.+Zhaauthor=Z.+J.+Yao&title=Synthesis+of+a+New+Conformation-Constrained+L-Tyrosine+Analogue+as+a+Potential+Scaffold+for+SH2+Domain+Ligands&doi=10.1021%2Fjo0340152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a New Conformation-Constrained L-Tyrosine Analogue as a Potential Scaffold for SH2 Domain Ligands</span></div><div class="casAuthors">Liu, Fa; Zha, Hui-Yan; Yao, Zhu-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6679-6684</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enantioselective synthesis of a new tricyclic tyrosine analog I is reported.  I, conformation-constrained SH2 domain ligand scaffold, was designed on the basis of the natural ligand, whose structure contains the elements of a tyrosine moiety having χ1 and χ2 angles constrained to values obsd. for a phosphotyrosyl (pTyr) residue bound to the p56lck SH2 domain.  It represents a unique, highly constrained amino acid, which may be of value in signal transduction studies.  Three key steps, an asym. tandem Michael addn., an intramol. Friedel-Crafts reaction, and an intramol. Mannich reaction, were successfully applied in the presented synthetic route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhyckVoIIDWrVg90H21EOLACvtfcHk0lgoVtCQ-oU12w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1egs7s%253D&md5=abfea2649a8418b5fc12fbfb82c92e82</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo0340152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0340152%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DZha%26aufirst%3DH.%2BY.%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26atitle%3DSynthesis%2520of%2520a%2520New%2520Conformation-Constrained%2520L-Tyrosine%2520Analogue%2520as%2520a%2520Potential%2520Scaffold%2520for%2520SH2%2520Domain%2520Ligands%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D6679%26epage%3D6684%26doi%3D10.1021%2Fjo0340152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayakrishnan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeppe, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Thiyl Glycosylate of Olefinic Proteins: S-Linked Glycoconjugate Synthesis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7798</span>– <span class="NLM_lpage">7802</span>, <span class="refDoi"> DOI: 10.1002/anie.200903135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1002%2Fanie.200903135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ektL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7798-7802&author=N.+Floydauthor=B.+Vijayakrishnanauthor=J.+R.+Koeppeauthor=B.+G.+Davis&title=Thiyl+Glycosylate+of+Olefinic+Proteins%3A+S-Linked+Glycoconjugate+Synthesis&doi=10.1002%2Fanie.200903135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Thiyl Glycosylation of Olefinic Proteins: S-Linked Glycoconjugate Synthesis</span></div><div class="casAuthors">Floyd, Nicola; Vijayakrishnan, Balakumar; Koeppe, Julia R.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">7798-7802, S7798/1-S7798/72</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe the development of a convergent approach for the synthesis of a novel class of S-linked glycoconjugate proteins through the site-specific ligation of 1-glycosylthiols to proteins.  The strategy exploits nonnatural amino acid incorporation for the introduction of L-homoallylglycine (L-Hag) into a protein and free-radical addn. hydrothiolation reactions, under conditions mild enough to retain protein activity throughout.  In this way, Hag functions as a new tag combined here with a new modification as part of a general "tag-modify" strategy for synthetic-protein construction.  While 1-thioglycoside formation by the free-radical addn. of 1-glycosylthiols to alkenes has been reported for the synthesis of small mols., to date this method has not been applied to the synthesis of S-linked glycoproteins or bioconjugates.  The unique reactivity profile of L-Hag, with an olefinic sidechain compared to the natural amino acids characteristically found in proteins, allows for a chemoselective chem. reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjW9T2A8yjC7Vg90H21EOLACvtfcHk0lgoVtCQ-oU12w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ektL%252FN&md5=5de684052119bc60b41972eb8d09467a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.200903135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200903135%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DN.%26aulast%3DVijayakrishnan%26aufirst%3DB.%26aulast%3DKoeppe%26aufirst%3DJ.%2BR.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DThiyl%2520Glycosylate%2520of%2520Olefinic%2520Proteins%253A%2520S-Linked%2520Glycoconjugate%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D7798%26epage%3D7802%26doi%3D10.1002%2Fanie.200903135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lg7SVR2QGHg0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS: High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers</span>. <i>SoftwareX</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1–2</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.softx.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.softx.2015.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=2015&pages=19-25&author=M.+J.+Abrahamauthor=T.+Murtolaauthor=R.+Schulzauthor=S.+P%C3%A1llauthor=J.+C.+Smithauthor=B.+Hessauthor=E.+Lindahl&title=GROMACS%3A+High+Performance+Molecular+Simulations+through+Multi-Level+Parallelism+from+Laptops+to+Supercomputers&doi=10.1016%2Fj.softx.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.softx.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.softx.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BJ.%26aulast%3DMurtola%26aufirst%3DT.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DP%25C3%25A1ll%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%253A%2520High%2520Performance%2520Molecular%2520Simulations%2520through%2520Multi-Level%2520Parallelism%2520from%2520Laptops%2520to%2520Supercomputers%26jtitle%3DSoftwareX%26date%3D2015%26volume%3D1%25E2%2580%25932%26spage%3D19%26epage%3D25%26doi%3D10.1016%2Fj.softx.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponder, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Force Fields for Protein Simulations</span>. <i>Adv. Protein Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/S0065-3233(03)66002-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2FS0065-3233%2803%2966002-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=14631816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1yhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=27-85&author=J.+W.+Ponderauthor=D.+A.+Case&title=Force+Fields+for+Protein+Simulations&doi=10.1016%2FS0065-3233%2803%2966002-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Force fields for protein simulations</span></div><div class="casAuthors">Ponder, Jay W.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Protein Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">Protein Simulations</span>),
    <span class="NLM_cas:pages">27-85, 1 plate</span>CODEN:
                <span class="NLM_cas:coden">APCHA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-3233</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review on history, performance and development of force fields for protein simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraAF5aG_QoCrVg90H21EOLACvtfcHk0lg7SVR2QGHg0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1yhsQ%253D%253D&md5=8e6a69c961b621868dbcf4698b3c813a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0065-3233%2803%2966002-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3233%252803%252966002-X%26sid%3Dliteratum%253Aachs%26aulast%3DPonder%26aufirst%3DJ.%2BW.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DForce%2520Fields%2520for%2520Protein%2520Simulations%26jtitle%3DAdv.%2520Protein%2520Chem.%26date%3D2003%26volume%3D66%26spage%3D27%26epage%3D85%26doi%3D10.1016%2FS0065-3233%2803%2966002-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">A Five-Site Model for Liquid Water and the Reproduction of the Density Anomaly by Rigid, Nonpolarizable Potential Functions</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">8910</span>– <span class="NLM_lpage">8922</span>, <span class="refDoi"> DOI: 10.1063/1.481505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1063%2F1.481505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2000&pages=8910-8922&author=M.+W.+Mahoneyauthor=W.+L.+Jorgensen&title=A+Five-Site+Model+for+Liquid+Water+and+the+Reproduction+of+the+Density+Anomaly+by+Rigid%2C+Nonpolarizable+Potential+Functions&doi=10.1063%2F1.481505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions</span></div><div class="casAuthors">Mahoney, Michael W.; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8910-8922</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The ability of simple potential functions to reproduce accurately the d. of liq. water from -37 to 100 °C at 1 to 10 000 atm has been further explored.  The result is the five-site TIP5P model, which yields significantly improved results; the av. error in the d. over the 100° temp. range from -37.5 to 62.5 °C at 1 atm is only 0.006 g cm-3.  Classical Monte Carlo statistical mechanics calcns. have been performed to optimize the parameters, esp. the position of the neg. charges along the lone-pair directions.  Initial calcns. with 216 mols. in the NPT ensemble at 1 atm focused on finding a model that reproduced the shape of the liq. d. curve as a function of temp.  Calcns. performed for 512 mols. with the final TIP5P model demonstrate that the d. max. near 4 °C at 1 atm is reproduced, while high-quality structural and thermodn. results are maintained.  Attainment of high precision for the low-temp. runs required sampling for more than 1 billion Monte Carlo configurations.  In addn., the dielec. const. was computed from the response to an applied elec. field; the result is 81.5±1.5 at 25 °C and the exptl. curve is mirrored from 0-100 °C at 1 atm.  The TIP5P model is also found to perform well as a function of pressure; the d. of liq. water at 25 °C is reproduced with an av. error of ∼2% over the range from 1 to 10 000 atm, and the shift of the temp. of max. d. to lower temp. with increasing pressure is also obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreTL07agP8GbVg90H21EOLACvtfcHk0lg7SVR2QGHg0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFCltr0%253D&md5=368765bd00124153b0c65d95b81e951a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1063%2F1.481505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.481505%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DA%2520Five-Site%2520Model%2520for%2520Liquid%2520Water%2520and%2520the%2520Reproduction%2520of%2520the%2520Density%2520Anomaly%2520by%2520Rigid%252C%2520Nonpolarizable%2520Potential%2520Functions%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2000%26volume%3D112%26spage%3D8910%26epage%3D8922%26doi%3D10.1063%2F1.481505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parrinello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span> <span> </span><span class="NLM_article-title">Polymorphic Transitions in Single Crystals: A New Molecular Dynamics Method</span>. <i>J. Appl. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7182</span>– <span class="NLM_lpage">7190</span>, <span class="refDoi"> DOI: 10.1063/1.328693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1063%2F1.328693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADyaL38XislSnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1981&pages=7182-7190&author=M.+Parrinelloauthor=A.+Rahman&title=Polymorphic+Transitions+in+Single+Crystals%3A+A+New+Molecular+Dynamics+Method&doi=10.1063%2F1.328693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphic transitions in single crystals:  A new molecular dynamics method</span></div><div class="casAuthors">Parrinello, M.; Rahman, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Physics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7182-90</span>CODEN:
                <span class="NLM_cas:coden">JAPIAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8979</span>.
    </div><div class="casAbstract">A Lagrangian formulation is introduced; it can be used to make mol. dynamics (MD) calcns. on systems under the most general, externally applied, conditions of stress.  In this formulation the MD cell shape and size can change according to dynamic equations given by this Lagrangian.  This MD technique was used to the study of structural transitions of a Ni single crystal under uniform uniaxial compressive and tensile loads.  Some results regarding the stress-strain relation obtained by static calcns. are invalid at finite temp.  Under compressive loading, the model of Ni shows a bifurcation in its stress-strain relation; this bifurcation provides a link in configuration space between cubic and hexagonal close packing.  Such a transition could perhaps be obsd. exptl. under extreme conditions of shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2_UQSeiXXPbVg90H21EOLACvtfcHk0lgTMtMu4s_MYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XislSnuw%253D%253D&md5=a0a5617389f6cabbf2a405c649aadf03</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1063%2F1.328693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.328693%26sid%3Dliteratum%253Aachs%26aulast%3DParrinello%26aufirst%3DM.%26aulast%3DRahman%26aufirst%3DA.%26atitle%3DPolymorphic%2520Transitions%2520in%2520Single%2520Crystals%253A%2520A%2520New%2520Molecular%2520Dynamics%2520Method%26jtitle%3DJ.%2520Appl.%2520Phys.%26date%3D1981%26volume%3D52%26spage%3D7182%26epage%3D7190%26doi%3D10.1063%2F1.328693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynn, A.</span></span> <span> </span><span class="NLM_article-title">G_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1951</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1021/ci500020m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500020m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlWiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1951-1962&author=R.+Kumariauthor=R.+Kumarauthor=A.+Lynn&title=G_mmpbsa%E2%80%94A+GROMACS+Tool+for+High-Throughput+MM-PBSA+Calculations&doi=10.1021%2Fci500020m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations</span></div><div class="casAuthors">Kumari, Rashmi; Kumar, Rajendra; Lynn, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1951-1962</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics Poisson-Boltzmann surface area (MM-PBSA), a method to est. interaction free energies, has been increasingly used in the study of biomol. interactions.  Recently, this method has also been applied as a scoring function in computational drug design.  Here a new tool g_mmpbsa, which implements the MM-PBSA approach using subroutines written inhouse or sourced from the GROMACS and APBS packages is described. g_mmpbsa was developed as part of the Open Source Drug Discovery (OSDD) consortium.  Its aim is to integrate high-throughput mol. dynamics (MD) simulations with binding energy calcns.  The tool provides options to select alternative at. radii and different nonpolar solvation models including models based on the solvent accessible surface area (SASA), solvent accessible vol. (SAV), and a model which contains both repulsive (SASA-SAV) and attractive components (described using a Weeks-Chandler-Andersen like integral method).  We showcase the effectiveness of the tool by comparing the calcd. interaction energy of 37 structurally diverse HIV-1 protease inhibitor complexes with their exptl. binding free energies.  The effect of varying several combinations of input parameters such as at. radii, dielec. const., grid resoln., solute-solvent dielec. boundary definition, and nonpolar models was investigated. g_mmpbsa can also be used to est. the energy contribution per residue to the binding energy.  It has been used to identify those residues in HIV-1 protease that are most crit. for binding a range of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrckNA7gLtUGrVg90H21EOLACvtfcHk0lgTMtMu4s_MYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlWiu7o%253D&md5=e70a138b71eed07054d58f91ba1a227f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fci500020m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500020m%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DLynn%26aufirst%3DA.%26atitle%3DG_mmpbsa%25E2%2580%2594A%2520GROMACS%2520Tool%2520for%2520High-Throughput%2520MM-PBSA%2520Calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1951%26epage%3D1962%26doi%3D10.1021%2Fci500020m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sept, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span> <span> </span><span class="NLM_article-title">Electrostatics of Nanosystems: Application to Microtubules and the Ribosome</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10037</span>– <span class="NLM_lpage">10041</span>, <span class="refDoi"> DOI: 10.1073/pnas.181342398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1073%2Fpnas.181342398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=11517324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10037-10041&author=N.+A.+Bakerauthor=D.+Septauthor=S.+Josephauthor=M.+J.+Holstauthor=J.+A.+McCammon&title=Electrostatics+of+Nanosystems%3A+Application+to+Microtubules+and+the+Ribosome&doi=10.1073%2Fpnas.181342398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Electrostatics of nanosystems: application to microtubules and the ribosome</span></div><div class="casAuthors">Baker, Nathan A.; Sept, David; Joseph, Simpson; Holst, Michael J.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10037-10041</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Evaluation of the electrostatic properties of biomols. has become a std. practice in mol. biophysics.  Foremost among the models used to elucidate the electrostatic potential is the Poisson-Boltzmann equation; however, existing methods for solving this equation have limited the scope of accurate electrostatic calcns. to relatively small biomol. systems.  Here we present the application of numerical methods to enable the trivially parallel soln. of the Poisson-Boltzmann equation for supramol. structures that are orders of magnitude larger in size.  As a demonstration of this methodol., electrostatic potentials have been calcd. for large microtubule and ribosome structures.  The results point to the likely role of electrostatics in a variety of activities of these structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA_CAlhE0uX7Vg90H21EOLACvtfcHk0lgTMtMu4s_MYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D&md5=1b861999ef12c6972e82e8ada0f387cb</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.181342398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.181342398%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BA.%26aulast%3DSept%26aufirst%3DD.%26aulast%3DJoseph%26aufirst%3DS.%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DElectrostatics%2520of%2520Nanosystems%253A%2520Application%2520to%2520Microtubules%2520and%2520the%2520Ribosome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2001%26volume%3D98%26spage%3D10037%26epage%3D10041%26doi%3D10.1073%2Fpnas.181342398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsyte-lovejoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rival-gervier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labrie, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigle, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMaggio, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasney, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siarheyeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattenden, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kireev, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petronis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">A Chemical Probe Selectively Inhibits G9a and GLP Methyltransferase and Genanylgeranyltransferase I with Antitumor Activity against Brest Cancer in Vivo</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1038/nchembio.599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1038%2Fnchembio.599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=21743462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=566-574&author=M.+Vedadiauthor=D.+Barsyte-lovejoyauthor=F.+Liuauthor=S.+Rival-gervierauthor=A.+Allali-hassaniauthor=V.+Labrieauthor=T.+J.+Wigleauthor=P.+A.+DiMaggioauthor=G.+A.+Wasneyauthor=A.+Siarheyevaauthor=A.+Dongauthor=W.+Tempelauthor=S.-C.+Wangauthor=X.+Chenauthor=I.+Chauauthor=T.+J.+Manganoauthor=X.-p.+Huangauthor=C.+D.+Simpsonauthor=S.+G.+Pattendenauthor=J.+L.+Norrisauthor=D.+B.+Kireevauthor=A.+Tripathyauthor=B.+L.+Rothauthor=W.+P.+Janzenauthor=B.+A.+Garciaauthor=A.+Petronisauthor=J.+Ellisauthor=P.+J.+Brownauthor=S.+V.+Fryeauthor=C.+H.+Arrowsmithauthor=J.+Jin&title=A+Chemical+Probe+Selectively+Inhibits+G9a+and+GLP+Methyltransferase+and+Genanylgeranyltransferase+I+with+Antitumor+Activity+against+Brest+Cancer+in+Vivo&doi=10.1038%2Fnchembio.599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells</span></div><div class="casAuthors">Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Liu, Feng; Rival-Gervier, Sylvie; Allali-Hassani, Abdellah; Labrie, Viviane; Wigle, Tim J.; DiMaggio, Peter A.; Wasney, Gregory A.; Siarheyeva, Alena; Dong, Aiping; Tempel, Wolfram; Wang, Sun-Chong; Chen, Xin; Chau, Irene; Mangano, Thomas J.; Huang, Xi-ping; Simpson, Catherine D.; Pattenden, Samantha G.; Norris, Jacqueline L.; Kireev, Dmitri B.; Tripathy, Ashutosh; Edwards, Aled; Roth, Bryan L.; Janzen, William P.; Garcia, Benjamin A.; Petronis, Arturas; Ellis, James; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">566-574</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein lysine methyltransferases G9a and GLP modulate the transcriptional repression of a variety of genes via dimethylation of Lys9 on histone H3 (H3K9me2) as well as dimethylation of non-histone targets.  Here we report the discovery of UNC0638, an inhibitor of G9a and GLP with excellent potency and selectivity over a wide range of epigenetic and non-epigenetic targets.  UNC0638 treatment of a variety of cell lines resulted in lower global H3K9me2 levels, equiv. to levels obsd. for small hairpin RNA knockdown of G9a and GLP with the functional potency of UNC0638 being well sepd. from its toxicity.  UNC0638 markedly reduced the clonogenicity of MCF7 cells, reduced the abundance of H3K9me2 marks at promoters of known G9a-regulated endogenous genes and disproportionately affected several genomic loci encoding microRNAs.  In mouse embryonic stem cells, UNC0638 reactivated G9a-silenced genes and a retroviral reporter gene in a concn.-dependent manner without promoting differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphv-2bZcBqwLVg90H21EOLACvtfcHk0lgTMtMu4s_MYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OmtLs%253D&md5=a944e99a910194c1a15240fc6dc8f852</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.599%26sid%3Dliteratum%253Aachs%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DBarsyte-lovejoy%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRival-gervier%26aufirst%3DS.%26aulast%3DAllali-hassani%26aufirst%3DA.%26aulast%3DLabrie%26aufirst%3DV.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DDiMaggio%26aufirst%3DP.%2BA.%26aulast%3DWasney%26aufirst%3DG.%2BA.%26aulast%3DSiarheyeva%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.-C.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DMangano%26aufirst%3DT.%2BJ.%26aulast%3DHuang%26aufirst%3DX.-p.%26aulast%3DSimpson%26aufirst%3DC.%2BD.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DNorris%26aufirst%3DJ.%2BL.%26aulast%3DKireev%26aufirst%3DD.%2BB.%26aulast%3DTripathy%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DPetronis%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DA%2520Chemical%2520Probe%2520Selectively%2520Inhibits%2520G9a%2520and%2520GLP%2520Methyltransferase%2520and%2520Genanylgeranyltransferase%2520I%2520with%2520Antitumor%2520Activity%2520against%2520Brest%2520Cancer%2520in%2520Vivo%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D566%26epage%3D574%26doi%3D10.1038%2Fnchembio.599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerty, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watowich, S. J.</span></span> <span> </span><span class="NLM_article-title">Selective and Membrane-Permeable Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Reverse High Fat Diet-Induced Obesity in Mice</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.1016%2Fj.bcp.2017.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=29155147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVegu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2018&pages=141-152&author=H.+Neelakantanauthor=V.+Vanceauthor=M.+D.+Wetzelauthor=H.-Y.+L.+Wangauthor=S.+F.+McHardyauthor=C.+C.+Finnertyauthor=J.+D.+Hommelauthor=S.+J.+Watowich&title=Selective+and+Membrane-Permeable+Small+Molecule+Inhibitors+of+Nicotinamide+N-Methyltransferase+Reverse+High+Fat+Diet-Induced+Obesity+in+Mice&doi=10.1016%2Fj.bcp.2017.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice</span></div><div class="casAuthors">Neelakantan, Harshini; Vance, Virginia; Wetzel, Michael D.; Wang, Hua-Yu Leo; McHardy, Stanton F.; Finnerty, Celeste C.; Hommel, Jonathan D.; Watowich, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-152</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is a crit. need for new mechanism-of-action drugs that reduce the burden of obesity and assocd. chronic metabolic comorbidities.  A potentially novel target to treat obesity and type 2 diabetes is nicotinamide-N-methyltransferase (NNMT), a cytosolic enzyme with newly identified roles in cellular metab. and energy homeostasis.  To validate NNMT as an anti-obesity drug target, the authors investigated the permeability, selectivity, mechanistic, and physiol. properties of a series of small mol. NNMT inhibitors.  Membrane permeability of NNMT inhibitors was characterized using parallel artificial membrane permeability and Caco-2 cell assays.  Selectivity was tested against structurally-related methyltransferases and NAD (NAD+) salvage pathway enzymes.  Effects of NNMT inhibitors on lipogenesis and intracellular levels of metabolites, including NNMT reaction product 1-methylnicotianamide (1-MNA) were evaluated in cultured adipocytes.  Effects of a potent NNMT inhibitor on obesity measures and plasma lipid were assessed in diet-induced obese mice fed a high-fat diet.  Methylquinolinium scaffolds with primary amine substitutions displayed high permeability from passive and active transport across membranes.  Importantly, methylquinolinium analogs displayed high selectivity, not inhibiting related SAM-dependent methyltransferases or enzymes in the NAD+ salvage pathway.  NNMT inhibitors reduced intracellular 1-MNA, increased intracellular NAD+ and S-(5'-adenosyl)-L-methionine (SAM), and suppressed lipogenesis in adipocytes.  Treatment of diet-induced obese mice systemically with a potent NNMT inhibitor significantly reduced body wt. and white adipose mass, decreased adipocyte size, and lowered plasma total cholesterol levels.  Notably, administration of NNMT inhibitors did not impact total food intake nor produce any observable adverse effects.  These results support development of small mol. NNMT inhibitors as therapeutics to reverse diet-induced obesity and validate NNMT as a viable target to treat obesity and related metabolic conditions.  Increased flux of key cellular energy regulators, including NAD+ and SAM, may potentially define the therapeutic mechanism-of-action of NNMT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0K0OY6S9HhbVg90H21EOLACvtfcHk0lhHiSQSEWPOTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVegu7vL&md5=4a798e5f69cf9989b8d7a9d0584f872d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DH.%26aulast%3DVance%26aufirst%3DV.%26aulast%3DWetzel%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DH.-Y.%2BL.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DFinnerty%26aufirst%3DC.%2BC.%26aulast%3DHommel%26aufirst%3DJ.%2BD.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26atitle%3DSelective%2520and%2520Membrane-Permeable%2520Small%2520Molecule%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520Reverse%2520High%2520Fat%2520Diet-Induced%2520Obesity%2520in%2520Mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D147%26spage%3D141%26epage%3D152%26doi%3D10.1016%2Fj.bcp.2017.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Policarpo, R.</span>; <span class="NLM_string-name">Decultot, L.</span>; <span class="NLM_string-name">May, E.</span>; <span class="NLM_string-name">Kuzmic, P.</span>; <span class="NLM_string-name">Carlson, S.</span>; <span class="NLM_string-name">Huang, D.</span>; <span class="NLM_string-name">Chu, V.</span>; <span class="NLM_string-name">Wright, B.</span>; <span class="NLM_string-name">Dhakshinamoorthy, S.</span>; <span class="NLM_string-name">Kannt, A.</span>; <span class="NLM_string-name">Rani, S.</span>; <span class="NLM_string-name">Dittakavi, S.</span>; <span class="NLM_string-name">Gaudet, R.</span>; <span class="NLM_string-name">Shair, M.</span></span> <span> </span><span class="NLM_article-title">High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)</span>. <span class="NLM_year">2019</span>, chemrxiv.org e-Print archive. <a href="https://chemrxiv.org/articles/High-Affinity_Alkynyl_Bisubstrate_Inhibitors_of_Nicotinamide_N-Methyltransferase_NNMT_/8010302/1" class="extLink">https://chemrxiv.org/articles/High-Affinity_Alkynyl_Bisubstrate_Inhibitors_of_Nicotinamide_N-Methyltransferase_NNMT_/8010302/1</a> <span class="refDoi"> DOI: 10.26434/chemrxiv.8010302.v1</span>  (accessed May 28, 2019).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;key=10.26434%2Fchemrxiv.8010302.v1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=R.+Policarpo&author=L.+Decultot&author=E.+May&author=P.+Kuzmic&author=S.+Carlson&author=D.+Huang&author=V.+Chu&author=B.+Wright&author=S.+Dhakshinamoorthy&author=A.+Kannt&author=S.+Rani&author=S.+Dittakavi&author=R.+Gaudet&author=M.+Shair&title=High-Affinity+Alkynyl+Bisubstrate+Inhibitors+of+Nicotinamide+N-Methyltransferase+%28NNMT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.26434%2Fchemrxiv.8010302.v1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.26434%252Fchemrxiv.8010302.v1%26sid%3Dliteratum%253Aachs%26aulast%3DPolicarpo%26aufirst%3DR.%26atitle%3DHigh-Affinity%2520Alkynyl%2520Bisubstrate%2520Inhibitors%2520of%2520Nicotinamide%2520N-Methyltransferase%2520%2528NNMT%2529%26date%3D2019%26doi%3D10.26434%2Fchemrxiv.8010302.v1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CHH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CHH','PDB','6CHH'); return false;">PDB: 6CHH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ROD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ROD','PDB','3ROD'); return false;">PDB: 3ROD</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00413">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21135"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00413">10.1021/acs.jmedchem.9b00413</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Analytical data for all new compounds including <sup>1</sup>H and <sup>13</sup>C NMR spectra; supporting figures for enzyme inhibition curves, molecular modeling results, and cellular MNA determination; supporting tables for selectivity assays and estimated binding energies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_001.pdf">jm9b00413_si_001.pdf (7.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00413/suppl_file/jm9b00413_si_002.csv">jm9b00413_si_002.csv (2.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00413&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00413%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-14%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00413" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a1c99295b3d82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
